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Abstract 
Microbial organisms have a diverse array of mechanisms to obtain phenotypic variation. 
Phenotypic variation not only enhances population fitness and competitiveness for a specific 
niche but it is also critical for the survival of a population to unexpected environmental changes. 
Further, in pathogenic organisms, phenotypic variation is directly associated with virulence. 
Therefore, besides of the contribution to our understanding of microbial evolution, dissecting the 
mechanisms that lead to phenotypic variation in pathogenic organisms is very clinically relevant. 
Candida albicans is the most successful opportunistic fungi that infect humans. C. 
albicans is an obligate diploid yeast with an almost exclusive clonal form of reproduction. In the 
absence of meiosis to introduce variation in the population, C. albicans needs alternative 
mechanisms to achieve variability, such as the colony morphology phenotypic switching 
(CMPS). CMPS is the formation of colonies that have an altered, heritable, and low frequency 
reversible morphology. CMPS is associated with pathogenesis in C. albicans: variant colony 
morphologies have been isolated during infections in humans and show an altered expression of 
diverse virulence factors, including the secretion of hydrolytic enzymes and resistance to 
antifungal drugs. Despite the potential role of CMPS in the pathogenesis of C. albicans, little is 
known about the mechanisms that regulate this phenomenon. In our lab, we serendipitously 
identified a negative regulator of CMPS in C. albicans: the Kelch protein Mds3. Mds3 had been 
previously associated with other morphogenetic processes in fungi, but the biological role of 
Mds3 in the cell was unknown. Therefore, my goals in this dissertation were to understand the 
function of Mds3 in the cell and to use this knowledge to gain insights into C. albicans CMPS 
mechanisms and regulation. Through a combination of bioinformatic, biochemical, and genetic 
analyses we found that Mds3 appears to be a large Kelch/BTB cytoplasmic scaffold protein that 
functions as a regulator of two major signaling cascades, the TOR and Ras pathways (Chapters 2, 
3, and 5). With this information, I was able to identify more CMPS regulators that belong to these 
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pathways and environmental signals that regulate CMPS and which are all strongly associated 
with signaling through these pathways (Chapters 4 and 5). Analyses of morphologically switched 
mds3Δ/Δ strains indicated that the phenotypic switch is accompanied by an increase in the 
sensitivity to the TOR inhibitor rapamycin, which suggests an increased dependence on TOR 
function in the switched strains. Further, the phenotypic switch was also accompanied by 
increased sensitivity to genotoxic agents and sometimes also by karyotypic rearrangements and 
aneuploidies (Chapter 4). Increased DNA damage and genomic instability are mechanisms 
associated with phenotypic variation in several highly diverse organisms, and could also be 
mechanisms leading to the phenotypic switch in C. albicans (Chapter 4). Taken together, I 
propose a model for CMPS in C. albicans in which defects in the signaling through the TOR and 
Ras signal transduction pathways as cells become nutrient limited and stressed lead to the 
accumulation of genetic and epigenetic alterations that eventually cause the phenotypic switch. 
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CHAPTER 1 
 
 
INTRODUCTION 
 2 
Candida albicans, the pathogen 
 
Candida albicans is a commensal of the skin and mucosas of most individuals and is also 
one of the most important fungal pathogens of humans (Calderone, 2002). Immunosupression in 
the host or prolonged broad spectrum antibiotic treatment are risk factors for C. albicans 
infections (Samonis and Bafaloukos, 1992; Gullo, 2009; Hauman et al., 1993). The growing 
population of immunocompromised patients due to medical advances such as chemotherapy and 
organ transplantation, and the steady increase in the AIDS population has led to an increase in the 
incidence of opportunistic C. albicans infections during the last decades (Pfaller et al., 1999; 
Hazen, 1995). C. albicans can also cause infections in otherwise healthy individuals. For 
example, C. albicans is one of the major causes of single or recurrent infections in the female 
genital tract (Sobel, 1992). Most C. albicans infections are superficial and treatable with 
antifungal therapy. However, C. albicans is also the fourth leading cause of nosocomial 
bloodstream infections, which are associated with more than 40% mortality rate despite 
antifungal treatment (Pfaller et al., 2001). Thus, C. albicans is responsible for a diverse array of 
superficial and systemic infections in humans that are associated with a high morbidity and 
mortality. 
 
 Virulence traits of C. albicans 
 Given the relevance of C. albicans as a pathogen, the most well studied characteristics of 
this organism are its virulence traits. C. albicans virulence attributes include the secretion of 
hydrolytic enzymes, adhesion to human cells, antifungal drug resistance, morphogenetic 
transitions, and phenotypic variation. 
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Hydrolytic enzymes 
C. albicans secretes three different types of enzymes: secreted aspartic proteinases 
(SAPs), lipases, and phospholipases. The SAPs are a family of ten secreted aspartic proteinases, 
eight of them are secreted to the extracellular space and two of them are GPI-linked to the cell 
wall (Monod et al., 1994; Naglick et al., 2003). Mutations in selected SAP genes and inactivation 
of proteinase activity through the use of pepstatin A or anti-SAP antibodies led to reduced 
virulence in diverse models of infection, indicating the SAPs are important for C. albicans 
pathogenesis (Schaller et al., 2005). Further, the different SAP genes are transcribed under 
diverse environmental conditions in vitro and at different location or stages of infection in murine 
models and in the human host (Monod et al., 1998; Naglick et al., 1999; Cassone et al., 1987). 
The actual target of the SAPs in the host remains elusive, although SAPs have been proposed to 
act on host extracellular matrix and immune system components (Gropp et al., 2009; Schaller et 
al., 2005). Thus, there is a clear role for secreted aspartic proteinases in C. albicans pathogenesis.  
C. albicans also secrete phospholipases and lipases into the extracellular space. 
Phospholipases hydrolyze ester linkages in glycerophospholipids, while lipases (and esterases) 
hydrolyze ester bonds of triacylglycerols. Two genes encode extracellular phospholipases: PLB1 
and PLB2. Phospholipases are synthesized in vivo during infection in the human host, and their 
role in pathogenesis has been associated with tissue penetration, adhesion to epithelial cells, and 
interaction with host signal transduction pathways (Pugh and Cawson, 1977; Leidich et al., 1998; 
Filler et al., 1991). Lipases are encoded by a lipase isoenzyme family, composed of ten LIP genes 
(Hube et al., 2000). Different LIP genes have been found to be induced under different growth 
conditions in vitro, and during infection in murine models of infection and in the human host, 
suggesting that they fulfill a role in pathogenesis (Tsuboi et al., 1996; Stehr et al., 2004; Schaller 
et al., 2005). However, the role of lipases in C. albicans virulence remains unclear.  
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Thus, C. albicans genome encodes a diverse array of extracellular hydrolytic enzymes 
which are mainly associated with tissue invasion and colonization. Expression of the genes 
encoding different hydrolytic enzymes is regulated according to the location and stage of the 
infection, suggesting a role in pathogenesis. Importantly, inhibition of SAPs activity can prevent 
tissue invasion in animal models and disease progression in AIDS patients. Further, 
phospholipases are also required for infection (Cauda et al., 1999; Hoegl et al., 1988; Leidich et 
al., 1998). Therefore, a better understanding of the function of C. albicans hydrolytic enzymes 
might provide targets for combinatory antifungal therapy.  
 
Adhesion to epithelial cells 
In order to colonize and invade tissue, C. albicans needs to adhere to the surface of the 
cells. C. albicans genome contains multiple adhesins, including Als proteins, Hwp1, Eap1, and 
Csh1 (Sundstrom, 2002; Hoyer et al., 2008). Similar to the hydrolytic enzyme families, the 
different genes in the adhesin families are expressed under different conditions and 
morphogenetic states (Cheng et al., 2005; Green et al., 2004, 2006; Argimon et al., 2007). The 
different adhesins also play different roles in C. albicans virulence. For example, Als proteins 
bind to diverse host substrates, including the surface of endothelial or epithelial cells, collagen, 
fibronectin, and laminin; Als5 can mediate self-binding, and Als3 also mediates invasion to 
endothelial cells by inducing host cell phagocytosis (Zhu and Filler, 2010; Phan et al., 2007; 
Hoyer et al., 2008). Several Als proteins are required for biofilm formation, and Hwp1, a hyphae-
specific adhesin, is required for biofilm formation and mating (Ene and Bennett, 2009; Nobile et 
al., 2008). Adherence is a key step in fungal pathogenesis. Since adhesins are expressed on the 
cell surface they constitute potential antifungal targets, underscoring the relevance of identifying 
them and understanding their function. In this regard, a vaccine against Als3 has been developed 
and is currently under clinical trials (Lin et al., 2009). 
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Antifungal drug resistance 
Most antifungal drugs available for therapy target components of the fungal cell 
envelope, including the synthesis of ergosterol and β1,3 glucans, and also ergosterol itself (Odds 
et al., 2003). Examples of these antifungals include azoles, polyenes, echinocandins, 
morphollines, and allylamines. Other targets for antifungal drugs include DNA and RNA 
synthesis (flucytosine), microtubule assembly (griseofulvin), and protein synthesis (sordarins) 
(Odds et al., 2003). C. albicans is not naturally resistant to any of these antifungal drugs, but it 
shows a remarkable ability to generate resistance during infection and in vitro (Cannon, et al., 
2007; Cowen, 2008; White et al., 1998, 2002; White, 1997; Anderson, 2005; Selmecki et al., 
2006, 2009; Kurtz et al., 1996). 
The best studied mechanisms of antifungal drug resistance are against azoles, a family of 
drugs that target specific enzymes in the ergosterol biosynthetic pathway. Ergosterol is a lipid 
critical to ensure fluidity of the plasma membrane. Azoles prevent the formation of ergosterol, 
which is replaced by a toxic sterol as a consequence of the defective metabolism (Cowen, 2008). 
Antifungal resistance in C. albicans is mediated by several mechanisms involving transcriptional 
changes, point mutation, and genomic rearrangements that lead to the amplification of drug efflux 
pumps or alterations in drug targets (White et al., 1998; Cowen, 2008). For example, C. albicans 
can acquire azole resistance by upregulating the expression of drug transporters (CDR1, CDR2, 
and MDR1), by altering the target enzyme (ERG11) through point mutations followed by gene 
conversion mechanisms that amplify the more resistant ERG11 allele, or by upregulation of 
ERG11 transcription; and by altering the ergosterol biosynthetic pathway to reduce or eliminate 
the production of toxic sterols (MacPherson et al., 2005; Coste et al., 2004; Dunkel et al., 2008; 
Selmecki et al., 2006, 2008, 2009). Finally, C. albicans can also enhance antifungal drug 
resistance by forming biofilms (Sanglard et al., 2009; d‟Enfert, 2006). Therefore, C. albicans has 
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many diverse mechanisms to acquire resistance to antifungal drugs, which makes this feature an 
important concern for clinicians and a critical area of research. 
 
Morphogenetic transitions 
C. albicans can transition between different morphogenetic states, including the yeast-
pseudohyphal-hyphal transition (Y-PH-H), and chlamydospore formation (Staib and 
Morschhauser, 2007; Biswas et al., 2007). The ability of C. albicans to switch between the yeast 
and hyphal morphologies is a critical virulence trait (Mitchell, 1998). Mutants locked in either 
morphology show reduced virulence in animal models of infections (Lo et al., 1997; Murad et al., 
2001; Bastidas and Heitman, 2009; Saville et al., 2003, 2008; Carlisle et al., 2009). Further, the 
different morphologies are required for biofilm formation, trigger different immune responses in 
the host, and have different abilities to adhere to cells, to secrete hydrolytic enzymes, to invade 
tissues, and to disseminate in the host (Baillie and Douglas, 1999; Richard et al., 2005; Hawser 
and Douglas, 1995; Acosta-Rodriguez et al., 2007; Romani et al., 2003, 2004; Mitchell et al., 
1998; Gow et al., 2002). Therefore, Y-PH-H morphogenetic transitions in C. albicans have 
pleiotropic effects on this fungus pathogenesis. 
The Y-PH-H transition in C. albicans requires the induction of complex morphogenetic 
programs that respond to different environmental cues and that are regulated by several 
(sometimes overlapping) signaling pathways. For example, hyphal formation in C. albicans can 
be triggered by alkaline pH, body temperature, serum, high CO2 pressure, N-acetyl-glucosamine, 
the embedment in a matrix, and starvation (Biswas et al., 2007). Several signal transduction 
pathways are required for the proper response to the different environmental signals, including 
the Rim101, cAMP/PKA, MAPK, and TOR pathways (Biswas et al., 2007; Davis, 2009; Monge 
et al., 2006; Cutler et al., 2001; Bastidas et al., 2009; Zacchi et al., 2010a). Y-PH-H in C. albicans 
is regulated by many signals and signal transduction pathways and is critical for pathogenesis. 
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C. albicans can also form chlamydospores. Chlamydospores are spherical cells with a 
thick wall that form at hyphal tips during growth in poor nutrient media. Chlamydospores can be 
found during C. albicans infections. However, the role of chlamydospores on C. albicans 
virulence is unclear (Staib and Morschhauser, 2007). Only a handful of genes have been 
identified as regulators of chlamydospore formation, including SCH9 and MDS3, two genes that 
we will discuss later (Nobile et al., 2003; Bambach et al., 2009; Eisman et al., 2006; Staib and 
Morsschauser, 2005). Thus, chlamydospore formation is an intriguing and rather unexplored type 
of morphogenetic transition in C. albicans. 
 
Phenotypic switching 
Although C. albicans is able to mate at a low frequency, it does not appear to undergo 
meiosis, a major mechanism to introduce variation in a population (Forche et al., 2009; Soll, 
2009). Since phenotypic variation is critical for the survival of any organism in a changing 
environment, C. albicans requires of alternative mechanisms to achieve variation. High-
frequency phenotypic switching has been suggested to account for some of the variation observed 
in this fungus and is thus an important virulence trait (Soll, 1992). C. albicans undergoes two 
types of phenotypic switching: white-opaque switching and colony morphology phenotypic 
switching. 
White-opaque switching (W-O) is the bi-stable switch between a white, hemispherical 
colony formed by round cells and a grey, flat colony formed by more elongated cells with 
pimples in their cell wall (Slutsky et al., 1987; Anderson et al., 1990). Opaque cells are the 
mating competent type, and the transition from white to opaque phase is required for mating in C. 
albicans (Miller et al., 2002). Pheromone signaling from opaque cells to white cells can trigger 
white cells biofilm formation, a phenomenon that has been proposed to help the mating process 
(Daniels et al., 2006; Soll, 2009). The white and opaque cells differ in their expression of several 
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virulence attributes, including antigenicity, adhesion to cells, Y-PH-H transitions, sensitivity to 
neutrophils, secretion of hydrolytic enzymes, antifungal drug susceptibility, and the ability to 
avoid macrophage phagocytosis or develop infections in different pathogenesis models (Lohse 
and Johnson, 2008; Anderson et al., 1989, 1990; Kennedy et al., 1988; Kolotila and Diamond, 
1990; Morrow et al., 1992; Vargas et al., 2000; Kvaal et al., 1997, 1999). Thus, the W-O 
switching in C. albicans is involved in mating and leads to marked differences in pathogenesis. 
The second type of phenotypic switching in C. albicans is colony morphology 
phenotypic switching (CMPS). CMPS, also known as the 3153A-type switching because it was 
re-discovered in this common laboratory C. albicans strain, refers to the generation of variant 
colony morphologies at a frequency of ~10
-4
 (Figure 1.1; Slutsky et al., 1985; Negroni, 1935). 
Variant colony phenotypes include, but are not limited to, star (Figure 1.1B), ring (Figure 1.1C), 
and irregular wrinkle (Figure 1.1D), while the normal colony morphology of C. albicans is 
smooth (Figure 1.1A). Several characteristics define CMPS. First, the switch only occurs in a 
small fraction of the population. Second, the colony morphology phenotypic switch is heritable. 
Third, the switch is only partially stable, and switched strains continue to give rise to colonies 
with a different morphology at a low frequency, including the possibility of reverting to the wild-
type colony morphology. CMPS is associated with pathogenesis in C. albicans. Morphologically 
switched colonies that are genetically similar have been found in infected patients (Hellstein et 
al., 2993; Jones et al., 1994; Vargas et al., 2000; Soll et al., 1987, 1988, 1989). Further, 
phenotypic switching affects the expression of several virulence traits in C. albicans, including 
antifungal drug resistance, morphogenesis, secretion of hydrolytic enzymes, adhesion to cells, 
and virulence in murine models of infection (Gallagher et al., 1992; Vargas et al., 1994, 2004; 
Dutton and Penn, 1989). Thus, CMPS is a mechanism to achieve phenotypic variation in C. 
albicans, especially important due to its effects on the expression of virulence attributes in C. 
albicans. 
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Figure 1.1: Example of colony morphology variations in the C. albicans strain 3513A 
(from Slutsky et al., 1985). A) Smooth, B) Star, C) Ring, D) Irregular-wrinkle. 
 
Given the important role in pathogenesis of phenotypic switching, much effort has been 
devoted to understand their mechanisms of regulation. The great majority of the studies have 
focused on W-O switching, probably to its simpler bi-phasic characteristic. The W-O switch is 
regulated epigenetically by histone modifying enzymes and by feedback regulatory loops that 
involve several transcription factors, including Wor1, Efg1, Czf1, and Wor2 (Huang et al., 2006; 
Zordan et al., 2006, 2007; Srikantha et al., 2001; Hnisz et al., 2009; Klar et al., 2001). Further, 
several environmental signals also affect W-O switching, including temperature, CO2 
concentration, N-acetyl-glucosamine, and oxidative stress (Kolotila and Diamond, 1990; 
Ramirez-Zavala et al., 2008; Huang et al., 2010; Rikkerink et al., 1988; Lohse and Johnson, 2009; 
Alby and Bennett, 2009). 
Unlike the W-O switch, very little is known about the environmental signals, 
mechanisms, and genetic factors that regulate CMPS in C. albicans. The only environmental 
signals known to contribute to CMPS are growth on low-zinc, amino acid rich medium and 
exposure to low doses of UV radiation (Slutsky et al., 1985; Pomes et al., 1985; Soll, 1992; 
Bedell and Soll; 1979). It is also known that CMPS is sometimes accompanied by karyotypic 
alterations. However, repeated efforts to determine a correlation between particular karyotypes 
and phenotypes have failed, suggesting that the karyotypic rearrangements are not the cause of 
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CMPS (Rutschenko et al., 1993, 1994; Rustchenko-Bulgac and Howard, 1993; Rustchenko, 
2007; Ramsey et al., 1994; Barton and Scherer, 1994). Finally, two negative regulators of CMPS 
are known: Ssn6 and Mds3 (Garcia-Sanchez et al., 2005; Chapter 4). Ssn6 is a protein directly 
involved in transcription: it forms a co-repressor complex with Tup1. Ssn6 also regulates Y-PH-H 
morphogenetic transitions in C. albicans (Hwang et al., 2003). Deletion of SSN6 leads to the 
formation of colonies with variant, unstable morphology, which include alterations in colony size 
and colony surface wrinklyness, and that are reminiscent of CMPS. Importantly, expression of 
SSN6 in variant ssn6
-
 colonies immediately restores wild-type colony morphology. The 
mechanism through which SSN6 regulates CMPS is unclear, but it is likely through its direct 
effects on gene transcription (Garcia-Sanchez et al., 2005; Hwang et al., 2003). The second 
regulator of CMPS, Mds3, is a poorly characterized fungal-specific protein, and the focus of this 
dissertation (see below). Thus, although CMPS appears to be important for C. albicans 
pathogenesis and as a mechanism to generate variability in this fungus, there is very little known 
about the mechanisms and signals that govern CMPS.  
 
Microbial phenotypic variation 
CMPS belongs to a larger class of phenomena that generate phenotypic variation. Here, I 
summarize the current knowledge on microbial phenotypic variation mechanisms, focusing 
mostly on human pathogenic fungi, but also on bacteria and protozoa. 
 
Phenotypic switching in fungi 
Besides C. albicans, phenotypic switching has been described in several fungal species, 
including C. glabrata, C. lusitaniae, C. tropicalis, Trichosporon assahii, Pneumocystis spp., 
Histoplasma capsulatum, Paracoccidioides brasilensis, Cryptococcus neoformans, and C. gattii 
(Slutsky et al., 1985, 1987; Ichikawa et al., 2004; Goldman et al., 1998; Jain et al., 2006; 
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Srikantha et al., 2008; Jain et al., 2009; Macoris et al., 2006; Ichikawa et al., 2004; Stringer et al., 
2007; Soll et al., 1988; Keely et al., 2003; Eisssenberg et al., 1996). In all cases, phenotypic 
switching leads to alterations in the colony morphology which may be associated with differences 
in virulence trait expression.  
C. glabrata, the second most prevalent Candida species in human infections, presents 
two types of switching: core switching, in which colonies with different brown coloration appear 
on agar supplemented with CuSO4; and irregular wrinkly switching (Lachke et al., 2000, 2002). 
C. glabrata core phenotypic switching occurs in vivo (Brockert et al., 2003). Further, most 
clinical C. glabrata isolates can switch between colony colors, although one type of color is 
predominant in natural isolates and it is also associated with increased virulence in murine models 
of infection. It is unclear what makes one colony type more virulent than the others (Srikantha et 
al., 2005). Thus, C. glabrata also undergoes phenotypic switching, and this switching appears to 
play a role in pathogenesis. 
C. lusitaniae is an emergent pathogenic yeast of medical concern due to its ability to 
readily acquire resistance in vivo to the antifungal drug amphotericin B. Similar to C. glabrata, C. 
lusitaniae also undergoes core switching (Sterling and Merz, 1998; Blinkhorn et al., 1989; Miller 
et al., 2006). Core switching has been associated with the acquisition of resistance to 
amphotericin B (Yoon et al., 1999). Thus, core switching might be a common type of switching 
in certain pathogenic Candida species, which is of particular relevance given its strong 
association with virulence. 
H. capsulatum is an intracellular fungal pathogen which causes primarily respiratory 
infections that can subsequently become systemic (Wheat et al., 2006). When plated on agar 
surfaces, this fungus gives rise to colony phenotypic variants. Cells from these colony variants 
adopt unusual morphologies inside macrophages. One of these H. capsulatum colony variants 
lacks α-1,3-glucan, a major cell wall constituent and critical for virulence, which explains why 
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these variant cells have reduced macrophage toxicity (Klimpel and Goldman, 1987, 1988; 
Eissenberg et al., 1996; Holbrook and Rappleye, 2008). It has been suggested that one role of 
phenotypic variation in H. capsulatum is to enhance persistence in the host (Eissenberg et al., 
1996). Therefore, in H. capsulatum, colony phenotypic variation is also associated with 
pathogenesis. 
Perhaps the fungal phenotypic switching phenomenon that has been most studied (from 
the pathogenesis perspective) is that of Cryptococcus. Cryptococcus is one of the main causes of 
chronic respiratory diseases and meningitis in immunocompromised individuals. Phenotypic 
variation in Cryptococcus occurs in vivo, and the variants display altered virulence in vivo and 
differential expression of virulence traits in vitro (Goldman et al., 1998; Fries et al., 1999, 2005; 
Franzot et al., 1998; Guerrero et al., 2006, 2010). The colony variants include smooth, mucoid, 
wrinkled, serrated, and pseudohyphal morphologies (Jain et al., 2008). Phenotypic switching in 
Cryptococcus has been proposed to be a mechanism of microevolution, which generates fungal 
variants during acute and chronic infections that allow the persistence of infection (Guerrero et 
al., 2006). The mechanisms leading to the switch in Cryptococcus remain poorly understood. 
Karyotypic instability has been observed in certain switched Cryptococcus strains, but it has not 
been possible to correlate karyotypic alterations with particular phenotypes (Fries et al., 1999). 
Cryptococcus generates phenotypic variants in vivo, which appear to have an important role in 
determining the outcome of the infection.  
To sum up, phenotypic switching of colony morphologies is common in diverse fungal 
pathogens and in many cases a direct role for the phenotypic switch in pathogenesis has been 
demonstrated. Despite extensive research in many different fungi, the underlying mechanisms of 
CMPS are unknown. Importantly, CMPS is not an effect of in vitro culture of laboratory strains. 
CMPS happens in vivo during commensalism and during infection. CMPS has been proposed to 
be a mechanism to generate variation and of microevolution in fungal pathogens. It may be 
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interesting to understand what mechanisms regulate CMPS in the different fungi, not only from 
an evolutionary perspective, but also because of their relevant role in fungal pathogenesis. 
 
Phenotypic variation in bacteria and protozoa 
Bacteria and protozoan parasites have also developed strategies to alter their phenotypes 
and antigenic composition of their cellular surface. Phenotypic variation in bacteria is important 
to generate phenotypic diversity and for niche adaptation. Two types of phenotypic variation in 
bacteria are phase and antigenic variation. Both phenomena are generated through genetic, 
epigenetic, and post-translational mechanisms that lead to the synthesis of different enzymes and 
secondary metabolites, and to the expression of different surface antigens (such as pili, fimbriae, 
and outer polysaccharides) (Zieg et al., 1977; Yamamoto and Kutsukake, 2006; Bayliss et al., 
2001; van de Broek et al., 2005). Phenotypic variation can be enhanced in certain environments. 
For example, growth in a biofilm triggers the formation of phenotypic variants in Streptococcus 
pneumoniae and Pseudomonas aeruginosa. These biofilm variant strains enhance the resistance 
to stress in the biofilm, and also have a different ability to disseminate or accelerate biofilm 
formation, contributing to the survival of the biofilm community (Allegrucci and Sauer, 2007; 
Boles et al., 2004). Similarly, protozoan parasites such as Trypanosoma brucei and Plasmodium 
falciparum have evolved sophisticated mechanisms to alter their surface antigens and, thus, 
successfully evade the pressure of the immune system (Morrison et al., 2009; Ralph and Scherf, 
2005). In both organisms, antigenic variation leads to the formation of subpopulations expressing 
different surface antigens (VSG or PfEMP1) that arise stochastically (see below). These 
subpopulations are able to continue the infection once the rest of the population is eliminated by 
the immune system. Therefore, phenotypic variation is a common feature of diverse 
microorganisms that thrive in different ecosystems, and it serves the common purpose of 
enhancing the population fitness and ensuring population survival. 
 14 
Mechanisms of phenotypic variation 
 
Genetic (mutation, genomic rearrangements) and epigenetic mechanisms 
To achieve phenotypic variation, microbes often combine genetic variation with 
epigenetic mechanisms. One good example of combined genetic and epigenetic mechanisms to 
generate variation is P. falciparum. P. falciparum expresses an outer membrane protein, PfEMP1, 
which is one of the main antigens recognized by the immune system and, thus, a useful substrate 
for immune evasion (Baruch et al, 1995; Smith et al., 1995; Su et al., 1995). The PfEMP1 family 
can be encoded by 60-70 var genes, located near the telomeric regions of P. falciparum 
chromosomes (Gardner et al., 2002). These var genes are subject to a high frequency of ectopic 
recombination and give rise to novel variants of PfEMP1 (Freitas-Junior et al., 2000). Each P. 
falciparum strain encodes in its genome a large number of PfEMP1 variants, but epigenetic 
mechanisms operating at the subtelomeric and telomeric regions restrict expression to only one 
var gene at a given time, while simultaneously allowing for a high frequency of var switching 
(Duraisingh et al., 2005; Verstrepen and Fink, 2009; Ralph and Scherf, 2005). This system allows 
for the temporary expression of unique PfEMP1 versions, thereby providing constant substrate 
for immune evasion and ensuring the establishment of a chronic infection. 
T. brucei also employs a combination of mechanisms to generate surface variation in its 
main antigen VSG. T. brucei contains ~ 1600 VSG genes and pseudogenes, located mostly at 
subtelomic regions (Marcello and Barry, 2007; Wickstead et al, 2004). There are ~20-45 VSG 
expression sites (ES), and VSG genes are recombined into them by gene conversion, reciprocal 
telomeric VSG exchange, and recombination of VSG pseudogenes to generate VSG mosaics 
(Thon et al., 1999; Pays et al., 1985; Morrison et al., 2009). Only one ES is active at a time, and it 
is unclear how this happens. It has been proposed that activity of only one ES is achieved through 
the localization of ES in ES bodies (a specialized nuclear compartment), which can apparently 
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only accommodate and allow transcription of one ES at a time (Navarro and Gulk, 2001). Given 
the necessity to evade the immune system in order to ensure a successful chronic infection, T. 
brucei has evolved a successful mechanism to generate a wide range of surface phenotypic 
variation through the combination of several genetic and cellular approaches.  
The var and VSG genes belong to a group of genes called contingency genes. Contigency 
genes are present in virus, bacteria, fungi, and protozoa. These genes are subject to higher 
mutation rate than the rest of the genome because their function is to provide phenotypic variation 
(Moxon et al., 1994; Deistch et al., 1997). Noticeably, an increasing number of examples indicate 
that contingency loci are usually placed nearby the telomeres, including the above mentioned P. 
falciparum and T. brucei, and also the fungus Pneumocystis, and the bacteria Borrelia. Telomeric 
and subtelomeric regions are subject to epigenetic silencing mechanisms, higher frequency of 
recombination, and tend to cluster at the nuclear periphery, providing an ideal location for genes 
that need to be mutated, recombined, or silenced (Barry et al., 2003). For example, the fungus 
Pneumocystis carinii has ~ 100 genes per haploid genome encoding the major surface 
glycoprotein (MSG), which are located in 2-4 gene clusters at subtelomeric regions (Stringer and 
Keely, 2001). Similar to T. brucei‟s VSG, MSGs can only be transcribed from a unique 
expression site in P. carinii. These arrangements are also observed in bacteria containing linear 
chromosomes, like Borrelia burgdoferi and Haemophilus influenzae (Barbour and Restrepo, 
2000; Moxon et al., 2006). The presence of contingency loci in fundamentally different 
organisms is an indication of the efficiency of these mechanisms to provide phenotypic variation. 
Besides P. carinii, other fungi also have gene families located near telomeric regions. For 
example, Saccharomyces cerevisiae can obtain surface phenotypic variation by regulating the 
expression of the FLO gene family located nearby the telomeres, which encode flocullins. S. 
cerevisiae can genetically and epigenetically regulate the expression of the FLO genes. At a 
frequency of ~10
-3
, S. cerevisiae gives rise to wrinkly colonies with increased flocculation due to 
 16 
FLO10 mis-expression. FLO10 mis-expression occurs due to mutations in IRA1 and IRA2, the 
Ras GTPase activators. The mutations in IRA1/2 are frameshift mutations or transversions, and 
occur at a higher frequency than in the rest of the genome. Thus, the effect of Ira
-
 on S. cerevisiae 
colony switching appears to be dependent on Ras overactivation (Halme et al., 2004). Another 
example is C. glabrata. C. glabrata can alter its ability to adhere to a surface by modifying the 
expression of adhesins encoded by the subtelomeric EPA gene family. This fungus has evolved 
an exquisite system to induce EPA6 expression only during urinary tract infections. C. glabrata is 
auxotrophic for nicotinic acid, which is a precursor of NAD+, the cofactor of the Sir silencing 
enzymes. Nicotinic acid is low in the urinary tract. This leads to low intracellular NAD+ levels, 
improper Sir protein function, and, thus, EPA6 derepression. The expression of EPA6 allows C. 
glabrata to adhere to the epithelial cells in the urinary tract (Domergue et al, 2005). Unlike C. 
glabrata and S. cerevisiae, C. albicans does not encode genes involved in adhesion to surfaces 
near the telomeres, and epigenetic mechanisms governing subtelomeric gene expression in C. 
albicans have not been defined yet. However, C. albicans harbors the TLO gene family at 
subtelomeric regions, and although some of the TLO genes are known to be expressed, the 
function and regulation of these genes is unknown (van het Hoog et al., 2007). Given the 
relevance of subtelomeric genes in the other organisms discussed here, it is possible that TLO 
genes in C. albicans also fulfill a role in this fungus survival and pathogenesis. 
Bacteria have developed other mechanisms to achieve phenotypic variation, including 
phase variation and bistability. Phase variation requires genetic alterations, whereas bistability is 
an epigenetic switch (Dubnau and Losick, 2006). Phase variation is common in bacteria, and 
involves the ability to express only one member of a gene family at any given time. Some 
mechanisms of phase variation include DNA conversion, genomic rearrangements, accumulation 
of mutations due to DNA repair/replication errors, and differential methylation (epigenetic) (van 
den Broek et al., 2005). For example, Salmonella typhimurium expresses one of two flagelin 
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genes, and the expression is controlled by a reversible chromosomal inversion in the promoter 
region (Zieg et al., 1977; Silverman et al., 1979). Phase variation is regulated by environmental 
cues, including temperature, the composition of the media, and stress. On the other hand, 
bistability refers to a clonal population that can switch between two distinguishable states 
(Veening et al., 2008). Some common bistable phenomena in bacteria include: the persister 
effect, in which bacteria like Staphylococcus aureus survives antibiotic treatment by a stochastic 
decrease in growth rate and metabolism (Bigger, 1944; Keren et al., 2004); entry into genetic 
competence or sporulation; and the swimming and chaining phenomenon in Bacillus subtilis and 
Caulobacter crescendus (Kearns and Losick, 2005; Skerker and Laub, 2004). Phase variation and 
bistability allow for the generation of heterogeneous bacterial subpopulations, and are regulated 
or stochastic processes achieved through a myriad of genetic and epigenetic mechanisms. 
One process to generate variation during environmental stress is stress-induced 
mutagenesis, which has been very well characterized in bacteria (Rosenberg, 2001; Galhardo et 
al., 2007; Foster, 2007). In a stressful environment that has halted the growth of the population, 
mutagenesis may provide the cells with a growth advantage. The mutations can be caused by 
defects in recombination and DNA repair, the induction of the error prone DNA polymerase (Pol 
IV), or by the SOS and catabolite repression systems (Taddei et al., 1995; Kivisaar, 2003). 
Transient or long term inactivation of DNA repair mechanisms or the activity of DNA 
polymerases defective in the proofreading subunit cause the “mutator” phenotype (Funchain et 
al., 2000; Giraud et al., 2001; Aersten and Michiels, 2004). “Mutator” phenotypes also exist in 
eukaryotes. For example, “mutator” phenotypes have been implicated in cancer development, 
they can be induced in yeast, and occur naturally in lymphocytes during somatic hypermutation 
(Drotschmann et al., 2000; Harris et al., 1999; Loeb et al., 2008). Thus, environmental stress is a 
potent inducer of variation in highly diverse organisms. 
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 Codon usage 
Most living organisms share a common genetic code. However, throughout evolution 
there has been several codon reassignments (Moura et al., 2009). In C. albicans, the codon CUG 
that is normally translated as leucine has been replaced with serine, an amino acid that is 
structurally different (Santos and Tuite, 1995). The tRNA that recognizes CUG codons in C. 
albicans can be aminoacylated with serine (with a 97% frequency) but also with leucine (with a 
3% frequency), indicating that a percentage of the proteins that contain CUG codons will have 
intrinsic structural and functional variations (Suzuki et al., 1997). Experimental increase of the 
frequency at which CUG codons are recognized by leucine and not serine generated a burst of 
phenotypic variation in C. albicans, including alterations in cellular and colony morphology, 
adhesive properties, and gene expression; and in some cases the changes were accompanied by 
karyotypic alterations (Miranda et al., 2007). Thus, CUG ambiguity has the potential to generate 
variability in vivo in C. albicans. It is possible that, under certain conditions or simply 
stochastically, C. albicans might be able to alter the frequency at which the tRNACAG is 
aminoacylated with leucine or serine, thereby generating phenotypic and genetic variability.  
 
Transcriptional noise, translation error, and Hsp90 
One mechanism that is responsible for the generation of phenotypic diversity in otherwise 
identical individuals is transcriptional noise. Transcriptional noise is the stochastic variability in 
gene expression (Ozbudak et al., 2002). The effect of transcriptional noise on a phenotype 
depends on the strength of the promoter, i.e. phenotypic differences due to transcriptional noise 
are most observable in genes that have low transcription (Kaern et al., 2005). Stochasticity in 
gene expression can have beneficial effects on population fitness and survival (Freed et al., 2008). 
Further, if alterations in gene expression are part of feedback regulatory loops, these alterations 
may become epigenetically fixed and allow for the maintenance of a particular phenotype (Raser 
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and O‟Shea, 2005; Sriram et al., 2009). Thus, transcriptional noise is an important mechanism 
that allows rapid adaptation to environmental change, but it is also involved in more long-term 
adaptation strategies. 
Another mechanism of variation is translational errors. Precision during protein synthesis 
is critical to ensure the proper function of any polypeptide and to avoid protein mis-folding and 
aggregation. However, protein synthesis is error prone: ~15% of average length proteins contain a 
minimum of one mis-incorporated amino acid (Parker, 1989; Ogle and Ramakrishnan, 2005). 
Although organisms have developed mechanisms to enhance the fidelity of protein synthesis, 
synthesis error can have some benefits (Drummond and Wilke, 2009). For example, allowing a 
certain level of translation or folding mistakes increases the phenotypic diversity without 
impacting the genetic sequence. Microorganisms take advantage of mechanisms that induce 
ribosomal mistakes, such as programmed frame-shifting (ribosomes shift to a different open 
reading frame) and ribosome skipping. Ribosomal mistakes can increase the diversity of 
polypeptides that can be produced with the same mRNA, allow for the synthesis of polypeptides 
that carry otherwise deleterious mutations (e.g. an early stop codon), and produce proteins with 
novel phenotypes (Farabaugh, 1996; Pleiss et al., 2007; Engelberg-Kulka et al., 1979; Drummond 
and Wilke, 2009). Thus, alterations in protein synthesis can lead to phenotypic diversity and 
genome evolution. 
Besides protein translation efficiency, organisms need to ensure protein stability and 
folding. Improperly folded proteins have a modified function or are non-functional and can 
aggregate, which has severe consequences on cellular function (Ecroyd and Carver, 2008). To aid 
in protein folding cells have molecular chaperones. One example of a highly conserved chaperone 
is Hsp90 (Taipale et al., 2010). However, Hsp90 is a specialized chaperone that not only 
functions in protein folding, it also has the ability to buffer cryptic mutations, allowing for the 
normal function of proteins that otherwise would show an altered function (Yahara et al., 1999). 
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When Hsp90 function is compromised or Hsp90 is less available (e.g. due to stress), the 
phenotypic variability that Hsp90 had masked is displayed. Thus, Hsp90 allows for the evolution 
of genes under non-selective pressure. Hsp90 is associated with many signal transduction 
pathways, including the PKA and TOR pathways (see below), and functions in several 
morphogenetic processes in yeast, flies, and plants (Sollars et al., 2003; Queistch et al., 2002; 
Shapiro et al., 2009; Rutheford and Lindquist, 1998; Delgoffe et al., 2009). Thus, modulation of 
Hsp90 function allows for the acquisition and display of phenotypic variation. 
Finally, there are other mechanisms to generate variation that I have not discussed here, 
such as the movement of transposable elements. All organisms need to generate variation, and it 
is likely that some of the mechanisms cells employ to generate variation are more common 
among highly diverse organisms than previously expected. 
Phenotypic variation is a way organisms have to cope with environmental changes. Thus, 
it is logical that many of the mechanisms that lead to the generation of phenotypic variation 
function in response to the environment. In order to sense environmental changes, cells use an 
array of signal transduction pathways. Alterations in the function of these pathways are directly 
linked with the generation of phenotypic variation in highly diverse organisms, including yeast 
and mammals. Two major signal transduction cascades that regulate cell growth in response to 
the environment and that are also directly involved in phenotypic variation are the Ras/protein 
kinase A (PKA) and the Target of Rapamycin (TOR) signal transduction pathways (Mennon and 
Manning, 2009; Bjornsti and Houghton, 2004; Prasad et al., 2003; Taddei et al., 1995; Weeks, 
2000; Fuchs et al., 2010; Horinouchi et al., 2001; Janion et al., 2002; Menon and Manning, 2008). 
Interestingly, the protein that is the focus of study in this dissertation, Mds3, functions as a 
regulator of both of these signal transduction pathways (Chapters 3, 5 and 6). Therefore, below I 
summarize the current knowledge on the structure and function of this signal cascades in fungi. 
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The Ras and TOR signal transduction pathways 
 
Two critically important signal transduction pathways in eukaryotic organisms are the 
Ras and TOR pathways. Both pathways are responsible for regulating cellular growth in response 
to environmental nutrients. During active growth and in nutrient replete conditions, the Ras and 
TOR pathways promote protein synthesis and cellular division. Entry to stationary phase or 
starvation requires Ras and TOR pathways inactivation, which leads to induction of stress 
responses, autophagy, and cell cycle arrest (Thevelein and de Winde, 1999; Wullschleger et al., 
2006; Rohde et al., 2001; Zaman et al., 2008). Inactivation of the TOR pathway also leads to the 
activation of the nitrogen catabolite repression response, which allows for the metabolism of poor 
nitrogen sources (Cardenas et al., 1999). Since the Ras and TOR pathways regulate many similar 
processes they share some downstream effectors, but the actual level of crosstalk between the 
pathways in yeast is not fully understood (Zaman et al., 2008; Lempiainen et al., 2009; Schmelzle 
et al., 2004; Zurita-Martinez and Cardenas, 2005; Soulard et al., 2010). 
 
The Ras pathway 
In S. cerevisiae and C. albicans Ras functions upstream of both the cAMP/PKA and 
MAPK pathways (Thevelein and de Winde, 1999; Biswas et al., 2007) (Figures 1.2 and 5.1). Ras 
is a small G protein that is active when bound to GTP and inactive when bound to GDP (Broach, 
1991). The GTP-GDP exchange factor of Ras is Cdc25 (and Sdc25 in S. cerevisiae), an upstream 
activator of Ras1. GTP-bound Ras activates adenylate cyclase (Cyr1/Cdc35) (Thevelein and de 
Winde, 1999). This activation is facilitated by Srv2 (or Cap1) (Bahn and Sundstrom, 2001; 
Fedor-Chaiken et al., 1990). Adenylate cyclase is also activated by the Gpr1-Gpa2 parallel circuit 
(Maidan et al., 2005; Miwa et al., 2004; Xue et al., 1998). Active adenylate cyclase produces 
cAMP, which activates PKA by binding to its regulatory subunit, Bcy1, and causing the 
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dissociation of Bcy1 from the PKA catalytic subunits, the Tpks (Toda et al., 1987). C. albicans 
has two PKA catalytic subunits: Tpk1 and Tpk2, which have both redundant and independent 
functions (Bockmuhl et al., 2001; Giacommetti et al., 2009; Souto et al., 2006). S. cerevisiae has 
three PKA subunits (Toda et al., 1987b). Thus, PKA is activated by Ras and Gpr1/Gpa2 via 
adenylate cyclase. In addition, Ras also activates the MAPK pathway in both S. cerevisiae and C. 
albicans, and Gpa2 functions in a cAMP-independent pathway (Monge et al., 2006; Leberer et 
al., 2001; Wilson et al., 2010). 
    
Figure 1.2: Ras/PKA and Gpr1/Gpa2 circuits in C. albicans. ? on arrow indicates that 
function is inferred from S. cerevisiae studies. 
 
Since overactivation of the Ras/PKA pathway has several negative consequences for cell 
survival, signaling through this pathway needs to be fine-tuned and downdregulated when 
necessary. Downregulation of the Ras/PKA pathway can be achieved in several of its steps. Ras 
can be inactivated by the GTPase Ira2 (and Ira1 in S. cerevisiae). Gpa2 activity is antagonized by 
the Kelch proteins Gpb1/Gpb2, which are also inducers of Ira1/Ira2 activity (Harashima et al., 
2006). It is to note that C. albicans does not appear to have Gpb1/Gpb2 homologs. Finally, 
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adenylate cyclase function is antagonized by Pde1 and Pde2, two phosphodiesterases that degrade 
cAMP and promote PKA inactivation (Ma et al., 1999; Jung and Stateva, 2003).  
In sum, the structure of the Ras/PKA signal cascade is conserved between S. cerevisiae 
and C. albicans, although C. albicans appears to lack some pathways members like Scd25, 
Gbp1/2, and Ira1 that are presentin S. cerevisiae. Further, there are functional differences between 
these pathways in both organisms. In S. cerevisiae, the cdc25Δ and ras1Δ ras2Δ mutants are 
inviable (Broek et al., 1987). However, in C. albicans the mutant in CDC25 grows similar to 
wild-type, and the double ras1Δ/Δ ras2Δ/Δ mutant is still viable (Zhu et al., 2009; Enloe et al., 
2000; Leberer et al., 2001). Further, in S. cerevisiae the cyr1Δ mutant is inviable, while the C. 
albicans cdc35Δ/Δ mutant is viable (Leberer et al., 2001). In S. cerevisiae, the Gpr1-Gpa2 circuit 
is required for glucose sensing (Thevelein and de Winde, 1999). However in C. albicans there is 
conflicting evidence that either support the S. cerevisiae model, or suggest that glucose sensing is 
mediated by Cdc25 while the ligand of Gpr1 is unknown (Zaman et al., 2008; Maidan et al., 
2005; Miwa et a., 2004). Therefore, although there is high conservation in the molecular 
architecture of the Ras/PKA signaling cascade between S. cerevisiae and C. albicans, there also 
appear to be major differences between the function of Ras or of Ras downstream effectors in 
these fungi. 
                Ras has a critical role in the activation of different signal cascades in eukaryotes and, 
thus, has been intensively studied. In S. cerevisiae, the Ras/PKA pathway is a positive regulator 
of ribosomal protein synthesis, ribosome biogenesis, and translation; and a negative regulator of 
the Rim15 dependent activation of stationary phase program, and of Msn2/4 dependent stress 
responses (Figure 1.2; Zaman et al., 2008; Thevelein and de Winde, 1999). Besides glucose and 
CO2, the upstream environmental signals that feed into PKA are unclear (Klengel et al., 2005; 
Zaman et al., 2008). In C. albicans, the function of the Ras/MAPK/PKA pathway is critical for 
pathogenesis (Hogan and Sundstrom, 2009). For example, the Ras/MAPK/PKA pathways are 
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required for several morphogenetic processes, including the yeast-hyphal transition and the white-
opaque switching, and for virulence in murine models of infection (Leberer et al., 2001; Bahn et 
al., 2007; Huang et al., 2010). However, despite the efforts to dissect the Ras pathway in S. 
cerevisiae, it is still not fully understood how Ras receives signals from upstream effectors, what 
types of signals feed into Ras, and what other roles Ras plays in the cell besides of the activation 
of the MAPK and PKA pathways (Zaman et al., 2008).  
 
The TOR pathway 
A second major signal transduction pathway in eukaryotes is the TOR pathway. TOR is a 
kinase that functions as a member of a large multiprotein complex (Loewith et al., 2002). The 
most direct upstream activator of TOR is Rhb1 (or RHEB, in mammals), whose function is 
antagonized by Tsc1 and Tsc2 (Figure 1.3). TOR phosphorylates several downstream effectors, 
although the only ones that have been clearly shown to be substrates of TOR are Tap42 and the 
kinase Sch9 (Urban et al., 2007; Duvel et al., 2003). In S. cerevisiae, Tap42 binds the type 2A 
phosphatases Pph21/22/3 and the type 2A like phosphase Sit4 and has a dual function on the 
activation of these phosphatases (Duvel and Broach, 2004; Wang et al., 2003). While 
phosphorylated, Tap42 is bound to the phosphatases and keeps them inactive within the TOR 
multiprotein complex. Upon TOR inactivation, the Tap42-phosphatase complex is released, and 
the phosphatases exert their TOR dependent function until they dissociate from Tap42 (Yan et al., 
2006; Di Como and Jiang, 2006). Studies in flies and mammals have uncovered many more 
upstream members and downstream effectors of the TOR pathway, as well as several feedback 
regulatory loops in which TOR participates (Wullschleger et al., 2006). However, the dissection 
of the TOR pathway in S. cerevisiae has been slower, perhaps complicated by the fact that S. 
cerevisiae has two TOR kinases, Tor1 and Tor2, which are found in two different (although 
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sometimes interchangeable complexes) (Loewith et al., 2002), while mammals and C. albicans 
have only one TOR kinase (Figure 1.3; Helliwell et al., 1994).  
 
Figure 1.3: TOR signal transduction pathway (as it may be in C. albicans). P: indicates 
phosphorylation. In boxes: TOR regulated transcription factors. 
 
Besides the number of TOR kinases, there are other differences between S. cerevisiae and 
C. albicans TOR pathways. S. cerevisiae has a gene encoding Rhb1, but its role in the TOR 
pathway is unclear (Urano et al., 2000). Further, S. cerevisiae does not encode homologs of 
TSC1/2. On the contrary, C. albicans has both Rhb1 and Tsc2, and an rhb1Δ/Δ mutant is more 
sensitive to rapamycin, indicating that at least Rhb1 is likely functioning in the TOR pathway in 
C. albicans (Tsao et al., 2009). Finally, C. albicans only appears to have Pph21 and Sit4. 
Notably, the structure of the TOR pathway in C. albicans appears more similar to the mammalian 
mTOR pathway than to the structure of the TOR pathway in S. cerevisiae. 
The TOR pathway shares functional similarities with the PKA pathway. TOR activation 
leads to enhanced protein synthesis, ribosome synthesis, and protein translation, while 
simultaneously repressing processes required to survive stress and starvation, like the STRE 
response, the retrograde response, the nitrogen catabolite repression response, and autophagy 
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(Rohde and Cardenas, 2004; Schmelzle and Hall, 2000). TOR also regulates actin filaments and 
cytoskeleton dynamics (Loewith et al., 2002). It is unclear what signals activate/inactivate the 
TOR pathway, although TOR has been shown to respond to environmental nitrogen and carbon 
sources (Di Como and Arndt, 1996; Jacinto, 2008). The TOR pathway in C. albicans is required 
for several morphogenetic processes, including the yeast-hyphal transition and chlamydospore 
formation (Cutler et al., 2001, Bastidas et al., 2009; Lee et al., 2004; Nobile et al., 2003; Zacchi et 
al., 2010a). Given the myriad of processes that the TOR pathway is involved in, TOR is likely to 
be required for the expression of other virulence traits in C. albicans as well. In fact, I show here 
that both the Ras and TOR pathways are also regulators of CMPS in C. albicans (Chapters 4,5). 
The Ras and TOR pathways are critical signal transduction pathways that regulatecellular 
growth in response to environmental nutrients. These pathways share the control of several 
downstream effectors. The intimate connection between the Ras and TOR pathways is clear in 
mammalian cells, where Ras is an upstream activator of TOR. However, in S. cerevisiae the level 
of crosstalk between Ras and TOR and the interdependence of the pathways is still controversial. 
Besides their role in nutrient sensing, these pathways are required for proper control of 
morphogenetic processes, they are involved in aging, DNA damage responses, and in mammals 
they are also directly involved in cancer development. Therefore, it is important to understand the 
function of the Ras and TOR pathways and the consequences of their de-regulation in cellular 
growth and survival.  
 
Using Mds3 as a tool to understand CMPS in C. albicans 
The fungal pathogen C.albicans, an asexual diploid yeast, is able to obtain phenotypic 
variation by the colony morphology phenotypic switching (CMPS) (see above for more 
information on this). CMPS occurs in vivo and is associated with alterations in the expression of 
virulence factors, which strongly suggest an important role for CMPS during C. albicans 
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infection. Despite the role of CMPS in pathogenesis in C. albicans, very little is known about the 
mechanisms that regulate CMPS in this fungus. In our laboratory, we serendipitously found that 
the protein Mds3 is a negative regulator of CMPS in C. albicans. After prolonged incubation of 
mds3Δ/Δ colonies in rich medium we observed the formation of extensions and blebs on the 
colony surface, which we call papilli (Figure 4.1A). Cells isolated from these mds3Δ/Δ papilli 
gave rise to colonies with altered, heritable, and low frequency reversible colony morphologies, 
all characteristics that perfectly match the definition of CMPS (Figure 4.1B; Soll, 1992). Thus, 
the mds3Δ/Δ papilli contain morphologically switched cells, and Mds3 acts as a negative 
regulator of CMPS. We had discovered a new genetic tool to gain insights on CMPS mechanisms 
and regulation: MDS3. 
The mechanism(s) through which Mds3 and the second known CMPS regulator Ssn6 
effect CMPS in C. albicans likely differ. The ssn6Δ/Δ mutant is highly unstable and gives rise to 
switched colonies rapidly, whereas in the mds3Δ/Δ mutant the initial switch likely occurs when 
cells have entered stationary phase. Further, the switch in the ssn6Δ/Δ mutant involves the whole 
colony indicating that the switch occurred in the colony-founder cell. On the contrary, the 
mds3Δ/Δ mutant requires the intermediate step of papilli formation to give rise to 
morphologically switched colonies, indicating that the switch occured within the colony during 
the prolonged incubation (Chapter 4; Garcia-Sanchez et al., 2005). It is to note that once the 
mds3Δ/Δ mutant has switched, it continues to produce colonies with variant morphologies at a 
frequency of 10
-2
, without the need of an intermediary papilli (our unpublished results). Thus, 
Ssn6 and Mds3 represent two distinct tools to study CMPS, although it is also possible that Ssn6 
functions downstream of Mds3. 
Little was known about Mds3 when I began this work. MDS3 encodes a 1383 amino acid 
protein with putative N-terminal Kelch-domains (Chapter 2, Davis et al., 2002). Mds3 was 
initially shown to be a negative regulator of meiosis and sporulation in S. cerevisiae and was 
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proposed to function upstream or in parallel to the Ras/PKA pathway (Benni and Neigeborn, 
1997; McDonalds et al., 2009). In C. albicans, MDS3 was found to be required for growth and 
morphogenesis at alkaline pH, growth on LiCl, and biolfilm and chlamydospore formation (Davis 
et al., 2002; Nobile et al., 2005; Richards et al., 2005). Despite the role of Mds3 in important 
morphogenetic and developmental processes in S. cerevisiae and C. albicans, the biological 
function of Mds3 was unknown.  
 
In this dissertation I aimed to study the mechanisms of CMPS in C. albicans using the 
mutant in MDS3 as our genetic tool. My goal was to understand the biological role of Mds3 in C. 
albicans cells and the role of Mds3 in the generation of phenotypic diversity in this human 
pathogen. I found that Mds3 appears to be a Kelch/BTB protein localized in cytoplasmic spots 
that functions as a regulator of both the TOR and the Ras pathways in C. albicans (Chapter 2, 3 
and 5). Consequently, I found that both the TOR and Ras pathways are involved in the regulation 
of CMPS, and I identified additional negative regulators of CMPS, including Ras1 and the TOR 
effector Sch9 (Chapter 5). Through the characterization of the phenotypic variants from the 
mds3Δ/Δ mutant, I conclude that there is likely more than one mechanism associated with the 
phenotypic switch, including genomic instability and DNA repair defects (Chapters 4, 5). I also 
found environmental conditions that effect CMPS in C. albicans, such as glucose starvation, 
amino acids, and environmental pH, all conditions that are known to directly influence the 
function of the TOR, Ras/PKA and Sch9 pathways (Chapter 4, 5). Taken together, I have 
elaborated a model of CMPS in C. albicans that shares many similarities with the model of stress-
induced mutagenesis in bacteria. I propose that CMPS in C. albicans is a regulated process, 
triggered during stationary phase, in which defects in the signaling through the TOR and Ras 
pathways lead to the stepwise accumulation of genetic and epigenetic alterations that eventually 
cause the phenotypic switch.  
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CHAPTER 2 
 
 
BIOINFORMATIC AND MUTATIONAL ANALYSIS OF MDS3 
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SUMMARY 
 In order to get insights into the function of Mds3, I performed bioinformatic, mutational, 
and localization studies of Mds3. The bioinformatic analysis of the open reading frame (ORF) of 
MDS3 suggested that Mds3 contains six N-terminal Kelch domains, followed by a serine rich 
bridge, and a C-terminal region with low homology to a BTB/POZ domain that is highly 
conserved among Mds3‟s orthologs in Candida and Saccharomyces cerevisiae. Several 
disordered regions are distributed throughout the ORF of Mds3, suggesting that Mds3 is a 
modular Kelch/BTB protein. The functional relevance of the Kelch and BTB domains were 
determined by point and insertional mutagenesis in the domains. A Tn7 insertional mutagenesis 
of Mds3‟s ORF was performed in order to find a region that would tolerate the insertion of an 
epitope tag. Twenty-one MDS3-Tn7 alleles were generated that did not cause a truncated protein, 
but only one out of 13 alleles analyzed allowed the insertion of a V5-HIS6 tag without affecting 
Mds3 function. Mds3-V5 localized in cytoplasmic spots. Thus, based on the studies performed 
Mds3 appears to be a cytoplasmic modular Kelch/BTB protein. It would be interesting to further 
dissect the localization, molecular interactions, and posttranslational modifications of Mds3. To 
this end, many tools have been generated and several of them are described in this chapter. 
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INTRODUCTION 
Mds3 is associated with several morphogenetic and growth-related processes in fungi. In 
S. cerevisiae, Mds3 (hereafter referred to as ScMds3) and its paralog Pmd1 function as negative 
regulators of meiosis (Benni and Neigeborn, 1997; McDonald et al., 2009). In C. albicans, Mds3 
is required for chlamydospore formation, for filamentation, and for biofilm formation (Davis et 
al., 2002; Nobile et al., 2003; Richard et al., 2005), and it is also a negative regulator of colony 
morphology phenotypic switching in C. albicans (Chapter 4). Mds3 is required for growth and 
filamentation at alkaline pH and for growth in the presence of LiCl (Davis et al., 2002). Mutants 
in MDS3 also show a slight growth defect in YPD. Thus, Mds3 is involved in diverse 
morphogenetic processes in fungi, including some that are critical for C. albicans virulence, and 
for proper pH responses. 
Mds3 is a fungal specific protein, with putative uncharacterized orthologs in diverse 
fungal genera, including Debaryomyces, Ashbya, and Schizosaccharomyces. In S. pombe the 
ortholog of MDS3 is RAL2, a gene encoding a 611 amino acids protein involved in mating and 
proposed to function as a Ras1 guanyl-exchange factor (Fukui et al., 1989). However, the 
homology between Mds3 and Ral2 is limited to the Kelch domains (e-value: 9e
-08
 from BLASTp 
sequence alignment). ScMds3 has also been associated with the Ras pathway in S. cerevisiae, 
although it remains unclear whether ScMds3 is a member of the Ras pathway or if it functions in 
parallel (Benni and Neigeborn, 1997; McDonald et al., 2009). Thus, Mds3 is conserved in fungi 
and might be a member of a signal transduction pathway.  
To begin to gain insights into Mds3 function, I performed a bioinformatic analysis of 
MDS3‟s open reading frame (ORF) in order to identify potential functional domains. 
Furthermore, I performed mutational analysis of MDS3 in order to corroborate the biological 
relevance of the bioinformatic predictions and to identify a benign location within MDS3 that 
would tolerate an epitope tag. Finally, I epitope tagged Mds3 and used it for indirect 
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immunofluorescence localization experiments. Our results suggest that Mds3 functions as a 
cytoplasmic scaffold protein. 
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MATERIALS AND METHODS 
Bioinformatic analysis 
The amino acid sequence alignments were performed using BLASTp available at NCBI 
http://blast.ncbi.nlm.nih.gov/Blast.cgi and Clustal 2.0.12 Multiple Sequence alignment 
http://www.ebi.ac.uk/Tools/clustalw2/index.html. Programs available on-line through the 
ExPASy server from the Swiss Institute of Bioinformatics http://www.expasy.ch/tools/ were used 
to analyze Mds3, ScMds3, and Pmd1 ORFs from C. albicans and S. cerevisiae, including MyHits 
http://myhits.isb-sib.ch/cgi-bin/motif_scan, PreDisorder (http://casp.rnet. 
missouri.edu/predisorder.html), Signal IP 3.0 http://www.cbs. dtu.dk/services/SignalP/, COILS 
http://www.ch.embnet.org/software/COILS_form.html, ePESTfind http://emboss.bioinformatics. 
nl/cgi-bin/emboss/epestfind, MITOPROT http://ihg2. helmholtz-muenchen.de/ihg/mitoprot.html, 
and PTS1 http://mendel.imp.ac.at/mendeljsp/sat/pts1/ PTS1predictor.jsp. Further, ProtComp 
(http://linux1.softberry.com/berry.phtml?topic=protcompan&group=programs&subgroup=proloc) 
and WoLFPSORT (http://wolfpsort.org/) were used to predict protein localization.  
The N-terminal region of Mds3 was modeled by Andy Kruse and Douglas Ohlendorf 
(Department of Biochemistry, University of Minnesota) as follows. To model Mds3, predictions 
of disorder, secondary structure, and folding were determined using the Phyre server 
(http://www.sbg.bio.ic.ac.uk/~phyre/). The structural models were prepared with Modeller 
(http://www.salilab.org/modeller/), using a structure-guided sequence alignment, followed by 
manual adjustments based on the Kelch repeat motifs that could be readily identified. The final 
structure was generated using the best scoring model available. Due to the lack of closely 
homologous structures, the disordered regions and the loops inter Kelch motifs were not possible 
to model. The 3-D images presented here were made with PyMol (http://pymol.org/rel/099/).  
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C. albicans strains and plasmid construction 
All C. albicans strains used in this study are listed in Table 2.1. All strains were 
constructed by chemical transformation (Wilson et al., 1999) with PmeI or NheI linearized 
vectors. Integration of MDS3 containing vectors was verified by genomic DNA PCR using 
primers MDS3 Seq 2 and MDS3 NruI Seq 3‟ (Table 2.3). 
The MDS3::V5 tagged vectors pLZ38, pLZ39, and pLZ86 were constructed as follows. 
To construct plasmid pLZ38 and pLZ39, the V5-HIS6 tag was PCR amplified from plasmid 
pTRACER-EF (Invitrogen) using primers Mds3 HpaI V5His6 5‟ and Mds3 HpaI V5His6 3‟ or 
Mds3 BstBI V5His6 5‟ and Mds3 BstBI V5His6 3‟ (Table 2.3) and in vivo recombined into HpaI 
or BstBI digested plasmid pDDB353 (Zacchi et al., 2010, see Chapter 3), respectively, using S. 
cerevisiae L40 strain. HpaI and BstBI are unique restriction sites in MDS3 ORF located at 
nucleotide position 4131 and 3129 from the START codon (Figure 2.2A). To construct plasmid 
pLZ86, the V5-HIS6 tag was PCR amplified from pTRACER-EF (Invitrogen) using primers 56-
V5 5‟ and 56-V5 3‟ (Table 2.3) and in vivo recombined into PmeI digested pDDB500 (Zacchi et 
al., 2010, see Chapter 3) to give pLZ86 (the V5 tag was placed at position 1056 because insertion 
at 1051 disrupted MDS3 function (data not shown)). pLZ86 rescued an mds3∆/∆ mutant, 
indicating that Mds3 tolerated the addition of the 23 amino acids of the V5-His6 tag at amino acid 
position 1056; pLZ38 and pLZ39 only partially rescued an mds3∆/∆ mutant. pLZ86 was 
linearized with NheI for integration into DAY938 to generate strain LUZ379. pLZ38 and pLZ39 
were linearized with PmeI for integration in to DAY956 to generate strains LUZ14 and LUZ20. 
The strain containing an MDS3::HA C-terminal tagged allele (LUZ23) was constructed 
by transforming strain DAY415 with a 3xHA::ADH1term::URA3 cassette PCR amplified from 
plasmid pDDB367 (pGM1874, Gerami-Nejad et al., 2009) using primers MDS3 HA C-ter 5‟ and 
MDS3 URA3 c-ter 3‟ (Table 2.3). 
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The MDS3 vectors pLZ78-83 were constructed as follows. Plasmid pDDB353 was used 
as template to PCR amplify (Pfu Turbo DNA polymerase, Stratagene) two overlapping segments 
that spanned the N-terminal region of MDS3 using primers MDS3 Seq 1 combined with any of 
the second-Kelch-repeat mutational 3‟ primers, and MDS3 Nru1 Seq 3‟ combined with the 
corresponding second-Kelch-repeat mutational 5‟ primer (Tables 2.3). Both PCR products were 
transformed with AflII-digested pDDB353 or pLZ38 into trp- S. cerevisiae strain L40 to produce 
pLZ78-83 through in vivo recombination (Table 2.2). The mutated MDS3 ORF of each plasmid 
was verified by sequencing. Plasmids were linearized with PmeI for transformation into 
DAY938, to generate strains LUZ397, LUZ399, LUZ400, and LUZ402, and into DAY956 to 
generate LUZ316. 
The mutations in pLZ78-82 were subcloned into pLZ86 by ligating the ~3.8kb XhoI/NruI 
gel purified band from pLZ78-82 to the ~9.8kb XhoI/NruI gel purified fragment from pLZ86 to 
give pLZ122-125 (Table 2.2). Plasmids were verified by sequencing, and the presence of the V5 
tag was verified by MluI digestion. pLZ122-125 were linearized with NheI for integration into 
DAY938, to generate strains LUZ461, 462, 464, and 466.  
Vector construction and random Tn7 mutagenesis protocols have been described (Zacchi 
et al., 2010; see Methods Chapter 3). After Tn7 excision, religated Mds3 alleles were subcloned 
into pDDB409 as previously described, to construct pLZ87-101 and  pLZ107-111 (Table 2.2 and 
2.5). pLZ118-120 containing clones 35.1, 104.1, and 108.1 were also prepared, although they 
were not phenotypically assessed. Plasmids were linearized with NheI for transformation into 
DAY938 to generate strains LUZ426-458. Independently transformed mutants with pLZ93, 
pLZ100, and pLZ101 gave conflicting results upon re-testing, and therefore have been excluded 
from the analysis. 
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Media and growth conditions 
C. albicans was routinely grown at 30ºC in YPD (2% Bacto-peptone, 2% dextrose, 1% 
yeast extract). For selection of His
+
 or Trp
+
 transformants, synthetic medium without histidine or 
tryptophan was used (0.17% yeast nitrogen base without ammonium sulfate (Q-BioGene), 0.5% 
ammonium sulfate, 2% dextrose, and supplemented with a dropout mix containing amino and 
nucleic acids except those necessary for the selection (Adams et al., 1997)). Media were buffered 
at the indicated pH using 150mM HEPES. Filamentation assays were performed in M199 
medium (Gibco BRL) buffered at pH 8 and incubated at 37ºC. For solid media filamentation 
assays, strains were pre-grown in liquid YPD at 30ºC, 3ul were spotted onto M199 pH 8 medium, 
and incubated at 37ºC for 5 days. For liquid assays of filamentation, strains were pre-grown in 
liquid YPD at 30ºC and diluted 1:100 in M199 pH 8. Samples were incubated for 2 hrs. To 
determine the % of hyphae producing cells samples were quantified under the microscope. The 
values reported are representative of two independent experiments, in which every strain was 
tested at least in duplicate. For growth assays in YPD, YPD + 150mM LiCl, and YPD pH 9, 
strains were pre-grown in liquid YPD at 30ºC, streaked onto the media or serially 5-fold diluted 
and plated, and incubated at 30ºC for 2 days. All media were supplemented with 80 µg/ml 
uridine. For solid media, 2% Bacto-agar was added. 
 
Protein extraction and Western Blot analysis 
Overnight cultures of C. albicans were diluted 40-fold into YPD medium and grown for 
4 hours at 30°C. Cells were pelleted and resuspended in ice-cold RIPA buffer (50mM Tris pH 8, 
150mM NaCl, 1% NP-40, 3mM EDTA, 0.5% deoxycholate, 0.1% SDS) containing 1µg/ml 
leupeptin, 2µg/ml aprotinin, 1µg/ml pepstatin, 0.1mM phenylmethylsulfonyl fluoride, and 10 mM 
dithiothreitol and lysed by vortexing with acid-washed glass beads 4X 2 min at 4 ºC, with 2 min 
resting in ice in between. Cell lysates were pelleted and supernatants stored at -80°C. For Western 
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blot assays 50 uL of total protein was resuspended in 2X SDS gel-loading buffer (100mM Tris-
Cl, pH 6.8; 200mM dithiothreitol; 4% SDS; 0.1% bromophenol blue; 20% glycerol), boiled at 95-
100ºC for 5 minutes and run in 6% SDS-PAGE gel. Proteins were transferred to nitrocellulose 
and blocked in 5 % nonfat milk in TBS-T (50mM Tris, pH 7.6, 150mM NaCl, 0.1% Tween 20). 
Blots were incubated with 1:5000 αV5 (Invitrogen) or 1:1000 αHA (F-7 probe, Santa Cruz) in 5% 
non-fat milk TBS-T, washed in TBS-T, and incubated with 1:10,000 αmouseIgG–horseradish 
peroxidase antibody (GE Healthcare) in 5% nonfat milk in TBS-T. Blots were washed in TBS-T, 
incubated with ECL reagent (GE Healthcare), and exposed to film. 
 
Immunofluorescence 
  YPD overnight cultures were diluted 1:200 in 12.5 ml M199 pH 8 and incubated at 30°C 
for 4 hours in agitation. Cells were fixed 1 hr at room temperature (~23°C) in gentle agitation (80 
rpm) with 3.7% formaldehyde, washed with 2 ml Solution B (100mM pH 7.5 phosphate buffer, 
1.2M sorbitol) (Pringles et al., 1989), resuspended in 1ml Solution B containing 0.5mg/ml Yeast 
Lytic Enzyme (MPBio) and 2 ul β-mercaptoethanol, and spheroplasted at 37°C for no longer than 
30 min. Cells were washed twice by pelleting 5 min at 0.5 rcf and resuspending in 1ml Solution 
B. Cells were resuspended in 1ml Solution B and spotted on polylysine coated microscope slides. 
Samples were blocked with 5% bovine serum albumin (BSA) in TBS for 10 min, incubated 1 hr 
with 1:50 αV5 antibody (Invitrogen), washed 10X with TBS-T, incubated 1 hr with 1:500 
αmouseIgG-AlexaFluor555 SFX (Invitrogen), washed 10X with TBS-T, and coated with Gel 
Mount Aqueous Mounting media (Sigma) containing 1:1000 DAPI. Images were captured using 
a Zeiss Axio camera, Axiovision 4.6.3 software (Zeiss), and a Zeiss AxioImager fluorescence 
microscope. All images were processed with Adobe Photoshop 7.0 software. All the antibody 
procedures were done at room temperature in a humid chamber and in the dark once the 
fluorescent antibody was applied. 
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RESULTS 
Bioinformatic analysis 
To begin to elucidate Mds3 function, I performed several bioinformatic analyses on the 
ORF of MDS3 and its orthologs in S. cerevisiae ScMDS3 and PMD1, including domain searches, 
prediction of disorder, coils, and PEST domains. The amino acid sequence alignment of Mds3 
with ScMds3 and Pmd1 obtained through BLASTp at NCBI showed that these proteins share 
higher similarity within the first 600 N-terminal residues [27% and 32% identity, E values of 1e
-60
 
or 3e
-36
, respectively], and ~150 residues between amino acids 900 and 1,050 from Mds3 [37% 
and 35%, E values of 4e
-25
 and 2e
-24
, respectively] (Figure 2.1). Domain searches using several 
databases only identified one putative Kelch domain in the N-terminal region of Mds3 between 
amino acids 112-166 (4.9e
-06
) (Figure 2.1, underlined) and a serine rich region between amino 
acids 630-885 (2.7e
-09
) (e values from MyHits) (Figure 2.2A). Similarly, ScMds3 is predicted to 
encode two Kelch motifs between amino acids 159-211 (3.2e
-10
) and 232-268 (1.1e
-05
), and a 
serine rich region between amino acids 660 and 851 (3.1e
-05
). Pmd1 is predicted to encode a 
Kelch domain between amino acids 131-183 (1.7e
-08
) and a serine rich region between amino 
acids 638 and 1009 (3.9e
-08
).  Interestingly, the InterProScan program (version 7.1) predicted a 
BTB/POZ domain between amino acids 1014 and 1067 of ScMds3. Although this prediction is 
not extensive to Mds3 or Pmd1, the putative BTB/POZ domain in ScMds3 falls within the highly 
conserved internal region between the three proteins (Figure 2.2A). Thus, it appears that all three 
proteins share sequence similarity in two distinct regions in their ORFs: at the N-terminus, where 
they encode at least one Kelch domain, and closer to the C-terminus, where they possibly encode 
a BTB/POZ domain. 
Figure 2.1: CLUSTAL 2.0.12 multiple sequence alignment of Mds3, ScMds3, and 
Pmd1. Only the alignment for the 600 N-terminal residues (A) and the residues between 
~900-1050 (B) in Mds3 are shown. Underlined is the only Kelch repeat detected 
bioinformatically. Sc=S. cerevisiae, Ca=C. albicans. 
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A) 
Scpmd1          MTVLQPPSSVCYPLNLPIVPNPN----LDEATRKKLTLECRTGAAVELARSGVFVHGGLT 56 
ScMds3          MPLLQPSTCFCYPLKLPPLPLTSDSNEFDECARKRLTLDYRTGSAVTLTRSNIFVHGGLT 60 
CaMds3          MSTLIPTASACYSLQLPPTEKDD-----------RLNLNVRTGSASTLYNSLIFVHGGLT 49 
                *. * *.:. **.*:**     .           :*.*: ***:*  * .* :******* 
 
Scpmd1          LPLNLTIINSLQLQKELILYFGKQKDRNADFKTLADWISPEIFFLDLISRTWQRINTTID 116 
ScMds3          IPLNLPVVNSMQLQKELILFFAKEKNNGSSFRNLNEWISKETFFLDLMSRTWYRVKTSFD 120 
CaMds3          IGLELLNYTIPELN---EIFYNRINISASKYKTVEKYLSGELFYLSLIERNWSRVVLEEL 106 
                : *:*   .  :*:    ::: : :   :.::.: .::* * *:*.*:.*.* *:      
 
Scpmd1          TTSENELNNGLS------------------------FKERLFHSMCFTESNIYIFGGLMV 152 
ScMds3          QRTEELLKAESSSAKADNDTNEIRTDIKKGKSLESPLKERLFHSLCYLDGCLYIFGGLTV 180 
CaMds3          EIRP---------------------------------KPRLLHQICAFNNCLYLFGGLAL 133 
                                                     * **:*.:*  :. :*:**** : 
 
Scpmd1          SPHNG--YELIATNELWKLDLKTKCWSLISE-------NPQITRRFNHSMHVLNEN---N 200 
ScMds3          SPQSG--YELIATNELWKLDLNTKKWSLLSD-------DPQIARRFNHTMHVKNEN---N 228 
CaMds3          SQENDEDPTLVPCNDLWEFDLVLKKWTLLDDGSNYELDDAVPSPRFNHKLTVISSLSFAN 193 
                * ...    *:. *:**::**  * *:*:.:       :.  : ****.: * ..    * 
 
Scpmd1          ENQDTKLIIVGGLDNMDIPVKKIDIFNLRTSLWESESKSDENPASKGSSKILVNIDGMPI 260 
ScMds3          DNRDTKLIIVGGLNNMDQPVKKIDIYNISQNCWHPKTIP------KQPMEITTNVNGIPL 282 
CaMds3          RKDHFGLFIAGGKDKQSNEIYDNSIFDLVEKRYVGSQPFR---LVATTGDDTKDKETGLN 250 
                 : .  *:*.** :: .  : . .*:::  . :  .           . .   : :     
 
Scpmd1          SLSHDSNFSVLIENNQAEIPTLALYYPQREANTSRRGTDDGSFSTYAHDLDDKSKLPKHH 320 
ScMds3          ALSKDQNFSILVENNEANVPALAFYMRSDQIDEYLG--------------KDSSKIKEN- 327 
CaMds3          EFVSNPEHFLNVDQTRNAILSITDDADTPNRKQNKNPSNHHESIVVYGPTRQTGDCQNS- 309 
                 :  : :. : :::..  : :::      : .                   :...  :   
 
Scpmd1          HHHHGDLKYFESDDADENAVKTLMSPIVILPLLGNSQGARMTSNPTQNNKENSILQVPFH 380 
ScMds3          ------------------------SPIVALPLLSESQGIRMPSNPALPKK---LLNVPYE 360 
CaMds3          ----------------------LVSFKVGKREIKGGKVLRLHKNSRVAKLK--QSIIPYN 345 
                                        *  *    :  .:  *: .*.   :       :*:. 
 
Scpmd1          LQYPSGNYFNYNIVVIGFYPDPQPSNLHCFIYNIASGKWIRVNIACTECSISMHRFWKLL 440 
ScMds3          LLAPTGDYFGFNIIIGGFHPNYQSSNFHCFIYDINSGKWSRVRTACPDCDINKHRFWRVF 420 
CaMds3          LRYPTAGLFGQNVVLTGFLP--DEYEISIFVYNRPTGKWSRLNIFCS-HEYGSHRFWGGF 402 
                *  *:.. *. *::: ** *  :  ::  *:*:  :*** *:.  *.  . . ****  : 
 
Scpmd1          IWKSHHQALLLGTRTDDFCSPSVQKFDHILSFSLPMLNGYNKLVNTKHTRTN-------- 492 
ScMds3          VWKSHHQTILLGTKTDDYYSPSVQRFDHLSTFGLPLVNIFNKTIQLPHHKIS-------- 472 
CaMds3          AWQSHHKVILIGNSMTSRTTSSVRFFSIMLTVSLPITNILVSSELSKGRSNNRTSSFVSH 462 
                 *:***:.:*:*.   .  :.**: *. : :..**: *   .         .         
 
Scpmd1          TS------QFENYSRYITVPLEMESTSSIFPPYAMVLGKDALEIFGKTLSDFEFITADGD 599 
ScMds3          TS------QFENYIRYIAPPLEMSSIQSVFPPYAMVLGKDALEIYGKPLSDFEFITSEGD 554 
CaMds3          SDKSPTAVSFSDYVHYAAPKTTYTTIRSVFPPEAITLGRNAFNRIGDLIADIELVSCNGD 582 
                :.      .*.:* :* :      :  *:*** *:.**::*::  *. ::*:*:::.:** 
 
Scpmd1          SIGVPVYLLRKRWGRYFDSLLSNGYANTSFNYEFNGDTSNIISFSPHTASKTTKFGNSS- 658 
ScMds3          SIGIPCYLLRKRWGRYFDMLLSQSYTKVCADYETTDTQSTLIKFSPHSSRNSSKAVRQEG 614 
CaMds3          RIPVSSAVLMERWGQHFISLLAKGYINAVDKFETDQALG--------------------- 621 
                 * :.  :* :***::*  **::.* :.  .:*     .                      
B) 
Scpmd1          FFSSKSYINNEKSRRLSYISNPESVESTNSNNNAIIELEPLLTPRSLYMPWSTASVRAFA 1125 
ScMds3          TIQTPTSSNNEWSR-QSVTSNTDSFDSLQSN--FALELEPLLTPRSLYMPWPTSTVRAFA 1022 
CaMds3          SIGFQEFNKNPISMFDNALLNFDNIDSENFR------MEPSLIPRKLYIPFMTLTVKAFC 938 
                 :      :*  *   .   * :..:* : .      :** * **.**:*: * :*:**. 
 
Scpmd1          EFFYTAQINGKWLLAPVTLDLLIMAKIYEIPILYELITEVLYKIISKKEEGLSVTCEALL 1185 
ScMds3          EFFYTGQVNSKWLLAPVALDLLVMAKIYEIPLLYKLILEVLYSILAKKEESLSLICTSLM 1082 
CaMds3          EYLYTGQIGNKWLLAPTLMDNLLISKFYRVPLLYDLISEILFGVIGKKEAYIIGEARKLK 998 
                *::**.*:..******. :* *:::*:*.:*:**.** *:*: ::.***  :   .  *  
 
Scpmd1          NLFQQKVSRYCNENEGKIRKQLDSSESYQDTLEIKRSLANIDNGYVDSYLLRNTSMAQSI 1245 
ScMds3          ETFRTKTLNSYKGDEEKTNTYLTSNDNYQELLKLKVSLENIDNGYYDPDLLRKQSRAQSS 1142 
CaMds3          ARYFKLLRGANIPIDSNYEFPMDEYDG---------FLDTVDDGYLDITLLKKASKIHAD 1049 
                  :           : : .  : . :.          * .:*:** *  **:: *  ::  
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 Mds3, ScMds3, and Pmd1 contain several regions that were predicted to be highly 
disordered by the program PreDisorder (Deng et al., 2009). In the three proteins, the disordered 
regions fell between two ordered regions spanning the predicted Kelch domain region and the 
putative BTB/POZ domain, and included the serine-rich region and the C-terminal portion 
(Figure 2.2B and data not shown). In Mds3 the program predicted a third ordered region of ~ 50 
amino acids that lies right before the serine-rich region, and a fourth ordered region of 136 amino 
acids between amino acids 1109 and 1245 that did not show any homology to any functional 
domain in database searches; and BLASTp searches only identified putative uncharacterized 
MDS3 orthologs in other fungal species.  
 
Figure 2.2: Bioinformatic and genetic analysis of Mds3. A) Representation of the 
putative functional domains in Mds3 identified bioinformatically, including sites of 
mutagenesis with Tn7 and epitope tags. SRR = serine rich region; B= BTB/POZ; 
P=PEST; C=coils. Triangle: V5 tags in unique restriction sites. Rhombus: 5 amino acid 
insertions obtained through Tn7 random mutagenesis. Red, yellow, and green colors 
indicate if the insertion is functional, partially functional, or non-functional, respectively. 
B) Prediction of ordered and disordered regions in Mds3. C) Hypothetical 3-D folding of 
the first 400 amino acids of Mds3 N-terminus into a six-bladed Kelch propeller. 
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I further characterized Mds3 and its orthologs using programs that predict signal 
peptides, coils, and PEST domains. While neither Mds3 nor Pmd1 were predicted to contain a 
signal peptide in their N-termini, Signal IP 3.0 predicted that ScMds3 contains a signal peptide 
(cut-off 0.48) at amino acid positions 1-11. The program COILS predicted that Mds3 contains 
coils between amino acids 1218 and 1237 (Figure 2.2A), while ScMds3 is predicted to have coils 
between amino acids 738-758, 1108-1125, 1267-1298, 1326-1351, and 1456-1476; and Pmd1 has 
a similar distribution as ScMds3. Other coils predictive programs produced similar results for 
Mds3 (data not shown). Finally, the program ePESTfind predicted that Mds3 contains a potential 
PEST domain between amino acids 631-644 (PEST Score: 12.76) (Figure 2.2A); while ScMds3 
was predicted to have potential PEST domains between amino acids 654-678 (PEST Score: 
18.91), 681-695 (PEST Score:20.61), 870-899 (PEST Score: 10.99), and 917-932 (PEST Score: 
9.16); and Pmd1 was predicted to have PEST domains between amino acids 707-723 (PEST 
Score:  6.42), 1026-1046 (PEST Score: 5.82), 1323-1346 (PEST Score: 15.09), and 1353-1367 
(PEST Score: 12.74). Thus, although there are differences between ScMds3, Pmd1, and Mds3, 
the programs identified three common features among these proteins: that they contain highly 
disordered regions in their ORFs that are similarly aligned, PEST domains, and a C-terminal 
region with coils. 
From the combination of all the bioinformatic data, the following picture of Mds3 
emerges (Figure 2.2). Mds3 appears to have at least one Kelch domain in the N-terminus, 
followed by a serine-rich region that contains a putative PEST domain, a ~150 amino acid 
segment highly conserved between C. albicans and S. cerevisiae with low homology to 
BTB/POZ domains, and a third ordered region close to the C-terminus, of unknown function, 
which ends in putative coil structural motifs. Furthermore, Mds3 contains highly disordered 
regions that span the serine rich and C-terminal regions. 
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Uncovering more Kelch domains 
Kelch domains are 44-56 amino acids long, and consist of a four-stranded antiparallel β-
sheet. Only 8 (generally) conserved residues are required to form a Kelch domain: 4 hydrophobic 
residues followed by 2 glycines constitute the second strand of the β-sheet, and are separated 
from 2 aromatic residues which are located each in the third and fourth strand of the β-sheet 
(usually W and Y). Kelch domains fold into a tertiary structure called the β-propeller, in which 
each Kelch domain constitutes a blade of the propeller (Adams et al., 2000). The sequence 
conservation between Kelch repeats is low, and the sequences that separate each strand and each 
β-sheet (loops) are variable in length. For these reasons, motif databases are often unable to 
identify the Kelch repeats. Manual alignment is sometimes required to uncover Kelch domains, as 
was the case of the Kelch proteins Gpb1/Krh2 and Gpb2/Krh1 (Harashima et al., 2002; Peeters et 
al., 2006). Because the Kelch β-propeller requires a minimum of four Kelch domains in order to 
fold properly but only one was found bioinformatically in Mds3, I manually searched for more 
Kelch domains in Mds3 and was able to model the N-terminus of Mds3 into a Kelch β-propeller, 
in collaboration with Douglas Ohlendorf and Andy Kruse (Department of Biochemistry, 
University of Minnesota). Using as a template other Kelch containing proteins, the N-terminus of 
Mds3 was modeled into a six-bladed Kelch propeller (Figure 2.2C). The first 4 Kelch domains 
were largely contiguous, except that the first strand of the first Kelch domain was at the C-
terminus of the protein (a common arrangement in other Kelch proteins (Prag and Adams, 2003)). 
However, the fifth and sixth Kelch domains appeared to be separated from the other Kelch 
domains by a longer stretch of amino acids. Loops of diverse lengths protruded from Mds3‟s 
Kelch propeller, which could serve as platforms for protein-protein interactions. Therefore, even 
though domain prediction algorithms only recognized one Kelch repeat, Mds3 N-terminal region 
appears to fold into a 6-bladed Kelch propeller. 
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 To further assess the functional relevance of the Kelch domains in the N-terminus of 
Mds3, I generated point mutations in the only Kelch domain detected bioinformatically (Figure 
2.1, underlined) and tested the alleles for mds3Δ/Δ complementation in YPD, LiCl, pH 9, and 
M199 pH 8. Following a previously published Kelch mutational strategy (Gomez et al., 2000), I 
constructed MDS3 alleles containing single or double amino acid substitutions in the second 
strand of the second Kelch repeat. I made conserved (L→I) and non-conserved substitutions (Y, 
I, G→A) (Figure 3.2 and Table 2.2), and tested the ability of the alleles to rescue an mds3Δ/Δ 
mutant. I also generated a Y→F mutation, which is moderately conservative change considering 
that F and Y are structurally similar and that F is more hydrophobic than Y (high hydrophobicity 
being the “conserved” characteristic of the amino acids in this location). As expected, strains 
carrying plasmids with conserved mutations (L→I and Y→F) behaved like the wild-type and 
mds3Δ/Δ + MDS3 strains for growth in YPD, YPD + LiCl, YPD pH 9, and filamentation in solid 
and liquid M199 pH 8 (Figure 2.3B and 2.3C and Table 2.4). Strains carrying plasmids with non 
conserved mutations (Y, I, G→A) behaved like the mds3Δ/Δ strain for growth in YPD, YPD + 
LiCl, YPD pH 9 and filamentation in solid and liquid M199 pH 8 (Figures 2.3B and 2.3C and 
Table 2.4). There was no observable difference between the two alleles that rescued the mds3Δ/Δ 
mutation and between the two alleles that did not rescue the mds3Δ/Δ mutation. Thus, these 
results indicate that the integrity of the predicted second Kelch domain is critical for Mds3 
function. It is important to note that the non-conserved mutations might affect folding/stability of 
Mds3. However, Western blot analysis of an mds3Δ/Δ + MDS3G129A L131S::V5 strain (LUZ83) 
showed Mds3-V5 expression at the expected size and no indication of degradation (data not 
shown). Overall, these results support the model that Mds3 contains a six bladed Kelch propeller 
in its N-terminus. 
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Figure 2.3: Functional characterization of the only bioinformatically identified Kelch 
repeat in Mds3 by site-directed mutagenesis. A) Description of the alleles constructed in 
the second blade of the second Kelch Repeat. Mutated amino acids are shown in red 
lowercase. B, C) Growth in YPD, YPD+150mM LiCl, and YPD pH 9, and filamentation 
in solid M199 pH 8 of the wild-type strain (DAY185), mds3Δ/Δ (DAY1118), and 
mds3Δ/Δ strains carrying wild-type (DAY1119) or mutated versions of MDS3: 
MDS3
Y126A L127A
 (LUZ397), MDS3
G129AL131S
 (LUZ399), MDS3
Y126F L127I
  (LUZ400), and 
MDS3
Y125I L127I
 (LUZ402). 
 
Random Tn7 mutagenesis: looking for a benign spot in MDS3 ORF 
Since there are no commercially available antibodies against Mds3, it was necessary to 
tag Mds3 with an epitope or with GFP in order to detect it. I first tried to tag Mds3 at unique 
internal restriction sites or at the C- or N-termini of the protein. Internal V5-His6 tagging of the 
Mds3 ORF at unique restriction sites (HpaI, BstBI, and NruI) (Figure 2.2A, red/yellow triangles) 
yielded Mds3-V5 versions that were partially or non-functional (Figure 2.4). The HpaI and 
BstBI-V5-His6 tagged alleles were partially functional (Figure 2.4A and 2.4B). This result was 
unexpected, since both restriction sites are predicted to lie within disordered regions which are 
generally more permissive to mutations (HpaI is ~ at amino acid 1377, and BstBI is ~ at amino 
acid 1043). The NruI-V5-His6 tag was located ~ at amino acid 382, within the predicted Kelch 
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domains, and was non-functional (Figure 2.4A and 2.4B). Further, addition of GFP to the N-
terminus or C-terminus of Mds3, or addition of a 3xHA tag at the C-terminus of Mds3 also 
yielded non-functional proteins (Figure 2.4 and data not shown). Since both the N-and C-terminal 
portions of Mds3 were predicted to fold into Kelch repeats (see above) it was not surprising that 
Mds3 did not tolerate insertions at any of these terminal regions. It became clear that finding a 
benign site in Mds3 that tolerated the epitope tag would require a more extensive functional 
analysis of Mds3‟s ORF. 
 
Figure 2.4: Functional characterization of the tagged Mds3 alleles. A) Growth in YPD, 
YPD+150mM LiCl, and YPD pH 9, and filamentation in solid M199 pH 8 of the wild-
type strain (DAY185), mds3Δ/Δ (DAY1118), mds3Δ/Δ+MDS3 (DAY1119) and the 
following tagged alleles: MDS3::V5 [V5 at amino acid position 1056] (LUZ379), 
MDS3::V5 [V5 at unique HpaI site] (LUZ14), MDS3::V5 [V5 at unique NruI site] 
(LUZ17), MDS3::V5 [V5 at unique BstBI site] (LUZ20), and MDS3::HA [HA at C-
terminus] (LUZ23). C) Western blot of tagged Mds3 alleles. Overnights of MDS3::V5 
(LUZ379) and MDS3::HA (LUZ23) were diluted 1:40 in YPD, and incubated for 4 hrs at 
30°C before protein extraction.  
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 In order to find regions within Mds3 that tolerated small insertions without significantly 
affecting Mds3 function, we performed random mutagenesis of Mds3‟s ORF using the GPS-LS 
Linker Scanning System. In this system, a Tn7 transposon is randomly inserted within the ORF of 
Mds3, and after excision the transposon leaves a 5 amino acid (15 nt) mutagenic insertion. We 
generated 34 MDS3 alleles with Tn7 insertions throughout the ORF (Table 2.5). Approximately 
one third of the insertions generated a stop codon (10/34 insertions) and 3/34 insertions had 
defective sequence runs making it impossible to determine precisely the location of the insertion 
or the mutation caused by the insertion. The remaining 21/34 insertions generated full length 
MDS3 alleles with 15 nucleotides (or 5 amino acids) insertions that spanned the Mds3 ORF, 
although most of the alleles were concentrated around the serine-rich region, between amino 
acids 470 and 950 (Figure 2.2A and Table 2.5). 13/21 alleles were successfully subcloned into a 
shuttle vector for integration into the HIS1 locus of Candida. Most of these alleles were tested for 
their ability to rescue the mds3Δ/Δ phenotypes for growth in YPD, YPD+LiCl, YPD pH 9, and 
for filamentation in solid and liquid M199 pH 8 (Figure 2.5 and Davis et al., 2002). Alleles 55.1, 
67.1, 12.1, 33.1, 36.1, and 82.1 behaved like the mds3Δ/Δ mutant in all media tested, indicating 
that the 15 nt insertions disrupted Mds3 function (Figure 2.5). Most MDS3-Tn7 alleles with a 
functional defect had insertions between amino acids 528 and 935, with the exception of allele 
MDS3-12.1 whose insertion was at amino acid position 1361 (Figure 2.5, Table 2.5). The null 
phenotype of allele MDS3-55.1, which carries an insertion at the region of Mds3 predicted to be a 
BTB/POZ region, indicates that indeed this region is required for Mds3 function (Figures 2.2 and 
2.5). On the other hand, alleles 4.2, 41.1, 56.1, and 20.1 behaved like the wild-type and 
mds3Δ/Δ+MDS3 strains in all media, indicating that their 15 nt insertions were not affecting 
Mds3 function (Figure 2.5). These MDS3-Tn7 alleles with a wild-type function had insertions 
either at the C-terminal region (amino acids position 1051, or 1378) or within or near the Kelch 
domains (amino acids position 226 and 526) (Figure 2.5 and Table 2.5). Therefore, the behavior 
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of the different alleles suggests that the middle region of Mds3 is less tolerant to insertions than 
the C-terminal region of Mds3, and that the region of the Kelch domains can tolerate small 
insertions (especially if they fall in the loops between the propeller blades). I noted that in all 
cases the alleles showed a homogeneous response in all media, i.e. they either showed a null 
phenotype or a wild-type phenotype in all conditions tested. It is also important to point out that 
the null phenotype of some of the Mds3-Tn7 alleles might be caused by misfolding or lower 
stability of the allele, and not because the insertions affect specific functional domains in Mds3. 
Overall, I found 4 MDS3 alleles that tolerated 15 nt insertions (Table 2.5). 
         
Figure 2.5: Functional characterization of the MDS3-Tn7 alleles. Growth in YPD, 
YPD+150mM LiCl, and YPD pH 9, and filamentation in solid M199 pH 8 of the wild-
type strain (DAY185), mds3Δ/Δ (DAY1118), mds3Δ/Δ+MDS3 (DAY1119) and the 
following alleles: MDS3-4.2 (LUZ426), MDS3-41.1 (LUZ427), MDS3-55.1 (LUZ431), 
MDS3-56.1 (LUZ433), MDS3-67.1 (LUZ436), MDS3-12.1 (LUZ441), MDS3-20.1 
(LUZ444), MDS3-33.1 (LUZ446), MDS3-36.1 (LUZ448), MDS3-82.1 (LUZ450). 
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Mds3 localization 
The subcellular localization of a protein is intimately connected with its function. Thus, 
finding where Mds3 localizes in Candida cells should aid in understanding Mds3 function. From 
bioinformatic analyses, neither ScMds3 nor Mds3 were predicted to be targeted to the peroxisome 
or the mitochondria (MITOPROT and PTS1), and Mds3 was predicted to be nuclear by 
ProtComp Version 6 and WoLFPSORT. However, large scale analysis of protein subcellular 
localization in yeast identified ScMds3 in the mitochondria (Sickmann et al., 2003, Reinders et 
al., 2006; Huh et al., 2003) and in the cytoplasm (Kumar et al.2002; Horton et al., 2007). Thus, to 
experimentally determine Mds3 localization in C. albicans, we constructed an epitope tagged 
version of Mds3 using the locations that tolerated small insertions discovered by the Tn7 
mutagenesis strategy (see above), and performed indirect immunofluorescence studies. 
Three MDS3::V5::HIS6 alleles were generated that contained the V5 epitope tag at either 
one of the three sites that tolerated the 5 amino acids insertion: amino acids positions 226, 526 
and 1051 (alleles 41.1, 4.2, and 56.1) [the fourth location: allele 20.1, was found after Mds3 had 
been successfully tagged and was therefore not used for tagging]. Replacing the 5 amino acids 
insertion with the 23 amino acids of the V5-His6 tag in the three sites generated non-functional 
alleles (data not shown). The lack of function of the tagged allele at position 226 can be explained 
by a disruption in the conformation of the Kelch domains in that area, similar to the NruI-V5-
His6 tag defect (see above). The insertions at amino acid positions 526 and 1051 fell in regions 
that were predicted to be ordered (Figure 2.2A), which might explain why these regions can 
tolerate a small insertion but not the insertion of the tag. The insertion at amino acid position 
1051 fell near a predicted disordered region. Therefore, we generated a construct in which the tag 
was placed at position 1056, within the predicted disordered region. This V5-His6 tagged allele at 
position 1056 was fully functional (strain LUZ379) (Figures 2.4 and 2.7) and produced a protein 
of the expected size (Figure 2.4C). The mds3Δ/Δ strain carrying a functional MDS3::V5::HIS6 
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tagged allele was grown in M199 pH 8 for 4 hours, fixed with formaldehyde, and used in indirect 
immunofluorescence studies to localize Mds3. Mds3 localized in discrete spots throughout the 
yeast cytoplasm (Figure 2.6).  
 
Figure 2.6: Mds3 localizes in discrete cytoplasmic spots. Indirect immunofluorescence 
of an untagged wild-type (a,c) and mds3Δ/Δ + MDS3-V5 (LUZ379) (b,d) strains. Red: 
Mds3-V5, Blue: DAPI. 
 
It would be interesting to determine if the localization of Mds3 is influenced by the 
function of the Kelch or putative BTB/POZ domains. For this purpose the Kelch domain alleles 
tested above (Figure 2.3 and Table 2.4) were tagged with a V5::HIS6 tag in the benign location 
identified above. The tagged Kelch alleles were tested for growth in YPD, YPD+LiCl, and for 
filamentation in solid M199 pH 8 to determine if there was an additive effect of the V5::HIS6 tag 
and the Kelch mutations in the function of Mds3. We did not observe any additive effect of both 
mutations on the function of Mds3 (Figure 2.7). Thus, the alleles are ready to be used to 
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determine protein stability and localization of the Kelch alleles. A similar process should be 
carried out with the Tn7 allele MDS3-55.1 which fell within the predicted BTB/POZ domain. 
 Therefore, from these bioinformatics, genetic, and localization studies, Mds3 appears to 
be a cytoplasmic Kelch/BTB protein, which contains a serine rich region bridging the N- and C-
terminus of the protein, two other ordered regions of unknown function, and several highly 
disordered regions that span the ORF. 
 
Figure 2.7: Functional characterization of the MDS3-Kelch::V5 tagged alleles. A,B) 
Growth in YPD and YPD+150mM LiCl, and filamentation in solid M199 pH 8 of the 
wild-type strain (DAY185), mds3Δ/Δ (DAY1118), mds3Δ/Δ+MDS3 (DAY1119), 
mds3Δ/Δ+MDS3::V5 (LUZ379) and the following Kelch::V5 tagged alleles: MDS3Y125I 
L127I
::V5 (LUZ462), MDS3
Y126F L127I
::V5 (LUZ461), MDS3
Y126A L127A
::V5 (LUZ464), and 
MDS3
G129AL131S
::V5 (LUZ466). 
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DISCUSSION 
 
Bioinformatic analyses are a useful first step to predict potential functions of 
uncharacterized proteins. The combination of bioinformatic domain searches and protein 
modeling showed that Mds3 likely contains a six-bladed Kelch propeller in its N-terminus, 
followed by a serine rich region that contains a PEST domain, and two ordered regions in the C-
terminal half, one of which has low homology to BTB/POZ domains. Thus, Mds3 appears to be a 
modular protein: a multidomain protein with flexible, disordered linker regions (Dyson and 
Wright, 2005).  
The most prominent functional domain in Mds3 is the N-terminal Kelch propeller. 
Although the first crystallized Kelch β-propeller belongs to the enzyme galactose oxidase, the 
Kelch propellers are generally considered to function as protein-protein interaction domains 
(Adams et al., 2000). Kelch motifs have very low sequence conservation. However, alterations in 
key residues such as the glycines and the hydrophobic residues in the second β-strand of a Kelch 
domain (the most conserved of the strands) can render the protein non-functional (Gomez et al., 
2000). Accordingly, we found that site-directed mutagenesis to non-conserved residues in the 
second β-strand of the bioinformatically predicted Kelch domain of Mds3 had significant effects 
on protein function (Figure 2.2A and 2.3). The loops that protrude from the propeller, which are 
variable in length, can also function as sites for protein interactions. This might explain why 
several 5 amino acid insertions and most 23 amino acids insertions in the Kelch domain areas 
rendered a non-functional protein (Figure 2.2A, 2.4, and data not shown). It remains possible that 
the lack of function of Mds3 alleles carrying non-conserved point mutations or insertions is due 
to an increased instability of the protein. However, similar point mutations in Rag2 Kelch 
domains did not alter protein stability (Gomez et al., 2000), and we also detected expression of 
non-complementing Mds3
G129A L131S
-V5 tagged and Mds3-C-terminal-HA tagged strains by 
Western blot, with no obvious evidence of protein degradation (Figure 2.4B and data not shown). 
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Thus, it is likely that the different mutations within the Kelch domains are affecting Mds3 
function by limiting its ability to interact with other proteins, and not by causing protein 
degradation. Overall, the four approaches: two bioinformatic and two mutational, independently 
support the conclusion that the first ~400 amino acids of the Mds3 N-terminal region fold into a 
six-bladed Kelch β-propeller whose integrity is required for Mds3 to fulfill its role in growth, 
resistance to LiCl and pH 9, and filamentation in C. albicans.  
 The second domain predicted in ScMds3 was the BTB domain (Figure 2.2A). Similar to 
Kelch domains, BTB domains have a low degree of sequence conservation. However, the 
secondary structure and overall arrangement of the domain is conserved: 5 α-helices with a 3-
stranded β-sheet at one end (Perez-Torrado et al., 2006). Even though the BTB domain was 
identified in ScMds3 only with low homology, there is high sequence similarity between 
ScMds3, Mds3, and Pmd1 in that region of the proteins. Further, secondary structure predictions 
using Phyre indicate that the “BTB” region in Mds3 folds into α-helices, and that there is a 
potential 2-stranded β-sheet N-terminal to the domain (data not shown), which supports the 
existence of a poorly conserved BTB domain in Mds3 as well. Independent evidence suggests 
that this region is critical for function. First, insertional mutations in the “BTB” region caused 
Mds3 to lose functionality (Figure 2.5, allele MDS3-55.1). Second, overexpression of the C-
terminal region of ScMds3 has a dominant negative effect, suggesting titration of an interacting 
factor (Benni and Neigeborn, 1997). BTB domains can homo-, hetero-, or oligo-dimerize, 
depending on the sequence and structure of the domain; and they are usually involved in 
transcription and protein degradation (Perez-Torrado et al., 2006). BTB domains are usually 
associated with Kelch domains in metazoans (Prag and Adams, 2003). The function of most 
Kelch/BTB proteins remains unknown, but they have been suggested to function in multi-protein 
complexes (Prag and Adams, 2003). Overall, our results suggest that Mds3 is a Kelch/BTB 
protein.  
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Mds3 contains a ~250 amino acids long serine rich region in the middle of the protein, 
which is predicted to have a PEST domain. PEST domains are segments of low sequence 
conservation rich in proline (P), glutamic acid (E), serine (S), threonine (T), and aspartic acid that 
are flanked by arginine or lysine residues. The presence of PEST domains often correlates with 
short half life of proteins, and they are thought to be cleavage sites that promote protein 
degradation by proteosomes (Rogers et al., 1986; Rechsteiner and Roggers, 1996). In fact, PEST-
like regions are cleaved by calpains (Tompa el at., 2004) and caspases (Garay-Malpartida et al., 
2005). Many of the proteins with caspase cleavage domains are involved in signal transduction 
pathways, such as mTOR, MAPK, and PI3K/Akt (Belizario et al., 2008). Furthermore, PEST 
regions often contain consensus sites for several kinases, and it has been shown that many PEST-
containing proteins are regulated by phosphorylation. While Mds3 was predicted by a stringent 
evolutionary proteomics approach to be a substrate for PKA (amino acid position 754 in ScMds3 
and 518 in Mds3), the predicted phosphorylation sites do not fall within the predicted PEST 
domains (Budovskaya et al., 2005 and Figure 2.2A). However, it is possible that Mds3 is a 
substrate for other kinases, such as PKC and TOR. Therefore, the presence of putative PEST 
domains and phosphorylation sites in Mds3 suggests that Mds3 function is controlled 
posttranslationally through different mechanisms. 
 One interesting aspect of Mds3 that became evident from the bioinformatic analysis was 
the presence of several highly disordered regions across the ORF (Figure 2.2B). Intrinsically 
disordered proteins are common in eukaryotes, and fulfill diverse functions including 
transcriptional and translational regulation and signal transduction (Dyson and Wright, 2005; 
Garza et al., 2009). Proteins vary in the distribution and extent of their disordered regions, 
ranging from highly unstructured to modular (multidomains joined by linkers) to highly folded 
structures. Posttranslational modifications such as phosphorylation, or the binding to a substrate 
can alter the conformation and function of an unstructured region and cause it to fold into a 
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secondary or tertiary defined structure. The flexibility of the disordered regions allows proteins to 
adopt different conformations, increasing the type and number of targets they can interact with. 
Thus, many modular proteins function as scaffolds in multiple signal transduction pathways and 
are part of multi-protein complexes (Iakoucheva et al., 2002; Dyson and Wright, 2005). The 
modular characteristics and length of the Mds3 ORF, and the presence of two potential protein-
protein interaction domains, suggest that indeed Mds3 could function as a molecular scaffold. 
Another bioinformatic prediction for ScMds3, but not Mds3, was the presence of a signal 
peptide. Signal peptides target the nascent amino acid chain to the endoplasmic reticulum, where 
it is re-directed for secretion to the extracellular space or to organelles such as the mitochondria 
or the chloroplasts (Martoglio and Dobberstein, 1998; Hedge and Bernstein, 2006). Interestingly, 
ScMds3, but not Pmd1, was predicted to contain a signal peptide, suggesting localization and/or 
functional differences between the paralogs. In support of this, large scale proteomic analyses 
found ScMds3 (but not Pmd1) in the mitochondria (Sickmann et al., 2003; Reinders et al., 2006; 
Huh et al., 2003). Our results and those of others also localize Mds3 in the cytoplasm (Figure 2.5, 
Kumar et al., 2002; Horton et al., 2007), where Mds3 appears to localize to discrete spots 
randomly dispersed in the cytoplasm (Figure 2.5). While some of these spots could indeed be the 
mitochondria, another appealing hypothesis is that they constitute vesicles or endosomes. Besides 
a role in vesicle trafficking, endosomes provide a surface for the convergence of multiple 
signaling pathways, including the Rim101 pathway, the mating response pathway, and the TOR 
dependent and independent nitrogen starvation response pathway (Mitchell, 2008; Hancock, 
2003; Zurita-Martinez et al., 2007; Sturgill et al., 2008; Aronova et al., 2007; Slessareva et al., 
2006; Puria et al., 2008; Xu et al., 2004). A second appealing hypothesis is that the cytoplasmic 
spots are plasma membrane microdomains. Plasma membrane microdomains, such as the Ras 
nanoclusters, are involved in the regulation of signal transduction (Hancock and Parton, 2005; 
Tian et al., 2007). Since we hypothesize that Mds3 functions as a scaffold in signal transduction 
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pathways, its localization on the surface of endosomes or at plasma membrane microdomains 
would be ideal to fulfill this role. 
In sum, our bioinformatic, mutational, and localization studies support a model in which 
Mds3 is a cytoplasmic, modular, Kelch-BTB protein that functions as a scaffold and participates 
in the regulation of signal transduction cascades.  
 
Plenty of work is still required to better understand the function of Mds3. However, I 
have presented here preliminary data and have constructed molecular tools that should aid in 
answering some of the questions regarding localization, structure, posttranslational modifications, 
and molecular interactions of Mds3. For example, the availability of tagged Mds3 alleles under 
the control of its own promoter or overexpressed (data not shown) are ideal for large scale 
experiments to find Mds3 binding partners and determine Mds3 putative posttranslational 
modifications. Studies of co-localization of Mds3 with endosomal and other organelle markers 
(such as Mitotracker, etc) using immunofluorescence and confocal microscopy or subcellular 
fractionation should contribute to define the localization of Mds3 in the cell. Further, it would be 
interesting to determine whether the Kelch and/or putative BTB domains are required for proper 
Mds3 protein interactions or localization. Finally, if Mds3 is indeed a phospho-protein, it would 
be interesting to find the kinase(s) and phosphatases responsible for the phosphorylation/de-
phosphorylation of Mds3; to determine what residues in Mds3 are important for phosphorylation; 
to determine what role the phosphorylation plays on Mds3 function, localization, interactions, 
stability, and structural conformation; and to find the signals (if any) that lead to changes in the 
phosphorylation status of Mds3. A similar analysis can be performed for any other 
posttranslational modification that Mds3 is shown to undergo.  
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TABLES 
Table 2.1. C. albicans strains used in this study 
Strain Parent Genotype Reference 
DAY1 
(BPW17) 
SC5314 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG 
arg4::hisG/arg4::hisG 
Wilson et 
al., 1999 
DAY185 DAY286 ura3::λimm434/ura3::λimm434  pHIS1::his1::hisG/his1::hisG  
ARG4::URA3::arg4::hisG/arg4::hisG 
Davis et al., 
2000 
DAY938 BWP17 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3dpl200 
Zacchi et 
al., 2010 
DAY1118 DAY938 ura3::λimm434/ura3::λimm434  HIS1::his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3dpl200 
Zacchi et 
al., 2010 
DAY1119 DAY938 ura3::λimm434/ura3::λimm434  HIS1::MDS3::his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3dpl200 
Zacchi et 
al., 2010 
LUZ14 DAY956 ura3::λimm434/ura3::λimm434  HIS1::MDS3::V5::his1::hisG/ 
his1::hisG  arg4::hisG/arg4::hisG  mds3::ARG4/mds3::dpl200 
This study 
LUZ17 DAY956 ura3::λimm434/ura3::λimm434  HIS1::MDS3::V5::his1::hisG/ 
his1::hisG  arg4::hisG/arg4::hisG  mds3::ARG4/mds3::dpl200 
This study 
LUZ20 DAY956 ura3::λimm434/ura3::λimm434  HIS1::MDS3::V5::his1::hisG/ 
his1::hisG  arg4::hisG/arg4::hisG  mds3::ARG4/mds3::dpl200 
This study 
LUZ23 DAY415 ura3::λimm434/ura3::λimm434 his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::ARG4/MDS3::HA::URA3 
This study 
LUZ316 DAY956 ura3::λimm434/ura3::λimm434  HIS1::MDS3G129A 
L131S::V5::his1::hisG/ his1::hisG  arg4::hisG/arg4::hisG  
mds3::ARG4/mds3::dpl200 
This study 
LUZ379 DAY938 ura3::λimm434/ura3::λimm434  HIS1::MDS3::V5::his1::hisG/ 
his1::hisG  arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3dpl200 
This study 
LUZ397 DAY938 ura3::λimm434/ura3::λimm434  HIS1::MDS3Y126A L127A::his1::hisG/ 
his1::hisG  arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3dpl200 
This study 
LUZ399 DAY938 ura3::λimm434/ura3::λimm434  HIS1::MDS3G129A 
L131S::his1::hisG/his1::hisG  arg4::hisG/arg4::hisG  
mds3::ARG4/mds3::URA3dpl200 
This study 
LUZ400 DAY938 ura3::λimm434/ura3::λimm434  HIS1::MDS3Y126F 
L127I::his1::hisG/his1::hisG  arg4::hisG/arg4::hisG  
mds3::ARG4/mds3::URA3dpl200 
This study 
LUZ402 DAY938 ura3::λimm434/ura3::λimm434  HIS1::MDS3L125I L127I::his1::hisG/ 
his1::hisG  arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3dpl200 
This study 
LUZ426 DAY938 ura3::λimm434/ura3::λimm434  HIS1::MDS3-
4.2::his1::hisG/his1::hisG  arg4::hisG/arg4::hisG  
mds3::ARG4/mds3::URA3dpl200 
This study 
LUZ427 DAY938 ura3::λimm434/ura3::λimm434  HIS1::MDS3-41.1::his1::hisG/ 
his1::hisG  arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3dpl200 
This study 
LUZ431 DAY938 ura3::λimm434/ura3::λimm434  HIS1::MDS3-55.1::his1::hisG/ 
his1::hisG  arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3dpl200 
This study 
LUZ433 DAY938 ura3::λimm434/ura3::λimm434  HIS1::MDS3-56.1::his1::hisG/ 
his1::hisG  arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3dpl200 
This study 
LUZ436 DAY938 ura3::λimm434/ura3::λimm434  HIS1::MDS3-67.1::his1::hisG/ 
his1::hisG  arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3dpl200 
This study 
LUZ441 DAY938 ura3::λimm434/ura3::λimm434  HIS1::MDS3-12.1::his1::hisG/ 
his1::hisG  arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3dpl200 
This study 
LUZ444 DAY938 ura3::λimm434/ura3::λimm434  HIS1::MDS3-20.1::his1::hisG/ 
his1::hisG  arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3dpl200 
This study 
LUZ446 DAY938 ura3::λimm434/ura3::λimm434  HIS1::MDS3-33.1::his1::hisG/ 
his1::hisG  arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3dpl200 
This study 
LUZ448 DAY938 ura3::λimm434/ura3::λimm434  HIS1::MDS3-36.1::his1::hisG/ 
his1::hisG  arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3dpl200 
This study 
LUZ450 DAY938 ura3::λimm434/ura3::λimm434  HIS1::MDS3-82.1::his1::hisG/ 
his1::hisG  arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3dpl200 
This study 
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LUZ451/3 DAY938 ura3::λimm434/ura3::λimm434  HIS1::MDS3-35.1::his1::hisG/ 
his1::hisG  arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3dpl200 
This study 
LUZ455/7 DAY938 ura3::λimm434/ura3::λimm434  HIS1::MDS3-104.1::his1::hisG/ 
his1::hisG  arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3dpl200 
This study 
LUZ458 DAY938 ura3::λimm434/ura3::λimm434  HIS1::MDS3108.1::his1::hisG/ 
his1::hisG  arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3dpl200 
This study 
LUZ461 DAY938 ura3::λimm434/ura3::λimm434  HIS1::MDS3Y126F 
L127I::V5::his1::hisG/ his1::hisG  arg4::hisG/arg4::hisG  
mds3::ARG4/mds3::URA3dpl200 
This study 
LUZ462 DAY938 ura3::λimm434/ura3::λimm434  HIS1::MDS3L125I 
L127I::V5::his1::hisG/ his1::hisG  arg4::hisG/arg4::hisG  
mds3::ARG4/mds3::URA3dpl200 
This study 
LUZ464 DAY938 ura3::λimm434/ura3::λimm434  HIS1::MDS3Y126A 
L127A::V5::his1::hisG/ his1::hisG  arg4::hisG/arg4::hisG  
mds3::ARG4/mds3::URA3dpl200 
This study 
LUZ466 DAY938 ura3::λimm434/ura3::λimm434  HIS1::MDS3G129A 
L131S::V5::his1::hisG/ his1::hisG  arg4::hisG/arg4::hisG  
mds3::ARG4/mds3::URA3dpl200 
This study 
DAY414 
(L40) 
S. 
cerevisiae 
MATα  his3∆200  trp1-901  leu2-3,-112  ade2 LYS2::(lexAop)4-HIS3  
URA3::(lexAop)8-lacZ  GAL4 
Vojtek et 
al., 1993 
 
 
 
Table 2.2. Plasmids used in this study 
Plasmid Description Reference 
pDDB353 HIS1- MDS3 complementation vector Zacchi et al., 2010 
pDDB408 pGEM-T-MDS3 for Tn7 mutagenesis Zacchi et al., 2010 
pLZ38 HIS1- MDS3::V5HIS6 vector, V5 in unique HpaI site This study 
pLZ39 HIS1- MDS3::V5HIS6 vector, V5 in unique BstBI site This study 
pLZ78 HIS1- MDS3
L125I L127I vector This study 
pLZ79 HIS1- MDS3
Y126A L127A vector This study 
pLZ81 HIS1- MDS3
G129A L131S  vector This study 
pLZ82 HIS1- MDS3
Y126F L127I  vector This study 
pLZ83 HIS1- MDS3
G129A L131S::V5HIS6  vector This study 
pLZ86 HIS1-MDS3::V5HIS6 vector This study 
pLZ87 HIS1-MDS3-4.2 vector This study 
pLZ92 HIS1-MDS3-41.1 vector This study 
pLZ93 HIS1-MDS3-42.1 vector This study 
pLZ96 HIS1-MDS3-55.1 vector This study 
pLZ97 HIS1-MDS3-56.1 vector This study 
pLZ99 HIS1-MDS3-67.1 vector This study 
pLZ100 HIS1-MDS3-91.1 vector This study 
pLZ101 HIS1-MDS3-95.1 vector This study 
pLZ107 HIS1-MDS3-12.1 vector This study 
pLZ108 HIS1-MDS3-20.1 vector This study 
pLZ109 HIS1-MDS3-33.1 vector This study 
pLZ110 HIS1-MDS3-36.1 vector This study 
pLZ111 HIS1-MDS3-82.1 vector This study 
pLZ118 HIS1-MDS3-35.1 vector This study 
pLZ119 HIS1-MDS3-104.1 vector This study 
pLZ120 HIS1-MDS3-108.1 vector This study 
pLZ122 HIS1- MDS3
Y126F L127I ::V5HIS6 vector This study 
pLZ123 HIS1- MDS3
L125I L127I::V5HIS6 vector This study 
pLZ124 HIS1- MDS3
Y126A L127A::V5HIS6 vector This study 
pLZ125 HIS1- MDS3
G129A L131S::V5HIS6 vector This study 
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Table 2.3. Primers used in this study 
Primer Sequence Reference 
MDS3 Seq 1 TGTTTTCACCCCTCACGCCC This study 
MDS3 Seq 2 TGGTGGATTGGCTCTACTGC This study 
MDS3 Nru1 Seq 3’ TTATGATGAGATTGCCATGC This study 
MDS3 L125I L127I 5' GTGCATTCAACAATTGTattTATattTTTGGTGGATTGGCTC This study 
MDS3 L125I L127I 3' GAGCCAATCCACCAAAaatATAaatACAATTGTTGAATGCAC This study 
MDS3 Y126A L127A 5' GTGCATTCAACAATTGTCTAgctgctTTTGGTGGATTGGCTC This study 
MDS3 Y126A L127A 3' GAGCCAATCCACCAAAagcagcTAGACAATTGTTGAATGCAC This study 
MDS3 G129A L131S 5' GTCTATATCTATTTgctGGAtcaGCTCTACTGCAAGAAAATGACG This study 
MDS3 G129A L131S 3' CGTCATTTTCTTGCAGTAGAGCtgaTCCagcAAATAGATATAGAC This study 
MDS3 Y126F L127I 5' GTGCATTCAACAATTGTCTAtttattTTTGGTGGATTGGCTC This study 
MDS3 Y126F L127I 3' GAGCCAATCCACCAAAaataaaTAGACAATTGTTGAATGCAC This study 
56-V5 5’ AGCTTCGAAAATTCATGCAGATAGTGTCGCAATGTCTTTGGGT
AAGCCTATCCCTAACCC 
This study 
56-V5 3’ AAGCATTTCGCAGATTATTACTTGTAACCGATTTCTTTTTATGG
TGATGGTGATGATGAC 
This study 
MDS3 HpaI V5His6 5' TATTAAATCTAGTAGTAAAAAGCGTGGAATATTTGGATTGGGT
AAGCCTATCCCTAACCC 
This study 
MDS3 HpaI V5His6 3' AATATACACCCCTATATTATTATCTTTTTAATCCTGTTAAATGG
TGATGGTGATGATGAC 
This study 
MDS3 BstBI V5His6 3' CGATGATGGCTACCTTGATATTACATTGTTGAAAAAAGCTGGT
AAGCCTATCCCTAACCC 
This study 
MDS3 BstBI V5His6 3' CTTTTTCAAAGACATTGCGACACTATCTGCATGAATTTTCGAA
TGGTGATGGTGATGATGAC 
This study 
MDS3 HA C-ter 5' TCTATTAAATCTAGTAGTAAAAAGCGTGGAATATTTGGATTGT
TAACAGGATTAAAAAGACGGATCCCCGGGTTAATTAA 
This study 
MDS3 URA3 C-ter 3' CATATAATTAGCCTATTCAACCAATATAACGTGAATATACACC
CCTATATTATTAGAATTCCGGAATATTTATGAGAAAC 
This study 
 
 
Table 2.4. Effects of mutations in Mds3s‟ second Kelch repeat on filamentation in M199 pH 8 
Strain Genotype Average +/- SD 
DAY185 MDS3/MDS3 45.8 ± 6.2 
DAY1118 mds3Δ/Δ 8.2 ± 4.2 
DAY1119 mds3Δ/Δ + LYLFGGLAL 52.3 ± 14.8 
LUZ402 mds3Δ/Δ + iYiFGGLAL 35.5 ± 6.7 
LUZ400 mds3Δ/Δ + LfiFGGLAL 49.6 ± 5.6 
LUZ397 mds3Δ/Δ + LaaFGGLAL 9.5 ± 2.2 
LUZ399 mds3Δ/Δ + LYLFaGsAL 8.0 ± 2.1 
SD= standard deviation 
 
 59 
Table 2.5. MDS3 Tn7 mutant alleles in pDDB408 
Allele 
name 
Amino acid 
position 
Stop codon Wild-type sequence 
with insertions 
Subcloned Phenotype 
4.2 526 NO SDKlfkhkSP YES Wild-type 
8.2 999 YES LKAv.tkaRY YES ND 
12.1 1361 NO SSSclnssASS YES Null 
13.1 714 YES STv.tstAI YES ND 
15.1 733 NO SFQlfkhqSN NO ND 
20.1 1378 NO FGLlfkqlLT YES Wild-type 
26.1 379 NO RPTclnttGK NO ND 
32.1 446 YES SSEFv.telS YES ND 
33.1 676 NO KPQclntqKD YES Null 
35.1 620 NO DQAlfkqaLGL NO ND 
36.1 528 NO KSPTclnttAV YES Null 
40.1 384 YES KWSrv.tsRLN NO ND 
41.1 226 NO KRYclnryVG YES Wild-type 
42.1 424 NO TSSclnssVR YES ND 
43.1 293 YES HESiv.tsIV NO ND 
47.1 34 YES TGSavt.tsAS YES ND 
48.1 123 NO FNNclnnnCL NO ND 
51.3 344 NO IPYnfkhyNLR NO ND 
52.1 440 YES PITnv.ttNI YES ND 
54.1 425 YES TSScv.tsVRF NO ND 
55.1 935 NO TVKclnskAF YES Null 
56.1 1051 NO DSVclnsvAM YES Wild-type 
57.1 ? ? ? YES ND 
60.1 1183 YES DAPsv.tpSDY NO ND 
67.1 607 NO AKGlfkqgYI YES Null 
69.1 ? ? ? NO ND 
82.1 732 NO SSFlfkhfQSN YES Null 
91.1 656 NO LSSclntsSSG YES ND 
93 856 YES IESv.tesSLD NO ND 
95.1 876 NO VPGclntgEN YES ND 
97 ? ? ? NO ND 
104.1 658 NO SSSvfkqsGE NO ND 
108.1 1266 NO IIPnfkqpTVS NO ND 
109 873 NO KVSmfkqsSSV NO ND 
? Indicates defective sequence run. (.) Indicates a STOP codon 
ND= not determined 
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CHAPTER 3 
 
 
MDS3 REGULATES MORPHOGENESIS IN CANDIDA ALBICANS THROUGH 
THE TOR PATHWAY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Zacchi, L.F., Gomez Raja, J., Davis, D.A. (2010). Mds3 regulates morphogenesis in Candida 
albicans through the TOR pathway. Molecular and Cellular Biology. 30(14):3695-3710. 
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SUMMARY 
 The success of Candida albicans as a major human fungal pathogen is dependent on its 
ability to colonize and survive as a commensal on diverse mucosal surfaces. One trait required for 
survival and virulence in the host is the morphogenetic yeast-to-hyphal transition. Mds3 was 
identified as a regulator of pH-dependent morphogenesis that functions in parallel with the classic 
Rim101 pH sensing pathway. Microarray analyses revealed that mds3∆/∆ cells had an expression 
profile indicative of a hyperactive TOR pathway, including the preferential expression of genes 
encoding ribosomal proteins and a decreased expression of genes involved in nitrogen source 
utilization. The transcriptional and morphological defects of the mds3∆/∆ mutant were rescued by 
rapamycin, an inhibitor of TOR, and this rescue was lost in strains carrying the rapamycin 
resistant TOR1-1 allele or an rbp1∆/∆ deletion. Rapamycin also rescued the transcriptional and 
morphological defects associated with loss of Sit4, a TOR pathway effector, but not loss of 
Rim101 or Ras1. The sit4∆/∆ and mds3∆/∆ mutants had additional phenotypic similarities 
suggesting that Sit4 and Mds3 function similarly in the TOR pathway. Finally, we found that 
Mds3 and Sit4 co-immunoprecipitate. Thus, Mds3 is a new member of the TOR pathway that 
contributes to morphogenesis in C. albicans as a regulator of this key morphogenetic pathway. 
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INTRODUCTION 
 Eukaryotic cell growth and morphogenesis is effected by numerous environmental 
signals. These environmental signals are integrated by highly conserved regulators, including 
Ras, PKC, and the target of rapamycin (TOR). These regulators govern the activity of signal 
transduction pathways, which generally promote changes in gene expression affecting an 
appropriate cellular response to the environmental signal. TOR is an essential kinase conserved 
throughout eukaryotic evolution. In mammalian systems, mTOR is required for embryogenesis 
(Hwang et al., 2008) and for cellular morphogenesis in neurons (Han et al., 2008), vacuolar 
smooth muscle cells (Martin et al., 2004), and T-cells (Delgoffe et al., 2009). In the model yeast 
S. cerevisiae, TOR plays a fundamental role in morphogenesis being required for pseudohyphal 
growth and sporulation (Cutler et al., 2001; Zheng and Schreiber, 1997). TOR governs 
morphogenesis by regulating numerous biological processes including, autophagy, translation, 
and ribosome biogenesis (Wullschleger et al., 2006). Thus, in eukaryotic cells, TOR responds to 
environmental signals to promote growth and morphogenetic changes. 
In the fungal opportunistic pathogen Candida albicans, the most well studied 
morphogenetic transition is the yeast-hyphal switch. The switch between the yeast and hyphal 
growth forms plays a critical role in C. albicans ability to colonize as a commensal and cause 
disease as a pathogen. Yeast cells are small, non-adherent, less immunogenic and divide rapidly, 
which may allow C. albicans to successfully outcompete the faster growing bacterial flora and 
the immune responses as well as pass through capillary beds during disseminated disease. Hyphal 
cells are long, extremely adherent, promote profound immune responses, and divide more slowly. 
Further hyphal cells secrete numerous degradative enzymes and are invasive (Gow et al., 2002; 
Mitchell, 1998). Hyphal cells may allow C. albicans to maintain itself on mucosal surfaces and in 
immunocompromised hosts, enter the bloodstream. Both yeast and hyphal cells are observed in 
commensally colonized and diseased sites, demonstrating the relevance of this morphogenetic 
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switch for C. albicans survival in the host. This idea is further supported by genetic analyses 
demonstrating that C. albicans mutants locked in a yeast or filamentous form are unable to cause 
disease (Lo et al., 1997; Murad et al., 2001). Thus, the yeast-hyphal morphogenetic switch is 
critical for pathogenesis. 
Because the yeast-hyphal transition is critical for pathogenicity, much work has been 
devoted to identifying the environmental sensors and signal transduction pathways that respond to 
these signals. The yeast-hyphal morphogenetic switch is governed by a plethora of environmental 
cues, including pH, nutrient availability, temperature, and host factors (Alonso-Monge et al., 
2009; Cottier and Muhlschelgel, 2009; Davis, 2009; Mitchell, 1998). For example, neutral-
alkaline environmental pH is sensed by the Rim101 signal transduction pathway resulting in 
proteolytic activation of the Rim101 transcription factor, which promotes hyphal formation 
(Davis et al., 2000b; Porta et al., 1999; Ramon et al., 1999). Loss-of-function mutants in the 
Rim101 pathway do not form hyphae in response to neutral-alkaline environmental pH and show 
reduced virulence in animal models of infection (Davis et al., 2000a, Nobile et al., 2008). 
Similarly, nutrient levels are sensed by the TOR pathway, which also promotes hyphal formation 
and is required for pathogenesis (Bastidas et al., 2009; Cutler et al., 2001; Lee et al., 2004). These 
studies highlight the profound link between morphogenesis and virulence in the host in response 
to environmental signals, such as pH and starvation. 
In order to gain further insights in C. albicans adaptation to environmental pH, we 
identified additional signal transduction pathways that contribute to adaptation to environmental 
pH. For example, calcineurin and its associated transcription factor Crz1 were found to act in 
parallel with Rim101 for adaptation to alkaline pH in C. albicans (Kullas et al., 2007). Further, 
using a forward genetics approach, MDS3 was identified as a positive regulator of alkaline pH 
responses in C. albicans (Davis et al., 2002). Like calcineurin, Mds3 was shown to act in parallel 
to Rim101 to promote neutral-alkaline pH responses. Mds3 also governs adaptation to neutral-
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alkaline pH response in S. cerevisiae, however this function was originally masked by the 
presence of the redundant Mds3 paralog, Pmd1. While the well studied Rim101 pathway is 
required for adaptation to environmental pH, Mds3 plays a key role in adaptation to 
environmental pH. 
MDS3 was originally identified in S. cerevisiae as a positive regulator of meiosis, a 
morphogenetic process that requires an alkaline environment (Benni and Neigeborn, 1997; 
Esposito and Klapholz, 1981). In C. albicans, Mds3 is involved in a variety of morphogenetic 
processes, including the yeast-hyphal transition, chlamydospore formation, and biofilm formation 
(Davis et al., 2002; Nobile et al., 2003; Richard et al., 2005). Despite a clear role for Mds3 in 
diverse morphogenetic processes in fungi, how Mds3 promotes morphogenesis is unknown. 
Work done in S. cerevisiae suggested that Mds3 may transmit starvation signals to Ras (Benni 
and Neigeborn, 1997; McDonald et al., 2009). However, we demonstrate that Mds3 contributes to 
morphogenesis in C. albicans through the negative regulation of the TOR pathway. We find that 
an mds3∆/∆ mutant has transcriptional defects indicative of a hyper-active TOR pathway and that 
these transcriptional defects are rescued by rapamycin, a TOR pathway inhibitor. Further, the 
filamentation defects associated with the mds3∆/∆ mutant are rescued by rapamycin. We also 
demonstrate that loss of Sit4, a downstream effector of TOR, mimics loss of Mds3. In C. albicans 
loss of Sit4 or Mds3 results in resistance to rapamycin, whereas in S. cerevisiae this loss results in 
sensitivity to rapamycin, suggesting that TOR functions are distinct in these two species. Finally, 
we demonstrate that Mds3 and Sit4 interact suggesting a mechanism of TOR pathway regulation. 
In total, our results establish that Mds3 is a member of the TOR pathway and suggest that Mds3 
regulates C. albicans development and morphogenesis through the TOR pathway. 
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MATERIALS AND METHODS 
C. albicans strains and plasmids 
 All yeast strains used in this study are listed in Table 3.1. DAY938 was constructed by 
deleting the second copy of MDS3 from VIC1, the MDS3/mds3::ARG4 parent of strain VIC3 
(Davis et al., 2002), using an mds3::URA3-dpl200 disruption cassette amplified with primers 
MDS3 5DR and MDS3 3DR (Table 3.2). Strains DAY1122 and DAY1123 were constructed by 
transforming strains DAY938 and DAY286 respectively with the tor1::HIS1 disruption cassette, 
which was amplified using primers TOR1 5DR and TOR1 3DR (Table 3.2). All deletions are 
from the start to the stop codon and were generated by chemical transformation (Wilson et al., 
1999). Correct integration of the disruption cassettes was verified by the PCR using the Mds3null 
5-detect and Mds3null 3-detect primers or TOR1 5‟detect-2 and TOR1 3‟detect primers (Table 
3.2). DAY1118 and DAY1119 were generated by transforming DAY938 with the PmeI-digested 
plasmids pDDB343 and pDDB353, respectively. 
 Strains DAY1120, DAY1121, DAY1124, DAY1125, and DAY1321 that contain the 
TOR1-1 allele were generated as previously described with minor modifications (Cruz et al., 
2001). Briefly, primers TOR1 A-C and TOR1 A-C Rev (Table 3.2) were annealed and used for 
transformation. Transformants were selected on YPD supplemented with 100nM rapamycin. 
Rapamycin resistant clones were screened by NheI digestion of a PCR product amplified with 
primers JOHE6247 and JOHE6248 and were verified by sequencing (Cruz et al., 2001). 
DAY1255 was then generated by transforming DAY1120 with PmeI-digested pDDB343. The 
correct genotype of all the mutants carrying TOR1-1 and/or tor1::HIS1 alleles was verified by 
Southern blot of NheI/NcoI or NheI/PvuII digestions of genomic DNA (data not shown), and 
using PCR products amplified with primers TOR1 probe 5‟ and TOR1 probe 3‟ or TOR1 
probe5‟-2 and TOR1 probe 3‟ as probes (Table 3.2). The probes were radiolabelled with [α-32P]-
dCTP using the Prime-a-Gene labeling system (Promega). 
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The mds3∆/∆ sit4∆/∆ mutant DAY1233 was constructed by sequentially deleting both 
MDS3 alleles from the sit4∆/∆ strain DAY972, using the mds3::URA3-dpl200 disruption cassette 
amplified with primers MDS3 5DR and MDS3 3DR described above. The URA3-dpl200 marker 
was recycled by growing the cells in SC medium supplemented with 5-fluoroorotic acid (5-FOA). 
The mds3∆/∆ rbp1∆/∆ mutant DAY1239 was constructed by sequentially deleting both 
MDS3 alleles from the rbp1∆/∆ strain DAY1230. Strain DAY1230 was generated by recycling 
the MX3::URA3R::MX3 marker in strain DAY1223 (Cruz et al., 2001) in 5-FOA. The 
mds3::URA3-dpl200 disruption cassette was amplified with primers MDS3 5DR and MDS3 3DR 
described above and the URA3-dpl200 marker was recycled by growing the cells in 5-FOA. 
DAY1234, which contains a functional SIT4-cMyc allele was constructed by introducing 
a C-terminal MYC-TADH1-URA3 cassette. The MYC-TADH1-URA3 cassette was PCR amplified 
with primers Sit4 MYC Nter 5‟ and Sit4 MYC URA3 Nter 3‟, from plasmid pDDB372 
(pMG1095 (Gerami-Nejad et al., 2009)) (Table 3.2). Correct integration of the cassette was 
verified by the PCR using primers 5‟ Myc detect and Sit4 3‟ detect (Table 3.2) and by Western 
Blot, using anti-Myc antibody (R950-25, Invitrogen). 
To construct the strains for the co-immunoprecipitation studies, DAY1234 was 
transformed with NheI digested pDDB499 (MDS3-HA) to generate strain DAY1236. DAY1234 
was also transformed with PmeI digested pDDB353 (untagged MDS3 vector) to generate the 
control strain DAY1235. 
 The MDS3 complementation vector pDDB353 was constructed as follows. Plasmid 
pDDB343 was generated by replacing the NruI restriction site in pDDB78 with a PmeI site. 
Primers DDB78 PmeIxNruI 5‟ and DDB78 PmeIxNruI 3‟ were annealed and used for gap repair 
of the NruI digested pDDB78 through in vivo recombination in trp- S. cerevisiae strain L40 to 
generate plasmid pDDB343. Wild-type MDS3 sequence with flanking promoter and terminator 
sequences was amplified in two high fidelity PCRs (Pfu Turbo DNA polymerase, Stratagene) 
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using primer pairs MDS3 5comp new and MDS3 5-2 comp new, and MDS3 3comp new-2 and 
MDS3 3-2comp new-2 from strain BWP17 genomic DNA (Table 3.2). Both PCR products were 
transformed with EcoRI/NotI-double digested pDDB343 into strain L40 to produce plasmid 
pDDB353 through in vivo recombination. The complete ORF of MDS3 was verified by 
sequencing. 
 The MDS3-HA tagged vector DDB499 was constructed as follows. In order to find a 
location in MDS3‟s ORF that could be tagged without affecting Mds3 function, we performed 
random mutagenesis of MDS3 using the GPS-LS Linker Scanning System (New England 
BioLabs). A NheI/AhdI fragment from plasmid DDB353 containing MDS3 and its flanking 
regions was cloned into a NheI/AhdI digested pGEM-T Easy vector (Promega) pDDB407, to 
generate plasmid pDDB408. pDDB408 was used as substrate for random Tn7 insertion 
mutagenesis. Plasmids carrying Tn7 integrations within MDS3‟s ORF were screened by the PCR 
using primer S and primer N (Promega), MDS3null 5-detect, and MDS3null 3-detect (Table 3.2). 
The Tn7 transposon was excised and plasmids were religated, leaving a 15bp insertion that 
contains a PmeI site. Plasmids containing mutated versions of MDS3‟s ORF were AhdI/NdeI 
digested, subcloned into a NotI/EcoRI digested pDDB409 by in vivo recombination and tested for 
complementation of an mds3∆/∆ mutant. Plasmid pDDB500, containing a 5 amino acid insertion 
at amino acid 1051, was selected for HA tagging. The HA tag was PCR amplified from plasmid 
pDDB369 (pMG1921 (Gerami-Nejad et al., 2009)) using primers MDS3-HA 56 5‟ and MDS3-
HA 56 3‟ (Table 3.2) and in vivo recombined into the PmeI digested plasmid pDDB500 using S. 
cerevisiae L40 strain, to generate pDDB499, which inserts HA after residue 1056. pDDB499 
rescued the mds3∆/∆ mutant, indicating that Mds3 tolerated the addition of the 29 amino acids of 
the 3xHA tag. 
Plasmid pDDB409 was constructed by replacing the unique NruI site in pDDB78 with a 
26 bp linker containing NgoMIV-KpnI-NheI restriction sites. The 26 bp primers NgoMIV KpnI 
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NheI x NruI 5' and NgoMIV KpnI NheI x NruI 3' were annealed, and ligated in NruI digested 
pDDB78 to give pDDB409.  
 
Media and growth conditions 
 C. albicans was routinely grown at 30ºC in YPD (2% Bacto-peptone, 2% dextrose, 1% 
yeast extract). For selection of Ura
+
, His
+
 or Trp
+
 transformants, synthetic medium without 
uridine, histidine or tryptophan was used (0.17% yeast nitrogen base without ammonium sulfate 
(Q-BioGene), 0.5% ammonium sulfate, 2% dextrose, and supplemented with a dropout mix 
containing amino and nucleic acids except those necessary for the selection (Adams et al., 1997)). 
Media were buffered at the indicated pH using 150mM HEPES. The assays for filamentation in 
the presence of rapamycin were performed in M199 medium (Gibco BRL) buffered at pH 8, and 
SLAD (0.17% yeast nitrogen base without ammonium sulfate (Q-BioGene), 50µM ammonium 
sulfate, 2% dextrose). Filamentation assays were conducted at 37ºC except as indicated. 
Rapamycin (LC Laboratories) was added to the media at the indicated concentrations from a 
stock solution in 90% ethanol-10% Tween-20. For liquid assays of filamentation in the presence 
of rapamycin, strains were pre-grown in liquid YPD at 30ºC, pelleted, resuspended in an equal 
volume of PBS and diluted 1:100 in M199 pH 8 supplemented with rapamycin or solvent alone. 
Samples were incubated for 6 hrs. To determine the % of hyphae producing cells, samples were 
gently sonicated and quantified under the microscope. The values reported represent the average 
of at least two independent experiments, in which every strain was tested at least in duplicate. For 
filamentation in serum, strains were pre-grown in liquid YPD at 30ºC, diluted 1:100 in liquid 
YPD supplemented with 10% fetal bovine serum (Gibco) and incubated at 37ºC for 5.5 hrs. For 
growth assays in the presence of rapamycin, strains were pre-grown in liquid YPD at 30ºC, 
diluted in PBS to an OD 600nm of 1.6, then serially diluted 5-fold in PBS, spotted on YPD or 
Spider medium (1% mannitol, 1% nutrient broth, 0.2% K2HPO4, pH 7.2 before autoclaving (Liu 
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et al., 1994)) supplemented with rapamycin or solvent alone and incubated at 30ºC for 2 or 3 
days. All media except that for selection of Ura
+
 transformants were supplemented with 80 µg/ml 
uridine. For solid media, 2% Bacto-agar was added, except for Spider medium which used 1.35% 
Bacto-agar.  
 
Microarray analysis 
 Strains were pre-grown in YPD at 30ºC, pelleted, washed with M199 pH 4 or pH 8 
medium, diluted 40-fold in pre-warmed M199 pH 4 or pH 8 and incubated for 4 hrs at 37ºC with 
agitation. Procedures for RNA extraction, microarray construction and analysis have been 
previously described (Bensen et al., 2004). Corrected P values for the Gene Ontology (GO) 
categories were obtained using the GO Term Finder algorithms available through the Candida 
Genome Database website (www.candidagenome.org) on February 2009.  
 
Northern blot analysis 
 Cells were grown overnight in YPD at 30°C. The following day, cells were washed with 
M199 medium at either pH4 or pH8 and diluted 40-fold into fresh M199 pH4 or pH8 medium 
containing solvent or 5nM rapamycin and incubated for 4 hours at 37°C with agitation. For 
Spider medium experiments, cells were diluted 1:40 in Spider medium containing solvent or 5nM 
rapamycin and incubated for 4 hours at 37°C with agitation. For YPD medium experiments, cells 
were grown as described previously (Bastidas et al., 2009). Briefly, YPD overnights were 
inoculated into YPD at an OD ~0.1. Cells were grown 5 hours at 30°C, followed by 1 hour at 
30°C with solvent or 20nM rapamycin. Cells were then harvested and frozen in a dry ice-EtOH 
bath. RNA extraction and Northern blot procedures were previously described (Bensen et al., 
2004), except that the PCR products for the probes were purified with a PCR purification kit 
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(Qiagen). RNA concentration was measured using a NanoDrop Spectrophotometer ND-1000. 
Probes for ECE1 and HWP1 were described previously (Davis et al., 2002). 
 
Statistical analysis 
 Statistical analysis for data in Table 5 was performed using the software SAS 9.13 (SAS 
Institute Inc. 2004). We used repeated ANCOVA analysis (assuming different variances for each 
strain) and included “day of experiment” as covariate. We tested for strain-treatment interaction, 
and compared specific strain treatment effects after adjusting for multiple comparisons using 
Bonferroni correction (14 comparisons were made, significant P values < 0.05/14=0.0036). 
 
Microscopy 
 Pictures of colonies were taken using a Canon Powershot A560 digital camera on a Zeiss 
Opton microscope. Images of liquid cultures were captured using a Zeiss Axio camera, 
Axiovision 4.6.3 software (Zeiss), and a Zeiss AxioImager fluorescence microscope. All images 
were processed with Adobe Photoshop 7.0 software. 
 
Protein purification and Western blot analysis 
Overnight cultures of C. albicans were diluted 200-fold into M199 pH 8 or YPD medium 
and grown for 4-5 hours at 30°C. Cells were pelleted and resuspended in ice-cold RIPA buffer 
(50mM Tris pH 8, 150mM NaCl, 1% NP-40, 3mM EDTA, 0.5% deoxycholate, 0.1% SDS) 
containing 1µg/ml leupeptin, 2µg/ml aprotinin, 1µg/ml pepstatin, 0.1mM phenylmethylsulfonyl 
fluoride, and 10 mM dithiothreitol and lysed by vortexing with acid-washed glass beads for 1 
hour at 4 ºC. Cell lysates were pelleted and supernatants stored at -80°C. For Western blot assays 
of input, ~1.25 mg of total protein was resuspended in 2X SDS gel-loading buffer (100mM Tris-
Cl, pH 6.8; 200mM dithiothreitol; 4% SDS; 0.1% bromophenol blue; 20% glycerol), boiled at 95-
 72 
100ºC for 3 minutes and run in 8% SDS-PAGE gel. Proteins were transferred to nitrocellulose 
and blocked in 6 % nonfat milk in TBS-T (50mM Tris, pH 7.6, 150mM NaCl, 0.1% Tween 20). 
Blots were incubated with anti-HA (F-7 probe, Santa Cruz) or anti-Myc (Invitrogen) at 1:1000 
dilution or 1:5000 respectively in 6% non-fat milk TBS-T, washed in TBS-T, and incubated with 
anti-mouse–horseradish peroxidase antibody (GE Healthcare) at 1:5000 in 6% nonfat milk in 
TBS-T. Blots were washed in TBS-T, incubated with ECL reagent (GE Healthcare), and exposed 
to film. 
 
Co-Immunoprecipitations 
Mds3-HA was immunoprecipitated as follows. ~18mg of total protein was incubated 
overnight at 4°C with 20µl of slurry anti-HA agarose beads (Sigma-Aldrich). Beads were washed 
four times with Tris-buffered saline (25 mM Tris, 0.15 M NaCl, pH 7.2, 0.05% Tween). Protein 
was eluted from the beads by resuspension in 50µl 2x SDS gel loading buffer and boiling for 5 
minutes. The products of two immunoprecipitations were combined, separated by SDS-PAGE, 
and analyzed by Western blot. 
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RESULTS 
Mds3 affects TOR-dependent gene expression 
 Mds3 acts in parallel to the Rim101 pathway to promote the yeast-to-hyphal 
morphogenetic switch in response to neutral-alkaline pH (Davis et al., 2002). To gain insights 
into how Mds3 contributes to pH responses, we determined the transcriptional profiles of wild-
type, rim101∆/∆, and mds3∆/∆ strains grown at pH 8 and pH 4 (Supplemental Table S3.1). The 
microarray experiments for all three strains were performed concomitantly, but the results for the 
wild-type and rim101∆/∆ strains, including the microarray methodology and validation, have 
been reported previously (Bensen et al., 2004).  
 Since Mds3 and Rim101 are required for growth and morphogenesis at alkaline pH, we 
expected that most transcriptional differences observed between the mutant strains and wild-type 
would occur at pH 8. Indeed, ~80% (287) and ~95% (180) of all differentially expressed ORFs in 
the mds3∆/∆ and rim101∆/∆ mutants, respectively, occurred at pH 8 (Table 3.3 and (Bensen et 
al., 2004)). Further, because the mds3∆/∆ and rim101∆/∆ mutants are defective for filamentation 
at alkaline pH, we expected to find common changes in the expression of hyphal associated 
genes. In fact, the expression of genes associated with cell wall/filamentation were decreased in 
the mds3∆/∆ and rim101∆/∆ mutants relative to the wild-type strain (Table 3.4 and (Bensen et al., 
2004)). Thus, mds3∆/∆ and rim101∆/∆ mutants share similar transcriptional defects, as predicted 
based on their similar phenotypes at alkaline pH. 
 However, as Mds3 and Rim101 act in parallel, we also expected to find differences 
between the transcriptional profiles of these mutants relative to the wild-type strain. Indeed 
several fundamental differences were observed. First, the mds3∆/∆ mutant affected the expression 
of twice as many genes as did the rim101∆/∆ mutant (363 total ORFs vs. 187 total ORFs, 
respectively) (Table 3.3). ~60% (229) of the genes affected by the mds3∆/∆ mutant were not pH-
regulated in wild-type cells, compared to ~38% (72) genes in the rim101∆/∆ mutant (Figure 3.1). 
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Second, the mds3∆/∆ mutant affected the expression of more genes at pH 4 than the rim101∆/∆ 
mutant (76 vs. 7 genes respectively) (Table 3.3). Third, in the rim101∆/∆ mutant, ~70% of the 
differentially expressed genes showed reduced expression, suggesting that Rim101 primarily 
functions as a positive regulator (Table 3.3). However, in the mds3∆/∆ mutant, the differentially 
expressed genes showed increased and reduced expression at an ~50:50 ratio, demonstrating that 
Mds3 functions as both a positive and negative regulator (Table 3.3). Overall, these results 
suggest that Mds3 has broader effects on gene expression than Rim101 and that Mds3 has roles in 
addition to adaptation to environmental pH. 
                  
Figure 3.1: VENN diagram of wild-type, Mds3, and Rim101-dependent genes. 
Differentially expressed genes in the mds3∆/∆ (white circle) or rim101∆/∆ (dark grey 
circle) mutants vs. the wild-type strain were separated into pH-dependent and pH-
independent depending on whether these ORFs were differentially expressed in wild-type 
cells in response to pH (light grey circle). Genes that were differentially regulated in the 
mds3∆/∆ or rim101∆/∆ mutant vs. the wild-type strain at both pH 8 and pH 4 were only 
included once in this analysis. Numbers in parentheses represent the % ORFs that are pH-
independent. 
 
To identify potential biological functions for Mds3, we analyzed the Mds3-dependent 
genes by gene ontology (GO). Of the genes up-regulated in the mds3∆/∆ mutant compared to the 
wild-type strain, the GO categories of “Glycolysis” and “Translation” were significantly over-
represented (P < 1.1E-04 and P < 5.3E-15 respectively) (Table 3.4 and Supplemental Table S3.1). 
In wild-type cells, most of the ORFs in “Translation” were expressed preferentially at pH 8 
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compared to pH 4 (Bensen et al., 2004). This suggests that loss of Mds3 enhances these gene 
expression changes observed in wild-type cells at alkaline pH. Of the genes down-regulated in the 
mds3∆/∆ mutant compared to the wild-type strain, the GO categories of “Amino acid transport” 
and “Vacuolar protein catabolic activity” (P < 4.7E-04 and P < 1.6E-03 respectively) were 
significantly overrepresented (Table 3.4). Further, the categories of “Amine transport,” „Lytic 
vacuole,” “Glycolysis,” and “Translation” were also overrepresented when this analysis was done 
in the mds3∆/∆ mutant exclusively for genes that are pH-independent (data not shown). These 
results show that Mds3 affects a variety of distinct processes, including growth and starvation 
responses, and supports the idea that Mds3 has functions in pH-independent processes. 
 In order to corroborate the microarray results, we analyzed the expression of several 
MDS3-dependent ORFs by Northern blot (Figure 3.2A). In M199 pH 8 medium, the glycolysis 
gene CDC19 and the translation genes RPS26A and TEF1 were expressed ~2 - 4-fold more in the 
mds3∆/∆ mutant than the wild-type or the complemented mds3∆/∆ +MDS3 strains (Figure 3.2A, 
lanes 6-8). Increased expression of CDC19, RPS26A, and TEF1 in the mds3∆/∆ mutant was also 
observed at pH 4 (Figure 3.2A, lanes 1-3), suggesting that Mds3 governs expression of these 
genes in a pH-independent manner. GAP2, an amino acid transport gene, was reduced > 2-fold in 
the mds3∆/∆ mutant compared to the wild-type or the mds3∆/∆ +MDS3 complemented strains at 
both pH 4 and pH 8 (Figure 3.2A, compare lanes 2 and 7 with lanes 1, 3, 6, and 8). These results 
establish the veracity of the microarray data and support the idea that Mds3 has pH-independent 
functions. 
The GO categories affected by the mds3∆/∆ mutant reflect processes that are 
transcriptionally regulated by the TOR pathway. During conditions of active growth, TOR 
positively regulates expression of genes involved in ribosomal biogenesis, translation initiation 
and elongation, rRNA and tRNA synthesis, and glycolysis (Wullschleger et al., 2006) and 
negatively regulates expression of genes involved in protein degradation and nitrogen catabolite 
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repression (NCR) (Bastidas et al., 2009; Cardenas et al., 1999; Hardwick et al., 1999; Shamji et 
al., 2000). During starvation conditions, TOR is inactive and genes involved in translation and 
glycolysis are repressed while genes involved in amino acid transport and vacuolar degradation 
are induced (Bastidas et al., 2009; Cardenas et al., 1999; Hardwick et al., 1999; Shamji et al., 
2000). Since the mds3∆/∆ mutant shows gene expression differences that reflect TOR activation, 
we hypothesized that Mds3 functions as a negative regulator of TOR. 
To address the idea that Mds3 is a negative regulator of TOR, we predicted that 
rapamycin, a TOR inhibitor (Heitman et al., 1991), would rescue the transcriptional defects 
associated with the mds3∆/∆ mutant. Indeed, 5nM rapamycin reduced expression of CDC19, 
RPS26A, and TEF1 and restored expression of GAP2 in mds3∆/∆ mutant cells compared to 
solvent alone (Figure 3.2A, compare lanes 6-8 and 11-13). Rapamycin did not appear to affect 
expression of RPS26A, TEF1, and GAP2 in the wild-type or mds3∆/∆+MDS3 complemented 
strains; however expression of CDC19 was increased ~2-fold compared to solvent alone. 
Regardless, in the presence of rapamycin expression of CDC19, RPS26A, TEF1, and GAP2 was 
quantitatively similar in wild-type, mds3∆/∆, and mds3∆/∆ +MDS3 cells. These results 
demonstrate that rapamycin restores the transcriptional defects due to loss of Mds3 and 
corroborates the idea that Mds3 acts as a negative regulator of TOR. 
In nutrient poor Spider medium, we observed similar transcriptional results (Figure 
3.2B). Expression of CDC19, RPS26A, and TEF1 was increased in the mds3∆/∆ mutant 
compared to wild-type (Figure 3.2B, compare lanes 1 and 2). Further, addition of rapamycin 
reduced CDC19, RPS26A, and TEF1 expression in the mds3∆/∆ mutant, wild-type, and mds3∆/∆ 
+MDS3 complemented strains. We noted that in Spider medium this rapamycin-dependent 
restoration of gene expression in the mds3∆/∆ mutant was less than that observed in M199 pH 8 
medium. We also found that in Spider medium, GAP2 was expressed poorly in wild-type cells 
and expressed at greater levels in the absence of MDS3. Addition of rapamycin increased GAP2 
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expression in all strains tested (Figure 3.2B, compare lanes 1-5 with 6-10). These results support 
the idea that Mds3 acts in the TOR pathway, and suggests that, not surprisingly, growth medium 
differences cause distinct effects. 
           
                              
Figure 3.2: Microarray validation by Northern blot analysis. Overnight YPD cultures of 
the wild-type (DAY185), mds3∆/∆ (DAY1118), mds3∆/∆+MDS3 (DAY1119), sit4∆/∆ 
(DAY972), sit4∆/∆ mds3∆/∆ (DAY1233), and mds3∆/∆ rbp1∆/∆ (DAY1239) strains 
were diluted in pre-warmed M199 pH 8 (A), Spider medium (B), or YPD (C) with or 
without rapamycin. Ethidium bromide staining was used as a loading control because 
commonly used loading controls (TEF1, ACT1 or TDH3) varied in expression due to the 
mutations, the growth conditions and/or the addition of the rapamycin. MDS3, SIT4, and 
RBP1 genotypes are noted above the samples: wild-type (+), deletion (∆), or 
complemented (p). 
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Rapamycin rescues the mds3∆/∆ mutant filamentation defect  
 The TOR pathway regulates fungal morphogenesis (Cutler et al., 2001), and rapamycin 
triggers the expression of hyphal associated genes in C. albicans (Bastidas et al., 2009). Since 
Mds3 also regulates morphogenesis and is required for the expression of hyphal associated genes 
(Davis et al., 2002), we asked if rapamycin also rescues expression of these genes in the mds3∆/∆ 
mutant (Figure 3.3A). Wild-type, mds3∆/∆, and mds3∆/∆ +MDS3 cells were incubated in M199 
pH 8 medium at 37°C, which promotes hyphal formation, with and without 5nM rapamycin and 
analyzed for expression of the hyphal associated genes HWP1 and ECE1 (Figure 3.3A). While 
the mds3∆/∆ mutant showed little HWP1 and ECE1 expression, addition of rapamycin 
completely restored this expression (Figure 3.3A, compare lanes 2 and 5). We noted that 
rapamycin also led to increased expression of HWP1 and ECE1 in both wild-type and mds3∆/∆ 
+MDS3 strains compared to solvent alone. Thus, rapamycin promotes expression of hyphal 
associated genes and rescues the mds3∆/∆ mutant defects in HWP1 and ECE1 expression. 
Since rapamycin rescued the transcriptional defects associated with loss of Mds3, we 
asked if rapamycin could also rescue the hyphal formation defect of the mds3∆/∆ mutant. In 
liquid M199 pH 8 medium at 37°C, >90% of wild-type cells germinated to form hyphae; <5% of 
mds3∆/∆ mutant cells germinated to form hyphae (Table 3.5 and Figure 3.3B). However, addition 
of 5nM rapamycin partially restored hyphal formation in the mds3∆/∆ mutant to 45% (P < 0.0001 
compared to mds3∆/∆ in solvent) (Figure 3.3B and Table 3.5). Rapamycin also promoted hyphal 
formation in wild-type cells compared to the solvent control (P <0.001) (Table 3.5), and we noted 
that the hyphae formed in the wild-type, mds3∆/∆, and mds3∆/∆ +MDS3 strains in the presence 
of rapamycin appeared less branched than in solvent alone. Similar results were observed in 
liquid SLAD medium, a nutrient poor medium, indicating that the effect of rapamycin is not 
specific to M199 medium (Figure 3.4A). These results demonstrate that rapamycin rescues the 
morphogenetic defect of the mds3∆/∆ mutant. 
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Figure 3.3: Rapamycin rescues mds3∆/∆ hyphal associated phenotypes. A) Northern 
blots of hyphae associated genes performed on the wild-type (DAY185), mds3∆/∆ 
(DAY1118), mds3∆/∆+MDS3 (DAY1119), and sit4∆/∆ (DAY972) strains grown for 4 
hrs in M199 pH 8 supplemented with solvent or 5nM rapamycin. MDS3 and SIT4 
genotypes are noted above the samples: wild-type (+), deletion (∆), or complemented (p). 
B) Overnight YPD cultures of the wild-type (DAY185), mds3∆/∆ (DAY1118), 
mds3∆/∆+MDS3 (DAY1119), sit4∆/∆ (DAY972), sit4∆/∆+SIT4 (DAY973), mds3∆/∆ 
sit4∆/∆ (DAY1233), rim101∆/∆ (DAY25), and ras1∆/∆ (DAY1109) strains were washed 
in PBS and diluted 1:100 in M199 pH 8 liquid medium with and without 5nM rapamycin. 
Cells were visualized under the microscope (40X) after 6 hrs of incubation at 30ºC or at 
37ºC. 
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Figure 3.4: Rapamycin rescues mds3∆/∆ filamentation defects in nutrient poor medium 
but cycloheximide does not. (A) Wild-type (DAY185), mds3∆/∆ (DAY1118), 
mds3∆/∆+MDS3 (DAY1119), sit4∆/∆ (DAY971), sit4∆/∆+SIT4 (DAY973), and 
mds3∆/∆ sit4∆/∆ (DAY1233) cells were grown for 6 hrs in SLAD liquid medium at 37°C 
with or without 10nM rapamycin. (B) Wild-type (DAY185) and mds3∆/∆ (DAY1118) 
cells were grown for 6 hrs in M199 pH 8 liquid medium at 37°C with or without 100µM 
cycloheximide. Similar results were observed with 150µM and 250µM cycloheximide 
but higher concentrations inhibited growth of all strains tested. 
 
We found that the effect of rapamycin on hyphal formation was not due to translational 
inhibition, because cycloheximide did not rescue the filamentation defect of the mds3∆/∆ mutant 
(Figure 3.4B). Further rapamycin is not a constitutive inducer of hyphal formation, because 
rapamycin did not rescue the mds3∆/∆ hyphal formation defect in M199 pH 8 medium at 30°C 
(Figure 3.3B). These results demonstrate that rapamycin is not a constitutive inducer of hyphal 
formation and further support a link between Mds3 and TOR. 
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To determine if the effect of rapamycin was actually dependent on TOR, we introduced 
the rapamycin resistant TOR1-1 allele into the wild-type and mds3∆/∆ strains and determined if 
rapamycin still promoted hyphal formation (Cafferkey et al., 1993; Cruz et al., 2001). As 
expected, strains carrying a TOR1-1 allele were resistant to rapamycin (Figure 3.5A). In the 
absence of rapamycin, the TOR1-1 allele did not affect hyphal formation in either the 
MDS3/MDS3 or mds3∆/∆ backgrounds (Figure 3.5B and Table 3.5). However, in the presence of 
rapamycin, the TOR1-1 allele prevented the rapamycin-induced hyphal formation observed in 
MDS3/MDS3 cells (Table 3.5), and the hypha formed showed a branching pattern similar to the 
wild-type strain without rapamycin (Figure 3.5B). Thus, in the MDS3/MDS3 background 
rapamycin-mediated phenotypes are TOR-dependent. In the presence of rapamycin, the TOR1-1 
allele reduced the rapamycin-induced hyphal formation observed in mds3∆/∆ cells by ~50% 
(Table 3.5). We hypothesized that the semi-responsive effect of rapamycin in the mds3∆/∆ TOR1-
1/TOR1 mutant was an attribute of the remaining wild-type TOR1 allele. To address this 
possibility, we constructed TOR1-1/∆ strains in the MDS3/MDS3 and mds3∆/∆ backgrounds. 
Deletion of one copy of TOR1 in either background had no significant effect on hyphal formation 
(Figure 3.5B and Table 3.5), demonstrating that TOR1 is not haploinsufficient. While the 
MDS3/MDS3 TOR1-1/∆ strain filamented similarly to the MDS3/MDS3 TOR1-1/TOR1 strain in 
the presence or absence of rapamycin, the mds3∆/∆ TOR1-1/∆ strain failed to filament in the 
presence or absence of rapamycin (Figure 3.5B and Table 3.5). The mds3∆/∆ TOR1-1/∆ mutant 
did form hyphae in serum, an MDS3-independent inducer of hyphal formation (data not shown 
and (Davis et al., 2002)), demonstrating that the mds3∆/∆ TOR1-1/∆ strain did not have an 
absolute block in hyphal formation. These results demonstrate that rapamycin rescues mds3∆/∆ 
phenotypes through TOR. 
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Figure 3.5: The effect of rapamycin on filamentation is TOR dependent. (A) Wild-type 
(DAY185), TOR1-1/tor1∆ (DAY1125), rbp1∆/∆ (DAY1223), mds3∆/∆ (DAY1118), 
mds3∆/∆ TOR1-1/tor1∆ (DAY1124), mds3∆/∆ rbp1∆/∆ (DAY1239), TOR1-1/TOR1 
(DAY1121), sit4∆/∆ (DAY972), and sit4∆/∆ TOR1-1/TOR1 (DAY1321) strains were 
grown overnight in YPD and serial dilutions spotted onto YPD with or without 15nM 
rapamycin. (B) Overnight YPD cultures of the wild-type and the mds3∆/∆ backgrounds 
carrying TOR1/TOR1 (DAY185 and DAY1118), TOR1/∆ (DAY1123 and DAY1122), 
TOR1-1/TOR1 (DAY1121 and DAY1255), TOR1-1/∆ alleles (DAY1125 and DAY1124) 
or rbp1∆/∆ deletion (DAY1223 and DAY1239); and (C) sit4∆/∆ TOR1/TOR1 (DAY972) 
and sit4∆/∆ TOR1-1/TOR1 (DAY1321) were washed in PBS and diluted 1:100 in M199 
pH 8 liquid medium with and without 5nM rapamycin. 
 
We noted that in the absence of a wild-type copy of TOR1, the TOR1-1 allele conferred 
growth defects in both the wild-type and mds3∆/∆ backgrounds (Figure 3.5A and 3.6), 
demonstrating that the TOR1-1 allele is not completely functional. Thus, we considered that this 
growth defect could influence our hyphal formation data. To address this, we constructed an 
mds3∆/∆ rbp1∆/∆ double mutant, which did not have a growth defect (Figure 3.5A). Rapamycin 
inhibits the TOR kinase as a complex with Rbp1 (FKBP12 in mammals), and rbp1∆/∆ mutants 
are rapamycin resistant (Figure 3.5A and (Cruz et al., 2001)). While rbp1∆/∆ mutants did not 
have a defect in hyphal formation, loss of Rbp1 in the mds3∆/∆ background completely blocked 
the ability of rapamycin to rescue the mds3∆/∆ hyphal formation defects (Figure 3.5B and Table 
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3.6). Loss of Rbp1 also prevented the transcriptional effects of rapamycin in the mds3∆/∆ mutant 
(Figures 3.2A lanes 16-18, and 3.2C lanes 11-12). In total, these results clearly demonstrate that 
the transcriptional effects of the mds3∆/∆ mutant have biological consequences that are 
associated with inappropriate activation of the TOR pathway. 
     
Figure 3.6: The TOR1-1/∆ mds3∆/∆ mutant grows poorly. (A) Overnight YPD cultures 
of the wild-type and the mds3∆/∆ backgrounds carrying TOR1/TOR1 (DAY185 and 
DAY1118), TOR1/∆ (DAY1123 and DAY1122), TOR1-1/TOR1 (DAY1121 and 
DAY1255), or TOR1-1/∆ alleles (DAY1125 and DAY1124) or rbp1∆/∆ deletion 
(DAY1223 and DAY1239) were streaked onto YPD medium at 30°C for 2 days. 
 
Mds3 and the TOR effector Sit4 act similarly 
One downstream effector of the TOR pathway is the type 2A-like phosphatase Sit4 
(Duvel and Broach, 2004; Duvel et al., 2003; Rohde and Cardenas, 2004). Sit4 promotes 
starvation responses and is inhibited by TOR-dependent phosphorylation during periods of active 
growth (DiComo and Jiang, 2006; Jiang and Broach, 1999). Thus, in the absence of Sit4, TOR-
dependent starvation responses are defective. Since the mds3∆/∆ mutant is also defective for 
TOR-dependent starvation responses and promotes TOR activation (Table 3.4 and Figure 3.2), 
we predicted that a sit4∆/∆ mutant may have similar transcriptional defects as the mds3∆/∆ 
mutant. Indeed, in the sit4∆/∆ mutant, CDC19, RPS26A, and TEF1 were expressed at higher 
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levels when compared to the wild-type strain at both pH 4 and pH 8 (Figure 3.2A, compare lanes 
4 and 9 with lanes 1 and 6) and in nutrient poor Spider medium (Figure 3.2B). We noted that at 
pH 4 CDC19 expression in the sit4∆/∆ mutant was ~4-fold higher than in the mds3∆/∆ mutant. 
Further, in the sit4∆/∆ mutant, GAP2 was not expressed at either pH 4 or pH 8, although it was 
expressed more in Spider medium similar to the mds3∆/∆ mutant. Thus, loss of Sit4 has similar 
transcriptional effects as loss of Mds3. 
Addition of rapamycin to sit4∆/∆ cells reduced expression of CDC19, RPS26A, and 
TEF1 to approximately wild-type levels in M199 pH 8 medium (Figure 3.2A, compare lanes 9 
and 14), but had a more modest effect on Spider medium (Figure 3.2B). Rapamycin also 
promoted expression of GAP2 in sit4∆/∆ cells. However in M199 pH 8 medium, GAP2 
expression was still ~2-fold lower than wild-type cells, indicating that Sit4 is required for full 
induction of GAP2. These results demonstrate that loss of Sit4 promotes activation of the TOR 
pathway similar to the loss of Mds3 and provides independent support for the idea that Mds3 acts 
in the TOR pathway. 
Sit4 is also required for hyphal formation in C. albicans ((Lee et al., 2004) and Figure 
3.3B). We found that sit4∆/∆ mutant cells expressed little HWP1 and ECE1 in M199 pH 8 
medium and that this defect was partially rescued by addition of rapamycin (Figure 3.3A, lanes 7 
and 8). Similar to the mds3∆/∆ mutant, rapamycin rescued the sit4∆/∆ hyphal formation defect in 
M199 pH 8 (12.9±0.1% in solvent vs 60.5±2.6% in rapamycin) and SLAD media (9.2±1.0% in 
solvent vs 19.2±0.5% in rapamycin) (Figure 3.3B and 3.4A), and this rescue was prevented by the 
TOR1-1 rapamycin resistant allele (Figure 3.5A and 3.5C). Importantly, rapamycin did not rescue 
the filamentation defects associated with loss of Ras1 or Rim101, which are not associated with 
the TOR pathway (Figure 3.3B). In total, these results suggest a functional association between 
Mds3 and Sit4. 
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 To determine if Mds3 and Sit4 act in the same pathway or parallel pathways, we 
constructed an mds3∆/∆ sit4∆/∆ double mutant. If Mds3 and Sit4 function in the same pathway, 
then the mds3∆/∆ sit4∆/∆ double mutant should have similar phenotypes as either single mutant; 
if Mds3 and Sit4 function in parallel pathways then the mds3∆/∆ sit4∆/∆ double mutant should 
have more severe phenotypes than either single mutant. The mds3∆/∆ sit4∆/∆ double mutant 
expressed CDC19, RPS26A, TEF1, and GAP2 similarly to the mds3∆/∆ and sit4∆/∆ single 
mutants in M199 pH 8 and Spider media (Figure 3.2A, compare lanes 7, 9, and 10). In M199 pH 
4 medium, the mds3∆/∆ sit4∆/∆ double mutant behaved similarly to the sit4∆/∆ single mutant, 
which had a more severe phenotype than the mds3∆/∆ mutant (Figure 3.2A, compare lanes 2, 4, 
and 5). In Spider medium, the mds3∆/∆ sit4∆/∆ double mutant also behaved similarly to the 
sit4∆/∆ single mutant. However, the mds3∆/∆ single mutant had a more severe phenotype, 
indicating a dominant effect of the sit4∆/∆ mutation (Figure 3.2B, compare lanes 2, 4, and 5). 
These results demonstrate that the mds3∆/∆ sit4∆/∆ mutant does not have transcriptional defects 
beyond that of the single mutants, suggesting Mds3 and Sit4 act in the same pathway. However, 
addition of rapamycin did not restore CDC19, RPS26A, and TEF1 expression in the mds3∆/∆ 
sit4∆/∆ double mutant (Figures 3.2A, lanes 12, 14-15 and 3.2B, lanes 7, 9-10), although it did 
restore GAP2 expression (Figure 3.2A, lanes 10 and 15). Rapamycin also did not rescue the 
hyphal formation defect associated with the mds3∆/∆ sit4∆/∆ double mutant (Figures 3.3 and 
3.4A), which suggests that Mds3 and/or Sit4 may have additional parallel functions. 
We noted that regardless of pH, wild-type cells grown in M199 medium express 
relatively little RPS26A and robust levels of GAP2, suggesting that this medium may be a nutrient 
poor medium (Figure 3.2A, lane 1). Since TOR responds to nutrient availability, we asked if 
Mds3 and Sit4 effect gene expression in a nutrient rich environment. Thus, we determined 
RPS26A and GAP2 expression in rich YPD medium with or without rapamycin. Unlike the 
results obtained for M199 pH 8 and Spider medium (Figure 3.2A and B), we observed robust 
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expression of RPS26A and no expression of GAP2 in wild-type cells, and cells lacking Mds3 
and/or Sit4 behaved similarly (Figure 3.2C, compare lane 1 with lanes 2, 4, and 5). Addition of 
rapamycin reduced expression of RPS26A and promoted expression of GAP2 in wild-type cells, 
as expected if TOR is inhibited (Figure 3.2C, lane 6). Addition of rapamycin had a similar effect 
on mds3∆/∆, sit4∆/∆, and mds3∆/∆ sit4∆/∆ mutants (Figure 3.2C, lanes 7, 9, and 10). Further, 
this effect is clearly due to TOR inhibition as RPS26A and GAP2 expression was similar in the 
mds3∆/∆ rbp1∆/∆ double mutant with and without rapamycin (Figure 3.2C, lanes 11 and 12). We 
noted that GAP2 expression in the presence of rapamycin was consistently higher in the mds3∆/∆ 
mutant and that this increase was SIT4-dependent. This is in contrast to the results observed in 
M199 pH 8 medium, where GAP2 expression in the mds3∆/∆ mutant in the presence of 
rapamycin appears to be Sit4-independent. These results suggest that M199 medium is a more 
nutrient poor medium than YPD and suggest that Mds3 and Sit4 contribute to the regulation of 
TOR-dependent targets in nutrient poor conditions. 
 
Mds3 promotes rapamycin sensitivity 
 Since rapamycin rescued the filamentation defects of the mds3∆/∆ and the sit4∆/∆ 
mutants, we wanted to determine if these mutations affected rapamycin sensitivity in C. albicans. 
On YPD medium, the wild-type, mds3∆/∆, and mds3∆/∆ + MDS3 strains showed similar 
rapamycin sensitivities, but the sit4∆/∆ mutant was resistant to rapamycin (Figure 3.7A). 
Complementation of the sit4∆/∆ mutant restored rapamycin sensitivity to wild-type levels. This 
result for the sit4∆/∆ mutant is in sharp contrast to the situation in S. cerevisiae where the sit4∆ 
mutant is sensitive to rapamycin and this sensitivity can be rescued by C. albicans SIT4, 
suggesting Sit4 is functioning similarly in the two organisms (Cutler et al., 2001; Lee et al., 
2004). These results indicate that MDS3 does not affect rapamycin sensitivity in rich medium, 
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and that unlike the case in S. cerevisiae Sit4 function promotes rapamycin sensitivity in C. 
albicans. 
 Since Mds3 appears to promote TOR-dependent responses in nutrient poor conditions, 
we considered that Mds3 may affect rapamycin sensitivity on nutrient poor medium. Indeed, 
while wild-type cells were sensitive to 5nM rapamycin on nutrient poor Spider medium, the 
mds3∆/∆ mutant was resistant (Figure 3.7A). Similar results were also observed for the sit4∆/∆ 
mutant. The mds3∆/∆ sit4∆/∆ double mutant behaved like the sit4∆/∆ single mutant on both 
media, suggesting that Sit4 and Mds3 do not make independent contributions to rapamycin 
sensitivity. These results demonstrate that Mds3 and Sit4 promote rapamycin sensitivity in C. 
albicans, and support the idea that different nutrient conditions have distinct constraints on the 
TOR pathway and the function of Mds3 and Sit4 in the TOR pathway. 
 Since the function of Sit4 in S. cerevisiae promotes rapamycin resistance (Cutler et al., 
2001), we predicted that the function of Mds3 in S. cerevisiae would be similar. To test this 
hypothesis, we determined the rapamycin sensitivity of congenic wild-type, mds3∆, pmd1∆ (an 
MDS3 paralog), and mds3∆ pmd1∆ S. cerevisiae strains (Figure 3.7B). On rich medium, the wild-
type and pmd1∆ mutant grew similarly in the presence of rapamycin, and the mds3∆ and mds3∆ 
pmd1∆ mutants were more sensitive to rapamycin. Similar results were observed in nutrient poor 
Spider medium, however we noted that the mds3∆ pmd1∆ double mutant grew extremely poorly 
on this medium (Figure 3.7B). Since the rapamycin sensitivities of the mds3∆ and mds3∆ pmd1∆ 
mutants were similar and since the pmd1∆ mutant did not confer rapamycin sensitivity, we 
conclude that Mds3, but not Pmd1 functions in the TOR pathway. Cells lacking Sit4 or Mds3 
have similar phenotypes in relation to rapamycin sensitivity, however these phenotypes are 
disparate between S. cerevisiae and C. albicans. Thus, we conclude that Mds3 and Sit4 function 
similarly in C. albicans and S. cerevisiae but that the effect of these functions has changed since 
C. albicans and S. cerevisiae split evolutionarily. 
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Figure 3.7: Mds3 and TOR pathway members have altered rapamycin resistance. (A) C. 
albicans wild-type (DAY185), mds3∆/∆ (DAY1118), sit4∆/∆ (DAY972), sit4∆/∆ +SIT4 
(DAY973), mds3∆/∆+MDS3 (DAY1119), and mds3∆/∆ sit4∆/∆ (DAY1233) strains were 
serially diluted in PBS and spotted onto YPD or Spider media with or without rapamycin. 
(B) S. cerevisiae wild-type (DAY1208), mds3∆ PMD1 (DAY1209), MDS3 pmd1∆ 
(DAY1210), and mds3∆ pmd1∆ (DAY1211) strains were serially diluted in PBS and 
spotted onto YPD or Spider media supplemented with or without rapamycin. Plates were 
photographed after 48 or 72 hrs growth at 30ºC. (C.) C. albicans strains, above, were 
serially diluted in PBS and spotted onto YPD, YPD supplemented with 150mM LiCl or 
buffered at pH 6 or pH 9. Growth was scored after 48 hrs of incubation at 30ºC. 
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Because the mds3∆/∆ and sit4∆/∆ mutants share a number of phenotypic traits, we wanted to 
determine if the sit4∆/∆ mutant had other mds3∆/∆-dependent phenotypes (Davis et al., 2002). 
While the sit4∆/∆ mutant has a slight growth defect on YPD, YPD +LiCl, or YPD pH 6 medium, 
the sit4∆/∆ mutant had a severe growth defect on YPD pH 9 medium that was rescued by 
reintroduction of a wild-type copy of SIT4 (Figure 3.7C). The mds3∆/∆ sit4∆/∆ double mutant 
grew worse on both YPD and YPD pH 9 medium than either single mutant (Figure 3.7C), 
supporting the idea that Mds3 and Sit4 have some independent functions. The mds3∆/∆ sit4∆/∆ 
double mutant grew similarly to the mds3∆/∆ mutant on LiCl medium, suggesting that Sit4 does 
not play a role in response to this stress medium. These results support a model in which Mds3 
and Sit4 function similarly in the TOR pathway, but are not completely dependent. 
 
Mds3 and Sit4 physically interact 
 Mds3 was identified as a protein that interacts with Sit4 in a S. cerevisiae proteomic 
screen (Gavin et al., 2002, 2006). Since we have demonstrated a strong genetic interaction 
between Mds3 and Sit4, we tested whether Mds3 and Sit4 can indeed physically interact. Thus, 
we generated a strain carrying a functional C-terminal 13xMyc tagged SIT4 allele and then 
introduced a functional MDS3 allele containing the 3xHA epitope. Whole cell extracts of cells 
grown in M199 pH 8 medium were immunoprecipitated with -HA and separated by SDS 
PAGE. Sit4-Myc was detected in similar amounts in whole cell extracts from strains with and 
without Mds3-HA (Figure 3.8). In -HA immunoprecipitates from cells containing Mds3-HA, 
Sit4-Myc was pulled down. Sit4-Myc was not detected in -HA immunoprecipitates in the 
absence of Mds3-HA, demonstrating that Sit4-Myc is specifically associating with Mds3-HA. 
Similar results were observed in whole cell extracts from cells grown in YPD, indicating that this 
interaction is not dependent on nutrient availability (Figure 3.8). Thus, Mds3 and Sit4 physically 
interact, demonstrating that Mds3 is a member of the TOR pathway. 
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Figure 3.8: Mds3 and Sit4 interact physically. C. albicans Sit4-Myc tagged (Sit4-M) 
strains with and without Mds3-HA (Mds3-H) (DAY1236 and DAY1235 respectively) 
were grown in M199 pH 8 and YPD. An aliquot of the whole cell extracts (WCE) were 
separated by SDS-PAGE and an aliquot was incubated with -HA beads, centrifuged, 
washed, and eluted (IP) prior to SDS-PAGE. Blots were probed with -HA first, 
stripped, and then probed with -Myc. 
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DISCUSSION  
 
 Growth and morphogenesis is controlled by numerous signal transduction pathways 
which respond to diverse environmental cues. The TOR pathway is a key regulator of growth and 
morphogenesis in eukaryotes, and in C. albicans, the TOR pathway governs the yeast-to-hyphal 
morphogenetic transition, which is critical for pathogenesis (Cutler et al., 2001; Whiteway and 
Oberholzer, 2004). Microarray analyses suggested that MDS3 is a member of the TOR pathway 
in C. albicans and this idea was supported by genetic, pharmacological, and biochemical 
approaches. Thus, Mds3 represents a new member of the TOR morphogenetic pathway. 
 
How does Mds3 contribute to the TOR pathway? 
Mds3 is a 1383 amino acid protein with predicted Kelch repeats in the N-terminal region 
but no other obvious motifs and functional domains (Davis et al., 2002). Kelch repeats form a -
propeller structure that functions as a protein-protein interaction domain, and is found in an array 
of proteins, including cytoskeletal proteins and signal transduction proteins (Adams et al., 2000; 
Feierbach et al., 2004; Harashima and Heitman, 2002; Lu and Hirsch, 2005). To the best of our 
knowledge Mds3 represents the first Kelch repeat protein associated with the TOR pathway. 
However, two components of the TOR complex, Lst8 and Kog1 (GβL and Raptor in mammalian 
systems), contain WD-40 domains, which also fold into β-propeller structures (Chen and Kaiser, 
2003; Gettemans et al., 2003; Kim et al., 2002, 2003; Loewith et al., 2002). Thus, we propose that 
Mds3 may act as a scaffold to facilitate interactions between TOR pathway members to control 
morphogenetic processes in C. albicans. 
Based on our results, which include the transcriptional and morphological similarities 
between the mds3∆/∆ and sit4∆/∆ mutants that are rescued by rapamycin and the interaction 
between Mds3 and Sit4, we propose two models to explain how Mds3 acts in the TOR pathway 
(Figure 3.9). First, Mds3 may act upstream of TOR potentially as a member of a nutrient sensitive 
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complex such as the one composed by Raptor, GβL, and mTOR (Kim et al., 2002, 2003). Support 
for this model comes from the fact that rapamycin, which inhibits TOR kinase activity, rescues 
the transcriptional defects and morphogenetic defects associated with the mds3∆/∆ mutant 
(Figures 3.2-3.4). Further, rapamycin-mediated rescue of the mds3∆/∆ mutant is lost with the 
introduction of a TOR1-1 allele or loss of Rbp1 (Figures 3.2 and 3.5). Based on this data Mds3 
appears to act upstream of TOR. However, for this model to be accurate, Mds3 interacts 
indirectly with Sit4. 
    
 
Figure 3.9: Models of Mds3 as a TOR pathway member. (A) Mds3 as an upstream 
negative regulator of TOR (left). Loss of Mds3 leads to increased expression of genes 
involved in translation and increased repression of Sit4 and less expression of the NCR 
genes (middle). This loss of negative regulation can be restored with rapamycin (right). 
(B) Mds3 as a downstream member of the Sit4-dependent pathway inhibited by TOR. 
This Sit4-dependent pathway inhibits expression of RP synthesis genes and promotes 
expression of NCR genes (left). Loss of Mds3 (or Sit4) leads to increased expression of 
genes involved in translation and decreased expression of the NCR genes (middle). 
Rapamycin inhibits TOR activation, restoring RP synthesis expression by reduced TOR 
kinase function. NCR expression is also restored, although this mechanism is not yet 
understood (right). 
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How could Mds3 function upstream of TOR? One possibility is that Mds3 modulates the 
interaction of Kog1 and Lst8, Raptor and GβL in mammalian systems, with TOR. GβL promotes 
TOR kinase activity, and Raptor-GβL constitutively interacts with mTOR. However, Raptor-
GβL-mTOR interaction is effected by nutrient signals (Kim et al., 2002). Under nutrient poor 
conditions Raptor-mTOR interaction is stabilized, which interferes with GβL-stimulation of 
mTOR (Kim et al., 2003). In yeast, Kog1-Lst8 interaction with Tor1 does not appear to be 
effected by nutrient status (Loewith et al., 2002). This led to the hypothesis that an additional 
factor, such as Mds3, may be involved that affects the activity of Kog1 and/or Lst8 on Tor1. 
An alternative model is that Mds3 acts downstream of Tor1 to promote starvation 
responses when Tor1 is inactive (Figure 3.9). Support for this model comes from the fact that the 
sit4∆/∆ mutant has similar transcriptional and morphological defects as the mds3∆/∆ mutant, and 
that these defects are rescued by rapamycin (Figures 3.2-3.5). Additionally both mds3∆/∆ and 
sit4∆/∆ mutants are sensitive to alkaline pH (Figure 3.7C). Since rapamycin inhibits TOR kinase 
activity, these results suggest that the transcriptional and morphogenetic defects associated with 
the mds3∆/∆ and sit4∆/∆ mutants are due to an increase in TOR kinase activity or TOR kinase-
dependent activities, and that reduced kinase activity by rapamycin is sufficient to rescue the 
sit4∆/∆ and mds3∆/∆ mutants. Finally the fact that Mds3 and Sit4 coimmunoprecipitate suggests 
that these proteins interact within the same complex either directly or indirectly. One potential 
problem for this model is the restoration of GAP2 expression by rapamycin in the mds3∆/∆ 
mutant (Figure 3.2). However, GAP2 expression is also rescued by rapamycin in the sit4∆/∆ 
mutant. Thus, additional PP2As, which are activated by rapamycin treatment, may promote 
expression of GAP2 independent of Mds3 or Sit4. A similar phenomenon has been described in S. 
cerevisiae (Cox et al., 2004; Georis et al., 2009; Tate et al., 2009). Finally, we noted that the 
TOR1-1 allele and mds3∆/∆ mutation had a synergistic effect, which generally suggests parallel 
pathways. However, the TOR1-1 allele and similar alleles, have altered functions in both S. 
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pombe and mammalian systems (McMahon et al., 2002; Vilella-Bach et al., 1999; Weisman and 
Choder, 2001) and we find that TOR1-1 confers growth defects in the absence of a wild-type 
TOR1 allele (Figures 3.5A and 3.6B). Thus, we propose that the TOR1-1 mds3∆/∆ synergism 
reflects defective kinase function in Tor1-1, which exacerbates the TOR pathway defects 
associated with the mds3∆/∆ mutant. 
 How could Mds3 function downstream of TOR? One possibility is that Mds3 acts as a 
scaffold bridging TOR activity to its effectors. For example, Sit4 activity is dependent upon its 
association with Tap42 and several Sit4 associated proteins (SAPs), and Mds3 may govern these 
associations (DiComo and Arndt, 1996; Duvel and Broach, 2004; Luke et al., 1996). Mds3 may 
facilitate or stabilize these interactions to promote Sit4 activity. Support for this idea comes from 
large scale protein-protein interaction analyses that identified Sap185, a Sit4 regulatory protein, 
as an Mds3 binding partner (DiComo and Arndt, 1996; Gavin et al., 2002, 2006; Luke et al., 
1996). 
 
Mds3, TOR, and nutrient sensing 
TOR kinase activity is controlled by nutrient availability (Crespo et al., 2002; DiComo 
and Arndt, 1996; Kim et al., 2002; Rohde and Cardenas, 2004). In nutrient rich conditions, TOR 
kinase activity is stimulated leading to activation of growth processes and inactivation of 
starvation responses. In starvation conditions, TOR kinase activity is inhibited preventing the 
activation of growth responses and leading to activation of starvation responses. Here, we found 
that wild-type cells promote expression of RPS26A and repression of GAP2 when grown in YPD, 
but promote expression of RPS26A, although to reduced levels compared to YPD, and GAP2 
when grown in M199 (Figure 3.2). This suggests that M199 is nutrient poor when compared to 
YPD. Further, wild-type cells divide slower in M199 pH 8 medium compared to M199 pH 4 
medium suggesting that M199 pH 8 is more poor than M199 pH 4 medium. This latter growth 
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difference can be explained by the inhibition of plasma membrane transporters and the 
dependence on endocytic uptake of nutrients in alkali environments (Munn and Riezman, 1994; 
van der Rest et al., 1995; Weissman et al., 2008). Thus, YPD > M199 pH 4 > M199 pH 8 in 
nutrient availability, and cells grown in these media may require different levels of TOR kinase 
activity. 
We found that the mds3∆/∆ and sit4∆/∆ mutants did not affect expression of TOR-
dependent genes when grown in YPD, as expected if Mds3 and Sit4 promote TOR-dependent 
starvation responses (Figure 3.2). In M199 pH 8 medium and Spider medium, the mds3∆/∆ and 
sit4∆/∆ mutants had similar defects suggesting that both media are nutrient poor and require 
TOR-dependent starvation responses. In M199 pH 4 medium, the mds3∆/∆ and sit4∆/∆ mutants 
did not repress CDC19, RPS26A, or TEF1 nor did they induce GAP2 to wild-type levels, 
supporting the idea that M199 pH 4 medium is a semi-starvation medium that requires some level 
of the TOR-dependent starvation response. In M199 pH 4 medium, the sit4∆/∆ mutant clearly had 
a more severe defect in repression of CDC19 and RPS26A and induction of GAP2 than the 
mds3∆/∆ mutant. This represents the first demonstration that Sit4 negatively regulates RP 
synthesis and is in contrast with work from S. cerevisiae, which suggests that Sit4 does not 
govern RP synthesis (Duvel et al., 2003; Schmelzle et al., 2004). However, these results suggest 
that Sit4 plays a more general role in promoting TOR-dependent starvation responses than Mds3. 
For example, Sit4 may be required under both semi-starvation and starvation conditions, whereas 
Mds3 may only function under starvation conditions. This idea is supported by the fact that the 
mds3∆/∆ mutant was resistant to rapamycin in nutrient poor medium, but not in rich medium, 
whereas the sit4∆/∆ mutant was resistant to rapamycin in both media (Figure 3.7A).  
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Mds3 function in C. albicans and S. cerevisiae 
 MDS3 was first identified in S. cerevisiae as a multicopy suppressor of the ∆mck1 
sporulation defect and was subsequently identified as a regulator of the C. albicans yeast-to-
hyphal transition (Benni and Neigeborn, 1997; Davis et al., 2002). These morphogenetic 
processes are promoted by neutral-alkaline environmental pH, which led to the idea that Mds3 is 
a pH response regulator similar to Rim101. This idea was supported by the fact that Mds3 is 
required for wild-type growth at alkaline pH (Davis et al., 2002). However, Mds3 is also required 
for chlamydospore and biofilm formation in C. albicans, neither of which require neutral-alkaline 
pH (Nobile et al., 2003; Richard et al., 2005). We also found that the mds3∆/∆ mutant has a slight 
growth defect on rich medium, which is acidic, and our microarray studies demonstrated that the 
mds3∆/∆ mutant showed transcriptional changes at both acidic and alkaline pH (Figures 3.1-
3.3A, 3.6 and Tables 3.3, 3.4, and S3.1). Thus, Mds3 clearly plays a broader role than neutral-
alkaline pH regulation in C. albicans, and we propose that the morphogenetic defects observed in 
the mds3∆/∆ mutant reflect defects in general cellular processes that are also required for growth 
and filamentation at alkaline pH. 
In S. cerevisiae, Mds3 and Pmd1 are proposed to act upstream or in parallel to the 
Ras/PKA pathway (Benni and Neigeborn, 1997; McDonald et al., 2009), because the sporulation 
defect of the mds3∆ pmd1∆ double mutant was rescued by the hyperactive RAS2V19 allele (Benni 
and Neigeborn, 1997). However, several lines of evidence suggest that Mds3 is unlikely to 
function upstream of Ras, independent of TOR. First, the hyperactive RAS2
V19
 allele rescues TOR 
pathway mutants in S. cerevisiae suggesting that Ras2 acts in parallel or downstream of the TOR 
pathway (Cutler et al., 2001; Schmelzle et al., 2004; Zurita-Martinez and Cardenas, 2005). 
Second, the filamentation defect of the ras1∆/∆ mutant is not rescued by rapamycin, unlike the 
mds3∆/∆ mutant (Figures 3.7 and (Feng et al., 1999; Leberer et al., 2001)). Third, we found that 
both the ∆sit4 and ∆mds3 mutants are sensitive to rapamycin in S. cerevisiae. Thus, we propose 
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that Mds3 acts in the TOR pathway in both S. cerevisiae and C. albicans, but that the hyperactive 
RAS2
V19
 allele is able to bypass this by acting either in parallel or downstream of TOR. 
 Why does S. cerevisiae encode two MDS3 paralogs? In S. cerevisiae, phenotypes 
associated with the ∆mds3 mutant are masked by the functionally redundant PMD1 (Benni and 
Neigeborn, 1997; Davis et al., 2002). However, we found that the S. cerevisiae ∆mds3 mutant, 
like the ∆sit4 mutant but not the ∆pmd1 mutant, was sensitive to rapamycin, which is the first 
demonstration that Mds3 and Pmd1 are not completely redundant in S. cerevisiae. In C. albicans, 
the mds3∆/∆ and sit4∆/∆ mutants behave similarly, however our results suggest that Mds3 has 
Sit4-independent functions. First, the mds3∆/∆ mutant is sensitive to high concentration of LiCl, 
whereas the sit4∆/∆ mutant is not (Figure 3.7C and (Davis et al., 2002)). Second, the mds3∆/∆ 
sit4∆/∆ double mutant has more severe growth defects on YPD and at alkaline pH than either 
single mutant (Figure 3.7C). Third, the filamentation defect of the mds3∆/∆ sit4∆/∆ double 
mutant is not rescued by rapamycin (Figures 3.3 and 3.4). Thus, in C. albicans, Mds3 has Sit4-
dependent and -independent function. This raises the interesting possibility that in S. cerevisiae, 
Mds3 governs the Sit4-dependent functions, rapamycin sensitivity, and Pmd1 governs the Sit4-
independent functions. It is not yet known if Sit4-independent functions of Mds3 in C. albicans 
occur through the TOR pathway or completely independent of the TOR pathway. 
While Mds3 appears to act in the TOR pathway in both C. albicans and S. cerevisiae, our 
results have demonstrated that the role of TOR pathway in these organisms has diverged. In S. 
cerevisiae, sporulation requires both nitrogen and carbon starvation and is negatively regulated by 
Mds3. This suggests that Mds3 functions as a positive regulator of the TOR pathway (Benni and 
Neigeborn, 1997; McDonald et al., 2009). However, we have clearly shown that Mds3 functions 
as a negative regulator of the TOR pathway in C. albicans during starvation conditions. Thus, 
while the TOR pathway is mechanistically similar in C. albicans and S. cerevisiae, the signals 
coming in to and/or responses coming out of the TOR pathway appear to be distinct. This idea is 
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supported by the rapamycin resistance observed for the mds3∆/∆ and sit4∆/∆ mutants in C. 
albicans compared to the sensitivity observed for these mutants in S. cerevisiae (Figure 3.7B and 
(Cutler et al., 2001; Lee et al., 2004). Regardless, several signal transduction pathways have been 
identified that while mechanistically similar lead to distinct responses in C. albicans and S. 
cerevisiae, which is not surprising given the ~300 million years of evolutionary distance between 
these organisms (Hogues et al., 2008; Ihmels et al., 2005; Martchenko et al., 2007; Tsong et al., 
2006). 
 
 Despite the fact that rapamycin initially triggered interest because of its antifungal 
properties against C. albicans (Vezina et al., 1975), the TOR pathway has received relatively little 
attention in this organism. In fact, most work has focused on the role of TOR in multicellular 
organisms in processes as diverse as angiogenesis and embryogenesis. However, TOR appears to 
have conserved functions in growth and stress responses in both multicellular and unicellular 
eukaryotes (Reiling and Sabatini, 2006; Wullschleger et al., 2006). Our studies demonstrate that 
the kelch repeat protein Mds3, which promotes morphogenetic processes critical for 
pathogenesis, such as the yeast-to-hyphal transition and biofilm formation, is a new member of 
the TOR pathway (Davis et al., 2000a; Kumamoto and Vinces, 2005; Nobile et al., 2006). Our 
study represents the first example in which a kelch repeat protein has been implicated in the TOR 
pathway and raises the possibility that an Mds3-like protein may exist in mammalian systems to 
promote TOR-dependent responses. 
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TABLES 
 
Table 3.1. C. albicans and S. cerevisiae strains used in this study 
Strain Parent Genotype Reference 
DAY1 
(BWP17) 
SC5314 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG 
arg4::hisG/arg4::hisG 
Wilson et al., 
1999 
DAY25 BWP17 ura3::λimm434/ura3::λimm434  HIS1::his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  rim101::ARG4/rim101::URA3 
Davis et al., 
2000a 
DAY185 DAY286 ura3::λimm434/ura3::λimm434  HIS1::his1::hisG/his1::hisG  
ARG4::URA3::arg4::hisG/arg4::hisG 
Davis et al., 
2000a 
DAY286 BWP17 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
ARG4::URA3::arg4::hisG/arg4::hisG 
Wilson et al., 
1999 
DAY414 
(L40) 
S. cerevisiae MATα  his3∆200  trp1-901  leu2-3,-112  ade2 LYS2::(lexAop)4-HIS3  
URA3::(lexAop)8-lacZ  GAL4 
Vojtek et al., 
1993 
DAY415 
(VIC1)1 
BWP17 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::ARG4/MDS3 
Davis et al., 
2002 
DAY439 
(VIC25) 
BWP17 ura3::λimm434/ura3::λimm434  HIS1::his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::Tn7::URA3/mds3::Tn7::UAU1 
Davis et al., 
2002 
DAY938 BWP17 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3-dpl200 
This study 
DAY956 DAY938 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::ARG4/mds3::dpl200 
This study 
DAY971 
(CM02) 
RM1000 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
sit4::HIS1/sit4::URA3  
Lee et al., 
2004 
DAY972 
(CM20) 
RM1000 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG 
sit4::HIS1/sit4::dpl200 
Lee et al., 
2004 
DAY973 
(CM22) 
RM1000 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
sit4::HIS1/sit4::dpl200 [pVEC1::SIT4] 
Lee et al., 
2004 
DAY1109 
(CDH107) 
CAI4 ura3::λimm434/ura3::λimm434 ras1::hisG-URA3-hisG/ras1::hisG Leberer et al., 
2001 
DAY1118 DAY938 ura3::λimm434/ura3::λimm434  HIS1::his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3-dpl200 
This study 
DAY1119 DAY938 ura3::λimm434/ura3::λimm434  HIS1::MDS3::his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3-dpl200 
This study 
DAY1120 DAY938 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3:: ARG4/mds3::URA3-dpl200 TOR1-
1/TOR1 
This study 
DAY1121 DAY185 ura3::λimm434/ura3::λimm434  HIS1::his1::hisG/his1::hisG  
ARG4::URA3::arg4::hisG/arg4::hisG TOR1-1/TOR1 
This study 
DAY1122 DAY938 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3-dpl200 
TOR1/tor1::HIS1 
This study 
DAY1123 DAY286 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
ARG4::URA3::arg4::hisG/arg4::hisG TOR1/tor1::HIS1 
This study 
DAY1124 DAY1122 ura3::λimm434/ ura3::λimm434  his1::hisG / his1::hisG  arg4::hisG/ 
arg4::hisG  mds3::ARG4/mds3::URA3-dpl200 TOR1-1/tor1::HIS1 
This study 
DAY1125 DAY1123 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
ARG4::URA3::arg4::hisG/arg4::hisG TOR1-1/tor1::HIS1 
This study 
DAY1208 SK1  his3/his3 leu2::hisG/leu2::hisG trp1::hisG/trp1::hisG 
lys2/lys2 ura3/ura3 ho::LYS2/ho::LYS2 
McDonald et 
al., 2009 
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(MWY64) 
DAY1209 
(CMY164) 
SK1 MATa/MAT  mds3::URA3/mds3::URA3 his3/his3 
leu2::hisG/leu2::hisG trp1::hisG/trp1::hisG lys2/lys2 ura3/ura3 
ho::LYS2/ho::LYS2 
McDonald et 
al., 2009 
DAY1210 
(CMY165) 
SK1 MATa/MAT  pmd1::LEU2/pmd1::LEU2 his3/his3 
leu2::hisG/leu2::hisG trp1::hisG/trp1::hisG lys2/lys2 ura3/ura3 
ho::LYS2/ho::LYS2 
McDonald et 
al., 2009 
DAY1211 
(CMY166) 
SK1 MATa/MAT  mds3::URA3/mds3::URA3 pmd1::LEU2/pmd1::LEU2 
his3/his3 leu2::hisG/leu2::hisG trp1::hisG/trp1::hisG lys2/lys2 
ura3/ura3 ho::LYS2/ho::LYS2 
McDonald et 
al., 2009 
DAY1223 
(YAG171) 
CAI4 ura3::λimm434/ura3::λimm434 rbp1::MX3/rbp1::CaURA3MX3R Cruz et al., 
2001 
DAY1230 DAY1223 ura3::λimm434/ura3::λimm434 rbp1::MX3/rbp1::MX3 This study 
DAY1231 DAY972 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG 
sit4::HIS1/sit4::dpl200 MDS3/mds3::URA3-dpl200 
This study 
DAY1232 DAY1231 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG 
sit4::HIS1/sit4::dpl200 MDS3/mds3::dpl200 
This study 
DAY1233 DAY1232 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG 
sit4::HIS1/sit4::dpl200 mds3::URA3-dpl200/mds3::dpl200 
This study 
DAY1234 DAY1 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  SIT4/SIT4-Myc-URA3 
This study 
DAY1235 DAY1234 ura3::λimm434/ura3::λimm434  HIS1::MDS3::his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  SIT4/SIT4-Myc-URA3 
This study 
DAY1236 DAY1234 ura3::λimm434/ura3::λimm434  HIS1::MDS3-
HA::his1::hisG/his1::hisG  arg4::hisG/arg4::hisG SIT4/SIT4-Myc-
URA3 
This study 
DAY1237 DAY1230 ura3::λimm434/ura3::λimm434 rbp1::MX3/rbp1::MX3 
MDS3/mds3::URA3dpl200 
This study 
DAY1238 DAY1237 ura3::λimm434/ura3::λimm434 rbp1::MX3/rbp1::MX3 
MDS3/mds3::dpl200 
This study 
DAY1239 DAY1238 ura3::λimm434/ura3::λimm434 rbp1::MX3/rbp1::MX3 
mds3::dpl200/mds3::URA3dpl200 
This study 
DAY1255 DAY1120 
ura3::λimm434/ura3::λimm434  HIS1::his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3:: ARG4/mds3::URA3-dpl200 TOR1-
1/TOR1 
This study 
DAY1321 DAY972 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG 
sit4::HIS1/sit4::dpl200  TOR1-1/TOR1 
This study 
1
Parent of VIC3 (mds3::ARG4/mds3::URA3). VIC1 was not described in Davis et al. (2002). 
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Table 3.2. Primers used in this study 
Name Sequence (5‟to 3‟) Reference 
MDS3 5DR TCTTAAGGCACAAGTTATTGGCTTGACGTAGAAGTTT
GCAAAGATTTTCACAATATCATGTTTCCCAGTCACGA
CGTT 
Davis et al., 2002 
MDS3 3DR ACCAATATAACGTGAATATACACCCCTATATTATTAT
CTTTTAATCCTGTTAACAATCCGTGGAATTGTGAGCG
GATA 
Davis et al., 2002 
MDS3null 5-detect GTGTCCCAATTTTGTCTAGC This study 
MDS3null 3-detect TGCGGAAGAACTGTAAACCC This study 
TOR1 5DR AGTAGATAATACTTCTAACTTTGATAGTAACATTAAC
GAAGAAAAACAAATCATTAATCATTTCCCAGTCACG
ACGTT 
This study 
TOR1 3DR TATTTCCCTTTATAAAATAGTTACACATACCATACTT
AACGACACATGACGATACTCAACGTGGAATTGTGAG
CGGATA 
This study 
TOR1 5’detect-2 TCTCTTAGTTGTTGAGTGGC This study 
TOR1 3’detect AAATTTCCTTCCAAACCTGC This study 
TOR1 A-C  GTTTTATGGCACGAACAATGGCACGATGCTTTGGAAG
ATGCTCGCAGGTTTTTCTTTGGTGAACACAACACAGA
AAAGATG 
This study 
TOR1 A-C Rev CATCTTTTCTGTGTTGTGTTCACCAAAGAAAAACCTG
CGAGCATCTTCCAAAGCATCGTGCCATTGTTCGTGCC
ATAAAAC 
This study 
JOHE6247 GGCAAGGTGTTTCTTGAAGC Cruz et al., 2001 
JOHE6248 TACTTCTTGATTCGCGATAGC Cruz et al., 2001 
DDB78 PmeIxNruI 
5’ 
ATAATCAAAATGAGTCAATTCTCACAACCGCTCGGTT
TAAACCGACACGTTTCAACGAAATGGCCTCCCCTACC
A 
This study 
DDB78 PmeIxNruI 
3’ 
TGGTAGGGGAGGCCATTTCGTTGAAACGTGTCGGTTT
AAACCGAGCGGTTGTGAGAATTGACTCATTTTGATTA
T 
This study 
MDS3 5comp new AAGCTCGGAATTAACCCTCACTAAAGGGAACAAAAG
CTGGTGGTCTTTAATTGGGCGGAC 
This study 
MDS3 3comp new-2 ACGACGGCCAGTGAATTGTAATACGACTCACTATAG
GGCGGTTCTCGATTAGTCCATTGACCTGCC 
This study 
MDS3 5-2comp new GATGGAGAGATGGGGACAGC This study 
MDS3 3-2comp 
new-2 
TTTGTCATGTTCACCCGACG This study 
TOR1 probe 5’ ATGAAATAGTGAGTCGCTCC This study 
TOR1 probe 5’-2 CTTTTGTTGCAAATGGCACC  This study 
TOR1 probe 3’ CTACCAAGCATAATGGGGTC This study 
RPS26A 5' CAAGAAAGGTAGAGGTCACG This study 
RPS26A 3' TTTAGCAGCATCTTGTGGAG This study 
CDC19 5’ a CTTCAATGTTGAAACTGTTCC This study 
CDC19 3’ b AACAGTGTTAGAGTGACCAG This study 
GAP2 5’ TTATTGTACAGTTATGTCCC This study 
GAP2 3’ CCAGCGAAAGCAAAGGCAGC This study 
TEF1-5’ ATAGTCATAATCAATCATGGGT Davis et al., 2000b 
TEF1-3’ CTTACATAATATTCAACTAGC Davis et al., 2000b 
Sit4 MYC N-ter 5' GATGGTGACTTATCAGTCAAGAACAATGCCAACAAA
CAACAAAGAAGTGATTATTTTTTGCGGATCCCCGGGT
TAATTAA 
This study 
Sit4 MYC URA3 N-
ter 3' 
GCATCATTAAGGGATTTGAAAAAAAAAGATATAAAT
ATAAAAATCATTCATCATTCGTTATCTAGAAGGACCA
CCTTTGATTG 
This study 
5’ Myc detect GAACAAAAATTAATTTCTGAAGAAGATTTA This study 
Sit4 3’ detect TGGTTTGTATGTGTAAGTCC This study 
NgoMIV KpnI NheI 
x NruI 5' 
TAGCCGGCTGGGTACCCGGCTAGCCA This study 
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NgoMIV KpnI NheI 
x NruI 3' 
TGGCTAGCCGGGTACCCAGCCGGCTA This study 
MDS3-HA-56 5' AGCTTCGAAAATTCATGCAGATAGTGTCGCAATGTCT
TTGTACCCATACGATGTTCCTGAC 
This study 
MDS3-HA-56 3' AAGCATTTCGCAGATTATTACTTGTAACCGATTTCTTT
TTGTAATCTGGAACGTCATATGG 
This study 
The sequences underlined indicate the restriction site created. Sequences in bold and underlined 
indicate point mutation. 
 
 
 
 
Table 3.3. Results of the transcriptional profiling of the wild-type, the mds3∆/∆, and the 
rim101∆/∆ C. albicans strains. 
Condition # of ORFs with ≥ 2-
fold difference 
# of ORFs expressed 
more in the mutant 
# of ORFs expressed 
less in the mutant 
mds3∆/∆ rim101∆/∆1 mds3∆/∆ rim101∆/∆1 mds3∆/∆ rim101∆/∆1 
WT pH 8 vs. 
mutant pH 8 
337  186 146 55 191 131 
WT pH 4 vs. 
mutant pH 4 
76 7 37 1 39 6 
ORFs ≥ 2-fold 
difference at pH 
8 and pH 4 
50 6     
Total  363 187     
1 
Data from (Bensen et al., 2004)
 
 1
0
3 
Table 3.4. GO categories of differentially expressed ORFs in the mds3∆/∆ and rim101∆/∆ mutants compared to wild type C. albicans. 
 Expressed more at pH 8 Expressed less at pH 8 Expressed more at pH 4 Expressed less at pH 4 
GO categories mds3∆/∆ rim101∆/∆ mds3∆/∆ rim101∆/∆ mds3∆/∆ rim101∆/∆ mds3∆/∆ rim101∆/∆ 
Amino acid biosynthesis 11 1 8 4 6 0 3 3 
Carbohydrate 
metabolism 
15 3 8 3 8 0 0 0 
 Glycolysis 6 0 0 0 5 0 0 0 
Translation 50 0 1 1 0 0 0 0 
 Initiation/Elongation 6 0 0 0 0 0 0 0 
 rRNA/tRNA 
processing 
5 0 0 0 0 0 0 0 
 Ribosome 37 0 1 0 0 0 0 0 
 Mitochondrial 2 0 0 1 0 0 0 0 
Protein synthesis/folding 15 2 1 2 2 0 0 0 
Protein 
degradation/autophagy 
2 0 11 0 0 0 1 1 
 Vacuolar protein 
catabolic activity 
0 0 5 0 0 0 0 1 
 Amino acid 
degrad/proteosome 
2 0 3 0 0 0 1 0 
 Others 0 0 3 0 0 0 0 0 
Lipid Metabolism 4 1 10 4 1 0 0 0 
Permeases/transport 9 9 33 25 2 0 13 0 
 Amino acid transport 0 2 12 5 0 0 4 0 
 Hexose transport 4 0 4 1 1 0 1 0 
 Other transport 5 7 17 19 1 0 8 0 
DNA 
replication/transcription 
7 1 2 0 1 0 2 0 
Transcript. factor/Signal 
transduction 
2 2 13 4 3 0 5 0 
 
 1
0
3 
1
0
4 
Electron transport 2 0 3 0 1 0 0 0 
Cell wall/filamentation 4 2 22 17 1 1 3 2 
Other 10 7 19 23 4 0 4 0 
Unknown/Novel 15 27 60 48 8 0 8 0 
Total ORFs     146      55 191 131 37 1 39 6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 105 
 
Table 3.5. Hyphal formation in M199 pH 8 in the presence and absence of 5nM rapamycin. 
Strain Genotype % of hyphae ± SEM
1
 
Solvent Rapamycin 
DAY185 MDS3/MDS3   TOR1/TOR1 88.5 ± 2.0 98.3 ± 2.0 
DAY1121 MDS3/MDS3   TOR1-1/TOR1 85.0 ± 2.2 89.6 ± 2.2 
DAY1123 MDS3/MDS3   TOR1/∆ 94.3 ± 0.7 98.5 ± 0.7 
DAY1125 MDS3/MDS3   TOR1-1/∆ 90.6 ± 1.6 93.3 ± 1.6 
DAY1118 mds3∆/∆   TOR1/TOR1 2.9 ± 3.2 44.5 ± 3.2 
DAY1120 mds3∆/∆   TOR1-1/TOR1 5.0 ± 3.2 23.4 ± 3.2 
DAY1122 mds3∆/∆   TOR1/∆ 5.1 ± 1.8 37.3 ± 1.8 
DAY1124 mds3∆/∆   TOR1-1/∆ 0.9 ± 0.3 0.8 ± 0.3 
 
 
 
 
Table 3.6. Hyphal formation in M199 pH 8 in the presence and absence of 5nM rapamycin 
 
Strain Genotype % of hyphae ± SEM
1
 
Solvent Rapamycin 
DAY185 MDS3/MDS3   RBP1/RBP1 75.6 ± 2.9 84.9 ± 4.0 
DAY1233 MDS3/MDS3   rbp1∆/rbp1∆ 91.4 ± 1.1 91.1 ± 1.7 
DAY1118 mds3∆/∆   RBP1/RBP1 4.4 ± 1.7 30.4 ± 3.5 
DAY1239 mds3∆/∆   rbp1∆/rbp1∆ 3.0 ± 0.9 3.5 ± 1.0 
 
                                                 
1
 SEM, standard error of the mean 
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Table S3.1 ORFs differentially expressed (≥2) in the mds3Δ/Δ mutant compared to the wild-type 
strain at pH 4 or at pH 8. 
ORFs  expressed less in the mds3∆/∆ mutant than in the wild-type strain at pH 4 
     
Orf19. Locus name S. cerevisiae 
ortholog or best hit 
log 2 
ratio 
Function/Process 
orf19.4274 PUT1 PUT1 -1.02 Amino acid biosynthesis 
orf19.986 GLY1 GLY1 -1.17 Amino acid biosynthesis 
orf19.4026 HIS1 HIS1 -4.17 Amino acid biosynthesis 
orf19.7631 SLD5 SLD5 -1.31 DNA replication 
orf19.5634 FRP1 FRE5 -1.38 Fe utilization 
orf19.5674 PGA10 FIT1 -1.57 Fe utilization/cell wall 
orf19.4025 PRE1 PRE1 -3.47 Protein degradation/proteosome 
orf19.6586 orf19.6586 NAB3 -1.66 RNA transcription 
orf19.5045 orf19.5045 PTP2 -1.14 Signal transduction 
orf19.4593 RGA2 RGA1, RGA2 -1.10 Signal transduction 
orf19.5635 PGA7 TIR1 -1.52 Structural 
orf19.5636 RBT5  -1.29 Structural 
orf19.909 STP4 STP4 -1.43 Transcription factor 
orf19.1837 TBP1 SPT15 -1.04 Transcription factor 
orf19.1255 ZCF5 HAP1 -1.18 Transcription factor 
orf19.4118 CNT  -1.39 Transport 
orf19.4779 orf19.4779 VBA5 -1.06 Transport 
orf19.2751 orf19.2751 MCH4 -1.26 Transport 
orf19.918 CDR11 PDR5 -1.55 Transport  
orf19.1979 GIT1 GIT1 -1.21 Transport (Carbon) 
orf19.4784 CRP1 CCC2 -1.54 Transport (Copper) 
orf19.3668 HGT2 RGT2 -1.96 Transport (glucose) 
orf19.3440 FRP5 ATO2 -1.09 Transport (Nitrogen) 
orf19.6937 PTR2 PTR2 -1.08 Transport (Nitrogen) 
orf19.6993 GAP2 GAP1 -1.14 Transport (Nitrogen) 
orf19.84 CAN3 CAN1 -1.01 Transport (Nitrogen) 
orf19.111 CAN2 CAN1 -1.21 Transport (Nitrogen) 
orf19.4063 GPT1 UGA4 -1.70 Transport (Nitrogen) 
orf19.7058 orf19.7058 RMD8 -1.15 Unknown function 
orf19.3973 orf19.3973 HUA1 -1.03 Unknown function 
orf19.1523 orf19.1523 -1.08 Unknown function 
orf19.2724 orf19.2724 MOT3 -1.14 Unknown function 
orf19.3369 MOH1 MOH1 -1.11 Unknown function 
orf19.5037 orf19.5037 -1.54 Unknown function 
orf19.1500 orf19.1500 YBL010C -1.07 Unknown function 
orf19.4873 orf19.4873 -1.30 Unknown function 
orf19.822 orf19.822  -1.50 Unknown function 
orf19.3117 CSA2  -1.60 Unknown function 
orf19.5282 orf19.5282 -1.15 Unknown function 
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ORFs  expressed more in the mds3∆/∆ mutant than in the wild-type strain at pH 4 
     
Orf19. Locus name S. cerevisiae 
ortholog or best hit 
log 2 
ratio 
Function/Process 
orf19.2551 MET6 MET6 1.07 amino acid biosynthesis 
orf19.5650 PRO3 PRO3 1.08 amino acid  biosynthesis 
orf19.3554 AAT1 AAT1 1.50 amino acid  biosynthesis 
orf19.3911 SAH1 SAH1 1.09 amino acid  biosynthesis 
orf19.7448 LYS9 LYS9 1.39 amino acid  biosynthesis 
orf19.88 ILV5 ILV5 1.38 amino acid  biosynthesis 
orf19.2608 ADH5 ADH2 1.33 Carbon metabolism/Ethanol 
catabolism 
orf19.7514 PCK1 PCK1 2.69 Carbon metabolism/Gluconeogenesis 
orf19.3651 PGK1 PGK1 1.60 Carbon metabolism/Glycolisys 
orf19.3575 CDC19 CDC19 1.17 Carbon metabolism/Glycolisys 
orf19.395 ENO1 ENO1 1.61 Carbon metabolism/Glycolisys 
orf19.542 HXK2 HXK2 1.09 Carbon metabolism/Glycolisys 
orf19.6814 TDH3 TDH3 1.48 Carbon metabolism/Glycolisys 
orf19.3358 LSC1 LSC1 1.24 Carbon metabolism/TCA 
orf19.5614 orf19.5614 RNH1 1.21 DNA replication 
orf19.5117 OLE1 OLE1 2.09 Fatty acid biosynthesis 
orf19.6882 OSM1 OSM1 1.06 NADH biogenesis 
orf19.4311 YNK1 YNK1 1.37 precursor biosynthesis 
orf19.7446 OPI3 OPI3 1.11 precursor biosynthesis 
orf19.7585 INO1 INO1 4.07 Precursor biosynthesis 
orf19.1154 EGD1 EGD1 1.28 Protein synthesis/folding 
orf19.5858 EGD2 EGD2 1.02 Protein synthesis/folding 
orf19.3707 YHB1 YHB1 1.65 Response to stress 
orf19.3669 SHA3 SKS1 3.52 Signal transduction 
orf19.535 RBR1  1.11 Structural 
orf19.5334 orf19.5334 TIS11 1.78 Transcription 
orf19.4941 TYE7 TYE7 2.42 Transcription/Carbon metabolism 
orf19.6327 HET1  1.00 Transport 
orf19.2021 HGT8 HXT6 1.06 Transport (Glucose) 
orf19.6078 POL93 YGR109W-B 1.33 Unknown function 
orf19.1344 orf19.1344 1.25 Unknown function 
orf19.2460 orf19.2460 1.15 Unknown function 
orf19.4503 orf19.4503 YGR169C-A 1.05 Unknown function 
orf19.1186 orf19.1186 1.22 Unknown function 
orf19.6329 orf19.6329 HPF1 1.18 Unknown function 
orf19.320 orf19.320 YOR246C 1.62 Unknown function 
orf19.7328 orf19.7328 1.01 Unknown function 
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ORFs expressed less in the mds3∆/∆ mutant than in the wild-type strain at pH 8 
     
Orf19. Locus name S. cerevisiae 
ortholog or best hit 
log 2 
ratio 
Function/Process 
orf19.4716 GDH3 GDH3 -2.22 Amino acid biosynthesis 
orf19.5519 GCV1 GCV1 -2.21 Amino acid biosynthesis 
orf19.4788 ARG5,6 ARG5,6 -1.08 Amino acid biosynthesis 
orf19.5610 ARG3 ARG3 -1.89 Amino acid biosynthesis 
orf19.385 GCV2 GCV2 -2.32 Amino acid biosynthesis 
orf19.1996 CHA1 CHA1 -2.37 Amino acid biosynthesis 
orf19.4026 HIS1 HIS1 -3.64 Amino acid biosynthesis 
orf19.7469 ARG1 ARG1 -2.40 Amino acid biosynthesis 
orf19.7668 MAL2 YGR287C -1.19 Carbon metabolism 
orf19.5806 ALD5 ALD5 -1.66 Carbon metabolism/Acetate 
orf19.4287 orf19.4287 XYL2 -1.21 Carbon metabolism/Ethanol 
orf19.789 PYC2 PYC2 -1.06 Carbon metabolism/gluconeogenesis 
orf19.6844 ICL1 ICL1 -2.37 Carbon metabolism/glyoxylate 
pathway 
orf19.4883 MLS1 MLS1 -1.85 Carbon metabolism/glyoxylate 
pathway 
orf19.1719 SGA1 SGA1 -1.50 Carbon metabolism 
orf19.4393 CIT1 CIT1 -2.53 Carbon metabolism/TCA cycle 
orf19.1743 ACS1 ACS1 -2.40 Chromatin modification 
orf19.3264 CCE1 CCE1 -1.62 DNA recombination 
orf19.3029 orf19.3029 EHD3 -1.70 Endocytosis 
orf19.7288 orf19.7288 YBR047W -1.95 Fatty acid Boxidation/Respiration 
orf19.1288 FOX2 FOX2 -1.48 Fatty-acid Boxidation 
orf19.1655 PXP2 POX1 -2.05 Fatty-acid Boxidation 
orf19.4121 orf19.4121 TES1 -1.13 Fatty-acid Boxidation 
orf19.5215 orf19.5215 TES1 -1.61 Fatty-acid Boxidation 
orf19.2809 CTN3 YAT2 -2.37 Fatty-acid Boxidation 
orf19.4551 CTN1 YAT1 -2.20 Fatty-acid Boxidation 
orf19.3684 orf19.3684 SPS19 -1.62 Fatty-acid Boxidation 
orf19.2896 SOU1 SPS19 -1.00 Fatty-acid Boxidation 
orf19.4041 orf19.4041 PEX4 -1.10 Fatty-acid/Precursor 
biosynthesis/peroxisome 
orf19.3538 FRE9 FRE3 -1.07 Fe metabolism 
orf19.5634 FRP1 FRE5 -2.41 Fe metabolism 
orf19.6548 ISU1 ISU1 -1.00 Fe metabolism 
orf19.1264 CFL2 FRE4 -1.50 Fe metabolism 
orf19.6073 HMX1 HMX1 -2.40 Fe metabolism 
orf19.7112 FRP2 FRE5 -3.00 Fe metabolism 
orf19.1325 ECM38 ECM38 -2.27 Glutathione metabolism 
orf19.1774 orf19.1774 FDH1 -2.68 NAD biogenesis 
orf19.1117 orf19.1117 FDH1 -3.03 NAD biogenesis 
orf19.638 FDH1 FDH1 -2.73 NAD biogenesis 
orf19.2114 orf19.2114 PRM10 -1.38 Nitrogen metabolism 
orf19.4736 orf19.4736 PHO8 -1.29 Phosphate metabolism 
orf19.7118 orf19.7118 ADK2 -1.13 Precursor biosynthesis 
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orf19.3567 BIO32 BIO3 -1.34 Precursor biosynthesis/Biotin 
orf19.2242 PRB1 PRB1 -2.57 Protein degradation 
orf19.1339 CPY1 PRC1 -1.31 Protein degradation 
orf19.4743 AFG1 AFG1 -1.61 Protein degradation 
orf19.4135 PRC2 PRC1 -1.42 Protein degradation 
orf19.1847 ARO10 ARO10 -2.17 Protein degradation 
orf19.539 LAP3 LAP3 -2.78 Protein degradation 
orf19.1891 APR1 PEP4 -1.04 Protein degradation 
orf19.7196 orf19.7196 PRB1 -2.37 Protein degradation 
orf19.7445 orf19.7445 VID24 -1.33 Protein degradation 
orf19.2480.1 AUT7 ATG8 -1.92 Protein degradation/autophagy 
orf19.4025 PRE1 PRE1 -3.21 Protein degradation/proteosome 
orf19.3682 CWH8 CAX4 -2.11 Protein synthesis 
orf19.2062 SOD4 SOD1 -2.21 Response to stress 
orf19.2781 orf19.2781 RCK1 -1.36 Response to stress 
orf19.791 RIM11 RIM11 -1.08 Signal transduction 
orf19.1943 orf19.1943 SDS22 -1.09 Signal transduction 
orf19.5962 SNF3 SNF3 -1.11 Signal transduction 
orf19.3415 PTK2 PTK1 -1.11 Signal transduction/transport 
orf19.3924 orf19.3924 SAY1 -2.22 Sterol biosynthesis 
orf19.1397 orf19.1397 CYB5 -1.05 Sterol biosynthesis 
orf19.2706 CRH11 CRH1 -1.18 Structural/Cell wall 
orf19.4072 IFF6 YBL113C -1.12 Structural/Cell wall 
orf19.3374 ECE1  -1.84 Structural/Cell wall 
orf19.175 orf19.175 MUC1 -2.10 Structural/Cell wall 
orf19.1327 RBT1  -1.06 Structural/Cell wall 
orf19.4975 HYR1  -2.04 Structural/Cell wall 
orf19.5302 PGA31  -1.35 Structural/Cell wall 
orf19.2941 SCW4 SCW4 -1.65 Structural/Cell wall 
orf19.1690 TOS1 TOS1 -1.27 Structural/Cell wall 
orf19.5635 PGA7  -2.63 Structural/Cell wall 
orf19.5636 RBT5  -1.59 Structural/Cell wall 
orf19.1321 HWP1  -1.12 Structural/Cell wall 
orf19.6336 PGA25  -1.95 Structural/Cell wall 
orf19.5760 IHD1 SRP40 -2.33 Structural/Cell wall 
orf19.3117 CSA2  -2.27 Structural/Cell wall 
orf19.3111 PRA1 ZPS1 -3.62 Structural/Cell wall 
orf19.876 PGA33  -1.07 Structural/Cell wall 
orf19.642 PGA13  -1.36 Structural/Cell wall 
orf19.7114 CSA1 MUC1 -4.46 Structural/Cell wall 
orf19.7363 KRE6 KRE6 -1.29 Structural/Cell wall 
orf19.5674 PGA10 FIT1 -2.17 Structural/Cell wall/Fe metabolism 
orf19.1632 orf19.1632 DCW1 -1.09 Structural/Cell wall/Precursor 
biosynthesis 
orf19.3353 orf19.3353 -2.03 Structural/Mitochondria 
orf19.2667 RPF1 RPF1 -1.06 Structural/Ribosome 
orf19.4590 RFX2 MTL1 -1.13 Transcription 
orf19.1150 orf19.1150 GLN3 -1.19 Transcription 
orf19.4647 HAP3 HAP3 -2.48 Transcription 
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orf19.2752 ADR1 ADR1 -1.57 Transcription 
orf19.909 STP4 STP4 -1.10 Transcription 
orf19.2736 orf19.2736 BUR6 -1.35 Transcription 
orf19.610 EFG1 SOK2 -1.15 Transcription 
orf19.5026 orf19.5026 YML081W -1.04 Transcription 
orf19.7381 ZCF37 LYS14 -1.02 Transcription 
orf19.918 CDR11 PDR5 -2.04 Transport 
orf19.3931 SFC1 SFC1 -1.02 Transport 
orf19.3526 ITR1 ITR2 -1.42 Transport 
orf19.6168 orf19.6168 USO1 -2.57 Transport 
orf19.1027 PDR16 PDR16 -1.20 Transport 
orf19.2751 orf19.2751 MCH4 -1.90 Transport 
orf19.2496 orf19.2496 ADY2 -2.44 Transport (Acetate) 
orf19.3981 MAL31 MAL31 -2.22 Transport (carbon) 
orf19.3646 CTR1 CTR1 -2.78 Transport (Copper) 
orf19.4356 HGT3 YDL199C -1.54 Transport (Glucose) 
orf19.2425 HGT18 YBR241C -1.29 Transport (Glucose) 
orf19.6141 HGT16 HXT1 -1.45 Transport (Glucose) 
orf19.6005 HGT5 STL1 -1.25 Transport (Glucose) 
orf19.4546 HOL4 HOL1 -1.93 Transport (ion) 
orf19.2179 SIT1 ARN1 -1.39 Transport (iron) 
orf19.7231 FTR2 FTR1 -2.79 Transport (Iron) 
orf19.6169 orf19.6169 ADY2 -2.63 Transport (Nitrogen and acetate) 
orf19.1224 FRP3 ATO2 -2.74 Transport (Nitrogen) 
orf19.84 CAN3 CAN1 -1.91 Transport (Nitrogen) 
orf19.1142 orf19.1142 AVT4 -1.08 Transport (Nitrogen) 
orf19.111 CAN2 CAN1 -2.68 Transport (Nitrogen) 
orf19.4059 orf19.4059 YHC3 -1.01 Transport (Nitrogen) 
orf19.97 CAN1 CAN1 -1.15 Transport (Nitrogen) 
orf19.2942 DIP5 DIP5 -2.36 Transport (Nitrogen) 
orf19.176 OPT4  OPT2 -2.55 Transport (Nitrogen) 
orf19.2810 AAP1 GAP1 -1.02 Transport (Nitrogen) 
orf19.528 MUP1 MUP1 -1.20 Transport (Nitrogen) 
orf19.6993 GAP2 GAP1 -3.13 Transport (Nitrogen) 
orf19.1210 orf19.1210 AVT5 -1.08 Transport (Nitrogen) 
orf19.7566 orf19.7566 GPN1 -1.66 Transport (Nitrogen) 
orf19.1585 ZRT2 ZRT2 -2.76 Transport (Zinc) 
orf19.3112 ZRT1 ZRT2 -3.20 Transport (Zinc) 
orf19.1534 ZRT3 ZRT3 -1.53 Transport (Zinc) 
orf19.4167 orf19.4167 -1.22 Unknown function 
orf19.1301 orf19.1301 -1.04 Unknown function 
orf19.2724 orf19.2724 -1.66 Unknown function 
orf19.411 orf19.411  -1.91 Unknown function 
orf19.4069 orf19.4069 -1.17 Unknown function 
orf19.4873 orf19.4873 -1.56 Unknown function 
orf19.4482 IFI3  -1.06 Unknown function 
orf19.3499 orf19.3499 -1.72 Unknown function 
orf19.1239 orf19.1239 -1.30 Unknown function 
orf19.3902 orf19.3902 -1.52 Unknown function 
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orf19.6329 orf19.6329 -1.82 Unknown function 
orf19.873 orf19.873  -1.87 Unknown function 
orf19.7608 orf19.7608 -1.53 Unknown function 
orf19.1152 orf19.1152 -1.25 Unknown function 
orf19.1461 orf19.1461 -1.28 Unknown function 
orf19.4445 orf19.4445 -1.44 Unknown function 
orf19.5799 orf19.5799 CAF120 -1.30 Unknown function 
orf19.1523 orf19.1523 -1.63 Unknown function 
orf19.1350 orf19.1350 -2.25 Unknown function 
orf19.4780 orf19.4780 YJR124C -1.11 Unknown function 
orf19.6017 orf19.6017 -1.93 Unknown function 
orf19.4795 orf19.4795 -1.08 Unknown function 
orf19.5063 orf19.5063 -2.29 Unknown function 
orf19.1675 orf19.1675 YDL133W -1.13 Unknown function 
orf19.376 orf19.376  -2.09 Unknown function 
orf19.3351 orf19.3351 -1.12 Unknown function 
orf19.3936 orf19.3936 GDE1 -1.22 Unknown function 
orf19.113 CIP1  -1.88 Unknown function 
orf19.715 orf19.715  -2.34 Unknown function 
orf19.716 orf19.716  -3.18 Unknown function 
orf19.3369 MOH1 MOH1 -1.27 Unknown function 
orf19.1107 orf19.1107 YDL173W -2.16 Unknown function 
orf19.5037 orf19.5037 -1.02 Unknown function 
orf19.5125 orf19.5125 YLR149C -1.46 Unknown function 
orf19.4269 orf19.4269 YLR253W -1.30 Unknown function 
orf19.1505 orf19.1505 -1.20 Unknown function 
orf19.2460 orf19.2460 -2.09 Unknown function 
orf19.419 orf19.419  -2.29 Unknown function 
orf19.1764 orf19.1764 -1.03 Unknown function 
orf19.6469 orf19.6469 YIL082W-A -1.14 Unknown function 
orf19.4792 orf19.4792 -1.26 Unknown function 
orf19.4210 orf19.4210 YGR110W -1.12 Unknown function 
orf19.1588 orf19.1588 FMP21 -1.10 Unknown function 
orf19.2701 orf19.2701 -1.88 Unknown function 
orf19.1258 orf19.1258 -1.10 Unknown function 
orf19.5138 IFA21  -1.34 Unknown function 
orf19.1562 orf19.1562 -1.96 Unknown function 
orf19.4246 orf19.4246 YKR070W -1.31 Unknown function 
orf19.822 orf19.822  -1.93 Unknown function 
orf19.6864 orf19.6864 -2.23 Unknown function 
orf19.334 orf19.334  -1.44 Unknown function 
orf19.2059 orf19.2059 -1.55 Unknown function 
orf19.6556 orf19.6556 -1.72 Unknown function 
orf19.5238 orf19.5238 -1.12 Unknown function 
orf19.3016 orf19.3016 -1.16 Unknown function 
orf19.4575 orf19.4575 YPL109C -1.19 Unknown function 
orf19.935 AGA1  -1.33 Unknown function 
orf19.7296 orf19.7296 -1.72 Unknown function 
orf19.7323 CBP1 FMS1 -1.48 Unknown function 
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orf19.7370 orf19.7370 YOL092W -1.06 Unknown function 
orf19.5952 orf19.5952 -2.48 Unknown function 
orf19.1350 orf19.1350 -2.62 Unknown function 
     
ORFs  expressed more in the mds3∆/∆ mutant than in the wild-type strain at pH 8 
     
Orf19. Locus name S. cerevisiae 
ortholog or best hit 
log 2 
ratio 
Function/Process 
orf19.2551 MET6 MET6 1.06 amino acid  biosynthesis 
orf19.4060 ARO4 ARO4 1.64 amino acid  biosynthesis 
orf19.4650 ILV6 ILV6 1.07 amino acid  biosynthesis 
orf19.1517 ARO3 ARO3 1.16 amino acid  biosynthesis 
orf19.5650 PRO3 PRO3 1.39 amino acid  biosynthesis 
orf19.3554 AAT1 AAT1 1.92 amino acid  biosynthesis 
orf19.3911 SAH1 SAH1 1.50 amino acid  biosynthesis 
orf19.3419 MAE1 MAE1 1.32 amino acid  biosynthesis 
orf19.2951 HOM6 HOM6 1.64 amino acid  biosynthesis 
orf19.7080 LEU2 LEU2 1.27 amino acid  biosynthesis 
orf19.88 ILV5 ILV5 1.83 amino acid 
biosynthesis/mitochondrial DNA 
orf19.2244 orf19.2244 YJR096W 2.34 Carbon metabolism 
orf19.5294 PDB1 PDB1 1.29 carbon metabolism 
orf19.2608 ADH5 ADH2 1.92 Carbon metabolism 
orf19.3133 GUT2 GUT2 1.38 carbon metabolism 
orf19.3097 PDA1 PDA1 1.16 Carbon metabolism 
orf19.5021 PDX1 PDX1 1.29 carbon metabolism 
orf19.7514 PCK1 PCK1 2.03 Carbon metabolism 
(gluconeogenesis) 
orf19.3651 PGK1 PGK1 1.46 Carbon metabolism/Glycolisys 
orf19.3967 PFK1 PFK1 1.18 Carbon metabolism/Glycolisys 
orf19.6540 PFK2 PFK2 1.10 Carbon metabolism/Glycolisys 
orf19.3575 CDC19 CDC19 2.15 Carbon metabolism/Glycolisys 
orf19.395 ENO1 ENO1 2.22 Carbon metabolism/Glycolisys 
orf19.542 HXK2 HXK2 1.54 Carbon metabolism/Glycolisys 
orf19.5024 GND1 GND1 1.14 Carbon metabolism/NADPH 
regeneration 
orf19.3358 LSC1 LSC1 1.70 Carbon metabolism/TCA 
orf19.1059 HHF1 HHF1 1.60 Chromatin component 
orf19.6924 HTA1 HTA1 1.40 Chromatin component 
orf19.6925 HTB1 HTB1 1.20 Chromatin component 
orf19.5614 orf19.5614 RNH1 1.06 DNA replication 
orf19.5117 OLE1 OLE1 1.42 Fatty acid biosynthesis 
orf19.979 FAS1 FAS1 1.83 Fatty acid biosynthesis 
orf19.7466 ACC1 ACC1 2.38 Fatty acid biosynthesis 
orf19.5949 FAS2 FAS2 2.23 Fatty acid biosynthesis 
orf19.7076 orf19.7076 GBP2 1.07 mRNA translocation 
orf19.6882 OSM1 OSM1 1.41 NADH biogenesis 
orf19.7522 orf19.7522 BNA3 1.70 NADH biogenesis 
orf19.5228 RIB3 RIB3 1.02 FAD biogenesis 
orf19.18 IMH3 IMD4 1.21 precursor biosynthesis 
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orf19.3331 ABC1 ABC1 1.43 precursor biosynthesis 
orf19.4311 YNK1 YNK1 1.16 precursor biosynthesis 
orf19.5630 APA2 APA1 1.04 Precursor biosynthesis 
orf19.7446 OPI3 OPI3 1.26 precursor biosynthesis 
orf19.7585 INO1 INO1 2.09 Precursor biosynthesis 
orf19.754 orf19.754 OLA1 1.03 Protein degradation/proteosome 
orf19.6582 PRE10 PRE10 1.02 Protein degradation/proteosome 
orf19.641 orf19.641 ERJ5 1.14 Protein folding 
orf19.4871 ERO1 ERO1 1.01 Protein folding 
orf19.6176 SEC61 SEC61 1.22 Protein folding 
orf19.717 HSP60 HSP60 1.01 Protein folding/mitoch integrity 
orf19.2013 KAR2 KAR2 1.84 Protein folding/synthesis 
orf19.4279 MNN1 MNN1 2.08 Protein synthesis 
orf19.5130 PDI1 PDI1 1.57 Protein synthesis 
orf19.5081 FUN12 FUN12 1.35 Protein synthesis 
orf19.5073 DPM1 DPM1 1.74 Protein synthesis 
orf19.3438 orf19.3438 SCJ1 1.18 Protein synthesis 
orf19.2965 orf19.2965 GET3 1.03 Protein synthesis 
orf19.1478 orf19.1478 STT3 1.06 Protein synthesis 
orf19.6988 orf19.6988 OST1 1.07 Protein synthesis 
orf19.1154 EGD1 EGD1 1.89 Protein synthesis/folding 
orf19.5858 EGD2 EGD2 1.83 Protein synthesis/folding 
orf19.3243 SRP54 SRP54 1.12 RNA  
orf19.7655 RPO21 RPO21 1.55 RNA synthesis 
orf19.7569 orf19.7569 SIK1 1.08 rRNA synthesis 
orf19.2762 AHP1 AHP1 1.21 Stress response 
orf19.4657 orf19.4657 NEM1 1.13 Structural 
orf19.30 orf19.30 SPF1 2.25 Structural 
orf19.1097 ALS2 FLO1 3.27 Structural/Cell wall 
orf19.4555 ALS4 FLO9 3.17 Structural/Cell wall 
orf19.1911 PGA52 YJL171C 1.72 Structural/Cell wall 
orf19.4109 PMT4 PMT4 1.37 Structural/Cell wall/precursor 
biosynthesis 
orf19.5334 orf19.5334 TIS11 2.20 Transcription 
orf19.4941 TYE7 TYE7 2.36 Transcription/Carbon metabolism 
orf19.1435 TEF1 TEF1 1.12 Translation elongation 
orf19.2651 CAM1-1 TEF4 1.07 Translation elongation 
orf19.382 TEF2 TEF2 1.11 Translation elongation 
orf19.3838 EFB1 EFB1 1.65 Translation elongation 
orf19.7382 CAM1 CAM1 1.84 Translation elongation 
orf19.407 GCD6 GCD6 1.11 Translation initiation 
orf19.3532 MRPL10 MRPL10 1.22 Translation/structural component of 
ribosome 
orf19.3559 MRPS35 MRPS35 1.23 Translation/structural component of 
ribosome 
orf19.1601 RPL3 RPL3 1.94 Translation/structural component of 
ribosome 
orf19.4336 RPS5 RPS5 1.79 Translation/structural component of 
ribosome 
orf19.4632 RPL20B RPL20A 1.38 Translation/structural component of 
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ribosome 
orf19.2232 RPL11 RPL11B 1.50 Translation/structural component of 
ribosome 
orf19.4490 RPL17B RPL17B 1.29 Translation/structural component of 
ribosome 
orf19.1700 RPS7A RPS7A 1.36 Translation/structural component of 
ribosome 
orf19.3789 RPL24A RPL24A 1.20 Translation/structural component of 
ribosome 
orf19.3334 RPS21 RPS2 1.69 Translation/structural component of 
ribosome 
orf19.3465 RPL10A RPL1A/RPL1B 1.73 Translation/structural component of 
ribosome 
orf19.840 RPL21A RPL21A 1.95 Translation/structural component of 
ribosome 
orf19.2935 RPL10 RPL10 1.65 Translation/structural component of 
ribosome 
orf19.3504 RPL23A RPL23A/RPL23B 1.68 Translation/structural component of 
ribosome 
orf19.4660 RPS6A RPS6A/RPS6B 2.04 Translation/structural component of 
ribosome 
orf19.2994 RPL13 RPL13A 1.42 Translation/structural component of 
ribosome 
orf19.2992 RPP1A RPP1A 1.28 Translation/structural component of 
ribosome 
orf19.2478.1 orf19.2478.1 RPL7A 2.24 Translation/structural component of 
ribosome 
orf19.6541 RPL5 RPL5 2.08 Translation/structural component of 
ribosome 
orf19.6312 RPS3 RPS3 1.75 Translation/structural component of 
ribosome 
orf19.6375 RPS20 RPS20 2.06 Translation/structural component of 
ribosome 
orf19.6265 RPS22A RPS22A 1.04 Translation/structural component of 
ribosome 
orf19.6085 RPL16A RPL16A 1.43 Translation/structural component of 
ribosome 
orf19.1635 RPL12 RPL12A 1.36 Translation/structural component of 
ribosome 
orf19.493 RPL15A RPL15B 1.93 Translation/structural component of 
ribosome 
orf19.1470 RPS26A RPS26A 1.82 Translation/structural component of 
ribosome 
orf19.6873 RPS8A RPS8A/RPS8B 1.62 Translation/structural component of 
ribosome 
orf19.6975 YST1 RPS0A 1.66 Translation/structural component of 
ribosome 
orf19.7015 RPP0 RPP0 1.81 Translation/structural component of 
ribosome 
orf19.7018 RPS18 RPS18A/RPS18B 1.57 Translation/structural component of 
ribosome 
orf19.7217 RPL4B RPL4B 2.23 Translation/structural component of 
ribosome 
orf19.3268 TMA19 TMA19 1.52 Translation/structural component of 
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ribosome 
orf19.5341 RPS4A RPS4B/RPS4A 1.52 Translation/structural component of 
ribosome 
orf19.6785 RPS12 RPS12 2.29 Translation/structural component of 
ribosome 
orf19.6002 RPL8B RPL8B 2.13 Translation/structural component of 
ribosome 
orf19.5982 RPL18 RPL18A/RPL18B 2.27 Translation/structural component of 
ribosome 
orf19.5927 RPS15 RPS15 1.66 Translation/structural component of 
ribosome 
orf19.236 RPL9B RPL9B 1.74 Translation/structural component of 
ribosome 
orf19.6906 ASC1 ASC1 1.38 Translation/structural component of 
ribosome/signal transduction 
orf19.2023 HGT7 HXT6 1.20 Transport 
orf19.2021 HGT8 HXT6 1.61 Transport 
orf19.2020 HGT6 HXT4 1.37 Transport 
orf19.4784 CRP1 CCC2 2.54 Transport 
orf19.3669 SHA3 SKS1 3.02 Transport 
orf19.4599 PHO89 PHO89 1.02 Transport 
orf19.7327 PHO88 PHO88 1.08 Transport 
orf19.3496 orf19.3496 CHC1 1.10 Transport/Intracellular vesicle 
transport 
orf19.4732 SEC24 SEC24 1.11 Transport/Intracellular vesicle 
transport 
orf19.2560 CDC60 CDC60 1.21 t-RNA 
orf19.2422 ARC1 ARC1 1.26 t-RNA 
orf19.2960 FRS2 FRS2 1.30 t-RNA 
orf19.6749 KRS1 KRS1 1.15 t-RNA 
orf19.4698 PTC8 PTC7 1.37 Signal transduction 
orf19.1782 orf19.1782 IRC22 1.46 Unknown function 
orf19.1344 orf19.1344 2.11 Unknown function 
orf19.4220 orf19.4220 YLR456W 1.00 Unknown function 
orf19.5293 orf19.5293 1.22 Unknown function 
orf19.2212 orf19.2212 1.38 Unknown function 
orf19.5525 orf19.5525 YMR315W 1.43 Unknown function 
orf19.1186 orf19.1186 1.08 Unknown function 
orf19.4149 orf19.4149 1.80 Unknown function 
orf19.1368 orf19.1368 1.17 Unknown function 
orf19.2775 orf19.2775 YNR021W 1.10 Unknown function 
orf19.4247 orf19.4247 1.03 Unknown function 
orf19.3318 orf19.3318 YBR255W 2.16 Unknown function 
orf19.4831 orf19.4831 1.16 Unknown function 
orf19.7328 orf19.7328 1.39 Unknown function 
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CHAPTER 4 
 
 
COLONY MORPHOLOGY PHENOTYPIC SWITCHING IN CANDIDA 
ALBICANS IS ASSOCIATED WITH GENOMIC ALTERATIONS AND 
DEFECTS IN DNA DAMAGE RESPONSE AND TOR PATHWAY FUNCTION  
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SUMMARY 
Variability is essential for adaptation to a constantly changing environment, and 
adaptation is critical for the success of any pathogen. In the absence of sexual reproduction (a 
major mechanism to generate variability in eukaryotes), the opportunistic pathogen Candida 
albicans can generate phenotypic variation by the colony morphology phenotypic switching 
(CMPS) process. CMPS is accompanied by changes in the expression of virulence factors and is 
thus associated with pathogenesis. Mds3, a member of the TOR pathway, is a poorly 
characterized negative regulator of CMPS. In this chapter, we aimed to characterize CMPS in the 
C. albicans mds3Δ/Δ strain, with the objective of identifying potential mechanisms of CMPS. We 
found that the phenotypic switch in the mds3Δ/Δ mutant is often accompanied by karyotypic 
rearrangements and aneuploidies, although these genomic alterations are not required for the 
switch to occur. CMPS in the mds3Δ/Δ mutant is also accompanied by changes in sensitivity to 
the TOR inhibitor rapamycin and to DNA damage agents (especially to the genotoxic oxidizing 
agent TBHP). Further, I found environmental conditions that can enhance (glucose starvation and 
glutamine) or inhibit (alkaline pH) CMPS in the mds3Δ/Δ mutant; and I began to explore whether 
MDS3 might also be involved in white-opaque switching. The results presented here provide 
intriguing evidence that suggest that switching in the mds3Δ/Δ mutant is associated with defects 
in TOR pathway function. 
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INTRODUCTION 
Phenotypic heterogeneity is strongly associated with increased population fitness. In 
pathogenic organisms, phenotypic variation can enhance virulence attributes such as antibiotic 
resistance, motility, adherence, and immune evasion (Avery 2006; Morrison et al., 2009). 
Pathogenic bacteria, protozoa, and fungi benefit from phenotypic variation during infection. For 
example, phenotypic variation aids in immune evasion by altering the expression of enzymes and 
surface antigens, such as bacterial pili, fimbriae, and outer polysaccharides, and fungal and 
protozoan surface glycoproteins, including the major surface glycoprotein MSG from 
Pneumocystis and the well studied variable surface glycoprotein VSG and PfEMP1 surface 
antigens from Trypanosoma spp. and Plasmodium spp. (Zieg et al., 1977; Yamamoto and 
Kutsukake, 2006; Bayliss et al., 2001; van de Broek et al., 2005; Wada et al., 1995; Brockert et 
al., 2003; Morrison et al., 2009; Ralph and Scherf, 2005). Thus, phenotypic variation is critical 
for the success of pathogens in their host.  
Phenotypic variation is a common phenomenon in diverse human pathogenic fungi, 
including Candida albicans, C. glabrata, C. lusitaniae, Trichosporon assahii, Pneumocystis spp., 
Histoplasma capsulatum, Paracoccidioides brasilensis, Cryptococcus neoformans, and C. gattii 
(Slutsky et al., 1985, 1987; Ichikawa et al., 2004; Goldman et al., 1998; Jain et al., 2006; 
Srikantha et al., 2008; Jain et al., 2009; Macoris et al., 2006; Ichikawa et al., 2004; Stringer et al., 
2007; Keely et al., 2003; Eissenberg et al., 1996). Phenotypic variation in pathogenic fungi 
happens during infection, and is associated with alterations in virulence (Slutsky et al., 1985, 
1987; Goldman et al., 1998; Jain et al., 2006; Srikantha et al., 2008; Jain et al., 2009). 
Establishing the real impact of fungal phenotypic switching on disease progression in humans and 
finding the mechanisms that lead to the formation of phenotypic variants in the highly diverse 
pathogenic fungi are future challenges for mycologists. 
 119 
Several phenotypic alterations observed in fungi are associated with changes in colony 
morphology (including size, texture, and color). For example, C. glabrata switches between 
different colony colors in plates supplemented with copper sulfate and reversibly switches 
between smooth and wrinkled colonies (Brockert et al., 2003; Lachke et al., 2002). Although the 
role of the different colony variants in C. glabrata remains unclear, they appear to have 
differential colonization abilities in distinct parts of the human body (Brockert et al., 2003). H. 
capsulatum gives rise to colony variants that have a differential ability to survive within and kill 
macrophages (Eissenberg et al., 1996; Kugler et al., 2000). Cryptococcus spp. also produces 
colonies with altered morphologies which display different infectivity in murine models of 
infection (Currie et al., 1995; Fries and Casadevall, 1998; Sukroongreung et al., 2001; Fries et al., 
1996, 1999, 2001, 2002, 2005; Guerrero et al., 2006). Thus, alterations in colony morphology are 
common expressions of phenotypic variation in diverse fungal pathogens and are associated with 
altered virulence. Despite its role in pathogenesis, the molecular mechanisms that lead to colony 
morphology changes in the different fungi are not known. 
C. albicans, the major fungal pathogen of humans, achieves phenotypic variation through 
two different morphogenetic processes that also involve changes in colony morphology: the 
white-opaque phenotypic switch (W-O) and the colony morphology phenotypic switch (CMPS) 
(Pfaller et al., 2001; Soll, 1992; Whiteway and Oberholzer, 2004). The W-O switch is a bi-stable, 
epigenetically determined switch between two different cellular and colonial morphologies: round 
cells that produce smooth and white colonies (white phase), and elongated cells with cell wall 
pimples that produce flat and grey colonies (opaque phase) (Huang et al., 2006; Zordan et al., 
2006; Srikantha et al., 2001, 2006; Slutsky et al., 1987; Anderson et al., 1990; Hnisz et al., 2009). 
CMPS, also known as the 3153A-type switching, refers to the appearance of colonies with 
altered, heritable colony morphologies at a frequency of ~10
-4
 (Slutsky et al., 1985; Negroni 
1935). The altered colony morphologies are interconvertible and can also revert to the wild-type 
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phenotype. Colonies with different morphologies have been isolated from infected patients, 
suggesting that morphologically switched variants have a role during infection (Jones et al., 1994; 
Vargas et al., 2000; Soll et al., 1987, 1988, 1989). Further, phenotypic switching affects the 
expression of several virulence traits in C. albicans, including antifungal resistance, 
morphogenesis, secretion of hydrolytic enzymes, adhesion to epithelial cell, susceptibility to 
neutrophils, and virulence in murine models of infection (Gallagher et al., 1992; Kennedy et al., 
1998; Kolotila and Diamond, 1990; Vargas et al., 1994, 2004; Kvaal et al., 1997, 1999; Anderson 
et al., 1989; Lan et al., 2002). Therefore, phenotypic switching is an important mechanism to 
generate variation in C. albicans with direct implications in the pathogenesis of this fungus. 
Only the white-opaque phenotypic switch has been well studied in C. albicans. The 
differences between the white and opaque phases on fungal physiology and pathogenesis have 
been explored (Lan et al., 2002; Kvaal et al., 1997, 1999). Further, the biological role of the W-O 
switch in mating and several genetic and epigenetic mechanisms, environmental signals and 
signaling cascades that regulate the W-O switch are well understood (Soll et al., 2009; Lohse and 
Johnson, 2009; Morschhauser, 2010).  
On the contrary, very little is known about the mechanisms and environmental signals 
that regulate CMPS in C. albicans. Several processes have been already associated with 
alterations in colony morphology in C. albicans, including karyotypic rearrangements, 
aneuploidies, loss of heterozygozity, and CUG codon ambiguity (Zacchi et al., 2010b (Appendix 
B); Forche et al., 2009; Rustchenko et al., 1994; Uhl et al., 2003; Miranda et al., 2007). Further, 
the molecular chaperone Hsp90 and epigenetic mechanisms, which are involved in the generation 
of morphogenetic and surface variation in C. albicans and other organisms, might constitute yet 
undefined CMPS mechanisms (Cowen, 2008; Cowen et al., 2005; Shapiro et al., 2009; Sollars et 
al., 2002; Queitsch et al., 2002; Verstrepen and Fink, 2009; Lohse and Johnson, 2009; Domergue 
et al., 2005). The only environmental condition known to affect CMPS is the concentration of 
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zinc in the medium: CMPS in C. albicans strain 3153A was observed on zinc-limited medium 
(rich in amino acids) but was inhibited with higher zinc concentrations (Bedell and Soll, 1979; 
L.F.Z. unpublished observation). However, the molecular mechanism by which zinc affects 
CMPS remains unclear. Given the relevance of CMPS on C. albicans lifestyle, it is important to 
understand the mechanisms that control it. 
While studying the role of Mds3 as a regulator of pH responses in C. albicans (Davis et 
al., 2002), we serendipitously found that Mds3 is a negative regulator of CMPS. The alterations 
in colony morphology of the switched mds3Δ/Δ strains are accompanied by changes in expression 
of several virulence traits, including antifungal drug resistance, adhesion to mammalian cells, 
protease secretion, and filamentation (M.J.H., S.S., Z.M., D.D. unpublished data). The heritability 
and reversibility of the colony morphology alteration in the switched mds3Δ/Δ strains fits the 
characteristics that define CMPS (Slutsky et al., 1985; Soll, 1992). Thus, Mds3 regulates CMPS 
in C. albicans, and constitutes a genetic tool to uncover the mechanism(s) of CMPS in this 
fungus. 
Mds3 appears to function as a cytoplasmic scaffold that regulates the TOR pathway and 
possibly other signal transduction cascades (Chapters 2, 5, and Zacchi et al., 2010a (Chapter 3)). 
Here, we expanded the characterization of the original mds3Δ/Δ mutant and of the switched 
mds3Δ/Δ strains by testing potential processes associated with CMPS, including karyotypic 
rearrangements, aneuploidies, and sensitivity to the TOR inhibitor rapamycin and DNA damage 
agents. I also constructed MTLa/a strains to test if MDS3 is involved in W-O switching. Further, I 
found environmental conditions that exacerbate (glucose starvation, glutamine) or inhibit 
(alkaline pH) the phenotypic switch, and found that alkaline pH appears to reduce cellular 
dependence on the TOR pathway. In line with this result, I found that most switched strains 
regained rapamycin sensitivity and are thus more dependent on TOR for growth. Even more, the 
TOR1-1 allele, a partial-function TOR1 allele, synergizes with the mds3Δ/Δ mutation to induce 
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CMPS. Our results suggest that phenotypic switching in the mds3Δ/Δ mutant is associated with 
the stepwise acquisition of alterations that lead to TOR signaling dependence during stationary 
phase. 
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MATERIALS AND METHODS 
Strain construction 
All strains used in this study are listed in Table 4.1. The SSY switched strains (Table 4.3) 
were obtained by isolating papilli from mds3Δ/Δ colonies; while the SSY parental strains were 
obtained by re-isolating the colony where papilli appeared (see Results and Figure 4.1). All SSY 
switched-parental strains are in pairs. The parental SSY strain constitutes the “aged-non-
switched” control.  
The mating type locus (MTLa/a) homozygous strains LUZ127 and LUZ145 were 
constructed by plating YPD overnights of the mds3Δ/Δ (DAY417) and wild-type (DAY286) 
strains on synthetic medium (SC) supplemented with 2% L-sorbose (Fluka) as carbon source. The 
loss of the MTLα allele and the presence of the MTLa allele were verified by genomic DNA PCR 
using primer pairs a1 ORF F and a1 ORF R, and MTLalpha2 5 detect and MTLalpha2 3 detect 
(Table 4.2). MTLa/Δ colonies were plated on YPD, and faster growing colonies (which 
reduplicated Chromosome 5 and are thus MTLa/a) were selected for further experiments.  
Strain LUZ166, which carries a deletion in the centromere of one Chromosome 5 (CEN5) 
was constructed as previously described (Ketel et al., 2009) using the primers listed in Table 4.2. 
Briefly, Helen Wang, from Judith Berman’s lab at the University of Minnesota, transformed the 
mds3Δ/Δ strain DAY956 with an icci::URA3 cassette PCR amplified from pGEM-URA3 with 
primers 2211 and 2212 (Table 4.2). Transformant screening and correct integration of the URA3 
cassette at CEN5 was performed in our laboratory by genomic DNA PCR, using primer sets: 
2003-945-1961 and 1915-944-1901 (Table 4.2). LUZ225-226 and LUZ227-228 were constructed 
by transforming LUZ166 with PmeI linearized plasmids pDDB343 and pDDB353, respectively 
(Chapter 3). 
Strains LUZ796 and LUZ798 were generated by transformation of SSY194 and SSY210 
with NruI digested pGEM-HIS1 (pDDB249). Strains LUZ797 and LUZ799 were generated by 
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transformation of SSY194 and SSY210 with NotI digested pVIN103 (pGEM-HIS1::MDS3, 
pDDB344) (Davis et al., 2002) (Table 4.1). Correct integration of pVIN103 was verified by 
genomic DNA PCR using primers MDS3 5-detect and MDS3 3-detect (Table 4.2). 
 
Media and growth conditions 
C. albicans was routinely grown at 30ºC in YPD (2% Bacto-peptone, 2% dextrose, 1% 
yeast extract). For MTL homozygosis and white-opaque switching experiments cells were plated 
on SC medium (0.17% yeast nitrogen base without ammonium sulfate (Q-BioGene), 0.5% 
ammonium sulfate, and supplemented with a dropout mix containing amino and nucleic acids 
(Adams et al., 1997)). Media were buffered at the indicated pH using 150mM HEPES. 
Rapamycin (LC Laboratories) was added to the media at the indicated concentrations from a 
stock solution in 90% ethanol-10% Tween-20. For growth assays in the presence of rapamycin, 
strains were pre-grown in liquid YPD at 30ºC, diluted in PBS to an OD 600nm of 1.6, then 
serially diluted 5-fold in PBS, spotted on YPD or Spider medium (1% mannitol, 1% nutrient 
broth, 0.2% K2HPO4, pH 7.2 before autoclaving (Liu et al., 1994)) supplemented with rapamycin 
or solvent alone and incubated at 30ºC for 2 or 3 days. For DNA damage experiments strains 
were pre-grown in liquid YPD at 30ºC, diluted in PBS to an OD 600nm of 1.6, then serially 
diluted 5-fold in PBS and spotted on YPD supplemented with methyl methanesulfonate (MMS, 
Sigma), hydroxyurea (HU, Sigma), or tert-butyl hydroxyperoxide (TBHP, Sigma); plates were 
incubated at 30°C in a plastic bag. All media were supplemented with 80 µg/ml uridine. For solid 
media, 2% Bacto-agar was added, except for Spider medium which required 1.35% Bacto-agar.  
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Comparative genomic hybridizations and contour-clamped homogeneous electric field 
(CHEF) electrophoresis 
The protocol for comparative genomic hybridizations (CGH) is explained in Appendix B- 
Materials and Methods. Contour-clamped homogeneous electric field (CHEF) electrophoresis 
was done using a CHEF DRIII System (Bio-Rad). Sample preparation for electrophoresis was 
performed as previously described (Chu et al., 1993) with minor modifications. Briefly, ~5x10
7
 
cells/ml from YPD overnights were harvested, washed twice in 0.05M EDTA pH 7.5, 
resuspended in 130 µl SCE (1M sorbitol, 0.1M sodium citrate [pH 5.8], 0.01M EDTA [pH 8.0]) 
containing lysing enzyme and then 250 µl of warm (45°C) 2% low-melting point agarose in 
0.125M EDTA pH 7.5 were added. Aliquots were transferred to molds for solidification. Solid 
agarose blocks were incubated 6 hrs at 37°C in 3 ml LET (0.1M EDTA, 0.01M Tris-HCl, pH 7.5, 
5% β-mercaptoethanol) for spheroplasting. LET was replaced with 1.5 ml NDS (0.1M EDTA, 
0.01M Tris-HCl, pH 7.5, 1% N-lauroyl sarcosine, 2 mg/mL proteinase K) and samples were 
incubated 24-48 hrs at 50°C for protein digestion. NDS was removed and plugs were washed 5-
6X with 0.05M EDTA and stored at 4°C. Whole chromosomes were separated in 0.6% agarose 
(PFGE grade) in 0.5X TBE buffer using the program: 60-120 sec switch ramp, 6 V/cm, 120° 
angle, ~100 mAmp, for ~24 hrs; followed by 720-900 sec ramp, 2.0 V/cm, 106° angle, for 12hr. 
 
Phenotypic switching assay 
Strains were grown overnight (>16 hrs) in YPD at 30°C, diluted to 10
-6
 in PBS, and 100 
µl plated on YP plates with 2% or 0.2% glucose, YPD plates buffered at pH 6 or pH 8, or YNB 
plates (0.17% yeast nitrogen base without amino acids) supplemented with 2% glycerol and 5mM 
glutamine, ammonium sulfate, or proline as sole carbon and nitrogen sources, respectively. Plates 
were incubated at 30°C for 48 hrs, and then at room temperature (~23-25°C) for three weeks, 
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wrapped in parafilm to prevent agar desiccation. The % of colonies showing papilli on the colony 
surface was scored every 2-3 days beginning at day 6 of incubation. 
 
White-opaque switching assay 
For white-opaque experiments, the protocol described in Alby and Bennet (2009) was 
followed. Briefly, overnights were started in 3 ml YPD and incubated in a shaker at RT (~25°C) 
for 24 hrs. Cultures were checked for purity of white cells (>99%) under the microscope. 
Dilutions were made in PBS, plated in SC medium, and incubated at room temperature for 3 
weeks. The presence of opaque sectors were readily visualized without the need for Phloxine B; 
however I noticed that addition of 1:10 Lugol’s solution (5% iodine, 10% potassium iodine) to 
the plates markedly aided in visualization, as it did not stain efficiently opaque colonies (Figure 
4.1C). Lugol solution stains stored carbohydrates. The difference observed in opaque vs. white 
cells might be an indication of differences in their metabolisms, as previously observed (Lan et 
al., 2002). The presence of opaque cells in opaque sectors was verified by microscopy. 
 
Photography and microscopy 
 Pictures of colonies were taken using a Canon Powershot A560 digital camera. Images of 
liquid cultures were captured using a Zeiss Axio camera, Axiovision 4.6.3 software (Zeiss), and a 
Zeiss AxioImager fluorescence microscope. All images were processed with Adobe Photoshop 
7.0 software. 
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RESULTS 
Prolonged incubation of mds3Δ/Δ colonies leads to the formation of extensions and blebs 
on the colony surface, usually characterized by a change in color and/or morphology [hereafter 
called papilli (Figure 4.1A, white arrow)]. The formation of papilli is the first manifestation of the 
phenotypic switch in the mds3Δ/Δ mutant. Cells isolated from mds3Δ/Δ papilli give rise to 
colonies with an altered, heritable morphology that is reversible at low frequency (M.T.A., 
M.J.H., Z.M., and S.S. unpublished data). These strains are referred to as “switched” strains 
(Figure 4.1B and data not shown). To control for changes that occurred during prolonged 
incubation, cells from the colony in which the papilli originated were also isolated, and are called 
“parental” (Figure 4.1A, green arrow). Parental strains always maintained the original mds3Δ/Δ 
colony morphology (Figures 4.4, 4.7, and data not shown). Re-introduction of a wild-type MDS3 
copy in the original mds3Δ/Δ strain prevented the formation of papilli, indicating that papilli 
formation is an MDS3-dependent phenotype (D.D. unpublished data). However, re-introduction 
of a wild-type MDS3 copy in the switched mds3Δ/Δ strains did not restore wild-type colony 
morphology nor did it alter the switching frequency, indicating that the events post-switching in 
the mds3Δ/Δ mutant are MDS3-independent (Figure 4.1C and L.F.Z. and M. D. unpublished 
results). In order to begin to understand the nature of the phenotypic switch, I constructed strains 
to determine if Mds3 is involved in white-opaque switching and searched for environmental 
conditions that affect the frequency of the switch. Further, we characterized the switched strains 
with the objective of finding common responses that might allow for a better understanding of the 
mechanisms behind the switch in the mds3Δ/Δ mutant.  
 
Effect of MDS3 deletion on white-opaque phenotypic switching 
The W-O phenotypic switch in C. albicans is a bi-stable switch between a white, dome-
shaped, creamy colony formed by round cells and a darker, flat colony formed by elongated cells 
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(Figure 4.1D). The switch from white to opaque is required for mating in C. albicans (Miller and 
Johnson, 2002). The W-O switch has been well studied and many environmental and genetic 
factors that regulate this switch are known (Morschhauser, 2010). If Mds3 was also involved in 
white-opaque switching, we would have identified a protein involved in the two major 
mechanisms to generate variability in C. albicans. Further, given the extensive knowledge on the 
mechanisms of W-O switching, finding that Mds3 is also a regulator of this phenomenon would 
provide us with information and genetic tools to understand Mds3 function and CMPS.  
            
Figure 4.1: Colony morphology and white-opaque phenotypic switching in the mds3Δ/Δ 
mutant (A) Example of papilli formation on an mds3Δ/Δ colony. The white arrow points 
to a “papilli” from which a switched strain was isolated; the green arrow points to the 
colony from which a “parental” strain was isolated; (B) Examples of switched mds3Δ/Δ 
strains displaying alterations in colony morphology; (C) Re-introduction of MDS3 into 
switched mds3/mds3 strains does not restore colony morphology to the wild-type 
phenotype. (i) Wild-type (DAY185), (ii) mds3/mds3 (GK09), (iii) SSY194, (iv) 
SSY194+MDS3-HIS1 (LUZ797), (v) SSY194+HIS1 (LUZ796), (vi) SSY210, (vii) 
SSY210+MDS3-HIS1 (LUZ799), (viii) SSY210+HIS1 (LUZ798). Picture taken after 
incubation in YPD at 37°C for 48 hrs; (D) Example of WO-1 (DAY1046) colonies with 
opaque sectors stained with lugol (i), and white (ii) and opaque (iii) cells under the 
microscope isolated from white and opaque sectors from WO-1 colonies. (E) Wild-type 
MTLa/α (DAY286) and MTLa/a strains (LUZ145), and mds3Δ/Δ MTLa/a (LUZ127) and 
WO-1 (DAY1046) strains were plated on SC medium and incubated at room 
temperature. Plates were scored for the formation of opaque sectors. The table shows the 
results at 10 days of incubation. 
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Homozygosis of the mating locus (MTL) in C. albicans is a pre-requisite for switching to 
the opaque phase (except in the case of an HBR1/Δ strain (Pendrak et al., 2004)). To test if Mds3 
regulates white-opaque switching, I constructed strains homozygous for the MTL locus in the 
wild-type and mds3Δ/Δ backgrounds and determined the frequency at which these strains 
produced opaque sectors/colonies when plated on synthetic medium. The WO-1 hyper-switching 
C. albicans strain was used as a control (Slutsky et al., 1987, Figure 4.1D). There was no 
difference in white-opaque switching between the wild-type MTLa/a and mds3Δ/Δ MTLa/a 
strains (Figure 4.1E). However, the frequency of white-opaque switching in the BWP17 
background was considerably lower than in the WO-1 strain (Figure 4.1E, compare the wild-type 
BWP17 with the WO-1 strain). Thus, in order to determine if Mds3 is involved in W-O 
switching, this experiment needs to be repeated plating a minimum of 6000 colonies/strain in 
order to obtain more reliable data. Alternatively, an mds3Δ/Δ mutant should be constructed in the 
WO-1 background and the switching frequency of the mds3Δ/Δ WO-1 mutant should be 
compared with the wild-type WO-1 strain. Further, since MTL locus homozygosis is required for 
white-opaque switching, it would be interesting to determine if MTL homozygosis has any effect 
on the rate of CMPS as well.  
 
Karyotypic rearrangements and aneuploidies are present in switched mds3Δ/Δ strains 
One mechanism associated with phenotypic variation in C. albicans is genomic 
rearrangements (Rustchenko et al., 1993, 1994; Arbour et al., 2009; Selmecki et al., 2006; Forche 
et al., 2009). Thus, we predicted that switched mds3Δ/Δ strains would carry aneuploidies or other 
genomic rearrangements. To test this idea, we performed CHEF gels and CGH analyses on 
different switched mds3Δ/Δ strains (in collaboration with Mingchun Li, Paul and Bebe Magee, 
Anna Selmecki, and Judith Berman, at the University of Minnesota). CHEF and CGH assays are 
useful for the visualization of genomic alterations, but they differ in their sensitivity and on the 
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type of rearrangements that are readily observable in each of them. For example, CGH cannot 
distinguish a normal/diploid C. albicans DNA content from a genome with balanced 
chromosomal rearrangements (which do not alter the overall DNA content) or from tetraploid 
strains. Conversely, CHEF analyses do not allow for the simple detection of changes in copy 
number of chromosomes, or of rearrangements in which the new chromosomal fragments migrate 
similarly to other normal size chromosomal bands. Thus, CHEF and CGH are complementary 
assays. 
 
Figure 4.2: Karyotypic rearrangements in switched mds3Δ/Δ strains observed through 
CHEF electrophoresis. Chromosomes R to 7 are listed on the left. The yellow arrows 
point to new chromosomal fragments. 
 
Gross karyotypic rearrangements can be detected by alterations in the band pattern 
obtained by CHEF analysis. We compared the karyotypes of 35 switched mds3Δ/Δ strains with 
the standard karyotype of C. albicans strain BWP17, and observed that nine strains (~26%) 
consistently showed a different karyotypic profile (Figure 4.2, Table 4.3). Of the nine strains with 
an aberrant karyotype, seven strains showed an extra band between Chromosomes 2 and 3, one 
(SSY16) showed an extra band between Chromosomes 1 and 2 and another between 
Chromosomes 2 and 3, and one strain (SSY55) showed an extra band between Chromosomes 4 
and 5 (Figure 4.2, Table 4.3). Notably, almost all the strains with altered karyotype (eight out of 
nine) showed an extra band between Chromosomes 2 and 3. Although the size of the extra band 
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between Chromosomes 2 and 3 varied among isolates, it may indicate a common type of 
karyotypic aberration associated with the switch. Overall, CHEF analyses showed that 
chromosomal rearrangements occur in the switched strains, but that most switched mds3Δ/Δ 
strains appear to have a normal karyotype. 
To complement the CHEF analyses, we performed CGH analyses in a smaller set of 
parental-switched mds3Δ/Δ strains. Three sets of matching parental-switched strains and one set 
of unmatched parental-switched strains (i.e. the parental strain pairs with a different switched 
strain) were analyzed by CGH (Figure 4.3, Table 4.3). While three out of four parental strains 
contained a normal diploid genome, the parental strain SSY209 showed a trisomy in 
Chromosome 6 and a loss of the Chromosome 5 monosomy at the HIS1 locus, a characteristic of 
BWP17 strains (Selmecki et al., 2005) (Figure 4.3A,C,E,G). Chromosome 5 of strain SSY209 
was only partially homozygous, because the MTL locus in this chromosome remained 
heterozygote, indicating that the event at Chromosome 5 likely involved a break induced 
recombination event or a single crossover (data not shown) (Forche et al., 2009). Three out of 
four switched strains showed aneuploidies (SSY34 showed a diploid genome): SSY73 and 
SSY75 showed partial Chromosome 2 aneuploidies, and SSY210 was trisomic for Chromosome 
6 (Figure 4.3B,D,F,H). Interestingly, SSY210 still contained a Chromosome 5 monosomy at the 
HIS1 locus. Since this Chromosome 5 monosomy is highly unlikely to occur randomly, these 
results suggest that the event that caused the partial homozygosis of Chromosome 5 in SSY209 
occurred after the switched SSY210 was generated (Figure 4.3E,F). SSY73 was monosomic for 
the left 1/5
th
 of Chromosome 2, while SSY75 was trisomic (or tetrasomic) for the right 4/5
th
 of 
Chromosome 2 (Figure 4.3B,D). The 20% shorter Chromosome 2 defined by CGH analysis could 
be the extra band observed between Chromosomes 2 and 3 in SSY73 by CHEF (Figure 4.2, Table 
4.3). However, CHEF analyses did not detect an extra band for strain SSY75 (data not shown), 
suggesting that the different results are either a property of variations in the colonies used for 
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each assay, or that the sensitivity of CHEF analyses is too low to consistently observe certain 
smaller karyotypic variations. Interestingly, the break point in Chromosome 2 at which SSY73 
and SSY75 became aneuploid is similar (Figure 4.3B,D). Thus, both CHEF and CGH analyses   
                   
                  
Figure 4.3: Aneuploidies are common in switched mds3Δ/Δ strains, but are not required 
for the phenotypic switch. The chromosomal content from three pairs of parental-
switched mds3Δ/Δ strains (SSY74 (A) - SSY73 (B); SSY76 (C) - SSY75 (D); SSY209 
(E) - SSY210 (F)), and an unpaired set of a parental (SSY35 (G)) and a switched (SSY34 
(H)) mds3Δ/Δ strains was compared to C. albicans strain SC5314 by CGH.  
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detect a higher frequency of karyotypic alterations in switched strains compared to the parental 
pairs that (may) involve Chromosome 2. Overall, CHEF and CGH results indicate that 
aneuploidies/karyotypic rearrangements occur in both switched and parental strains with a 
moderate frequency, and that they are not required for the switch to occur. 
 
Switched mds3Δ/Δ strains show increased DNA damage sensitivity 
 One mechanism to generate phenotypic diversity is by increasing the rate of genetic 
mutation (Loeb et al., 2008; Drotschmman et al., 2000; Funchain et al., 2000). One way to 
increase the rate of mutation is by relaxing the function of DNA repair mechanisms, which leads 
to an altered sensitivity to DNA damaging agents. Thus, I tested if the mds3Δ/Δ mutant showed 
an increased sensitivity to several DNA damaging agents: TBHP (an oxidizing agent), MMS 
(which indirectly causes double strand DNA breaks in cells deficient for homologous 
recombination), and HU (which inhibits DNA replication by depleting dNTP pools). As a control 
I used the rad50Δ/Δ C. albicans mutant which is hypersensitive to all these chemical stresses 
(Legrand et al., 2007). There was no difference in the sensitivity to TBHP or HU between the 
wild-type and mds3Δ/Δ strains (Figure 4.4). However, the mds3Δ/Δ mutant was more resistant to 
MMS than the wild-type strain (Figure 4.4). This result supports the idea that defective responses 
to genotoxic agents could lead to the phenotypic switch in the mds3Δ/Δ mutant. 
 The phenotypic switch in the mds3Δ/Δ mutant occurs after prolonged incubation. Thus, 
I wished to test if there was an effect of the aging of the colony on the sensitivity to genotoxic 
agents. Except SSY56, all the other fourteen msd3Δ/Δ parental strains tested showed similar 
TBHP sensitivity as the wild-type and original mds3Δ/Δ strains (Figure 4.4 and Table 4.3). 
Similarly, except SSY186, all other mds3Δ/Δ parental strains showed similar MMS sensitivity as 
the original mds3Δ/Δ strain (Figure 4.4 and Table 4.3). Finally, all six mds3Δ/Δ parental strains 
tested showed similar HU sensitivity as the the original mds3Δ/Δ strain (Figure 4.4 and Table 
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4.3). These results indicate that aging of the mds3Δ/Δ colony was generally not accompanied by 
any heritable alteration in the response to genotoxic stress.  
 Finally, I wished to determine if the phenotypic switch was associated with an 
alteration in the response to genotoxic agents. When I compared the sensitivity of switched vs. 
parental mds3Δ/Δ strains to DNA damage agents, I found that the phenotypic switch was 
generally accompanied by changes in the sensitivity to all genotoxic agents tested (Figure 4.4, 
Table 4.3). All fifteen switched mds3Δ/Δ strains tested showed increased sensitivity to TBHP. 
Eleven out of fifteen switched isolates showed enhanced MMS sensitivity compared to their 
parental mds3Δ/Δ counterparts; while four of the switched isolates showed similar MMS 
sensitivity as their parental mds3Δ/Δ counterparts (Figure 4.4, Table 4.3). Finally, four of the six 
switched mds3Δ/Δ strains were more sensitive to HU, one (SSY155) was equally sensitive as its 
parental counterpart, and one (SSY67) was highly resistant to HU (>50mM) (Figure 4.4). The 
degree of sensitivity to TBHP, MMS, or HU varied between the different isolates (Figure 4.4). 
Overall, these results indicate that the absence of MDS3 enhances resistance to the genotoxic 
agent MMS, but not TBHP or HU. Further, the results show that the phenotypic switch in the 
mds3Δ/Δ mutant is accompanied by changes in the ability of cells to tolerate the presence of 
TBHP, MMS, and HU in the medium, and that these changes are not simply due to the aging of 
the colony. In particular, the switched mds3Δ/Δ strains showed a reproducible increase in 
sensitivity to the oxidizing agent TBHP. 
 
Figure 4.4: The phenotypic switch in the mds3Δ/Δ mutant is accompanied by alterations 
in the sensitivity to DNA damaging agents. YPD overnights of the wild-type (DAY286), 
mds3Δ/Δ (DAY439 or DAY417), rad50Δ/Δ (DAY1063), and different mds3Δ/Δ 
switched-parental strains (SSY strains) were diluted in PBS to an ~OD600nm of 1.6, 
further diluted 1:5 in PBS and plated on YPD supplemented with TBHP, MMS (A,B) and 
HU (B). Plates were incubated at 30°C. Pictures were taken after 72 hrs incubation. 
Parental strains are in bold, and plated always above its corresponding switched pair. 
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Effects of glucose starvation and alkaline pH on mds3Δ/Δ mutant papilli formation 
Papilli formation in the mds3Δ/Δ mutant occurs only after prolonged incubation, a 
condition in which the colonies are starved for nutrients and have entered stationary phase. I 
reasoned that increasing the starvation signal might contribute to enhance papilli formation. To 
test this idea, I reduced the concentration of supplemented glucose in YPD to 0.2%, instead of the 
regular 2%. Indeed, I observed that while starving cells for glucose had no effect on wild-type 
cells, the % of colonies that showed papilli in the mds3Δ/Δ mutant (and the number of 
papilli/colony (data not shown)) increased significantly with time when compared with growth on 
2% glucose (Figure 4.5). However, I did not observe an earlier onset of papilli formation in the 
mds3Δ/Δ mutant in YPD with 0.2% glucose compared to 2% glucose, which suggests that other 
nutrients need to become limiting as well, perhaps the nitrogen source. In this regard, I observed 
that papilli formation in the mds3Δ/Δ mutant was enhanced in the presence of the amino acid 
glutamine as the only nitrogen source in the media, but not in the presence of ammonium or of 
the amino acid proline (data not shown). In fact, addition of proline appeared to inhibit papilli 
formation (data not shown). Alternatively, a secondary metabolite might need to build up in the 
medium to induce papilli formation. Importantly, the presence of glucose is not required for 
papilli formation as we can also observe papilli in medium supplemented with glycerol as carbon 
source (data not shown). Overall, these results indicate that papilli formation can be exacerbated 
by glucose starvation in the absence of MDS3, and that it is likely the overall nutritional 
composition of the medium, including the availability of particular nitrogen sources, which play a 
critical role in the regulation of CMPS.  
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Figure 4.5: Phenotypic switching in the mds3Δ/Δ mutant is enhanced under glucose 
starvation and repressed under alkaline pH conditions. YPD overnights from the wild-
type (DAY185) and mds3Δ/Δ (DAY1118) strains were diluted in PBS and plated in YP 
with 2% or 0.2% glucose, or YPD buffered at pH 6 or pH 8. Plates were incubated 48 hrs 
at 30°C and then at room temperature for over two weeks. (A) The graph shows the 
progressive accumulation of papilli in the mds3Δ/Δ mutant. (B) Papilli at day 15 of 
incubation. Results are representative of multiple independent experiments. * p value 
<0.05; ** p value < 0.005, using one-tailed paired Student test (comparisons against 
mds3Δ/Δ grown with 2% glucose). 
 
In C. albicans, Mds3 is required for growth and filamentation at alkaline pH, and Mds3 
also regulates the expression of several alkaline responsive genes (Davis et al., 2002; Zacchi et 
al., 2010a). Thus, I wished to test if alkaline pH would have an effect on the ability of the 
mds3Δ/Δ mutant to produce papilli. While buffering YPD at alkaline pH had no effect on the 
wild-type strain, it significantly inhibited papilli formation in the mds3Δ/Δ mutant (Figure 4.5). 
The inhibition of papilli formation was not due to the buffer in the medium, because the mds3Δ/Δ 
mutant formed papilli in unbuffered YPD and YPD buffered at pH 6 at the same rate (Figure 4.5). 
Thus, alkaline pH inhibits papilli formation in the mds3Δ/Δ mutant. 
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Alkaline pH induces rapamycin resistance in C. albicans  
We recently identified Mds3 as a regulator of the TOR pathway (Zacchi et al., 2010a). 
Mds3 is also required for proper alkaline pH responses (Davis et al., 2002; Zacchi et al., 2010a 
(Chapter 3)). Thus, I reasoned that alkaline pH might have an effect on TOR pathway function. 
To test this, I plated wild-type, mds3Δ/Δ, and mds3Δ/Δ+MDS3 cells in unbuffered YPD and YPD 
buffered at pH 6 or pH 8 supplemented with solvent or with the TOR kinase inhibitor rapamycin. 
As a control, I plated a sit4Δ/Δ mutant, which is resistant to rapamycin (Zacchi et al., 2010a). 
While buffering the media at pH 6 had no effect on rapamycin resistance compared to unbuffered 
YPD medium, buffering YPD at pH 8 caused a marked increase in rapamycin resistance for all 
strains (Figure 4.6). It is possible that rapamycin resistance at alkaline pH was caused by a 
decrease in rapamycin intake or stability. However, rapamycin has a transcriptional effect in 
M199 pH 8 at 6 hrs of incubation, and is able to delay wild-type filamentation in M199 pH 8 
solid medium after 48 hrs of incubation, indicating that at alkaline pH rapamycin is being 
incorporated into the cells and is exerting an effect (Zacchi et al., 2010a; Bastidas et al., 2009; 
and data not shown). A similar increase in rapamycin resistance was observed when cells were 
plated in SLAD medium supplemented with rapamycin (data not shown). The result observed in 
SLAD medium was not unexpected, since the low concentration of nitrogen sources in SLAD 
should already inactivate TOR function, making the cells less sensitive to further inactivation by 
rapamycin. Thus, alkaline pH is likely directly or indirectly reducing TOR function and/or the 
cellular dependence on TOR function, allowing for continued growth in the presence of normally 
inhibitory concentrations of rapamycin.  
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Figure 4.6: Alkaline pH enhances rapamycin resistance in C. albicans. YPD overnights 
of the wild-type (DAY185), mds3Δ/Δ (DAY1118), mds3Δ/Δ+MDS3 (DAY1119), and 
sit4Δ/Δ (DAY972) were diluted in PBS to an ~OD600nm of 1.6, further diluted 1:5 in 
PBS and plated on YPD supplemented with rapamycin. Plates were incubated at 30°C. 
Pictures were taken after 72 hrs incubation. 
 
Switched mds3Δ/Δ strains show increased rapamycin sensitivity 
 I reasoned that if the growth defects of the mds3Δ/Δ mutant were caused by a defective 
TOR pathway, then the appearance of the switched strains might reflect the formation of strains 
that are able to bypass and/or restore TOR function. To test the function of the TOR pathway in 
the mds3Δ/Δ switched strains I compared the growth of mds3Δ/Δ switched strains with their 
corresponding parental counterparts in media supplemented with rapamycin. In nutrient poor 
conditions, such as growth in Spider medium, the mds3Δ/Δ mutant is more resistant to rapamycin 
than the wild-type strain (Zacchi et al., 2010a). Thus, I hypothesized that the switched mds3Δ/Δ 
strains would have regained rapamycin sensitivity in nutrient poor medium. I also performed this 
experiment in nutrient rich YPD medium, to determine if the switch would alter the response to 
rapamycin in the mds3Δ/Δ strain in a condition in which this mutant does not normally have a 
phenotype. 
 Nineteen switched-parental mds3Δ/Δ strain pairs were plated on Spider and YPD media 
supplemented with rapamycin and their growth was compared to the wild-type and original 
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mds3Δ/Δ strains. In Spider medium, eighteen out of the nineteen parental strains behaved 
similarly to the original mds3Δ/Δ mutant, while one was more sensitive (SSY186, Table 4.3). 
Fifteen out of the nineteen switched mds3Δ/Δ pairs were more sensitive to rapamycin compared 
to the corresponding parental strains (including SSY186/5), and the remaining four were as 
resistant to rapamycin as their parental pair (Figure 4.7, Table 4,3). In YPD medium 
supplemented with rapamycin, fifteen of the nineteen parental strains grew similar to the original 
mds3Δ/Δ and wild-type strains; ten of their corresponding switched mds3Δ/Δ pairs were more 
sensitive to rapamycin, four were equally resistant, and one was more resistant than the 
corresponding parental mds3Δ/Δ pair (Figure 4.7, Table 4.3). The four remaining parental strains 
out of the nineteen pairs tested in YPD showed different rapamycin sensitivity when compared to 
the original mds3Δ/Δ strain: one was more resistant (SSY209) and three were more sensitive 
(SSY42, SSY76, SSY186). Of these four strains, the corresponding switched pairs SSY210 and 
SSY185 were more resistant to rapamycin compared to their parental mds3Δ/Δ pair, while SSY41 
and SSY75 were more sensitive. I noted that those switched-parental pairs that were equally 
resistant to rapamycin in Spider medium were also equally resistant to rapamycin in YPD 
medium. Further, the degree at which each switched strain was more sensitive to rapamycin was 
variable, suggesting differences in the mechanisms that lead to rapamycin sensitivity. Since the 
mds3Δ/Δ mutant does not have a phenotype in YPD supplemented with rapamycin (Zacchi et al., 
2010a) I was not expecting to see growth differences in the switched mds3Δ/Δ strains in YPD. 
However, most switched strains did show increased rapamycin sensitivity in YPD compared to 
their parental counterparts, although the phenotypic reversion in YPD medium was often more 
subtle than in Spider medium (Figure 4.7). Overall, these results indicate that the switch in the 
mds3Δ/Δ mutant is accompanied by an increase in rapamycin sensitivity in both poor and rich 
nutrient conditions. These resutls suggest that an alteration in the function of the TOR pathway is 
associated with the morphological switch in the mds3Δ/Δ mutant. Further, as observed previously 
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in the DNA damaging assays (Figure 4.4), most of the parental strains did not show an altered 
response to rapamycin, indicating that the processes that led to increased rapamycin sensitivity in 
the switched strains are not solely occurring due to the aging of the colony. 
 
Figure 4.7: The switch in the mds3Δ/Δ mutant is accompanied by enhanced rapamycin 
sensitivity. YPD overnights of the wild-type (DAY286), mds3Δ/Δ (DAY439 or DAY417) 
and different mds3Δ/Δ switched-parental strains (SSY strains) were diluted in PBS to an 
~OD600nm of 1.6, further diluted 1:5 in PBS and plated on YPD and Spider media 
supplemented with rapamycin. Plates were incubated at 30°C. Pictures were taken after 
72 hrs incubation. Parental strains are in bold, and plated always above its corresponding 
switched pair. * The Spider plate shown here for SSY55-68 contains 15nM Rapamycin. 
 
The TOR1-1 allele and mds3Δ have a synergism in papilli formation 
The role of Mds3 as a regulator of the TOR pathway, the effect of alkaline pH on papilli 
formation and on rapamycin resistance, and the increased sensitivity to rapamycin of the switched 
strains suggest that defects in the signaling through the TOR pathway is involved in the 
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phenotypic switch (Figures 4.5-4.7). Previously, we found that the TOR1-1 allele and MDS3 
deletion showed a synergistic growth defect, potentially caused by a partial or altered function of 
TOR1-1 (Zacchi et al., 2010a (Chapter 3)). If alterations in TOR signaling are indeed associated 
with papilli formation then I might also see a synergism between the TOR1-1 allele and the 
mds3Δ mutation on papilli formation.  
 
Figure 4.8: Synergistic effect of the TOR1-1 allele and mds3Δ/Δ deletion on papilli 
formation. YPD overnights from the wild-type (DAY185), TOR1/Δ (DAY1123), TOR1-
1/Δ (DAY1125), mds3Δ/Δ (DAY1118), mds3Δ/Δ TOR1/Δ (DAY1122), and mds3Δ/Δ 
TOR1-1/Δ (DAY1124) strains were diluted in PBS and plated in YPD. Plates were 
incubated 48 hrs at 30°C and then at room temperature for over two weeks. The results 
graphed are representative of two independent experiments (A). Results at day 14 (B). 
 
To test this idea, I determined papilli formation in wild-type and mds3Δ/Δ strains with a 
TOR1+/+, TOR1/Δ, and TOR1-1/Δ genetic background. There was no difference in papilli 
formation among the TOR1+/+, TOR1/Δ, and TOR1-1/Δ wild-type strains (except for a small 
increase in the TOR1-1/Δ strain), or between the mds3Δ/Δ TOR1+/+ and mds3Δ/Δ TOR1/Δ strains 
(Figure 4.8). However, the mds3Δ/Δ TOR1-1/Δ mutant showed a marked exacerbation in papilli 
formation compared with the mds3Δ/Δ TOR1+/+ and mds3Δ/Δ TOR1/Δ strains (Figure 4.8). The 
presence of the single TOR1-1 allele in the mds3Δ/Δ background increased both the % of colonies 
with papilli and the number of papilli/colony (Figure 4.8 and data not shown). Further, papilli 
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formation in the mds3Δ/Δ TOR1-1/Δ strain was observed 2-4 days before papilli appeared in the 
TOR1/Δ or TOR1+/+ mds3Δ/Δ strains, suggesting that defects in TOR pathway signaling 
accelerate the formation of papilli (Figure 4.8A). Since the TOR pathway is considered to 
respond primarily to nitrogen environmental sources, these results supports the hypothesis that 
besides glucose, nitrogen also needs to become limiting for papilli to appear (see above, Figure 
4.5) (Crespo et al., 2002; Wullschleger et al., 2006; Dann and Thomas, 2006). Overall, these 
results support a role for TOR pathway signaling in papilli formation in the mds3Δ/Δ mutant. 
 Taken together, we have continued to uncover the vast diversity of phenotypes 
associated with the alteration in colony morphology of the mds3Δ/Δ mutant, including expression 
of virulence traits (M.T.A., M.J.H., Z.M., S.J.M unpublished results), genomic rearrangements 
and sensitivity to DNA damage agents and rapamycin (Figures 4.2-4 and 4.7). I have also found 
environmental conditions that enhance (glucose starvation) and inhibit (alkaline pH) the 
phenotypic switch in the mds3Δ/Δ mutant. Overall, our results support a model in which papilli 
appear in the mds3Δ/Δ mutant during stationary phase due to the accumulation of genetic and 
epigenetic defects caused by a de-regulated TOR pathway. 
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DISCUSSION 
Despite the strong association between CMPS and pathogenesis in C. albicans there is 
very little known about the mechanisms that regulate CMPS in this fungus. Mds3 is a fungal 
specific protein that is a negative regulator of CMPS in C. albicans. Mds3 is also involved in 
other morphogenetic processes in C. albicans and S. cerevisiae, including filamentation, 
chlamydospore formation, and meiosis (Davis et al., 2002; Nobile et al., 2003; Benni and 
Neigeborn, 1997; McDonald et al., 2008). Bioinformatic, genetic, and biochemical analyses 
suggest that Mds3 is a cytoplasmic Kelch/BTB protein that functions as a regulator of the TOR 
pathway (Zacchi et al, 2010a; Chapters 2 and 3). Indeed, our results support a role for the TOR 
pathway on papilli formation in the mds3Δ/Δ mutant, and suggest that the switching in this strain 
renders the colony morphology switching phenotype MDS3-independent and TOR-dependent 
(Figure 4.9). 
       
What is the evidence that the switch in the mds3Δ/Δ mutant is associated with an alteration in the 
function of the TOR pathway? 
 Since Mds3 is a member of the TOR pathway (Chapter 3) it was reasonable to propose 
that TOR pathway function was associated with phenotypic switching. Four independent results 
support this idea. First, alkaline pH allows cells to grow in the presence of normally inhibitory 
concentrations of rapamycin (Figure 4.6). This suggests that alkaline pH could either contribute 
to TOR pathway inhibition, or, more likely, could activate mechanisms that bypass the need for 
an active TOR pathway. For example, similar to S. cerevisiae, alkaline pH could affect the 
function of the PKA pathway, a pathway which shares many downstream effectors with TOR 
(Dechant et al., 2010; Thevelein and de Winde, 1999; Soulard et al., 2010). Thus, the observation 
that alkaline pH significantly inhibits the switch in the mds3Δ/Δ mutant supports a role for TOR 
activation in the switching process (Figure 4.5). Second, there is a synergism in papilli formation 
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between the mds3Δ mutation and the TOR1-1 allele, a partial function allele that carries a point 
mutation in the rapamycin binding domain of TOR1 (Figure 4.8, Chapter 3). Third, the presence 
of glutamine –a TOR activator (Crespo et al., 2002; Dann and Thomas, 2006)-as the sole nitrogen 
source in the medium increased papilli formation in the mds3Δ/Δ mutant compared with the 
presence of ammonium, while the presence of the amino acid proline –which activates NCR 
mimicking TOR inhibition (Tate et al., 2008; Cox et al., 2000)- inhibited papilli formation (data 
not shown). Finally, and more importantly, the switch in the mds3Δ/Δ cells strongly correlates 
with increased rapamycin sensitivity, suggesting that these switched cells have become dependent 
on TOR pathway function (Figure 4.7). An analogous phenomenon to this last point, denominated 
“oncogene addiction”, occurs when certain mammalian tumor cells become dependent on the 
pathways that are upregulated. Tumors caused by an overactivation of the TOR pathway or of 
upstream TOR effectors become hypersensitive to, and thus treatable with, rapamycin (Menon 
and Maning, 2008; Weinstein, 2002; Strimpakos et al., 2009). Similarly, certain tumors develop 
and addiction to glutamine due to the TOR activating characteristics of this amino acid (Wise and 
Thompson, 2010). Thus, independent evidence suggests a role for the TOR pathway in 
phenotypic switching in the mds3Δ/Δ mutant. However, more direct evidence is needed to verify 
this hypothesis. To this end, strains in which several TOR pathway members are epitope tagged 
have been constructed, including Tap42-HA, and the transcription factors Npr1-HA and Gln3-
Myc (Wang et al., 2003; Beck and Hall, 1999; Schmidt et al., 1998), and are ready to be tested for 
alterations in protein expression, and for TOR dependent and independent phosphorylation 
patterns and molecular interactions (data not shown).  
 
How does the switch occur in the mds3Δ/Δ mutant?  
 The first manifestation of the switch in the mds3Δ/Δ mutant is the formation of papilli 
on the colony surface. Papilli become visible only after prolonged incubation (Figures 4.5 and 
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4.8), a condition in which nutrients become limited, toxic metabolites accumulate, stress 
responses are induced, and cell growth is inhibited: cells enter stationary phase, a state of 
quiescence. However, in order to enter stationary phase, cells need to inhibit TOR activity [TOR 
activity promotes cellular growth and cell division (Wullschleger et al., 2006)]. Cells that are 
unable to properly regulate the TOR pathway, such as mds3Δ/Δ cells, are likely to encounter 
difficulties in properly establishing the stationary phase program (Zacchi et al., 2010a). The 
switch in the mds3Δ/Δ cells is accompanied by karyotypic changes, by defects in the response to 
DNA damage agents, and by hypersensitivity to rapamycin (Figures 4.2-4 and 4.7). Karyotypic 
changes and the altered DNA damage response could function as mechanisms leading to the 
switch, while increased rapamycin sensitivity suggests alterations in TOR pathway function. 
Therefore, I propose a model in which the switch occurs due to the accumulation of genetic and 
epigenetic alterations that happen as mds3Δ/Δ cells try to enter stationary phase with a 
deregulated TOR pathway (Figure 4.9).  The deletion of MDS3 would predispose cells to undergo 
the phenotypic switch, but secondary events appear to be required for the switch to occur. 
 
Why do the switched mds3Δ/Δ mutant cells form papilli? 
 In a nutrient poor medium, the switch might give cells the ability to scavenge 
alternative nutrient sources. Metabolic adaptation is associated with phenotypic switching in other 
organisms, such as tumor formation and progression in mammalian organism (Furuta et al., 
2010). Further, the appearance of mutants with an altered metabolism that can outgrow an 
otherwise nutrient-limited population has been previously observed in evolution studies in yeast 
(Gresham et al., 2009; Dunham et al., 2002). Interestingly, a mutation in MDS3, likely a dominant 
gain of function mutation, led to increased fitness during S. cerevisiae evolution studies in 
glucose-limiting conditions, indicating that, similar to C. albicans, Mds3 also controls nutrient 
adaptation processes in yeast (Anderson et al., 2010). Different mechanisms are associated with 
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the increased fitness of evolving cells, including chromosomal rearrangements, aneuploidies, 
point mutations, and gene amplifications/deletions (Pavelka et al, 2010; Gresham et al., 2009; 
Dunham et al., 2002). In C. albicans aneuploidy is also associated with altered nutrient 
assimilation (Rustchenko, 2007; Janbon et al., 1998).  Thus, similar to the models for tumor 
progression in mammalian organisms (Merlo et al., 2006; Hanahan and Weinberg et al., 2000), 
papilli may form in the mds3Δ/Δ cells because of the acquisition of genetic (and epigenetic) 
alterations that provide these cells with a fitness advantage in a nutrient poor medium and/or that 
allow them to bypass cell cycle checkpoints and continue to divide under sub-optimal 
environmental conditions. (According to this model, the switched strains should be unable to 
enter stationary phase and should die of starvation faster than the original mds3Δ/Δ mutant. This 
idea awaits further experimentation).  
 The model in which the switch happens through a stepwise accumulation of changes 
helps to explain several characteristics of the mds3Δ/Δ switch. First, this model explains why 
switched mds3Δ/Δ cells do not revert to the original colony phenotype after a wild-type MDS3 
copy is incorporated back into them (Figure 4.1C and data not shown). Second, it explains why 
some parental colonies (which have aged, but not switched) retain the mds3Δ/Δ original colony 
morphology but carry genomic rearrangements and show altered resistance to DNA damage 
agents and rapamycin compared to the original mds3Δ/Δ mutant (Figures 4.3, 4.4 and 4.7, Table 
4.3). Third, this model explains why each switched strain displays different phenotypes: each 
strain has a diverse, (semi) independent set of alterations that lead to different phenotypic outputs. 
Importantly, since the switch is reversible, these alterations need to allow for “phenotypic 
reversion” (see below).  
 In summary, my current model to explain CMPS in the mds3Δ/Δ mutant is the 
following: increased stress due at least partially to starvation, together with other environmental 
signals like acidic pH and glutamine, contribute to the formation of switched mds3Δ/Δ strains 
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through a stepwise accumulation of (reversible) genetic and epigenetic alterations that increase 
TOR dependence and MDS3 independence (Figure 4.9). 
  
Figure 4.9: Summary model of CMPS in the mds3Δ/Δ mutant. See details in the text. 
HR: homologous recombination. The dashed arrows indicate that the phenotype is only 
seen in some switched strains, while solid arrow indicates >80% penetrance. 
 
Putative mechanisms leading to CMPS in the mds3Δ/Δ mutant 
Several mechanisms can generate variability in C. albicans, including karyotypic 
rearrangements, aneuploidies, and increased mutation rate. Formation of aneuploidies are one 
appealing mechanism to explain a reversible phenotypic phenomenon like CMPS in C. albicans 
for two reasons: first, aneuploidy formation is common in C. albicans; and second, certain types 
of rearrangements can be randomly gained and subsequently randomly lost, as observed for the 
association between Chromosome 5 aneuploidies and the acquisition of antifungal resistance or 
the ability to grow in sorbose (Bouchonville et al., 2009; Arbour et al., 2009; Selmecki et al., 
2005, 2006, 2008, 2009; Janbon et al., 1998). Our CHEF and CGH studies indicate that 
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karyotypic rearrangements and aneuploidies are present in mds3Δ/Δ switched strains, which is 
well in agreement with previous reports (Figures 4.2, and 4.3, Table 4.3) (Forche et al., 2009; 
Rustchenko et al., 1994; Rustchenko, 2007). However, not all switched strains appear to carry 
genomic rearrangements, and genomic rearrangements also occur in parental strains (Figure 4.3, 
Table 4.3). These results indicate that although karyotypic changes and aneuploidies are 
associated with the switch, they are not the cause of the switch nor they are required for the 
switch to occur (Barton and Scherer, 1994). We noted that one strain analyzed by CGH (SSY75) 
showed an aneuploidy that was not predicted by CHEF analysis (Figure 4.3, Table 4.3). These 
results suggest that CGH analyses are more sensitive than CHEF analyses in the detection of 
certain types of genomic changes, and that from our CHEF results we might be underestimating 
the actual level of genomic rearrangements in the switched mds3Δ/Δ strains.  
 Loss of heterozygosity (LOH) and aneuploidies of Chromosome 2 have been 
previously associated with changes in colony morphology in C. albicans (Forche et al., 2009). 
Interestingly, aneuploidies of Chromosome 2 appear to be one common feature in switched 
mds3Δ/Δ strains observed by CGH and suggested by CHEF analyses (Figure 4.3, Table 4.3).  The 
CGH analyses suggest that there is a common breakpoint in Chromosome 2 where aneuploidies 
occur in the switched strains (Figure 4.3B, D). This common breakpoint could be a chromosomal 
fragile site (Arlt et al., 2006). One interpretation of the CGH data is that the Chromosome 2 
aneuploidies might be causing a gene dosage effect: the ratio of the left 1/5
th
 to the right 4/5
th
 of 
Chromosome 2 is 1:2 (SSY73) or 2:3 (SSY75) (Figure 4.3B, D, Table 4.3). Chromosome 2 is one 
of the largest chromosomes in C. albicans genome. Therefore, speculating what genes or regions 
in Chromosome 2 might be involved in the putative dosage effect is difficult. However, we noted 
that BCY1, which encodes the protein kinase A (PKA) regulatory subunit, and TPK2, which 
encodes the major PKA catalytic subunit, are located in opposite sides of Chromosome 2 and 
would be subject to a dosage effect in these aneuploid strains (Figure 4.3, Candida Genome 
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Database, Souto et al., 2006; Tamaki, 2007; Giacometti et al., 2006). Given the 
happloinsufficiency of BCY1, these results suggest that these two aneuploid strains carry an 
overactive PKA pathway (Giacommetti et al., 2006). Other genes that might be amplified in the 
trisomic strain include RAS1, an upstream positive regulator of PKA; the TOR pathway members 
TOR1, SCH9, URE2, FHL1 (which requires TBF1 for function, also amplified in the trisomy); the 
stress responsive elements HOG1 and HSP78; and the zinc transporter ZRT2. Interestingly, Zrt1, 
a high-affinity zinc transporter, has been associated with a blebbing phenotype in S. cerevisiae 
strains caused by microsatellite rearrangements during stationary phase (Kelly et al., 2007). 
Further, zinc was identified as an environmental negative regulator of CMPS, suggesting a 
connection between zinc, Chromosome 2 aneuploidies, ZRT2, and CMPS (Bedell and Soll, 1979). 
Thus, it would be interesting to determine the frequency of Chromosome 2 aneuploidies in 
switched mds3Δ/Δ strains, and if the amplification or happloinsufficience in particular genes in 
this chromosome are associated with the switch in the mds3Δ/Δ mutant. 
 DNA damage response defects could be a mechanism leading to CMPS in C. albicans 
(Figure 4.9). DNA damage response defects lead to increase frequency of point mutations, defects 
in cell cycle checkpoints, and genomic instability, which can all lead to phenotypic alterations 
(Negrini et al., 2010; Drotschmann et al., 2000). Further, C. albicans mutants with defects in 
homologous recombination give rise to colonies with altered morphologies (Legrand et al., 2007). 
In line with this, the increased sensitivity to genotoxic agents observed in the switched strains 
would suggest that defective DNA damage response is contributing to CMPS in C. albicans 
(Figure 4.4, 4.9). The rate of phenotypic switching in the mds3Δ/Δ mutant is ~10-2 (not the 
frequency of papilli formation, but the frequency at which switched mds3Δ/Δ strains switch again 
to a different morphology), significantly above the normal rate of random point mutation in 
eukaryotes: 10
-8
. Such an increase in the mutagenic frequency would most certainly be lethal to 
any organism. Therefore, increased mutagenesis cannot solely account for CMPS in the mds3Δ/Δ 
 151 
mutant. However, a combination of an increased point mutation rate with an increased rate of 
chromosomal rearrangements (chromosomal loss, or LOH events) could be one way through 
which C. albicans can achieve variability and retain reversibility. (We must keep in mind that 
phenotypic reversibility does not imply genetic reversibility, i.e., we can achieve similar 
phenotypes by compensating a mutation in X with a mutation in Y, not necessarily with a 
reversion of X).  Further, the increased resistance to MMS observed in the original mds3Δ/Δ 
mutant suggests that this mutant might be able to tolerate and, therefore, accumulate DNA 
damage, which could eventually lead to the switch (Figure 4.9). Increased MMS resistance has 
been associated in yeast to low levels of the checkpoint protein Rad53 (Cordon-Preciado et al., 
2006; Aguilera and Gomez-Gonzalez, 2008). Further, S. cerevisiae rad53Δ mutants show high 
instability of repetitive DNA, which is often associated with chromosomal fragile sites (Lahiri et 
al., 2004). Thus, defects in Rad53 function could also explain the Chromosome 2 aneuploidies 
observed in the mds3Δ/Δ switched strains (Figure 4.3). Thus, it would be interesting to determine 
if Mds3 plays a role in Rad53 regulation or stability, and if Rad53 function is altered in the 
switched strains. Further, defects in nutrient signaling pathways like PKA and TOR are 
associated with DNA damage response [and Rad53 function] (Searle et al., 2004; Shen et al., 
2007; Budanov and Karin, 2008; Chapter 5), which supports the hypothesis that switched 
mds3Δ/Δ variants arise due to mechanisms that suppress TOR pathway defects.   
LOH events and epigenetic mechanisms are also associated with phenotypic variation. 
We did not determine LOH levels in the switched mds3Δ/Δ strains and only began to explore the 
role of epigenetic mechanisms in CMPS, thus we cannot discard a role for these processes in 
CMPS. We took several approaches to look at the role of epigenetic mechanisms in CMPS. First, 
we constructed mutants in histone deacetylases (HDACs) and determined their ability to produce 
colonies with altered morphology and/or papilli (Appendix A and data not shown). Second, in 
collaboration with Helen Wang and Judith Berman (University of Minnesota) we constructed 
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mds3Δ/Δ and mds3Δ/Δ+MDS3 strains with a URA3 marker replacing the Chromosome 5 
centromeric region in order to test if the absence of MDS3 had an effect on the ability of cells to 
express and/or silence URA3 at centromeres (see Methods, Table 4.1, Ketel et al., 2009). Third, 
since silencing requires different mechanisms at different chromosomal locations (Perrod and 
Gasser, 2003) I also tried to construct strains containing a URA3 cassette near the telomeres to 
look for differences in telomeric silencing; while I obtained recombinants at the correct location, 
the URA3 gene appeared to be lost instead of silenced (data not shown). We did not detect an 
increased frequency of switching in the HDACs mutants (data not shown), but we have not yet 
fully determined the role of MDS3 in gene silencing at the centromeres. Importantly, even though 
the original mds3Δ/Δ mutant might not show a gene silencing defect, alterations in silencing 
might arise stepwise and eventually contribute to the switch. Thus, it would be interesting to 
isolate switched variants from the mds3Δ/Δ cen5::URA3/CEN5 strains and determine their ability 
to silence URA3. 
 
Environmental signals affecting CMPS in the mds3Δ/Δ mutant 
 Why does glucose starvation enhance papilli formation and alkaline pH inhibits it? 
Glucose levels are sensed by several signaling pathways, including the PKA and TOR pathways. 
The PKA pathway receives signals from the Ras and Gpr1/Gpa2 parallel circuits, and low 
glucose concentration correlates with low PKA activity (Thevelein and de Winde, 1999). How 
the glucose signal feeds into the TOR pathway is still unclear. It is likely that the glucose signal 
feeds into downstream effectors of the TOR pathway, instead of upstream the TOR kinase 
(Bertram et al., 2002; Gorner et al., 2002; Di Como and Arndt, 1996; Kuruvilla et al., 2001). On 
the other hand, environmental alkaline pH activates the Rim101 pathway in fungi, which does not 
appear to have any connection with the TOR pathway (Davis, 2009). However, there is evidence 
that adaptation to alkaline pH also requires the activity of the cAMP/PKA pathway in both C. 
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albicans and C. neoformans, and the inhibition of TOR activity (Figure 4.6, O’Meara et al., 2009; 
Zacchi et al., 2010a (Chapter 3), Chapter 5). Thus, one possibility to explain the effect of glucose 
starvation and alkaline pH on the switch is that they may affect signaling pathways, such as PKA, 
that may regulate TOR or TOR downstream effectors. Alternatively, low glucose induces the 
phenomenon of caloric restriction involved in aging, a process regulated by the TOR and PKA 
pathways (Wei et al., 2008; Blagosklonny, 2009). The process of aging is associated with the 
accumulation of deleterious mutations (Gonzalo, 2010; Bitterman et al., 2003). It may be possible 
that mds3Δ/Δ cells cannot enter the aging program properly due to a TOR pathway deregulation, 
but that they still accumulate mutations. In this regard, overactivation of the TOR pathway by the 
amino acid glutamine might also contribute to deregulate the aging process, enhancing CMPS in 
C. albicans (data not shown) (Powers et al., 2006). Finally, alkaline pH might be neutralizing or 
preventing the accumulation of a particular metabolite that is required for papilli formation, as it 
occurs while yeast age (Burtner et al., 2009; Fabrizio et al., 2004). Regardless of the mechanism, 
environmental and nutritional signals undoubtedly play a key role in the regulation of the switch 
in the mds3Δ/Δ mutant.  
 The studies presented here begin to uncover the complexity of the phenotypes 
associated with the phenotypic switch in the mds3Δ/Δ mutant. Not only the switched strains 
display different colony morphologies and expression of a set of critical virulence traits, but they 
also show diverse genomic rearrangements and a differential response to genotoxic agents such as 
MMS and HU. These variable characteristics expose the inherent noise in the switching system 
and the diversity of responses associated with the switch. However, we have also found two 
generally unifying phenotypes of the switched mds3Δ/Δ strains: enhanced sensitivity to 
rapamycin and to the oxidizing agent TBHP. I propose that the increased rapamycin sensitivity of 
switched strains is a reflection of an increased TOR dependence (Figure 4.9). A deeper 
understanding of the processes that lead to rapamycin resistance and TBHP sensitivity in C. 
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albicans will likely contribute to uncover the mechanisms behind the phenotypic switching in the 
mds3Δ/Δ mutant. Defects in TOR pathway regulation are strongly associated with the generation 
of phenotypic diversity and tumor progression in mammalian organisms. If indeed TOR pathway 
defects are also causally associated with the generation of phenotypic diversity in C. albicans, we 
may have found a more malleable model than mammalian organisms to study these processes.  
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TABLES 
Table 4.1. C. albicans strains used in this study 
Strain Parent Genotype References 
DAY1 
(BPW17) 
SC5314 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG 
arg4::hisG/arg4::hisG 
Wilson et al., 
1999 
DAY286 DAY1 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
ARG4::URA3::arg4::hisG/arg4::hisG 
Wilson et al., 
1999 
DAY185 DAY286 ura3::λimm434/ura3::λimm434  pHIS1::his1::hisG/his1::hisG  
ARG4::URA3::arg4::hisG/arg4::hisG 
Davis et al., 
2000 
GK09 BWP17 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::Tn7::UAU1/mds3::Tn7::URA3 
Davis et al., 
2002 
DAY417 BWP17 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3 
Davis et al., 
2002 
DAY425 
(VIC11) 
BWP17 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG 
arg4::hisG/arg4::hisG  rim101::dpl200/rim101::dpl200  
mds3::UAU1/mds3::URA3 
This study 
DAY439 BWP17 ura3::λimm434/ura3::λimm434  HIS1::his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::Tn7::UAU1/mds3::Tn7::URA3 
Davis et al., 
2002 
DAY435 BWP17 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  MDS3::HIS1::mds3::Tn7::UAU1/ 
mds3::Tn7::URA3 
Davis et al., 
2002 
DAY956 BWP17 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::ARG4/mds3::dpl200 
Zacchi et al., 
2010a 
DAY972 RM1000 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG 
sit4::HIS1/sit4::dpl200 
Lee et al., 
2004 
DAY1046 WO-1  Slutsky et al., 
1987 
DAY1063 
(DKCa127) 
SN76 arg4/arg4 his1/his1 ura3::imm434/ura3::imm434 
iro1::imm434/iro1::imm434  rad50Δ::CdHIS1/rad50Δ::CdARG4 
Legrand et 
al., 2007 
DAY1122 DAY938 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3-dpl200 
TOR1/tor1::HIS1 
Zacchi et al., 
2010a 
DAY1123 DAY286 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
ARG4::URA3::arg4::hisG/arg4::hisG TOR1/tor1::HIS1 
Zacchi et al., 
2010a 
DAY1124 DAY1122 ura3::λimm434/ ura3::λimm434  his1::hisG / his1::hisG  
arg4::hisG/ arg4::hisG  mds3::ARG4/mds3::URA3-dpl200 TOR1-
1/tor1::HIS1 
Zacchi et al., 
2010a 
DAY1125 DAY1123 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
ARG4::URA3::arg4::hisG/arg4::hisG TOR1-1/tor1::HIS1 
Zacchi et al., 
2010a 
DAY1226 
(GKO782) 
BWP17 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  sch9::Tn7::UAU1/sch9::Tn7::URA3 
Davis et al., 
2002 
DAY1224 
(CJN6) 
GKO782 ura3::λimm434/ura3::λimm434  
SCH9::HIS1::his1::hisG/his1::hisG  arg4::hisG/arg4::hisG  
sch9::Tn7::UAU1/sch9::Tn7::URA3 
Nobile et al., 
2003 
LUZ111 DAY417 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3  MTLa/Δ 
This study 
LUZ124 DAY286 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
ARG4::URA3::arg4::hisG/arg4::hisG  MTLa/Δ 
This study 
LUZ127 LUZ111 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3  MTLa/a 
This study 
LUZ145 LUZ124 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
ARG4::URA3::arg4::hisG/arg4::hisG  MTLa/a 
This study 
LUZ166 DAY956 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::ARG4/mds3::dpl200  
cen5::URA3/CEN5 
This study 
LUZ225/6 LUZ166 ura3::λimm434/ura3::λimm434  HIS1::his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::ARG4/mds3::dpl200  
cen5::URA3/CEN5 
This study 
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LUZ227/8 LUZ166 ura3::λimm434/ura3::λimm434  
HIS1::MDS3::his1::hisG/his1::hisG  arg4::hisG/arg4::hisG  
mds3::ARG4/mds3::dpl200  cen5::URA3/CEN5 
This study 
LUZ796 SSY194 ura3::λimm434/ura3::λimm434  HIS1::his1::hisG/his1::hisG 
arg4::hisG/arg4::hisG mds3::Tn7::UAU1/mds3::Tn7::URA3 
This study 
LUZ797 SSY194 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG 
arg4::hisG/arg4::hisG 
mds3::Tn7::UAU1/mds3::MDS3::HIS1::Tn7::URA3 
This study 
LUZ798 SSY210 ura3::λimm434/ura3::λimm434  HIS1::his1::hisG/his1::hisG 
arg4::hisG/arg4::hisG mds3::Tn7::UAU1/mds3::Tn7::URA3 
This study 
LUZ799 SSY210 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG 
arg4::hisG/arg4::hisG 
mds3::Tn7::UAU1/mds3::MDS3::HIS1::Tn7::URA3 
This study 
 
 
Table 4.2. Primers used in this study 
Primer Sequence Reference 
a1-ORF-F TGGCATCTATACTGAGGACG This study 
a1-ORF-R CACTAAATACCGCAACTAAGAT This study 
MTL alpha2 5detect TCCTCATTTGGTAGAAAGAG This study 
MTL alpha2 3detect TTGTGCGCTCAATGCCTGGG This study 
944 AGACCTATAGTGAGAGAGCA Ketel et al., 2009 
945 CAAACAATCCTCTACCAACA Ketel et al., 2009 
1901 GGGATGAAGACTATGATGTGC Ketel et al., 2009 
1915 CAGCCTTTGAGCCCTATT Ketel et al., 2009 
1961 TCTACTAAAATCAACGAAGC Ketel et al., 2009 
2003 CAGTCGGGCGATTATCT Ketel et al.,2009 
2211 CAATTGTAACTACAAATTGTTACAGTTTTCAAATTCT
ACTCAAACAAGCATTCGAAGGACATTAATTAACGTT
TTCCCAGTCACGACGTT 
Ketel et al.,2009 
2212 CTGACTCCTCTAATTAATCAATTCTACAAACTTGAAT
TCAAACTTTTTATTCCAGTATTCTGATTGATCTGTGG
AATTGTGAGCGGATA 
Ketel et al.,2009 
MDS3 5-detect AAGCGCCTGTTACAGTCTAC Davis et al., 2002 
MDS3 3- detect AAATCAAATTCCCATAAGTC Davis et al., 2002 
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Table 4.3. Karyotypic rearrangements, aneuploidies, and resistance to rapamycin and DNA damage agents in switched mds3Δ/Δ strains. 
Switched 
strain 
mds3Δ/Δ 
parent 
CHEF Results CGH Results Rap YPD Rap Spider TBHP MMS HU 
SSY3 DAY425 Normal ND ND ND ND ND ND 
SSY5 DAY425 Normal ND ND ND ND ND ND 
SSY10 DAY425 Normal ND ND ND ND ND ND 
SSY16 DAY425 Band between Chr 1-2, and Chr2-3 ND = (S) SS ND ND ND 
SSY18 DAY425 Normal ND ND ND ND ND ND 
SSY20 DAY425 Normal ND ND ND ND ND ND 
SSY22 DAY417 Normal ND ND ND ND ND ND 
SSY24 DAY417 Normal ND ND ND ND ND ND 
SSY26 DAY417 Normal ND ND ND ND ND ND 
SSY28 DAY417 Normal ND ND ND ND ND ND 
SSY30 DAY417 Normal ND ND ND ND ND ND 
SSY32 DAY417 Band between Chr2-3 ND ND ND ND ND ND 
SSY34 DAY417 Normal Normal R+/- SS SS SS ND 
SSY36 DAY417 Normal ND ND ND ND ND ND 
SSY38 DAY417 Normal ND ND ND ND ND ND 
SSY40 DAY417 Band between Chr2-3 ND ND ND ND ND ND 
SSY41 DAY425 Band between Chr2-3 ND SS(S) SS ND ND ND 
SSY45 DAY425 Normal ND ND ND ND ND ND 
SSY47 DAY425 Normal ND ND ND ND ND ND 
SSY49 DAY425 Normal ND ND ND ND ND ND 
SSY51 DAY425 Normal ND ND ND ND ND ND 
SSY53 DAY425 Normal ND ND ND ND ND ND 
SSY55 DAY425 Band between Chr4-5 ND SSS SS SS S+/- S 
SSY57 DAY425 Normal ND ND ND ND ND ND 
SSY59 DAY425 Normal ND ND ND ND ND ND 
SSY61 DAY417 Normal ND ND ND ND ND ND 
SSY63 DAY417 Band between Chr2-3 ND S+/- SS SS S+/- ND 
SSY65 DAY417 Band between Chr2-3 ND S+/- S+/- SS S+/- S 
SSY67 DAY417 Band between Chr2-3 ND = = = = R 
SSY69 DAY417 Normal ND ND ND ND ND ND 
SSY71 DAY417 Normal ND ND ND ND ND ND 
SSY73 DAY417 Band between Chr2-3 1/5 segm. mon. Chr 2 S+/- SS SS SS ND 
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SSY75 DAY417 Normal 4/5 segm. tris. Chr2 = = ND ND ND 
SSY77 DAY417 Normal ND ND ND ND ND ND 
SSY79 DAY417 Normal ND ND ND ND ND ND 
SSY117 DAY439 ND ND SS SSS ND ND ND 
SSY137 DAY439 ND ND S+/- SSS S+/- S+/- ND 
SSY147 DAY439 ND ND S+/- SS SS SS ND 
SSY151 DAY439 ND ND S+/- S+/- SSS = ND 
SSY155 DAY439 ND ND = = SSS = = 
SSY159 DAY439 ND ND S+/- S+/- SS S+/- ND 
SSY161 DAY439 ND ND = = SS S+/- S+/- 
SSY171 DAY439 ND ND S+/- S+/- SS = ND 
SSY185 DAY439 ND ND R+/-(S) SSS(S) SSS = (S) ND 
SSY194 GKO9 ND ND ND ND ND ND ND 
SSY210 GKO9 ND Tris. Chr 6 =(R) SS SSS SS S+/- 
ND= not determined, R= more resistant than parental, S= more sensitive than parental, (R) or (S) indicate that the parental already had a phenotype compared to 
the original mds3Δ/Δ strain. S+/-, SS, SSS indicate the different degrees of the phenotype.  
Segm: segmental; Mon: monosomic; Tris: trisomic; Chr: chromosome 
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CHAPTER 5 
 
 
MDS3, AT THE CROSSROADS OF THE PATHWAYS TO PHENOTYPIC 
SWITCHING 
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SUMMARY 
 Candida albicans is one of the most important fungal pathogens of humans. As any other 
organism, C. albicans requires the ability to generate phenotypic variation for survival. One 
mechanism through which C. albicans obtains variation is through colony morphology 
phenotypic switching (CMPS). CMPS is defined as the stochastic formation of colonies with 
altered and heritable morphologies, and with low frequency reversibility. CMPS is associated 
with virulence in C. albicans. However, the mechanisms that lead to CMPS are not known. Mds3 
is a negative regulator of CMPS, but the role of Mds3 in CMPS is unclear. Mds3 is also a 
regulator of the TOR pathway, which has led me to propose that the deregulation of the TOR 
pathway in the absence of MDS3 predisposes C. albicans cells to undergo CMPS (Chapter 4). 
Here, I provide evidence that Mds3 is also a member of the Ras pathway in C. albicans, and I 
identify two new CMPS regulators: Ras1 and the TOR downstream effector kinase Sch9. The Ras 
and TOR pathways are critical regulators of cell growth in response to environmental nutrients, 
and they overlap in the regulation of many common downstream effectors, including those which 
are targets of Sch9. These results provide evidence that support the hypothesis that CMPS in C. 
albicans is a consequence of defects in the transmission of starvation and stress signals that are 
channeled through the TOR and Ras/cAMP signal transduction cascades. 
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INTRODUCTION 
 Candida albicans is one of the leading causes of superficial and nosocomial systemic 
infections in the USA (Pfaller et al., 2001). One feature that makes this fungus such a successful 
commensal and opportunistic pathogen is its ability to undergo morphogenetic changes. One of 
the better understood C. albicans morphogenetic transitions is the switch from yeast morphology 
to pseudohyphal and hyphal morphologies (Biswas et al., 2007). The ability of C. albicans to 
transition between these cellular morphologies is critical for pathogenesis (Lo et al., 1997; Saville 
et al., 2003, 2008). C. albicans also forms chlamydospores, which are thick-walled, spherical 
cells that appear at the tip of the hyphae during growth in certain nutrient poor media. 
Chlamydospores have been found during infections and might be associated with C. albicans 
virulence (Staib and Morschhauser, 2007). Finally, C. albicans undergoes two types of 
phenotypic switching: white-opaque switching and colony morphology phenotypic switching 
(CMPS) (Soll, 1992; Lohse and Johnson, 2009). Both types of phenotypic switch involve the 
formation of colonies with an altered morphology, and these morphological alterations are also 
associated with changes in the expression of virulence traits and pathogenesis in vitro and in vivo 
(Gallagher et al., 1992; Kennedy et al., 1998; Kolotila and Diamond, 1990; Vargas et al., 1994, 
2004; Kvaal et al., 1997, 1999; Anderson et al., 1989; Lan et al., 2002). White-opaque switching 
is a well studied bistable switch between two colonial and cellular morphologies (Soll et al., 
2009; Lohse and Johnson, 2009; Morschhauser, 2010). On the contrary, very little is known about 
CMPS, perhaps because the larger number of interconvertible and stochastically reversible colony 
morphologies involved in CMPS has hindered the efforts to understand the mechanisms that 
regulate this phenomenon in C. albicans (Slutsky et al., 1985; Soll, 1992). The fact that 
morphogenetic transitions are required for C. albicans ability to colonize, survive in the host, and 
cause infection underscores the importance in understanding their regulation. 
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 C. albicans morphogenetic transitions occur in response to the environment. The yeast-
hyphal transition is controlled by several environmental signals, including temperature, serum, 
alkaline pH, starvation, and CO2 concentration (Biswas et al., 2007; Cottier and Muhlschlegel, 
2009). Chlamydospore formation is influenced by temperature and nutrients, but also by O2 
concentration, light, and moisture (Staib and Morschhauser, 2007). White-opaque phenotypic 
switching is affected by temperature, CO2 concentration, and nutrients (Ramirez-Zavala et al., 
2008; Huang et al., 2010). Finally, CMPS responds to glucose, glutamine, alkaline pH, and zinc 
(Chapter 4; L.F.Z. unpublished observations; Bedell and Soll, 1979). Alterations in the 
environment have a direct impact on morphogenesis in C. albicans.  
Many signaling pathways are associated with specific responses to environmental signals 
(Bahn et al., 2007). For example, the response to glucose and CO2 concentration occurs through 
the cAMP/protein kinase A (PKA) pathway (Cottier and Muhlschelgel, 2009). The TOR pathway 
responds to nitrogen sources and, to a lesser extent, to carbon source availability (Rohde et al., 
2001, Wullschleger et al., 2006). The Rim101, calcineurin, and PKA pathways respond to 
alkaline pH (Davis, 2009; O’Meara et al., 2010; Kullas et al., 2007). Finally, changes in 
temperature are likely controlled by the function of heat shock proteins and the PKA pathway 
(Shapiro et al., 2009). Thus, morphogenetic processes in C. albicans are regulated by several 
signal transduction pathways, and some of them, such as the cAMP/PKA pathway, appear to have 
a more extensive role in morphogenesis than others (Hogan and Sundstrom, 2009).  
The two major cellular growth controlling pathways that respond to environmental 
nutrients in C. albicans are the PKA and the TOR pathway. In C. albicans, PKA is composed of 
two catalytic subunits, Tpk1 and Tpk2, and the regulatory subunit Bcy1 (Figures 5.1, 1.2; Souto 
et al., 2006; Giacometti et al., 2006, 2009; Bockmuhl et al., 2001; Thevelein and de Winde, 
1999). During active growth, cAMP produced by the adenylate cyclase Cdc35 binds Bcy1 
allowing PKA activation. Adenylate cyclase is activated by Ras1 and the Gpr1-Gpa2 parallel 
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circuit (Figure 5.1). Ras1 is active while bound to GTP, and inactive in its GDP bound state. The 
Ras guanine nucleotide exchange factor, Cdc25, and the activator of Ras GTPase, Ira2, function 
upstream of Ras1 and activate or inactivate Ras1 function, respectively (Thevelein and de Winde, 
1999). Ras1 also lies upstream of the MAPK cascade, which is composed of Cst20, Ste11, Cek1, 
and Hst7. Known downstream effectors of PKA and MAPK are the transcription factors Efg1 and 
Cph1, respectively (Leberer et al., 2001; Maidan et al., 2005; Zaman et al., 2008; Monge et al., 
2006). PKA is a positive regulator of transcription, translation, and glucose metabolism, and a 
repressor of glycogen accumulation and stress responses (Zaman et al., 2008). The Ras/PKA 
signaling cascade translates nutrient and stress environmental signals into changes of an array of 
cellular and metabolic responses in C. albicans, including protein synthesis and degradation, cell 
division and starvation responses. 
 
Figure 5.1: The Ras1 pathway in C. albicans. Figure adapted from Leberer et al (2001). 
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The second major growth controlling signal transduction pathway in yeast is the TOR 
pathway. Most of what is currently known about the fungal TOR pathway comes from studies in 
S. cerevisiae (Figure 1.3). In this yeast, the TOR pathway is composed of several upstream 
factors including Tsc1, Tsc2, and Rhb1. Tsc1/2 are negative regulators of Rhb1, which is a 
positive regulator of TOR (Wullscheleger et al., 2006; Rohde et al., 2008). TOR, which is a 
kinase, exists in two different multiprotein complexes, only one of which is sensitive to the TOR 
inhibitor rapamycin (Loewith et al., 2002; Heitman et al., 1991). One direct target of TOR 
activity is Tap42 (Duvel et al., 2003). During TOR activation, Tap42 remains bound to the 
downstream TOR effectors: the PP2A and PP2A-like phosphatases, inhibiting them (Duvel and 
Broach, 2004; Wang et al., 2003). These phosphatases control the response to stress and 
starvation in cells, and are activated upon TOR inhibition (Jacinto, 2007; Duvel and Broach, 
2004). One PP2A-like phosphatase that is critical for TOR-dependent regulation of nitrogen 
responses and protein degradation is Sit4, also associated with morphogenetic regulation in C. 
albicans (Lee et al., 2004; Zacchi et al., 2010a; Rohde et al., 2004). TOR also directly 
phosphorylates effectors involved in transcription, protein synthesis regulation, and glycolysis, 
such as the kinase Sch9 (Urban et al., 2007). Similar to the PKA pathway, the TOR pathway 
controls cellular processes such as cellular growth and division and starvation responses. 
However, TOR also regulates the nitrogen catabolite repression response (Lee et al., 2004; Cutler 
et al., 2001; Nobile et al., 2003; Zacchi et al., 2010a; Bastidas et al., 2009). Therefore, both the 
TOR and PKA pathway are major regulators of growth in response to environmental nutrients. 
The PKA and TOR pathways control several similar processes, either by regulating 
similar downstream effectors or by crosstalk in the pathways (Schmelzle et al., 2004; Zurita-
Martinez and Cardenas, 2005; Martin et al., 2004; Zaman et al., 2008; Soulard et al., 2010). In 
mammals, Ras is a positive regulator of TOR, and functions upstream the TOR kinase (Shaw and 
Cantley, 2006). In S. cerevisiae, however, the interaction between the TOR and Ras pathways is 
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less clear. It has been proposed that TOR controls PP2A-independent functions through the 
Ras/PKA pathway, while others suggest that TOR and PKA function in parallel (Schmelzle et al., 
2004; Zurita-Martinez and Cardenas, 2005; Martin et al., 2004; Soulard et al., 2010). Given their 
relevant role in cellular growth, it comes as no surprise that both the PKA and TOR pathways are 
strongly associated with the regulation of several morphogenetic processes in C. albicans, 
including yeast-hyphal transitions and chlamydospore formation (Lee et al., 2004; Cutler et al., 
2001; Nobile et al., 2003; Zacchi et al., 2010; Bastidas et al., 2009; Hogan and Sundstrom, 2009; 
Biswas et al., 2007; Leberer et al., 2001). The TOR pathway also plays a role in the regulation of 
CMPS in C. albicans (Chapter 4). In agreement with their often overlapping functions, here I 
show that the Ras pathway is also involved in CMPS regulation in this fungus. 
Only two genetic regulators of CMPS in C. albicans have been identified: the 
transcriptional co-repressor Ssn6 and the TOR pathway member Mds3. Ssn6 forms a co-repressor 
complex with Tup1, and is involved in the regulation of morphogenetic processes in C. albicans 
(Garcia-Sanchez et al., 2005; Hwang et al., 2003). Deletion of SSN6 leads to the formation of 
colonies with altered, unstable morphology that are reminiscent of CMPS (Garcia-Sanchez et al., 
2005). The mechanism through which SSN6 regulates CMPS is unclear, but it is likely through its 
direct, reversible effects on gene transcription.  
Mds3 is a large, cytoplasmic protein with N-terminal Kelch domains that is involved in 
the regulation of pH responses, chlamydospore formation, and yeast-hyphal transitions (Chapter 
2; Davis et al., 2002; Nobile et al., 2003). Mds3 is also a regulator of the TOR pathway in C. 
albicans. However, Mds3 displays phenotypes that are Sit4-independent and potentially TOR-
independent (Zacchi et al., 2010a). In S. cerevisiae, Mds3 has been associated with the Ras 
pathway. For example, Mds3 physically interacts with Cdc25, an mds3Δ pmd1Δ double mutant 
shares similar phenotypes with a cdc25Δ mutant [PMD1 is a paralog of MDS3 in S. cerevisiae 
(Benni and Neigeborn, 1997)], and an overactive RAS
V17
 allele rescues the early sporulation 
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defect of the mds3∆ pmd1Δ mutant (Benni and Neigeborn, 1997; McDonald et al., 2009, Krogan 
et al., 2006; Tonikian et al., 2009; Gavin et al., 2006; Collins et al., 2007). Thus, Mds3 could 
function in both the Ras and TOR pathways.  
Intrigued by the fact that Mds3 was associated with the Ras/PKA pathway in S. 
cerevisiae and that Mds3 appears to have Sit4-independent functions, I wished to determine the 
genetic interaction between Mds3, TOR, and Ras/PKA pathways in C. albicans. To this end, I 
tested mutants in the Ras/PKA, MAPK, Gpr1-Gpa2, and TOR pathways for phenotypes similar to 
an mds3Δ/Δ mutant. I also determined the genetic interaction between MDS3, SIT4, and RAS1 
using double mutants in these genes, and determined the ability of a RAS1
V13
 overactive allele to 
rescue the mds3Δ/Δ and sit4Δ/Δ mutations. I found that Mds3 appears to function upstream of 
Ras1 in C. albicans, probably acting on Cdc25 function. Mutants in CDC25 and RAS1 shared 
similar phenotypes with a mutant in MDS3, including growth and transcriptional responses to the 
TOR inhibitor rapamycin, and phenotypic switching. Further, I showed that CMPS is not 
mediated by the MAPK pathway, and I identified a third regulator of CMPS in C. albicans, the 
Sch9 kinase, a critical downstream effector of the TOR pathway. Therefore, Mds3 appears to 
function in both the TOR and Ras/cAMP pathways, and both of these pathways are negative 
regulators of CMPS in C. albicans. 
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MATERIALS AND METHODS 
C. albicans strains and plasmids 
 All yeast strains used in this study are listed in Table 5.1. The ras1∆/∆ sit4∆/∆ mutant 
LUZ613 was constructed by sequentially deleting both RAS1 alleles from the sit4∆/∆ strain 
DAY972, using the ras1::URA3-dpl200 disruption cassette PCR amplified from pDDB57 with 
primers RAS1 5DR and RAS1 3DR (Table 5.3). All deletions are from the start to the stop codon 
and were generated by chemical transformation (Wilson et al., 1999). Correct integration of the 
disruption cassettes was verified by the PCR using the RAS1 5’ detect, RAS1 3’ detect, and 
URA3 internal detect primers (Table 5.3). The URA3-dpl200 marker was recycled by growing the 
cells in SC medium supplemented with 5-fluoroorotic acid (5-FOA).  
The RAS1/ras1∆ mds3∆/∆ mutant (LUZ692) was constructed by sequentially deleting 
one copy of RAS1 and one copy of MDS3 from strain DAY415 using the ras1::URA3-dpl200 
disruption cassette described above, and the mds3::URA3dpl200 cassette amplified with primers 
MDS3 5 DR and MDS3 3 DR from pDDB57 (Tables 5.1 and 5.3). The URA3-dpl200 marker was 
recycled by growing the cells in SC medium supplemented with 5-fluoroorotic acid (5-FOA). To 
eliminate the remaining RAS1 copy from LUZ692 I used the regular ras1::URA3-dpl200 
disruption cassette described above, and a ras1int::URA3-dpl200 cassette with regions of 
homology within RAS1 open reading frame (ORF), amplified with primers RAS1 int 5DR and 
RAS1 int 3 DR (Table 5.3). A total of 89 transformants (20 of which were made with the 
ras1int::URA3-dpl200 cassette) were screened: 77 had ectopic integrations that retained the RAS1 
copy [70 mutants also retained the ras1::dpl200 copy (including 1 strain with a triplication), and 
6 strains only had the RAS1 allele]; 10 lost the ras1::dpl200 allele and retained the RAS1 wild-
type copy (5 of these were verified by PCR to be RAS1/ras1::URA3dpl200, indicating a marker 
replacement); and 2 appeared to have lost the RAS1 wild-type copy but the ras1::URA3-dpl200 
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allele did not give the expected band size by PCR [one of these strains was saved as LUZ754]. 
Nevertheless, I was not able to generate a ras1∆/∆ mds3∆/∆ double mutant. 
The complemented sit4Δ/Δ mds3Δ/Δ+MDS3 mutant LUZ621 was generated as follows. 
Strain DAY1233 was plated on 5-FOA to generate LUZ616. Loss of the mds3::URA3dpl200 
allele was verified by genomic PCR using primers MDS3 null detect 5’ and MDS3 null detect 3’ 
(Table 5.3). LUZ616 was transformed with BseRI digested plZ169, to generate LUZ621. 
Integration of a wild-type MDS3 copy was verified by genomic DNA PCR using primers MDS3 
null detect 5’, MDS3 null detect 3’, and MDS3 NruI Seq (Table 5.3). 
 The RAS1 and RAS1
G13V
 vectors pLZ172 and pLZ173 were constructed as follows. Wild-
type RAS1 ORF sequence with flanking promoter and terminator sequences was amplified in one 
high fidelity PCR (Pfu Turbo DNA polymerase, Stratagene) using primers RAS1 5’ comp and 
RAS1 3’ comp from strain BWP17 genomic DNA (Table 5.3). The PCR product was transformed 
with BamHI/XhoI-double digested pDDB76 into S. cerevisiae strain L40 to produce plasmid 
pLZ172 through in vivo recombination. Using pLZ172 as template, RAS1 was amplified in two 
high fidelity PCRs (Pfu Turbo DNA polymerase, Stratagene) using primers pairs RAS1 5’ comp 
and RAS1G13V 3’, and RAS1 3’ comp and RAS1G13V 5’ that carry the GGT to GTT non-
synonymous mutation that causes the G13V amino acid change (Table 5.3). The PCR products 
and BamHI/XhoI-double digested pDDB76 were in vivo recombined in S. cerevisiae strain L40 to 
produce plasmid pLZ173. The complete ORF of RAS1 in pLZ172 and pLZ173 was verified by 
sequencing using primers RAS1 5’ detect, and RAS1 5’ seq-2. During the construction of these 
plasmids, we noticed that while the CGD database (www.candidagenome.org) indicates that the 
ORF of both alleles of RAS1 are identical, C. albicans strains SC5314 (DAY963) and BWP17 
actually carry two different RAS1 alleles. Several independently constructed RAS1 plasmids and 
PCR amplified RAS1 from SC5314 and BWP17 genomic DNA were sequenced to corroborate 
the presence of two alleles. To sequence RAS1 from SC5314/BWP17 strains, RAS1 was amplified 
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in high fidelity PCRs (Pfu Turbo, Stratagene) from genomic DNA of C. albicans strains SC5314 
and BWP17, using primers Ras1 3’ comp and Ras1 5’ seq, purified (Qiagen) and sequenced using 
RAS1 5’ detect and RAS1 3’ detect. Sequence runs showed overlapping peaks at three positions 
from the START codon of RAS1: nt 113 (G→A), nt 225 (C→T), and nt 388 (C→G), and the lack 
of sequence homology after the N227, the 5
th
 asparagine residue (Figure 5.2), indicating the 
presence of two RAS1 alleles. This methodology does not allow me to distinguish the exact 
nucleotide sequence of each allele. However, I suggest that the sequence of one RAS1 allele is the 
one described in CGD, while the sequence of the second allele corresponds to the RAS1 allele 
from C. albicans strain 1006 [Pubmed reference AF177670] (Feng et al., 1999). The plasmids I 
used here contain the CGD RAS1 allele sequence. However, plasmids made in the second allele 
background show similar results (data not shown). 
 
Figure 5.2: C. albicans SC5314 has two RAS1 alleles. Sequence runs showing the 
overlapping peaks corresponding to the two alleles: A) the three point mutations, and B) 
the absence of an entire asparagine codon. 
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The MDS3 complementation vector pLZ169 was generated as follows. An AdhI/NheI 
double digestion of pDDB353 was in vivo recombined with a XhoI/BamHI double digestion of 
pDDB76 in S. cerevisiae strain L40 to give plasmid pLZ169. 
 
Media and growth conditions 
 C. albicans was routinely grown at 30ºC in YPD (2% Bacto-peptone, 2% dextrose, 1% 
yeast extract). For selection of Ura
+
 or Trp
+
 transformants, synthetic medium without uridine or 
tryptophan was used (0.17% yeast nitrogen base without ammonium sulfate (Q-BioGene), 0.5% 
ammonium sulfate, 2% dextrose, and supplemented with a dropout mix containing amino and 
nucleic acids except those necessary for the selection (Adams et al., 1997)). Media were buffered 
at the indicated pH using 150mM HEPES. Rapamycin (LC Laboratories) was added to the media 
at the indicated concentrations from a stock solution in 90% ethanol-10% Tween-20. For liquid 
assays of filamentation in the presence of rapamycin, strains were pre-grown in liquid YPD at 
30ºC, pelleted, resuspended in an equal volume of PBS and diluted 1:100 in M199 pH 8 
supplemented with rapamycin or solvent alone. Samples were incubated for 6 hrs at 37ºC. For 
growth assays in the presence of rapamycin, strains were pre-grown in liquid YPD at 30ºC, 
diluted in PBS to an OD 600nm of 1.6, then serially diluted 5-fold in PBS, spotted on YPD or 
Spider medium (1% mannitol, 1% nutrient broth, 0.2% K2HPO4, pH 7.2 before autoclaving (Liu 
et al., 1994)) supplemented with rapamycin or solvent alone and incubated at 30ºC for 2 or 3 
days. For DNA damage experiments, methyl methanesulfonate (MMS, Sigma), hydroxyurea 
(HU, Sigma), and tert-butyl hydroxyperoxide (TBHP, Sigma) were added to YPD media at ~45-
50°C; plates were incubated at 30°C in a plastic bag. All media except that for selection of Ura
+
 
transformants were supplemented with 80 µg/ml uridine. For solid media, 2% Bacto-agar was 
added, except for Spider medium which used 1.35% Bacto-agar.  
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Glycogen accumulation 
 Cells were grown overnight in YPD, 5 ul were spotted on YPD plates, grown at 30°C for 
48 hrs, and exposed to iodine vapors for ~1 min. Pictures of plates were taken immediately, using 
a Canon Powershot A560 digital camera. Images were processed with Adobe Photoshop 7.0 
software. 
  
Northern blot analysis 
 For RNA extraction, cells were grown as described by Bastidas et al (2009) and Zacchi et 
al (2010a). Briefly, strains were pre-grown in YPD, diluted to an OD600nm ~ 0.1, incubated at 
30°C for 5 hrs, followed by 1 hr incubation at 30°C after addition of 20nM rapamycin. RNA 
extraction and Northern blot procedures were previously described (Zacchi et al., 2010a). 
 
Phenotypic switching assay 
Strains were grown overnight (>16 hrs) in YPD at 30°C, diluted to 10
-6
 in PBS, and 100 
µl plated on YP plates with 2% or 0.2% glucose, or YPD plates buffered at pH 6 or pH 8. Plates 
were incubated at 30°C for 48 hrs, and then at room temperature (~23-25°C) for three weeks, 
wrapped in parafilm to prevent agar desiccation. The % of colonies showing papilli on the colony 
surface was scored every 2-3 days beginning at day 6 of incubation. 
 
Microscopy 
 Images of liquid cultures were captured using a Zeiss Axio camera, Axiovision 4.6.3 
software (Zeiss), and a Zeiss AxioImager fluorescence microscope. All images were processed 
with Adobe Photoshop 7.0 software. 
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RESULTS 
Mds3 and upstream PKA pathway members share similar functions 
Mds3 was initially associated with the Ras pathway in S. cerevisiae (Benni and 
Neigeborn, 1997; McDonald et al., 2009, Krogan et al., 2006; Tonikian et al., 2009; Gavin et al., 
2006; Collins et al., 2007). Since Mds3 has Sit4- and possibly TOR-independent functions in C. 
albicans, I hypothesized that these functions were Ras-dependent (Zacchi et al., 2010a). In C. 
albicans, Ras1 functions upstream of the PKA pathway, in parallel to Gpr1 and Gpa2, and 
upstream of the MAPK pathway (Figure 5.1; Maidan et al., 2005; Leberer et al., 2001). 
Therefore, I screened mutants in the PKA and MAPK pathways for mds3∆ related phenotypes, 
including growth in rich medium, LiCl, and alkaline pH, filamentation, and rapamycin resistance 
(Figure 5.3). In S. cerevisiae, the mds3Δ pmd1Δ mutant defects are rescued by an overactive 
RAS1
V17
 allele, suggesting that Mds3 may act as a positive regulator of Ras1 (Benni and 
Neigeborn, 1997). If Mds3 indeed functions as a positive regulator of Ras1, then we should see 
similar phenotypes in the mds3Δ/Δ mutant and mutants in the Ras/MAPK and/or in the Ras/PKA 
pathways. Further, since SCH9, a downstream effector of the TOR pathway, is required for 
similar morphogenetic processes as MDS3 [chlamydospore formation and filamentation], I 
reasoned that they may also share other functions (Nobile et al., 2003; Liu et al., 2010; Urban et 
al., 2007). Thus, I also included the sch9-/- mutant in this screen. Finally, Sit4, a second 
downstream effector of TOR that physically interacts with Mds3 and has some similar functions 
as Mds3 was also included as a control in the experiments (Rohde et al., 2004; Zacchi et al., 
2010, Lee et al, 2004). 
Figure 5.3A: Looking for MDS3-dependent phenotypes in mutants in the MAPK, PKA 
and TOR pathways. Overnights of the different strains (Table 1) were diluted in PBS and 
spotted on YPD, YPD supplemented with 150mM LiCl, YPD pH 9. Plates were 
incubated at 30°C and photographed after 48 or 72 hrs. 
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MDS3 is required for wild-type growth in rich medium, in the presence of LiCl, and at 
alkaline pH (Figure 5.3; Davis et al., 2002; Zacchi et al., 2010a (Chapter 3)). Thus, I tested the 
Ras/MAPK, PKA, and sch9-/- mutants for growth on YPD, LiCl, and pH9 media. The sit4∆/∆ 
mutant has a growth defect on YPD and pH 9 media, but not on LiCl (Figure 5.3A; Zacchi et al., 
2010a). However, SIT4 is required for growth in LiCl in the presence of rapamycin, which 
indicates that Sit4 plays a role in LiCl resistance during TOR inactivation (data not shown). All 
the mutants in upstream members of the Ras-PKA pathway, including CDC25, RAS1, and 
CDC35 showed a growth defect on YPD, LiCl, and pH 9 media (Figure 5.3A). On YPD and 
LiCl, the cdc35∆/∆ mutant showed the strongest defect. I did not detect any defect in growth on 
YPD, LiCl, or pH 9 media of the single tpk1∆/∆ and tpk2∆/∆ mutants, which are mutants in the 
PKA catalytic subunits, perhaps because in C. albicans Tpk1 and Tpk2 often have redundant 
roles (Figure 5.3A; Bockmuehl et al., 2001). Mutants in GPR1, GPA2, and in the MAPK pathway 
also did not show a growth defect on YPD, LiCl, and pH 9 media. It is to note however, that the 
 174 
downstream effector of the MAPK pathway, the transcription factor Cph1, showed a growth 
defect on LiCl (Figure 3A; Liu et al., 1994; Huang et al., 2008). The sch9-/- mutant showed a 
slight growth defect on YPD, but not on LiCl or pH 9 media. Therefore, the Ras-cAMP pathway, 
but not the Gpr1-Gpa2 or MAPK pathways, is required for growth on LiCl and pH 9. Further, the 
TOR downstream effectors Sit4, but not Sch9, is required for growth at alkaline pH, and neither 
is required for growth on LiCl. 
Another phenotype of the mds3∆/∆ mutant is resistance to rapamycin in nutrient poor 
Spider medium but not in rich YPD medium. Thus, I determined the response to rapamycin in 
YPD and Spider media of the PKA, MAPK, and sch9-/- mutants (Figure 5.3B). As previously 
observed, the sit4∆/∆ mutant is more resistant to rapamycin in both YPD and Spider media 
(Zacchi et al., 2010a (Chapter 3)). Mutants in CDC25 and RAS1 were more resistant to rapamycin 
than the wild-type strain in both YPD and Spider media (Figure 5.3B). Due to the severe growth 
defect of the cdc35∆/∆ mutant it was not possible to determine whether it was more or less 
sensitive to rapamycin than the wild-type strain in YPD medium, but it appears slightly more 
resistant to rapamycin than wild-type strain in Spider medium (Figure 5.3B). While the tpk1∆/∆ 
mutant behaved similarly to wild-type in both YPD and Spider media, the tpk2∆/∆ mutant was 
more sensitive to rapamycin in both media (Figure 5.3B). The gpr1∆/∆ and gpa2∆/∆ mutants 
were more sensitive than wild-type to rapamycin on YPD medium, but more resistant to 
rapamycin on Spider medium. The cst20∆/∆, hst7∆/∆, and cek1∆/∆ MAPK mutants were more 
sensitive to rapamycin than wild-type in YPD medium, but only the cst20∆/∆ mutant was also 
more sensitive than wild-type in Spider medium (Figure 5.3B). The cst20∆/∆ mutant, the first in 
the MAPK cascade, was the most sensitive to rapamycin in YPD of all the mutants in the MAPK 
pathway (Figure 5.1 and 5.3B). Again, contrary to the phenotype of the upstream MAPK mutants, 
the cph1∆/∆ mutant showed a weak resistance to rapamycin compared to the wild-type strain in 
both YPD and Spider media (Figure 5.3B). Finally, the sch9-/- mutant was highly sensitive to 
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rapamycin in both YPD and Spider media (Figure 5.3B). Thus, all the mutants in the different 
signal transduction cascades showed a growth defect in the presence of rapamycin, although 
disparate responses to rapamycin were observed in mutants belonging to the same pathway or that 
share the same downstream effectors. None of the mutants screened were resistant to rapamycin 
only in Spider medium, the phenotype of the mds3Δ/Δ mutant.  
 
 
Figure 5.3B: Looking for MDS3-dependent phenotypes in mutants in the MAPK, PKA 
and TOR pathways. Overnights of the different strains (Table 1) were diluted in PBS and 
spotted on YPD and Spider media supplemented with solvent or rapamycin. Plates were 
incubated at 30°C and photographed after 48 or 72 hrs. 
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MDS3 is required for filamentation in M199 medium buffered at pH 8 (Davis et al., 
2002). Thus, I tested the ability of the Ras/cAMP, PKA, MAPK, and TOR mutants to filament in 
M199 pH 8 (Figure 5.3C). The sit4∆/∆ mutant did not filament on M199 pH 8 media, as 
previously observed (Figure 5.3C; Zacchi et al., 2010a). Mutants in CDC25, RAS1, and CDC35 
also failed to filament, while mutants in GPA2 and CPH1 showed uneven filamentation around 
the perimeter of the colony. I noted that even though the mutant in SCH9 did not filament into the 
agar, it showed a wrinkly surface, indicative of filamentation within the colony (Figure 5.3C). 
Mutants in TPK1, TPK2, GPR1, HST7, and CEK1 filamented like the wild-type strain, while the 
mutant in CST20 showed a slightly enhanced filamentation compared to wild-type (Figure 5.3C). 
Thus, the Ras/cAMP pathway is clearly required for filamentation at alkaline pH, while the 
MAPKs, the Gpr1-Gpa2 circuit, and SCH9 have a more limited role, and the PKA subunits likely 
have redundant roles. 
 
Figure 5.3C: Looking for MDS3-dependent phenotypes in mutants in the MAPK, PKA 
and TOR pathways. Overnights of the different strains (Table 1) were spotted on M199 
pH 8 and incubated at 37°C for 6 days. 
 
In sum, these results indicate that the upstream members of the Ras/cAMP pathway have 
a similar function as Mds3. It is difficult to assess the role of adenylate cyclase and PKA on 
MDS3-dependent phenotypes due to the severe growth defect of the cdc35∆/∆ mutant and the 
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putative redundant function of the Tpk1/2 catalytic subunits. However, the MAPK pathway, 
which also functions downstream of Ras1 in C. albicans, did not show similar phenotypes as 
Mds3, suggesting that Mds3 does not function through the MAPK pathway. I noted that the 
MAPK effector Cph1 generally showed a different phenotype than the upstream MAPK 
members, indicating that the MAPK pathway is signaling through different effectors for the 
phenotypes tested, and that Cph1 is likely responding to other signaling pathways as well (Huang 
et al., 2008). Collectively, these results support the idea that, besides the TOR pathway, Mds3 
also functions through the Ras pathway. 
 
Genetic interaction between MDS3, SIT4, and RAS1 
My results suggested that Mds3 also functions in the Ras pathway in C. albicans. One 
way to test this idea is to determine the genetic interaction among MDS3, SIT4 and RAS1. To do 
this, I generated mds3Δ/Δ sit4Δ/Δ and ras1Δ/Δ sit4Δ/Δ double mutants, and tested them in the 
same growth assays described above. I was unable to construct an mds3Δ/Δ ras1Δ/Δ mutant, 
potentially because the double mutant has a severe growth defect (see Materials and Methods). 
As described previously, the mds3∆/∆ sit4∆/∆ double mutant showed an additive growth defect 
on rich medium and alkaline pH (reduced colony size), but not on LiCl as expected since only the 
mds3∆/∆ mutant has a phenotype in this medium (Figure 5.4A; Zacchi et al., 2010a). The 
ras1∆/∆ sit4∆/∆ double mutant showed a more severe growth defect than the mds3∆/∆ sit4∆/∆ 
double mutant on rich medium, and an additive growth defect at alkaline pH, but not on LiCl, as 
expected since only the ras1∆/∆ mutant has a phenotype in this medium (Figure 5.4A). Thus, 
both double mutants show additive growth defects in YPD and alkaline pH, but not on LiCl. 
These qualitative results suggest that Ras1 and Mds3 function in parallel pathways to Sit4 for 
growth on rich medium and at alkaline pH. 
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Figure 5.4A: Genetic interaction between MDS3, SIT4, and RAS1. Overnights of the 
wild-type (DAY185), mds3Δ/Δ (DAY1118), sit4Δ/Δ (DAY972), mds3Δ/Δ sit4Δ/Δ 
(DAY1233), mds3Δ/Δ+MDS3 sit4Δ/Δ (LUZ622), ras1Δ/Δ (DAY1109), ras1Δ/Δ+RAS1 
(DAY1228) and ras1Δ/Δ sit4Δ/Δ (LUZ613) strains were diluted in PBS and plated on 
YPD, YPD+150mM LiCl, YPD pH 9. Plates were incubated at 30°C for 48-72 hrs.  
 
Another phenotype of interest is rapamycin resistance. Both the sit4Δ/Δ and ras1Δ/Δ 
mutants are more resistant to rapamycin in YPD and Spider media, while the mds3Δ/Δ mutant is 
only more resistant to rapamycin on Spider medium (Figure 5.3B, and Zacchi et al., 2010a). As 
previously shown, in YPD medium supplemented with rapamycin, the mds3∆/∆ sit4∆/∆ double 
mutant behaved similar to the sit4∆/∆ mutant, as expected since only the sit4∆/∆ mutant has a 
phenotype in this medium (Figure 5.4B; Zacchi et al., 2010a). In Spider medium supplemented 
with rapamycin, the mds3∆/∆ sit4∆/∆ double mutant grew similar to the sit4∆/∆ mutant, and did 
not show an additive effect of both mutations (Figure 5.4B; Zacchi et al., 2010a). In YPD 
medium supplemented with rapamycin, the ras1∆/∆ sit4∆/∆ double mutant grew better than the 
ras1∆/∆ single mutant but worse than the sit4∆/∆ single mutant (Figure 5.4B). In Spider medium 
supplemented with rapamycin, the ras1∆/∆ sit4∆/∆ double mutant grew similar to the ras1∆/∆ 
single mutant (Figure 5.4B). I must note that it is difficult to separate the growth defect of the 
ras1Δ/Δ sit4Δ/Δ mutant from the effect of rapamycin and through this methodology I cannot 
distinguish conclusively if both genes are contributing to rapamycin resistance completely 
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independently or through a shared pathway. However, it appears that Sit4 and Ras1 may be 
contributing to rapamycin sensitivity through dependent and independent pathways. 
 
Figure 5.4B: Genetic interaction between MDS3, SIT4, and RAS1. Overnights of the 
wild-type (DAY185), mds3Δ/Δ (DAY1118), sit4Δ/Δ (DAY972), mds3Δ/Δ sit4Δ/Δ 
(DAY1233), mds3Δ/Δ+MDS3 sit4Δ/Δ (LUZ622), ras1Δ/Δ (DAY1109), ras1Δ/Δ+RAS1 
(DAY1228) and ras1Δ/Δ sit4Δ/Δ (LUZ613) strains were diluted in PBS and plated on 
YPD and Spider media supplemented with solvent or rapamycin. Plates were incubated at 
30°C for 48-72 hrs.  
 
The mds3Δ/Δ and sit4Δ/Δ mutants do not filament on solid M199 pH 8 medium, and have 
a defect in liquid M199 pH 8 medium that is partially rescued by rapamycin. However, Sit4 and 
Mds3 contribute independently to the filamentation response to rapamycin because the mds3Δ/Δ 
sit4Δ/Δ mutant does not filament with or without rapamycin in this medium (Figures 5.3C, 5.4C; 
Zacchi et al., 2010a). Thus, I wanted to test the effect of rapamycin on the ras1Δ/Δ mutant 
filamentation defect, and the effect of RAS1 deletion on the response of the sit4Δ/Δ mutant. To do 
this, I assessed the ability of the double mutants to filament on M199 pH 8 medium in the 
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presence or absence of rapamycin. In M199 pH 8 solid and liquid media with solvent neither the 
mds3∆/∆ sit4∆/∆ or ras1∆/∆ sit4∆/∆ double mutants filamented, as expected since the single 
mutants do not filament in this media either (except for the sit4∆/∆ mutant which shows a 
reduced filamentation in liquid M199 pH 8) (Figure 5.4C; Zacchi et al., 2010a). Addition of 
rapamycin to liquid M199 pH 8 partially rescued the filamentation defect of the mds3∆/∆ and 
sit4∆/∆ mutants, as previously observed, but did not rescue the ras1∆/∆ or the mds3∆/∆ sit4∆/∆ 
and ras1∆/∆ sit4∆/∆ mutants filamentation defect (Figure 5.4C; Zacchi et al., 2010a). These 
results indicate that the ability of the sit4Δ/Δ mutant to filament in response to rapamycin requires 
RAS1 and MDS3, and suggest that for this phenotype, SIT4 functions in parallel to MDS3. No 
strong conclusion can be drawn about the relationship between RAS1 and SIT4 from this assay. 
 
Figure 5.4C: Genetic interaction between MDS3, SIT4, and RAS1. Overnights of the 
wild-type (DAY185), mds3Δ/Δ (DAY1118), sit4Δ/Δ (DAY972), mds3Δ/Δ sit4Δ/Δ 
(DAY1233), mds3Δ/Δ+MDS3 sit4Δ/Δ (LUZ622), ras1Δ/Δ (DAY1109), ras1Δ/Δ+RAS1 
(DAY1228) and ras1Δ/Δ sit4Δ/Δ (LUZ613) strains were spotted on M199 pH 8 solid 
medium and plates were incubated at 37°C for 5-6 days; or were diluted 1:100 in M199 
pH 8 supplemented with solvent or 5nM rapamycin and incubated 6 hrs at 37°C. 
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Although these epistasis analyses should be performed quantitatively, overall these 
results indicate that MDS3 and SIT4 share common functions regarding growth in the presence of 
rapamycin, while they also contribute independently to growth on rich medium and alkaline pH, 
and to filamentation. Further, these results suggest that RAS1 and SIT4 have independent 
contributions to most phenotypes tested, including growth in rich medium, alkaline pH, and 
rapamycin, and that the rapamycin induced filamentation in the sit4Δ/Δ mutant is RAS1 
dependent. Collectively, these results suggest that while Sit4 functions with Mds3 in the same 
pathway for certain phenotypes, Sit4 and Ras1 function in different pathways.  
 To continue to dissect the genetic interaction between MDS3, SIT4, and RAS1, I 
determined the expression of TOR-dependent genes in the single and double mutants grown in 
YPD medium supplemented with solvent or 20nM rapamycin (Zacchi et al., 2010a). The TOR 
pathway positively regulates the expression of genes involved in glycolysis, transcription, and 
translation such as CDC19, RPS26A, and TEF1 (Bastidas et al., 2009; Cardenas et al., 1999). In 
YPD with solvent alone, the mds3∆/∆, ras1∆/∆, and sit4∆/∆ ras1∆/∆ mutants showed increased 
expression of the glycolytic enzyme CDC19 compared to the wild-type strain, while the sit4∆/∆ 
and mds3∆/∆ sit4∆/∆ mutants expressed CDC19 at similar levels than wild-type (Figure 5.5). 
Results for RPS26A were not as clear, although in the presence of solvent alone there appeared to 
be a reduction in RPS26A expression compared to wild-type in all single and double mutants that 
had a SIT4 deletion (Figure 5.5). TEF1 expression in solvent alone remained unchanged in all 
strains except in the sit4Δ/Δ mutant in which TEF1 expression is slightly lower than the rest of 
the strains (Figure 5.5). Addition of rapamycin to the medium reduced expression of CDC19, 
RPS26A, and TEF1 in all strains compared to solvent alone (Figure 5.5). However, the expression 
of CDC19 and TEF1 in the sit4∆/∆ ras1∆/∆ mutant remained above the level of all other strains. 
Thus, while I did not observe major transcriptional differences in the expression of TEF1 and 
RPS26A among the strains, these results suggest that Mds3, Sit4, and Ras1 regulate the 
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expression of glycolytic enzymes in YPD. In rich medium, Mds3 and Ras1 appear to function as 
negative regulators of CDC19 expression, and Mds3 negative regulation of CDC19 requires Sit4.  
   
Figure 5.5: The mds3Δ/Δ and ras1Δ/Δ mutant have a similar gene expression profile, and 
sit4Δ/Δ mutation is dominant to both mds3Δ/Δ and ras1Δ/Δ mutations. Overnights of the 
wild-type (DAY185), mds3Δ/Δ (DAY1118), sit4Δ/Δ (DAY972), mds3Δ/Δ sit4Δ/Δ 
(DAY1233), ras1Δ/Δ (DAY1109), and ras1Δ/Δ sit4Δ/Δ (LUZ613) strains were diluted 
0.125:40 in YPD medium and incubated at 30°C for 4 hrs, followed by 1 hr after addition 
of solvent or 20nM rapamycin. 
 
The TOR pathway negatively regulates the expression of genes involved in the uptake 
and metabolism of alternative nitrogen sources (Bastidas et al., 2009; Cardenas et al., 1999). One 
gene whose regulation is TOR dependent and that is commonly used to determine TOR pathway 
function is GAP2, which encodes an amino acid permease. In the presence of solvent alone, 
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GAP2 was not expressed in any strain. Addition of rapamycin induced GAP2 expression in all 
strains (Figure 5.5). The mds3∆/∆ and ras1∆/∆ strains showed a higher expression of GAP2 
compared to the wild-type strain and the sit4∆/∆ mutant, but the mds3Δ/Δ sit4Δ/Δ and ras1Δ/Δ 
sit4Δ/Δ mutants expressed GAP2 similar to the sit4Δ/Δ mutant. This indicates that GAP2 
overexpression in the mds3Δ/Δ and ras1Δ/Δ mutants in the presence of rapamycin is SIT4-
dependent (Figure 5.5; Zacchi et al., 2010a). GDH1 encodes a glutamate dehydrogenase and its 
expression is also regulated by the TOR pathway (Bastidas et al., 2009). In the presence of 
solvent alone, the wild-type, mds3∆/∆, and ras1∆/∆ strains expressed GDH1 at similar levels. 
This expression was SIT4-dependent, because all the strains with a sit4Δ/Δ mutation showed 
reduced expression of GDH1 compared to the wild-type (Figure 5.5). Addition of rapamycin did 
not affect GDH1 expression in the wild-type, mds3Δ/Δ, and ras1Δ/Δ strains, but it markedly 
increased GDH1 expression in all strains carrying a SIT4 deletion (Figure 5.5). These results 
suggest that for genes involved in nitrogen metabolism, MDS3 and RAS1 have a similar function, 
and the sit4∆/∆ mutation has a dominant effect (Figure 5.5). Further, these results support a 
model in which SIT4 functions downstream MDS3 and RAS1 for the regulation of genes involved 
in nitrogen metabolism. 
The TOR pathway also negatively regulates the expression of genes involved in protein 
degradation, such as LAP3 and PRC2 (Bastidas et al., 2009; Cardenas et al., 1999). In the 
presence of solvent alone the aminopeptidase LAP3 was not expressed in any strain (Figure 5.5). 
Addition of rapamycin induced expression of LAP3 in the wild-type, mds3Δ/Δ, and ras1Δ/Δ 
strains, but not in any strain with a SIT4 deletion. The expression of LAP3 was markedly higher 
in the mds3Δ/Δ and ras1Δ/Δ strains compared to the wild-type strain. Similar results were 
observed for CPY1, another vacuolar carboxypeptidase (data not shown). In the presence of 
solvent alone, the vacuolar carboxypeptidase PRC2 was expressed more in the mds3∆/∆, 
ras1∆/∆, and ras1Δ/Δ sit4Δ/Δ mutants compared to the wild-type, sit4Δ/Δ, and mds3Δ/Δ sit4Δ/Δ 
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strains (Figure 5.5). Addition of rapamycin induced expression of PRC2 in the wild-type, 
mds3Δ/Δ, and ras1Δ/Δ strains, but not in the sit4Δ/Δ mutant (Figure 5.5). The expression of PRC2 
was again markedly higher in the mds3Δ/Δ and ras1Δ/Δ strains compared to the wild-type strain. 
Again, PRC2 overexpression in the mds3Δ/Δ mutant was SIT4-dependent, as evidenced by the 
similar low levels of PRC2 expression in the sit4Δ/Δ and mds3Δ/Δ sit4Δ/Δ mutants. PRC2 
overexpression in the ras1Δ/Δ mutant was partially SIT4-dependent, since the ras1Δ/Δ sit4Δ/Δ 
strain showed lower PRC2 expression than the ras1Δ/Δ single mutant but higher expression than 
the sit4Δ/Δ alone (Figure 5.5). These results support a model in which SIT4 functions downstream 
MDS3 and RAS1 for the regulation of genes involved in protein degradation. 
Overall, the results show that besides contributing to the regulation of glycolytic 
enzymes, both Mds3 and Ras1 also contribute to the regulation of genes involved in nitrogen 
metabolism and protein degradation, which are TOR regulated processes (Figure 5.5; Zacchi et 
al., 2010a). Further, the function of Mds3 and Ras1 on gene expression is opposite to the function 
of Sit4 (Figure 5.5.). The physical interaction between Mds3 and Sit4, the genetic and physical 
evidence that Mds3 functions upstream of Ras1, and the fact that sit4Δ deletion is dominant to 
mds3Δ deletion and semi-dominant to ras1Δ deletion in the presence or absence of rapamycin 
support a model in which Mds3 acts as a positive regulator of Ras1 and as a negative regulator of 
Sit4 (through Ras1 dependent and independent mechanisms) (Figure 5.3-5; Zacchi et al.,2010a; 
Krogan et al., 2006; Tonikian et al., 2009; Gavin et al., 2006; Collins et al., 2007; Benni and 
Neigeborn, 1997; McDonald et al., 2009). In other words, these results support a model in which 
the TOR pathway member Sit4 functions downstream of the Mds3-Ras1 signal transduction 
pathway. 
It is critical to include in this analysis the mds3Δ/Δ ras1Δ/Δ double mutant. Since I was 
unable to construct this mutant through the regular knock-out strategy, alternative strategies to 
determine whether these two genes are synthetic lethal should be pursued. These include the use 
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of conditional knock-outs, the insertion of a third RAS1 copy elsewhere in the genome and 
deletion of the second RAS1 allele in locus, and the elimination of the last RAS1 copy by 
introducing Cre/loxP sites surrounding RAS1. If viable, the ras1Δ/Δ mds3Δ/Δ double mutant will 
likely have a significant growth defect, which makes the process of finding this mutant more 
difficult.  
 The mds3Δ/Δ mutant has a different transcriptional phenotype on rich vs. poor nutrient 
media (Zacchi et al., 2010a). Thus, I wanted to test if the ras1Δ/Δ mutant also shared the mds3Δ/Δ 
transcriptional defects in M199 pH 8 medium. After 4 hrs of incubation in M199 pH 8 with 
solvent alone the wild-type strain expressed GAP2, while the mds3Δ/Δ or ras1Δ/Δ strains did not 
(Figure 5.6A). Addition of rapamycin rescued GAP2 expression in both mutants to similar levels, 
indicating that the ras1Δ/Δ and mds3Δ/Δ mutants share similar phenotypes in poor nutrient 
medium as well (Figure 5.6A). Interestingly, I noted that in the mds3Δ/Δ mutant GAP2 was 
overexpressed compared to the wild-type strain after an overnight incubation in YPD medium 
(Figure 5.6A, time 0 hr). The ras1Δ/Δ mutant also expressed more GAP2 than the wild-type 
strain, but less than the mds3Δ/Δ mutant. These results suggest that absence of MDS3, and of 
RAS1 to a lesser extent, lead to an earlier activation of starvation responses compared to the wild-
type strain. Accordingly, I observed that the mds3Δ/Δ mutant accumulated more glycogen than 
the wild-type or mds3Δ/Δ+MDS3 complemented strains (Figure 5.6B). Therefore, Mds3 and 
Ras1 also share functions in nutrient poor medium. Importantly, these results support a previously 
formulated idea that in rich medium MDS3 is required to prevent the precocious induction of 
starvation responses (Benni and Neigeborn, 1997).  
 186 
       
Figure 5.6: In the absence of MDS3, starvation responses are upregulated. (A) YPD 
overnights from the wild-type (DAY185), mds3Δ/Δ (DAY1118), and ras1Δ/Δ 
(DAY1109) were washed in PBS, diluted in pre-warmed M199 pH 8, and incubated at 
37°C with or without 5nM Rapamycin. Samples for Northern Blot analysis were taken at 
time 0 and 4 hrs. (Similar results were observed for sit4Δ/Δ (DAY972)) B) Glycogen 
storage, the wild-type (+/+) (DAY185), mds3Δ/Δ (Δ/Δ) (DAY1118), and 
mds3Δ/Δ+MDS3 (p) (DAY1119) were grown overnight in YPD, spotted on YPD and 
exposed to iodine vapors after 48 hrs of incubation at 30°C. Pictures show iodine-stained 
colonies. 
 
An overactive RAS1 allele rescues the mds3Δ/Δ mutant, but not the sit4Δ/Δ mutant 
Studies in S. cerevisiae suggest that Ras1 functions downstream or in parallel to MDS3 
and TOR1 (Benni and Neigeborn, 1997; McDonald et al., 2009; Schmelze et al., 2004; Zurita-
Martinez et al., 2004; Krogan et al., 2006; Tonikian et al., 2009; Gavin et al., 2006; Collins et al., 
2007). My results suggest that Ras1 functions downstream of Mds3, but upstream or in parallel to 
the TOR effector Sit4 (Figures 5.3, 5.4, and 5.5). If indeed RAS1 is downstream of MDS3 in C. 
albicans, then expression of an overactive RAS1 allele should rescue mds3Δ/Δ phenotypes; if 
RAS1 functions upstream or in parallel to MDS3 and SIT4 , then the overactive allele will fail to 
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rescue some or all mds3Δ and sit4Δ mutants defects. In order to test these ideas I constructed a 
vector carrying an overactive RAS1
G13V
 allele under the control of its own promoter, and 
integrated this plasmid into the RAS1 locus of the wild-type, mds3∆/∆ and sit4∆/∆ mutants. 
Introduction of an overactive RAS1
G13V
 allele into the wild-type strain did not affect 
growth on rich medium, LiCl or pH 9, but enhanced filamentation on M199 pH 8 (Figure 5.7A 
and C). Since the ras1Δ/Δ mutant is resistant to rapamycin in YPD and Spider media (Figure 
5.4B), I predicted that the overactive allele would cause an enhanced sensitivity to the drug in the 
wild-type strain. However, introduction of the overactive RAS1
G13V
 allele (or of a third copy of 
RAS1) into wild-type cells had no effect on growth on YPD or Spider media supplemented with 
rapamycin (Figure 5.7B).  
Introduction of an overactive RAS1
G13V
 allele into the mds3Δ/Δ mutant rescued the growth 
phenotypes on rich medium, LiCl and pH 9, and induced filamentation on M199 pH 8 medium to 
the same extent as the wild-type strain with the RAS1
G13V
 allele (Figure 5.7A and C). The 
RAS1
G13V
 allele enhanced mds3Δ/Δ growth on YPD medium in the presence of rapamycin, similar 
to the wild-type strain (Figure 5.7B). The RAS1
G13V
 allele also abolished the rapamycin resistance 
of the mds3Δ/Δ strain on Spider medium (Figure 5.7B). Introduction of a third wild-type copy of 
RAS1 in the mds3Δ/Δ mutant did not have any phenotypic effect, indicating that the phenotypic 
rescue is a property of the RAS1
G13V 
mutation (Figure 5.7B). Therefore, the overactive RAS1
G13V
 
allele rescued all phenotypes of the mds3Δ/Δ mutant. 
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Figure 5.7A: An overactive RAS1
G13V
 allele rescues mds3Δ/Δ defects, but not sit4Δ/Δ 
defects. Overnights of the wild-type (DAY286), wild-type + RAS1 (LUZ756), wild-type 
+ RAS1
G13V
 (LUZ755), mds3Δ/Δ (DAY938), mds3Δ/Δ + RAS1 (LUZ684), mds3Δ/Δ + 
RAS1
G13V
 (LUZ686), sit4Δ/Δ (DAY972), sit4Δ/Δ + RAS1 (LUZ688), and sit4Δ/Δ + 
RAS1
G13V
  (LUZ690) strains were diluted in PBS and plated on (A) YPD, YPD+150mM 
LiCl, YPD pH 9. Plates were incubated at 30°C for 48-72 hrs. 
 
Introduction of an overactive RAS1
G13V
 allele into the sit4Δ/Δ mutant did not restore 
growth on rich medium or alkaline pH (Figure 5.7C). Further, the RAS1
G13V
 allele did not induce 
peripheral filamentation into the agar in the M199 pH 8 in the sit4Δ/Δ mutant, although it caused 
the colony to become wrinkly on the surface (Figure 5.7B and C). However, the RAS1
G13V
 allele 
did enhance the sit4Δ/Δ rapamycin resistance in both YPD and Spider media. A similar effect was 
also observed in S. cerevisiae (Figure 5.7C; Schmelzle et al., 2004). Therefore, an overactive 
RAS1
G13V
 allele not only did not rescue sit4Δ/Δ defects, but actually enhanced the rapamycin 
resistance of this mutant independently of the nutrients in the media. Overall, these data support a 
model in which Mds3 functions upstream of Ras1, and Ras1 functions upstream of Sit4. 
Alternatively, Sit4 and Ras1 may function in parallel pathways, as shown in S. cerevisiae 
(Schmelze et al., 2004), but they may govern a common set of downstream effectors.  
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Figure 5.7B, C: An overactive RAS1
G13V
 allele rescues mds3Δ/Δ defects, but not sit4Δ/Δ 
defects. Overnights of the wild-type (DAY286), wild-type + RAS1 (LUZ756), wild-type 
+ RAS1
G13V
 (LUZ755), mds3Δ/Δ (DAY938), mds3Δ/Δ + RAS1 (LUZ684), mds3Δ/Δ + 
RAS1
G13V
 (LUZ686), sit4Δ/Δ (DAY972), sit4Δ/Δ + RAS1 (LUZ688), and sit4Δ/Δ + 
RAS1
G13V
  (LUZ690) strains were diluted in PBS and plated on (B) YPD and Spider 
media supplemented with solvent or rapamycin. Plates were incubated at 30°C for 48-72 
hrs. (C) Overnights were spotted on M199 pH 8 solid medium and plates were incubated 
at 37°C for 5-6 days. 
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Discovering new regulators of CMPS 
 Given the similarities observed between the phenotypes of the mds3Δ/Δ, cdc25-/-, and 
ras1Δ/Δ mutants (Figures 5.3-6), and the fact that Mds3 is predicted to interact with Cdc25, the 
upstream positive regulator of Ras1, I hypothesized that the Ras/cAMP pathway would be 
involved in the regulation of CMPS in C. albicans (Krogan et al., 2006; Tonikian et al., 2009; 
Gavin et al., 2006; Collins et al., 2007). Similarly, since Sit4 is a critical member of the TOR 
pathway, and since the mds3Δ/Δ and sit4Δ/Δ mutants share many phenotypes and interact 
physically, I hypothesized that the sit4Δ/Δ mutant would also form papilli (Figures 5.3 and 4; 
Zacchi et al. 2010a). Finally, since the sch9-/- mutant shares several phenotypes with the 
mds3Δ/Δ mutant (Figures 5.3), SCH9 is a member of the TOR pathway, and is also a regulator of 
chlamydospore formation [an MDS3-dependent morphogenetic process in C. albicans], I 
hypothesized that SCH9 is also involved in CMPS regulation (Urban et al., 2007; Nobile et al., 
2003). Thus, I tested mutants involved in the Ras pathway (including the mutants in MAPK and 
PKA pathways), the Gpr1-Gpa2 parallel circuit, and the TOR pathway mutants in SIT4 and SCH9 
for papilli formation (Figure 5.8A).  
 Overnights of all the strains were diluted in PBS, plated on YPD, and incubated 48 hrs at 
30°C followed by room temperature incubation. The percentage of mds3Δ/Δ colonies showing 
papilli on the surface increased with time, while the wild-type strain did not produce any papilli 
after 18 days of incubation (Figure 5.8A, B). Indeed, the cdc25-/- and ras1Δ/Δ mutants showed 
progressive papilli formation, reaching a similar percentage of colonies with papilli as the 
mds3Δ/Δ mutant (Figure 5.8A, B). Interestingly, the cdc35Δ/Δ mutant also showed some papilli 
production, albeit at lower levels than the mutants in upstream Ras/cAMP pathway members 
Cdc25 and Ras1. This suggests that although papilli formation is influenced by low cAMP levels 
in the cell, this is not the main trigger of papilli formation in the mds3Δ/Δ, cdc25-/- and ras1Δ/Δ 
cells. One way to test if cAMP prevents papilli formation in the mds3Δ/Δ, ras1Δ/Δ, and cdc35Δ/Δ 
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mutant would be by supplementing the medium with dibutyril-cAMP (a non metabolizable form 
of cAMP) and measuring papilli formation during time. Overall, these results confirm the 
hypothesis that the Ras/cAMP pathway contributes to the negative regulation of papilli formation 
in C. albicans. cAMP levels are positive regulators of PKA suggesting that the negative 
regulatory signal on CMPS is partially exerted by PKA (Figure 5.1). However, no papilli 
formation was observed in either of the single tpkΔ/Δ mutants, indicating that either the Tpk1/2 
catalytic subunits share a redundant function in CMPS or that the signal is channeled through a 
different downstream effector of Ras1.  
 
Figure 5.8A: CDC25, RAS1, and SCH9 are also negative regulators of CMPS. YPD 
overnights from the different strains (Table 1) were diluted in PBS and plated in YPD 
with 2% or 0.2% glucose, or YPD buffered at pH 6 or pH 8. Plates were incubated 48 hrs 
at 30°C and then at room temperature for over two weeks. Papilli formation was scored 
in YPD plates every two days beginning at day 6.  
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None of the MAPK mutants, gpr1Δ/Δ or gpa2Δ/Δ mutants showed papilli formation, as 
expected since these mutants did not share mds3Δ/Δ phenotypes (Figures 5.3, 5.4, 5.8A). 
Unexpectedly, the sit4Δ/Δ mutant did not form papilli (Figure 5.8A, B). However, the sch9-/- 
mutant formed a significantly higher % of papilli compared to the mds3Δ/Δ, cdc25-/-, or ras1Δ/Δ 
mutants (Figure 5.8). Given that low glucose enhances papilli formation (Chapter 4), this assay 
was repeated in glucose starvation conditions. In YP + 0.2% glucose I observed an increase in 
papilli formation in the mds3Δ/Δ, cdc25-/-, ras1Δ/Δ, and sch9-/- strains, but glucose starvation did 
not induce papilli formation in the other mutants (Figure 5.8B and data not shown). Thus, I have 
identified several regulators of papilli formation in C. albicans: the Ras/cAMP pathway members 
Cdc25, Ras1, and Cdc35, and the TOR pathway member Sch9.  
       
Figure 5.8B: CDC25, RAS1, and SCH9 are also negative regulators of CMPS. Examples 
of papilli formation in the wild-type (DAY185), mds3Δ/Δ (DAY1118), cdc25-/- 
(DAY1326), ras1Δ/Δ (DAY1109), cdc35Δ/Δ (DAY1319), sch9-/- (DAY1226), and 
sit4Δ/Δ (DAY972) strains in YP with 2% or 0.2% glucose.  
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A critical requirement of CMPS is heritability of the morphological switch. Thus I 
verified that the papilli from the cdc25-/-, ras1Δ/Δ, cdc35Δ/Δ, and sch9-/- mutants indeed 
contained colonies with a heritable morphological alteration (data not shown). Further, I observed 
that cells from many of the switched isolates also had marked cellular morphological alterations, 
which included enlarged, elongated, and vacuolized cells (Figure 5.8C). The changes in cellular 
morphology of the switched strains are not surprising, they had been previously observed in 
mds3Δ/Δ switched cells (data not shown), and they contribute to explain the changes in colony 
morphology (Dutton and Penn, 1989). Therefore CDC25, RAS1, CDC35, and SCH9 constitute 
new CMPS regulators in C. albicans. 
 
Figure 5.8C,D: CDC25, RAS1, and SCH9 are also negative regulators of CMPS. (C) 
Examples of cellular morphology from papilli from cdc25-/- (DAY1326), ras1Δ/Δ 
(DAY1109), cdc35Δ/Δ (DAY1319), and sch9-/- (DAY1226) strains. (D) Papilli 
formation scored in YP with 2% or 0.2% glucose, or YPD buffered at pH 6 or pH 8 in the 
wild-type (DAY185), mds3Δ/Δ (DAY1118), sit4Δ/Δ (DAY972), ras1Δ/Δ (DAY1109), 
sch9-/- (DAY1226), mds3Δ/Δ sit4Δ/Δ (DAY1233), and ras1Δ/Δ sit4Δ/Δ (LUZ613) 
strains. The graph represents the mean +/- standard deviation of three independent 
overnights/strain. 
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The unexpected result that SIT4 does not inhibit papilli formation in C. albicans and the 
fact that SIT4 appears to function downstream MDS3 and RAS1 prompted me to determine 
whether SIT4 would be required for CMPS formation in the mds3Δ/Δ and ras1Δ/Δ mutants 
(Figures 5.5, 5.7 and 5.8). The mds3Δ/Δ sit4Δ/Δ and ras1Δ/Δ sit4Δ/Δ mutants formed papilli at the 
same rate as the single mutants in regular YPD medium. However, during glucose starvation, a 
condition that enhances papilli formation in the single mds3Δ/Δ and ras1Δ/Δ mutants (Figure 
5.8B and D), the % of papilli formation of mds3Δ/Δ sit4Δ/Δ and ras1Δ/Δ sit4Δ/Δ double mutants 
was similar to the % of papilli formed by these mutants in regular YPD. This result indicates that 
absence of SIT4 abolishes the effect of glucose starvation on papilli formation (Figure 5.8D).  
Alkaline pH is an inhibitor of CMPS in the mds3Δ/Δ mutant (Chapter 4). Thus, I wished 
to determine if alkaline pH would inhibit CMPS in the ras1Δ/Δ and sch9-/- mutants (Figure 
5.8D). Indeed, alkaline pH also inhibits papilli formation in the ras1Δ/Δ and sch9-/- mutants, 
suggesting that these mutants are contributing to CMPS through a similar mechanism. Alkaline 
pH still inhibited papilli formation in the double mutants, indicating that Sit4 is not required to 
transmit the alkaline pH signal (Figure 5.8D). Therefore, the environmental signals that regulate 
CMPS in the mds3Δ/Δ mutant also regulate CMPS in the ras1Δ/Δ and sch9-/- mutant; and while 
SIT4 does not inhibit papilli formation in a wild-type background or in the presence of high levels 
of glucose, it appears to be required for the low glucose response observed in the mds3Δ/Δ and 
ras1Δ/Δ mutants. 
 
Similar to Mds3, Ras1 and Sch9 also contribute to MMS sensitivity 
 The mds3Δ/Δ mutant is more resistant to the DNA damage agent methyl 
methanesulfonate (MMS) than the wild-type strain. This feature of the mds3Δ/Δ mutant is 
relevant because defects in DNA damage response might lead to the phenotypic switch in the 
mds3Δ/Δ mutant (Chapter 4). Given the similar phenotypes on papilli formation of the ras1Δ/Δ 
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and sch9-/- mutants, I hypothesized that these mutants would also show enhanced MMS 
resistance. Thus, I grew the wild-type, mds3Δ/Δ, ras1Δ/Δ, ras1Δ/Δ+RAS1, and sch9-/- strains in 
the presence of MMS (Figure 5.9). I also tested a second DNA damaging agent, hydroxyurea 
(HU), which does not affect the growth of the mds3Δ/Δ mutant (Chapter 4). Indeed, the ras1Δ/Δ 
and sch9-/- mutants were also more resistant to MMS than the wild-type and ras1Δ/Δ+RAS1 
complemented strains, and there was no difference in growth in the presence of HU (Figure 5.9). 
These results support the idea that Mds3, Ras1, and Sch9 contribute to CMPS through similar 
mechanisms. 
 
Figure 5.9: Genetic interaction between MDS3, SIT4, and RAS1 in resistance to 
genotoxic stress. Overnights of the wild-type (DAY185), mds3Δ/Δ (DAY1118), sit4Δ/Δ 
(DAY972), mds3Δ/Δ sit4Δ/Δ (DAY1233), ras1Δ/Δ (DAY1109), ras1Δ/Δ+RAS1 
(DAY1228), ras1Δ/Δ sit4Δ/Δ (LUZ613), wild-type + RAS1 (LUZ756), wild-type + 
RAS1
G13V
 (LUZ755), mds3Δ/Δ (DAY956), mds3Δ/Δ + RAS1 (LUZ684), mds3Δ/Δ + 
RAS1
G13V
 (LUZ686), and sch9-/- (DAY1226) were diluted in PBS and plated on YPD 
medium supplemented with MMS and HU. Plates were incubated at 30°C for 48-72 hrs. 
 
SIT4 is required for enhanced papilli formation during glucose starvation (Figure 5.8D) 
and for the transcriptional response of the mds3Δ/Δ and ras1Δ/Δ mutants (Figure 5.5). Thus, I 
wanted to test if SIT4 was also required for MMS and HU resistance in the wild-type, mds3Δ/Δ, 
and ras1Δ/Δ strains. Since the sit4Δ/Δ mutant grew more slowly than the mds3Δ/Δ, ras1Δ/Δ, and 
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sch9-/- mutants it is difficult to determine if this mutant is more or less sensitive to MMS than the 
wild-type strain (Figure 5.9). Interestingly, the mds3Δ/Δ sit4Δ/Δ and ras1Δ/Δ sit4Δ/Δ mutants 
were hypersensitive to MMS, suggesting that Mds3, Ras1, and Sit4 contribute to MMS resistance 
through independent mechanisms (Figure 5.9). I did not observe a difference in HU sensitivity in 
the wild-type, mds3Δ/Δ, ras1Δ/Δ, and sch9-/- strains. However, the sit4Δ/Δ mutant was markedly 
resistant to HU compared to the wild-type, mds3Δ/Δ, and ras1Δ/Δ strains (Figure 5.9). The 
mds3Δ/Δ sit4Δ/Δ double mutant was as HU resistant as the sit4Δ/Δ mutant, however the ras1Δ/Δ 
sit4Δ/Δ was only slightly more resistant to HU than the ras1Δ/Δ strain (Figure 5.9). The negative 
synergism between the sit4Δ and ras1Δ mutations on HU resistance suggests that Ras1 is required 
for the enhanced HU resistance of the sit4Δ/Δ mutant (Figure 5.9). Therefore, Mds3, Ras1, and 
Sch9 sensitize cells to MMS, and deletion of SIT4 in an mds3Δ/Δ or ras1Δ/Δ background reduces 
the ability of these mutants to survive genotoxic stress.  
 Since the ras1Δ/Δ deletion affected growth in the presence of genotoxic agents and Mds3 
appears to function upstream Ras1 (Figure 5.3-5, 5.7, 5.9), I hypothesized that an overactive 
RAS1
G13V
 allele would rescue the mds3Δ/Δ mutant defects on MMS. Thus, I compared the growth 
on MMS of the wild-type and mds3Δ/Δ mutants containing an extra wild-type RAS1 copy or an 
overactive RAS1
G13V
 allele (Figure 5.9). While the RAS1
G13V
 allele did not alter MMS sensitivity 
in the wild-type strain, it restored MMS sensitivity in the mds3Δ/Δ mutant (Figure 5.9). I also 
tested the effect of the RAS1
G13V
 allele on HU resistance, and found that it had no effect on HU 
resistance in the wild-type or mds3Δ/Δ background (Figure 5.9). Addition of the extra RAS1 copy 
had no effect on MMS or HU resistance, indicating that the phenotypes observed are a property 
of the overactive RAS1
G13V
 allele. Thus, overactive RAS1
G13V
 can induce MMS sensitivity but not 
HU sensitivity, in the mds3Δ/Δ mutant.  
Taken together, the results presented here suggest that Mds3 also functions through the 
Ras/cAMP pathway in C. albicans. Mds3 and Ras1 share many similar functions, including LiCl, 
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alkaline pH, and rapamycin tolerance, MMS sensitivity, and the regulation of genes involved in 
the nitrogen catabolite response and protein degradation in a SIT4 dependent manner. 
Importantly, I found that Ras1 and the TOR pathway member Sch9 are also CMPS regulators, 
and that they appear to respond to the same CMPS environmental stimuli as Mds3. The TOR 
pathway effector Sit4, which appears to function downstream of Mds3 and Ras1, not only does 
not inhibit papilli formation but it actually appears to be required for papilli formation during 
glucose starvation in the absence of MDS3 or RAS1. These results indicate that there is a strong 
association between nutrient sensing through the TOR and Ras/cAMP pathways and CMPS 
during prolonged incubation and stationary phase. Given the extensive knowledge on Ras1 and 
Sch9 function compared to Mds3 function, associating CMPS with the Ras/cAMP and 
Sch9/Sit4/TOR pathways will significantly contribute to understanding the mechanism of the 
switch.  
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DISCUSSION 
 Colony morphology phenotypic switching (CMPS) in C. albicans is poorly understood. 
Only two regulators of CMPS have been described, Ssn6 and Mds3, and they appear to affect 
CMPS through different mechanisms (Chapter 4; Garcia-Sanchez et al., 2005). Here, I describe 
two additional CMPS regulators: Ras1 and Sch9, which are members of the cAMP/MAPK and 
TOR pathways, respectively. Further, I provide evidence that indicates that, besides regulating the 
TOR pathway, Mds3 is also an upstream member of the Ras/cAMP pathway in C. albicans. 
These results place Mds3 in a critical position to regulate two major signal transduction pathways 
that sense environmental nutrients in fungi and support a model in which CMPS arises due to 
defective starvation responses (Chapter 4). 
 
Regulation of CMPS occurs via two major signal transduction pathways  
 The first CMPS regulator identified in this work is Ras1. In S. cerevisiae, Mds3 is 
associated with the Ras pathway (Benni and Neigeborn, 1997; McDonald et al., 2008, Krogan et 
al., 2006; Tonikian et al., 2009; Gavin et al., 2006; Collins et al., 2007). Similarly, my data 
suggests that in C. albicans Mds3 also functions upstream of Ras1, probably as a positive 
regulator of Cdc25 (Figure 5.10). For example, mutants in MDS3 and RAS1 (and CDC25, for 
those phenotypes in which it was tested) shared most phenotypes, including sensitivity to LiCl 
and alkaline pH, filamentation defects, rapamycin and MMS resistance, and enhanced expression 
of genes involved in starvation responses in a SIT4-dependent manner (Figures 5.3-5.6). 
Importantly, similar to Mds3, Ras1 is also a negative regulator of CMPS (Figure 5.8). Colonies 
from the mds3Δ/Δ and ras1Δ/Δ mutants produced papilli during prolonged incubation, and this 
papilli formation was inhibited by alkaline pH and enhanced by glucose starvation in a SIT4-
dependent manner in both mutants (Figure 5.8, Chapter 4). Finally, a RAS1 overactive allele 
rescued all phenotypes of the mds3Δ/Δ mutant [it was not possible to test for rescue of papilli 
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formation because colonies with a RAS1 overactive allele became large and wrinkly making the 
papilli difficult to distinguish] (Figure 5.7, 5.9). Thus, CMPS is also regulated by the Ras 
pathway, and Mds3 is an upstream member of this pathway.  
 However, there were also phenotypic differences between the ras1Δ/Δ mutant and the 
mds3Δ/Δ mutant which suggests a complex interaction between these genes. First, the ras1Δ/Δ 
mutant was resistant to rapamycin in YPD, while the mds3Δ/Δ mutant was not; and while Mds3 
and Sit4 contributed to rapamycin resistance through the same pathway, Ras1 and Sit4 appeared 
to contribute to rapamycin resistance through dependent and independent pathways (Figures 5.3, 
5.4; Zacchi et al., 2010a). Second, the gene expression defects in the ras1Δ/Δ mutant were only 
partially SIT4-dependent (Figure 5.5). Finally, GAP2 expression after an overnight incubation 
was markedly higher in the mds3Δ/Δ mutant compared to levels of the ras1Δ/Δ mutant (Figure 
5.6). Therefore, while these data indicate that Mds3 and Ras1 function through the same pathway, 
Mds3 and Ras1 differ in their interactions with the TOR downstream effector Sit4. Importantly, 
an overactive Ras1 allele was unable to rescue sit4Δ/Δ defects, supporting a model in which Sit4 
functions downstream of Ras1 (Figure 5.7). Alternatively, Sit4 could function independently of 
Ras1. Testing the phenotypes of the mds3Δ/Δ ras1Δ/Δ double mutant is critical to more definitely 
establish the association between Mds3 and Ras1. Overall, the data presented here indicate that 
Ras1 is a negative regulator of CMPS in C. albicans, and suggest that Ras1 regulates CMPS 
through similar mechanisms as Mds3. 
 The second CMPS regulator identified is the Sch9 kinase. Sch9 is a downstream 
effector of the TOR pathway, and proposed to be the ortholog for the mammalian S6K1 kinase, 
which is involved in protein synthesis (Urban et al., 2007; Huber et al., 2009). In C. albicans 
Sch9 is required for proper yeast-hyphal and chlamydospore morphogenetic transitions, similar to 
Mds3 (Nobile et al., 2003; Liu et al, 2010; Davis et al., 2002). Importantly, the sch9-/- mutant 
makes papilli after prolonged incubation at a higher proportion than the mds3Δ/Δ mutant (Figure 
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5.8). Similar to the mds3Δ/Δ mutant, the sch9-/- papilli formation is inhibited by alkaline pH and 
exacerbated by glucose starvation (Figure 5.8). Interestingly, we had previously shown that the 
combination of the TOR1-1 allele with an mds3Δ mutation caused a marked increase in papilli 
formation (Chapter 4). The TOR1-1 mutation has been shown to affect the ability of the TOR 
kinase to phosphorylate and thus, regulate some of its downstream effectors, including S6K1 in 
mammals, the human ortholog of Sch9 (McMahon et al., 2002; Urban et al., 2007). Thus, it is 
possible that the enhanced papilli formation in the TOR1-1/Δ mds3Δ/Δ mutant is due to a defect in 
Sch9 function. It would be interesting to determine if there is an alteration in the phosphorylation 
pattern of Sch9 in the absence of MDS3 and if altering the TOR-dependent phosphorylation sites 
in Sch9 would rescue the mds3Δ/Δ mutant defects (Urban et al., 2007). Finally, similar to MDS3, 
SCH9 deletion confers MMS resistance (Figure 5.9). Overall, our data indicate that the 
downstream TOR pathway effector Sch9 is a negative regulator of CMPS in C. albicans, and 
suggest that Sch9 regulates CMPS through similar mechanisms as Mds3. However, there were 
several phenotypic differences between the mds3Δ/Δ and sch9-/- mutants, which include growth 
on LiCl and at pH 9, sensitivity to rapamycin, and filamentation on solid M199 pH 8 (Figure 5.3; 
Liu et al., 2010). Considering the current model of Mds3 and Sch9 function in the TOR pathway 
(Figure 5.10; Chapter 3, Figure 3.9; Chapter 1, Figure 1.3; Huber et al., 2009), these results 
suggest that Sch9 would only mediate some of Mds3’s TOR-dependent functions. 
 The results presented here suggest that Mds3 has a dual-function on the TOR pathway 
(Figure 5.10). During growth in nutrient- poor M199 pH 8 medium, Mds3 functions as a negative 
regulator of TOR (Zacchi et al., 2010a). However, in nutrient-rich medium like YPD, Mds3 
appeared to function as a positive regulator of TOR. For example, absence of MDS3 led to 
enhanced starvation responses, including increased expression of GAP2 and genes encoding 
protein degradation enzymes, and enhanced glycogen storage (Figures 5.5, 5.6). I noticed that the 
ras1Δ/Δ mutant did not induce GAP2 expression to the levels of the mds3Δ/Δ mutant during an 
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overnight incubation, suggesting that these responses in the mds3Δ/Δ mutant could only be 
partially mediated by a defective Ras pathway (Figure 5.6). By being able to alter its effects on 
the regulation of the TOR pathway in the presence of different environmental signals, Mds3 
would be contributing to fine-tune the activity of this major signal transduction pathway. 
 Taking all the data together, I propose the following model to explain CMPS regulation 
in C. albicans (Figure 5.10). CMPS is negatively regulated by the Ras/cAMP and TOR signal 
transduction pathways in response to environmental cues. Under conditions of nutrient depletion 
and in the absence of Mds3, Ras1, or Sch9, the Ras/cAMP and TOR pathways cannot transmit 
nutrient starvation signals efficiently, which leads to uncoordinated growth arrest, compromises 
entry into stationary phase, and induces replication stress. Replication stress is associated with 
increased DNA damage and genome instability (Weinberger et al., 2007; Burhans and 
Weinberger, 2007). Stress and DNA damage could accumulate during stationary phase and 
eventually trigger a suppressive response that induces unrestricted cellular growth and hence 
allows for papilli formation (Chapter 4). In support of this idea, the similar effect of MDS3, RAS1, 
and SCH9 deletion on resistance to the genotoxic agent MMS suggests that these mutants do not 
respond properly to DNA damage-induced growth arrest, and continue to replicate under 
suboptimal conditions. Thus, defective DNA damage responses and cell cycle checkpoints in 
these mutants are possible common mechanisms of CMPS (see Chapter 4, discussion). Ras and 
Sch9 are associated with DNA damage, genomic instability, and the generation of variability in 
yeast and mammals (Madia et al., 2009; Weinberger et al., 2007; Bitterman et al., 2003; Fabrizio 
et al., 2005), which supports a role for these proteins and their signaling cascades in phenotypic 
switching in C. albicans.  
 It would be interesting to deep-sequence several switched strains and their non-
switched counterparts, including not only the mds3Δ/Δ, ras1Δ/Δ, and sch9-/- mutants, but also 
environmental isolates. This would allow us to determine the following: 1) Which type/s of 
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genomic rearrangements happen in the switched strains?; 2)  is there an increased overall 
mutation rate associated with the switch?; and importantly: 3) are there any particular 
mutations/rearrangements/aneuploidies, LOHs, etc associated with the switch and/or that 
correlate with any particular phenotype? 
   
Figure 5.10: Model of Mds3, Ras1, and Sch9 regulation of CMPS in C. albicans. 
 
The connection between TOR and Ras 
 What is the relationship between the TOR and Ras pathways in C. albicans? Since the 
Ras/PKA pathway regulates similar downstream effectors as the TOR pathway, we would expect 
some level of redundancy in their function. In this scenario, mutants in the PKA pathway should 
show hypersensitivity to TOR inhibition by rapamycin. Indeed, the tpk2Δ/Δ mutant was more 
sensitive to rapamycin (Figure 5.3B). However, deletion of the upstream members of the PKA 
pathway, including CDC25, RAS1, and the GPR1/GPA2 circuit showed rapamycin resistance 
(Figure 5.3B). The increased rapamycin resistance in the cdc25Δ/Δ and ras1Δ/Δ mutants was not 
due to a defect in MAPK signaling, since all MAPKs showed enhanced sensitivity to rapamycin 
(Figure 5.3B). Therefore, rapamycin resistance appears to be a property of Cdc35, the adenylate 
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cyclase, which lies downstream of both Ras1 and Gpr1/Gpa2 (Maidan et al., 2005; Wilson et al., 
2010). Given the above result, it was no surprise that introduction of an overactive Ras1 allele 
induced rapamycin sensitivity in the mds3Δ/Δ mutant. However, this result is still 
counterintuitive: why would the overactivation of a pathway enhance dependence on a parallel 
pathway? One possibility is that the product of Cdc35 activity: cAMP acts on other signaling 
pathways independently of PKA, as it has been shown to occur in mammals (Busca et al., 2000; 
Cass et al., 1999; Tsygankova et al., 2000). In this model, tpk2Δ/Δ deletion might induce 
rapamycin sensitivity by increasing cAMP levels due to the relief of Tpk negative feedback on 
Cdc35 (Nikawa et al., 1987; Ma et al., 1999; Thevelein and De Winde, 1999). Alternatively, the 
difference between the Ras1 and PKA phenotypes might lie downstream of Ras1 but 
independently of cAMP and MAPK. For example, it is possible that Ras1 also regulates the 
function of the TOR pathway or of TOR downstream effectors, an idea supported by the results 
that suggest that Sit4 functions downstream of Ras1 (Figures 5.5, 5.7). Such a molecular 
arrangement is already established in mammalian organisms, in which Ras functions upstream of 
the TOR kinase (Wullschleger et al., 2006). Finally, there could be a regulatory feedback between 
the Ras and TOR pathways. Such an arrangement would ensure that both pathways act in concert 
to regulate growth and metabolism. Feedback regulatory mechanisms are common within the 
Ras/PKA and within the TOR pathways (Lempiainen et al., 2009, Thevelein and de Winde, 1999; 
Kockel et al., 2010). 
 
 The generation of phenotypic variability is critical for the perpetuation of any organism 
in its environment. The almost clonal reproductive style of C. albicans forces this organism to 
exploit alternative mechanisms to produce phenotypic variation in their populations. One such 
phenomenon is colony morphology phenotypic switching. Here, I show that CMPS is regulated 
by the Ras/cAMP and the TOR signal transduction pathways. I suggest that mutations in these 
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pathways cause uncoordinated growth arrest during stationary phase, leading to the accumulation 
of DNA damage and genomic instability. These processes eventually trigger the formation of 
variant strains that outgrow the colonies forming the papilli. The results shown here indicate that, 
similar to what is observed in mammals, flies, and S. cerevisiae, there is an intricate connection 
between signal transduction networks in C. albicans. It would be interesting to dissect the 
interaction between these signaling cascades in order to understand how C. albicans cells use 
these pathways to control several morphogenetic and virulence attributes in response to diverse 
environmental cues. 
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TABLES 
Table 5.1. C. albicans strains used in this study 
Strain Parent Genotype Reference 
DAY1 
(BPW17) 
SC5314 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG 
arg4::hisG/arg4::hisG 
Wilson et 
al., 1999 
DAY185 DAY286 ura3::λimm434/ura3::λimm434  pHIS1::his1::hisG/his1::hisG  
ARG4::URA3::arg4::hisG/arg4::hisG 
Davis et al., 
2000 
DAY415 BWP17 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::ARG4/MDS3 
Zacchi et 
al., 2010 
DAY938 BWP17 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3dpl200 
Zacchi et 
al., 2010a 
DAY956 BWP17 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::ARG4/mds3::dpl200 
Zacchi et 
al., 2010a 
DAY1118 DAY938 ura3::λimm434/ ura3::λimm434  HIS1::his1::hisG / his1::hisG  
arg4::hisG/ arg4::hisG  mds3::ARG4/mds3::URA3-dpl200 
Zacchi et 
al., 2010a 
DAY1119 DAY938 ura3::λimm434/ ura3::λimm434  HIS1::MDS3::his1::hisG/ his1::hisG  
arg4::hisG/ arg4::hisG  mds3::ARG4/mds3::URA3-dpl200 
Zacchi et 
al., 2010a 
DAY1109 
(CDH107) 
CAI4 ura3/ura3 ras1::hisG-URA3-hisG/ras1::hisG Leberer et 
al., 2001. 
DAY972 
(CM20) 
RM1000 ura3::λimm434/ ura3::λimm434  his1::hisG/ his1::hisG  
sit4::HIS1/sit4::dpl200 
Lee et al., 
2004. 
LUZ599 DAY972 ura3::λimm434/ ura3::λimm434  his1::hisG/ his1::hisG  
sit4::HIS1/sit4::dpl200  RAS1/ras1::ura3-dpl200 
This study 
LUZ602 LUZ599 ura3::λimm434/ ura3::λimm434  his1::hisG/ his1::hisG  
sit4::HIS1/sit4::dpl200  RAS1/ras1::dpl200 
This study 
LUZ613 LUZ602 ura3::λimm434/ ura3::λimm434  his1::hisG/ his1::hisG  
sit4::HIS1/sit4::dpl200  ras1::ura3-dpl200/ras1::dpl200 
This study 
LUZ616 DAY1233 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG 
sit4::HIS1/sit4::dpl200 mds3::dpl200/mds3::dpl200 
This study 
LUZ622 LUZ616 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG 
sit4::HIS1/sit4::dpl200 MDS3::URA3::mds3::dpl200/mds3::dpl200 
This study 
LUZ640 DAY415 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::ARG4/MDS3  RAS1/ras1::URA3-
dpl200 
This study 
LUZ651 LUZ640 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::ARG4/MDS3  RAS1/ras1::dpl200 
This study 
LUZ682 LUZ651 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::ARG4/mds3::URA3-dpl200  
RAS1/ras1::dpl200 
This study 
LUZ692 LUZ682 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::ARG4/mds3::dpl200  
RAS1/ras1::dpl200 
This study 
LUZ684 DAY956 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::ARG4/mds3::dpl200  
RAS1/RAS1::RAS1::URA3 
This study 
LUZ686 DAY956 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  mds3::ARG4/mds3::dpl200  
RAS1/RAS1::RAS1G13V::URA3 
This study 
LUZ688 DAY972 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG   
sit4::HIS1/sit4::dpl200  RAS1/RAS1::RAS1::URA3 
This study 
LUZ690 DAY972 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
sit4::HIS1/sit4::dpl200  RAS1/RAS1::RAS1G13V::URA3 
This study 
LUZ756 DAY1 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG   
arg4::hisG/arg4::hisG  RAS1/RAS1::RAS1::URA3 
This study 
LUZ755 DAY1 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG   RAS1/RAS1::RAS1G13V::URA3 
This study 
DAY1224 
(CJN6) 
BWP17 ura3::λimm434/ura3::λimm434  SCH9::HIS1::his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  sch9::Tn7::UAU1/sch9::Tn7::URA3 
Nobile et 
al., 2003 
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DAY1226 
(GKO782) 
BWP17 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  
arg4::hisG/arg4::hisG  sch9::Tn7::UAU1/sch9::Tn7::URA3 
Davis et al., 
2002 
DAY1227 
(CDH108) 
CAI4 ura3Δ/Δ ras1Δ::hisG/ras1Δ::hisG Leberer et 
al., 2001 
DAY1228 
(CDH110) 
CAI4 ura3Δ/Δ ras1Δ::hisG/ras1Δ::hisG  pVEC [RAS1] Leberer et 
al., 2001 
DAY1233 DAY972 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG 
sit4::HIS1/sit4::dpl200 mds3::URA3-dpl200/mds3::dpl200 
Zacchi et 
al., 2010a 
DAY1305 
(HPY300U) 
SC5314 tpk1Δ::hisG/tpk1Δ::hisG ura3Δ/ura3::URA3 Parker et 
al., 2004 
DAY1307 
(HPY400U) 
SC5314 tpk2Δ::hisG/tpk2Δ::hisG ura3Δ/ura3::URA3 Parker et 
al., 2004 
DAY1309 
(LDR8) 
CAI4 ura3Δ/Δ  grp1Δ::hisG/gpr1Δ::hisG-URA3-hisG Maidan et 
al., 2005 
DAY1311 
(NM6) 
CAI4 ura3Δ/Δ  gpa2Δ::hisG/gpa2Δ::hisG-URA3-hisG Maidan et 
al., 2005 
DAY1314 
(CK43B-16) 
CAI4 ura3Δ/Δ  cek1Δ::hisG/cek1Δ::hisG-URA3-hisG Csank et al., 
1998 
DAY1316 
(CDH22) 
CAI4 ura3Δ/Δ  cst20Δ::hisG/cst20Δ::hisG-URA3-hisG  Leberer et 
al., 1996 
DAY1317 
(CDH9) 
CAI4 ura3Δ/Δ  hst7Δ::hisG/hst7Δ::hisG-URA3-hisG Leberer et 
al., 1996 
DAY1318 
(CDH72) 
CAI4 ura3Δ/Δ  cph1Δ::hisG/cph1Δ::hisG-URA3-hisG Leberer et 
al., 1996 
DAY1319 
(CR216) 
CAI4 ura3Δ/Δ  cdc35Δ::hisG/cdc35Δ::hisG-URA3-hisG Harcus et 
al., 2004 
DAY1326 
(BMY15) 
BWP17 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG 
arg4::hisG/arg4::hisG  cdc25::Tn7::URA3/cdc25::Tn7::UAU1 
Enloe et al., 
2000 
L40 S. 
cerevisiae 
MATa, his3∆200, trp1-901, leu2-3, 112, ade2, LYS2::(lexAop)4-HIS3, 
URA3::(lexAop)8-lacZ, GAL4 
Vojtek et 
al., 1993. 
 
Table 5.2. Plasmids used in this study 
Plasmid Description Reference 
pDDB57 URA3-dpl200 cassette for gene disruption  
pDDB78 HIS1 vector  
pDDB295 ARG4-URA3 vector  
pLZ169 MDS3 in pDDB76 complementation vector This study 
pLZ172 RAS1 in pDDB76 This study 
pLZ173 RAS1G13V  in pDDB76 This study 
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Table 5.3. Primers used in this study 
Primer Sequence Reference 
MDS3 5DR TCTTAAGGCACAAGTTATTGGCTTGACGTAGAAGTTTGCA
AAGATTTTCACAATATCATGTTTCCCAGTCACGACGTT 
Davis et al., 2002 
MDS3 3DR ACCAATATAACGTGAATATACACCCCTATATTATTATCTTT
TAATCCTGTTAACAATCCGTGGAATTGTGAGCGGATA 
Davis et al., 2002 
MDS3null 5-detect GTGTCCCAATTTTGTCTAGC This study 
MDS3null 3-detect TGCGGAAGAACTGTAAACCC This study 
RAS1 5DR CAAAAAAATCAAAAAGAAACCCCGGGCAAACACAAATTC
ATATCCACACATATACATACCTTTCCCAGTCACGACGTT 
This study 
RAS1 3DR AACAATCAATTGGATAGGTAAATAGATAGATAAAAATACG
AGAACTTTTTAGTTAGCTCAGTGGAATTGTGAGCGGATA 
This study 
RAS1 5’ detect TGATTAATTGGACATTGACC This study 
RAS1 3’ detect TGAATTGTTCATCTTCTCCC This study 
RAS1 5’ seq AATCCCTCCCTAACCCCAGC This study 
RAS1 5’seq-2 CAAGATGGATTAGCATTGGC This study 
URA3 internal 
detect 
GTATGGGGTTGTTGCTCAGG This study 
RAS1 5’ comp AAGCTCGGAATTAACCCTCACTAAAGGGAACAAAAGCTGG
TATGTATCATTGCCACACAC 
This study 
RAS1 3’ comp ACGACGGCCAGTGAATTGTAATACGACTCACTATAGGGCG
AATGGAACAACTGGTGGTGG 
This study 
RAS1G13V 5’ GTTGTTGGAGGTGTTGGTGTTGGTAAATCCG This study 
RAS1G13V 3’ CGGATTTACCAACACCAACACCTCCAACAAC This study 
3’detect TGTGGAATTGTGAGCGGATAACAATTTCAC  
RAS1 3’ out ACTATATCAGCTCAACCTCG This study 
MDS3 NruI Seq TTATGATGAGATTGCCATGC This study 
LAP3 5' ACGAAATCAACCCAATCTCC This study 
LAP3 3' ACCATCATTAACTGGGTTGC This study 
PRC2 5' TTGGCATTAGAGTTGGGTCC This study 
PRC2 3' CAAATCACCTGTGTCTGGAG This study 
RPS26A 5' CAAGAAAGGTAGAGGTCACG Zacchi et al., 2010a 
RPS26A 3' TTTAGCAGCATCTTGTGGAG Zacchi et al., 2010a 
GDH1 5'   TTGGCCAGATACATTGGTCC This study 
GDH1 3' TCACCTTGGTCAAACATGGC This study 
GAP2 5' TTATTGTACAGTTATGTCCC Zacchi et al., 2010a 
GAP2 3' CCAGCGAAAGCAAAGGCAGC Zacchi et al., 2010a 
CDC19 5’ a CTTCAATGTTGAAACTGTTCC Zacchi et al., 2010a 
CDC19 3’ b AACAGTGTTAGAGTGACCAG Zacchi et al., 2010a 
TEF1-5’ ATAGTCATAATCAATCATGGGT Davis et al., 2000 
TEF1-3’ CTTACATAATATTCAACTAGC Davis et al., 2000 
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CHAPTER 6 
 
 
CONCLUDING REMARKS 
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Candida albicans, one of the most frequent fungal pathogens for humans, is an obligate 
commensal yeast that colonizes highly diverse anatomical locations in the human body 
(Calderone, 2002). C. albicans appears to reproduce clonally, with a low mating frequency and a 
non-meiotic, parasexual cycle (Heitman, 2006; Johnson, 2003). Thus, C. albicans requires 
additional mechanisms to those involved in its reproduction in order to generate the variation it 
needs to survive a constantly changing environment. It has been proposed that C. albicans can 
achieve phenotypic variation through a process called colony morphology phenotypic switching 
(CMPS) (Soll, 1992). CMPS is the stochastic, low frequency emergence of colonies that have a 
heritable, but reversible alteration in morphology (Slutsky et al., 1985). CMPS has been 
associated with C. albicans commensal and pathogenic lifestyles (Soll, 1992). Genetically 
similar, but not identical C. albicans commensal strains were isolated from different anatomical 
locations in humans, and these genetic differences, presumably involved in niche specialization, 
were suggested to be an output of CMPS (Soll, 1992; Soll et al., 1991; Scherer and Stephens, 
1988). Similarly, morphologically variant, but genetically similar colonies can be isolated from 
sites of infection in humans, and they usually display altered expression of virulence traits (Soll et 
al., 1988, 1989; Jones et al., 1994; Vargas et al., 2000, 2004). CMPS generates phenotypic 
diversity in C. albicans and is thus important to ensure the survival of this fungus in the host. 
 
The regulation of CMPS 
CMPS was originally defined as a stochastic process (Slutsky et al., 1985; Soll, 1992). 
Here, I show that CMPS in C. albicans is not stochastic. In fact, CMPS is regulated by 
environmental cues such as glucose starvation, amino acids, and alkaline pH, and is under the 
control of two major signal transduction pathways: the Ras/cAMP and the TOR pathways (Figure 
6.1, Chapters 4, 5). Both pathways regulate cellular growth in response to environmental 
nutrients, and control several critical processes including protein synthesis, protein degradation, 
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and carbohydrate metabolism (Wullschleger et al., 2006; Thevelein and de Winde, 1999). 
Through a combination of bioinformatic, biochemical, and genetic approaches, we determined 
that the negative regulator of CMPS, Mds3, was a member of the TOR pathway, and obtained 
evidence that Mds3 is also a member of the Ras/cAMP pathways in C. albicans (Chapters 3, 5; 
Zacchi et al., 2010a; Benni and Neigeborn, 1997; McDonald et al., 2009). Based on this 
information, I was able to identify the upstream Ras/cAMP members Cdc25, Ras1, and Cdc35 
and the downstream TOR effector Sch9 as additional negative regulators of CMPS (Chapter 5; 
Zacchi et al., 2010a; Benni and Neigeborn, 1997; McDonald et al., 2009). Further, the TOR 
downstream effector Sit4, which is required for TOR-dependent induction of starvation responses 
(Duvel and Broach, 2004), appears to be required for CMPS induction during glucose starvation 
(Chapter 5). Even though the TOR pathway has traditionally been associated with the response to 
nitrogen sources, the fact that Sit4 function is effected by carbon sources had been previously 
shown (Di Como and Arndt, 1996). Thus, the data presented here supports the conclusion that 
CMPS in C. albicans is a process regulated by distinct environmental cues and by the TOR and 
Ras signal transduction pathways. 
The TOR and Ras/cAMP pathways are associated with morphogenetic processes and 
phenotypic variation in very different organisms. For example, cAMP and the TOR pathway are 
involved in phenotypic variation in metazoans, and cAMP is also associated with morphogenesis, 
virulence, and phenotypic variation in diverse microbes (Mennon and Manning, 2009; Bjornsti 
and Houghton, 2004; Prasad et al., 2003; Taddei et al., 1995; Weeks, 2000; Fuchs et al., 2010; 
Horinouchi et al., 2001; Janion et al., 2002). In C. albicans, these pathways regulate white-
opaque switching, the yeast-hyphal transition, and chlamydospore formation (Huang et al., 2010; 
Cutler et al., 2001; Bastidas et al., 2009; Zacchi et al., 2010a; Lee et al., 2004; Nobile et al., 2003; 
Biswas et al., 2007). Therefore, signal transduction pathways (or second messengers, cAMP) that 
are involved in phenotypic variation in diverse organisms also regulate CMPS in C. albicans. 
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This suggests that there is certain level of conservation in the networks that regulate phenotypic 
variation throughout evolution that is maintained among distantly related organisms. 
 
The mechanisms of CMPS: lessons from the mutants 
One common characteristic of the mds3Δ/Δ, cdc25-/-, ras1Δ/Δ, and sch9-/- C. albicans 
mutants is that they all manifest CMPS by producing papilli on their colony surface after 
prolonged incubation (Chapters 4, 5). But how does papilli form in these mutants? One possibility 
is that the absence of the Ras and TOR pathways components Mds3, Cdc25, Ras1, or Sch9 leads 
to defects in signal transduction. Defects in the Ras and/or TOR pathways cause defective stress 
responses and lead to increased DNA damage and genomic instability. This generates mutations 
and genomic rearrangements which may accumulate during stationary phase (Figure 6.1) (Madia 
et al., 2009; Lee et al., 2001; Searle and Sanchez, 2004; Searle et al, 2004; Douville et al., 2004; 
Yarosh et al., 2000; Budanov and Karin, 2008). The accumulation of genetic (and epigenetic) 
alterations would then allow for the release from stationary phase cell-growth controlling signals 
and, thus, overgrowth with the consequent formation of papilli that contain phenotypic variants. 
In sum, I propose a model in which the phenotypic switch in C. albicans is caused by the 
progressive acquisition of random genetic/epigenetic alterations, especially during stationary 
phase growth, due to inappropriate responses to environmental, nutritional, and stress signals 
(Figure 6.1).  
The model I propose for CMPS is similar to the bacterial mechanisms for phenotypic 
variation called stationary-phase mutation and stress-induced mutagenesis (Rosenberg, 2001; 
Galhardo et al., 2007; Foster, 2007). Stress-induced mutagenesis is a process in which mutations 
accumulate in a population of cells that are growth-limited and under stress, for example due to 
nutrient limitation, and which eventually may lead to growth-control escape (McKenzie et al., 
2000). Further, in non-growing bacterial populations, the induction of the SOS response, which 
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prevents the accumulation of DNA damage, is cAMP dependent, which further links the cAMP 
pathway with phenotypic switching (Taddei et al., 1995). In agreement with this idea, the TOR 
pathway, including Sch9, and the Ras/cAMP pathway are also involved in the regulation of DNA 
damage responses in eukaryotes (Chapter 5; Madia et al., 2009; Lee et al., 2001; Searle and 
Sanchez, 2004; Searle et al, 2004; Douville et al., 2004; Yarosh et al., 2000; Budanov and Karin, 
2008). Our model also contributes to explain why CMPS in C. albicans is observed after 
exposure to UV light, a potent inducer of DNA damage (Slutsky et al., 1985; Pomes et al., 1985). 
The CMPS model proposed here has an intriguing resemblance to the stepwise acquisition of 
mutations that are hallmarks of cancer in mammals (Hanahan and Weinberg, 2000), and poses the 
(perhaps naïve) question if CMPS formation in C. albicans could eventually become a model to 
study tumor formation and progression.  
 
Figure 6.1: Model of CMPS regulation in C. albicans 
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Due to the apparently unpredictable nature of the transcriptional and genetic events that 
cause CMPS in C. albicans, each switched isolate displays a different array of phenotypes. 
Switched mds3Δ/Δ strains vary in their colony morphology, in their antifungal drug sensitivity, 
and in their ability to secrete proteinases or adhere to cells (our unpublished results). However, 
despite this inherent noise in the system of study, there appear to be two common responses that 
unify the switched strains: the increased susceptibility to rapamycin and to DNA damaging agents 
(Chapter 4). An increased susceptibility to rapamycin suggests an increased dependence on TOR 
function and points to an alteration in the function of this pathway. The increased sensitivity to 
DNA damage agents in the switched strains could also be associated with the defects in the TOR 
and Ras signal transduction pathways, and supports the model in which the accumulation of DNA 
damage contributes to the switch. However, we must keep in mind that an increased sensitivity to 
rapamycin or DNA damage may also be an output of the switch, not an indication of the cause. 
Thus, a better understanding of the interaction between the TOR and Ras pathways in C. 
albicans, and of the pathways and mechanisms controlling DNA damage responses and genomic 
instability in this organism should shed light on the mechanisms of the switch. 
 
What is the role of CMPS in C. albicans?  
One classical example that illustrates the importance of phenotypic variation is the ability 
of different pathogens to evade the immune system by altering the expression of their surface 
antigens. This property is shared by highly diverse microorganisms, including the protozoan 
Trypanosoma brucei, the fungus Pneumocystis carinii, the bacteria Neisseria gonorrhoea, and the 
virus HIV (Morrison et al, 2009; Borst, 2002; Stringer, 2007; Klenerman et al., 2002; Mumford et 
al., 2007; Hills and Davies et al., 2009). Organisms able to maintain a low frequency of 
phenotypic variation in their population have higher chances of survival after unpredicted 
environmental changes (Avery et al., 2006; Dubnau and Losick, 2006; Zieg et al., 1977; Moxon 
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et al., 1994; Acar et al., 2008). In bacterial population genetics, this phenomenon is called bet-
hedging (Veening et al., 2008). In the case of C. albicans, phenotypic variation likely has 
additional functions than being an adaptive bet-hedging strategy against potential environmental 
challenges, as previously suggested (Soll, 2002). There are at least two reasons for this. First, C. 
albicans is an obligate commensal of humans and has evolved remarkably efficient signal 
transduction pathways that allow it to respond to constantly changing microenvironments (Bahn 
et al., 2007; Biswas et al., 2007; Davis, 2009). Second, neither during the commensal state nor 
during infection have the morphologically switched variants ever been the isolated majority, 
indicating that they do not overtake a C. albicans population (Odds, 1997; Jones et al., 1994; 
Vargas et al., 2000; Soll et al., 1987, 1988, 1989). An exception to this argument is the 
acquisition of antifungal drug resistance, but in this case there is a very clear selective pressure 
for the variant phenotype. Therefore, CMPS in C. albicans is likely a way to generate in situ 
diversity with altruistic characteristics, and/or a mechanism to accelerate evolution in a clonal 
population, a concept related to stress-induced mutagenesis in bacteria (Rosenberg, 2001, 
Galhardo et al., 2007; Foster, 2007).  
One possible role of CMPS in C. albicans is the generation of variants with an altruistic 
or cooperative role, a phenomenon observed in other organisms including bacteria, slime mold, 
and yeast (Boyd and Richerson, 1980; Ackermann et al., 2008; Smukalla et al., 2008; Brown and 
Buckling, 2008; Gardner and Kumerli, 2008, Diggle et al., 2007). For example, Salmonella 
typhimurium can induce an inflammatory response in the gut to eliminate competing microflora 
by having a few individuals upregulate the expression of specific virulence factors (Ackermann et 
al., 2008). C. albicans phenotypic variants may grow to form “micropopulations” within a 
colonized surface/tissue, whose function is to provide the community with a survival advantage. 
For example, the ability of certain “micropopulations” to secrete more hydrolytic enzymes might 
allow for enhanced tissue invasion. Further, variants may arise which are able to produce 
 215 
different levels of quorum sensing signals or biofilm matrix, that can divide faster, that can 
interact with bacteria differently, that can induce or repress a particular immune response, that 
can adhere better to surfaces, and/or that can scavenge nutrients more efficiently. For instance, 
opaque C. albicans cells induce biofilm formation in white cells through pheromone signaling 
(Daniels et al., 2006). Biofilm formation is advantageous for C. albicans because it increases 
resistance to antifungal drugs and constitutes a source of inoculums to facilitate dissemination, 
colonization, and infection (d’Enfert et al., 2006; Hawser and Douglas, 1995). In other words, C. 
albicans variants may arise due to its altruistic, cooperative function in the community. If the 
variations are not detrimental, they are maintained in the population and may eventually 
contribute to the evolution of the pathogen (see below).  
Alternatively, CMPS might be a mechanism to accelerate adaptation (Rosenberg et al., 
2001). In this situation, acceleration of evolution could only happen in a restricted number of 
individuals, which would enter a high frequency switching mode compared to the rest of the 
population. This idea is supported by the fact that most of the switched strains that have been 
isolated in vivo are in a high frequency switching mode (Soll et al., 1987; Vargas et al., 2000). 
These “switchers” would generate random variability that may get fixed in the population. 
However, under a “switcher” condition, the fixation of the variation can only occur if it is 
successfully transferred to a non-switcher strain (Elena and Lenski, 2003). This might happen in 
C. albicans through mating, followed by a parasexual cycle (Forche et al., 2008). It would be 
interesting to determine if the strains that are in high CMPS frequency mode are also in a “high 
frequency mating” mode, similar to the WO-1 strain (Slutsky et al., 1987; Miller et al., 2002). 
Although mating in C. albicans was thought to inevitably require mating type locus homozygosis, 
it has recently been shown that it can happen in strains with a heterozygous mating locus (Alby 
and Bennett, 2009; Pendrak et al., 2004; Lohse and Johnson, 2009). This indicates that alternative 
means exist to induce C. albicans to mate, many of them unexplored, such as epigenetic silencing 
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of the mating locus, and CMPS or the mechanisms that lead to CMPS might be some of them. 
Alternatively, the formation of “switchers” might be transient and environmentally regulated 
(Giraud et al., 2001; Aersten and Michiels, 2005). Formation of “switchers” strains in vivo has 
been reported in other systems (Giraud et al., 2002; Oliver et al., 2000). Therefore, I propose that 
the primordial role of CMPS and other mechanisms to generate variation in C. albicans is to 
generate in situ phenotypic variation and/or to accelerate evolution (with the consequent 
generation of strains pre-adapted to future environmental challenges as a by-product). 
 
CMPS in the host 
Much remains to be learned about the role and mechanisms of CMPS in C. albicans 
commensal/opportunistic pathogen lifestyle. For instance, although CMPS has been shown to 
occur in vivo, the factors that trigger CMPS and the frequency at which it happens is not known. 
Colonies with an altered morphology have been found more frequently during infections than 
during a commensal state, which suggest that there is a selective advantage for the formation or 
persistence of phenotypic variants during infection. Given the often significant increase in 
population size associated with an infection, it is possible that CMPS is a population-density 
dependent effect associated with, for example, quorum sensing (D.D.; Forche et al., 2009; Dutton 
and Penn, 1989; Soll et al., 1988, 2002; Kruppa et al., 2009). Further, it is important to keep in 
mind that not all phenotypic variation will lead to alterations in colony morphology, as 
demonstrated by ours and others results (Chapter 4; Anderson and Odds, 1985). Thus, by simply 
monitoring colony morphology we are likely underestimating the actual level of phenotypic 
variation in the C. albicans population. This indicates that, despite the available data, we still do 
not have a clear picture of the levels of phenotypic variation of C. albicans in vivo, nor of the 
effects of this variation on C. albicans survival in the host.  
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How could CMPS be triggered in the host? While in the host, C. albicans is subject to 
many different stress signals and to nutrient limitation. One possibility to explain CMPS involves 
a combination of environmental stress with transcriptional noise (Freed et al., 2008, Sriram et al., 
2009). The transcriptional noise may affect the expression of a key CMPS regulator. This idea 
implies the existence of a master CMPS regulatory locus, similar to the Wor1 regulation of the 
white-opaque phenotypic switching in C. albicans (Zordan et al., 2006, 2007; Lohse and Johnson, 
2009). In other words, CMPS might be the consequence of the bi-stable formation of “switchers”. 
Alternatively, transcriptional noise may affect the expression of a member or a common 
downstream effector of the TOR and Ras pathways, and would induce a transient defect in TOR 
or Ras signaling causing the formation of phenotypic variants. A second possibility is that 
members or effectors of the TOR or Ras pathways can be reversibly functionally limited (e.g. by 
sequestration in subcellular compartments), leading to a transient “switcher” state. One example 
of such mechanism leading to increased mutation rates is the functional limitation of the DNA 
mismatch repair system in bacteria (Galhardo et al., 2007). The advantage of transcriptional noise 
coupled to an epigenetic regulatory feedback circuit or to the functional limitation of specific 
effectors is that the change from non-“switcher” to “switcher” would be reversible. 
Another possibility to explain CMPS regulation is that stress and nutrient limitation may 
increase the chances that a specific but reversible mutation occurs in one of the members of the 
TOR or Ras pathways. This system is similar to the formation of wrinkly colonies in S. cerevisiae 
due to expression of FLO10 that is caused by the mutagenic inactivation of the upstream Ras 
pathway members IRA1 and IRA2 (Halme et al., 2004). Intriguingly, these mutations in IRA1 and 
IRA2 appear to happen at a higher frequency than random mutation (Halme et al., 2004). If C. 
albicans had a similar mechanism, the “switcher” effect would not be transient and the “switcher” 
would remain locked in that state, unless, for example, a system similar to phase variation in 
bacteria existed that would ensure the reversibility of the switcher phenotype.  
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Finally, it is possible that CMPS in C. albicans is linked to the age of the cell. Aging is 
associated with genomic instability and DNA damage, and is regulated by signal transduction 
pathways including TOR, Sch9, and Ras (Bitterman et al., 2003; Wei et al., 2008). Thus, aged 
cells might be the source of CMPS in vivo. This idea is supported by the result that alkaline pH, 
which in S. cerevisiae inhibits age-dependent cell death, can also inhibit papilli formation in the 
mds3Δ/Δ, ras1Δ/Δ, and sch9-/- C. albicans mutants (Chapters 4, 5; Fabrizio et al., 2004). One 
way to test this would be by preventing mds3Δ/Δ cells from entering the aging program either by 
genetic or environmental mechanisms, and determining whether the mds3Δ/Δ colonies still form 
papilli. Another possibility that is directly related with the idea of aging is that papilli formation 
could be associated with the adaptive re-growth phenomenon observed in S. cerevisiae. During 
adaptive re-growth, a small subpopulation of cells can grow by utilizing nutrients released by the 
bulk of a population dying from starvation (Longo et al., 2005; Fabrizio et al., 2004). This idea is 
supported by my results that switched strains have increased sensitivity to oxidative agents 
(Chapter 4), which is a condition that enhances adaptive re-growth frequency in S. cerevisiae 
(Fabrizio et al., 2004). Further, adaptive re-growth is associated with an increased mutation rate, 
which is in agreement with my model of CMPS formation (see above). It would be interesting to 
compare the mutation rates of the mds3Δ/Δ mutant with the wild-type during logaritmic and 
stationary growth phase, and during glucose limitation and growth at acidic vs. alkaline pH 
(which are environmental conditions that affect CMPS rates (Chapter 4, 5)). 
Thus, there are multiple possibilities that may account for the occurrence of CMPS in the 
host, and I have only mentioned here a few of them. A deeper understanding of the mechanisms 
that lead to CMPS in vitro, together with a more careful study of the frequency of CMPS in vivo, 
of the phenotypes of the switched strains, of the environments from where the switched strains 
were isolated, and of the genetic alterations associated with the switch will certainly shed light on 
the biological role of this phenomenon in C. albicans. In particular, dissecting the genetic and 
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genomic alterations associated with the switch –through a combination of deep-sequencing, 
comparative genomic hybridization, loss of heterozygosity assays, flow cytometry, and contour-
clamped homogeneous electric field electrophoresis- might show common mutations or genomic 
aberrations that are associated with the phenotypic switch itself, or with particular phenotypic 
variants. 
 
The importance of being Mds3  
The data I present here indicates that Mds3 plays an important role in the regulation of 
both the Ras and TOR pathways (Figure 6.1). But what is the function of Mds3 on these 
pathways? In the Ras pathway, Mds3 appears to function as an upstream positive regulator of 
Ras. First, mutants in MDS3, CDC25, and RAS1 share similar phenotypes, both in C. albicans 
and in S. cerevisiae (Chapter 5, McDonald et al., 2009). Second, the RAS1
V13
 and RAS2
V17
 alleles 
can rescue mds3Δ/Δ phenotypes in C. albicans and S. cerevisiae, respectively (Chapter 5, Benni 
and Neigeborn, 1997). Third, Mds3 and Cdc25 physically interact in S. cerevisiae (Krogan et al., 
2006; Tonikian et al., 2009; Gavin et al., 2006; Collins et al., 2007). Thus, Mds3 appears to 
function as a positive upstream regulator of Ras1, possibly effecting Cdc25 function/localization. 
It would be interesting to determine whether Mds3 and Cdc25 also interact in C. albicans, what 
genetic and environmental factors effect this interaction, and what role Mds3 plays on Cdc25 
function. 
The role of Mds3 on the TOR pathway appears to be more difficult to dissect. Our initial 
studies suggested that Mds3 acts as a negative regulator of TOR function (Chapter 3). However, 
subsequent analysis indicated that Mds3 could also function on the TOR pathway as a positive 
regulator (Chapter 5). For example, the mds3Δ/Δ mutant appears to induce starvation responses 
more rapidly than the wild-type strain (Chapter 5), implying that the TOR pathway is more 
readily inactivated in the absence of Mds3. Further, the mds3Δ/Δ mutant appears to survive 
 220 
longer during starvation conditions than the wild-type strain (data not shown), a phenomenon 
associated with the downregulation of growth activating pathways like TOR and Ras. In fact, 
TOR downregulation in worms, flies, and mammals leads to life span extension; and the tor1Δ/Δ, 
ras2Δ/Δ, and sch9Δ/Δ S. cerevisiae mutants show extended life spans compared to the wild-type 
strain (Fabrizio et al., 2001; Longo, 1999; Bonawitz et al., 2007; Wei et al., 2008; Kapahi et al., 
2004; Harrison et al., 2009; Hansen et al., 2007). Together, these results do not support a model 
in which Mds3 functions as a negative regulator of TOR. Rather, Mds3 might function as a 
modulator, acting positively or negatively on the pathway according to specific environmental 
cues. Such a dual-function protein, Raptor, has already been described for the mTOR pathway in 
mammals (Kim et al, 2002, 2003). The homolog of Raptor in S. cerevisiae and C. albicans is 
Kog1. Kog1 interaction with TOR is not effected by nutrients, suggesting that alternative factors, 
such as Mds3, might fulfill this role in these fungi (Loewith et al., 2002). Further, a model in 
which loss of MDS3 leads to reduced TOR signaling is in agreement with the effect of loss of 
SCH9, the downstream TOR effector, on papilli formation. Alternatively, our results might also 
be explained if the increased starvation responses observed in the mds3Δ/Δ mutant are mediated 
by a reduced function of the Ras pathway, while the TOR pathway remains overactive. The effect 
of the sch9Δ/Δ mutant on papilli might then be explained by a feedback regulatory loop that 
causes TOR hyperactivation, already observed in S. cerevisiae (Lempiainen et al., 2009). 
However, in the simpler model Mds3 would act as a positive regulator of TOR during stationary 
phase (Figure 6.1). 
The studies presented here suggest that there is a crosstalk between the TOR and Ras 
pathways in C. albicans, in which the TOR downstream effector Sit4 is also a downstream 
effector of Ras1 (Figure 6.1, Chapter 5). This arrangement is more similar to the mammalian Ras 
and mTOR pathways than to the S. cerevisiae Ras and TOR pathways (Schmelzle et al., 2004; 
Zurita-Martinez and Cardenas, 2005; Shaw and Cantley, 2006; Soulard et al., 2010). Regulatory 
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feedbacks between TOR and other signaling pathways exist in other systems and are critical for 
fine-tuning the function of these pathways (Carracedo et al., 2008, Kockel et al., 2010). The 
discovery that Mds3 is a member of the fungal TOR and Ras pathways opened up interesting 
possibilities of regulatory feedbacks between these networks mediated by Mds3. In fact, the 
molecular structure and subcellular localization of Mds3 are ideal for a protein that works as a 
(dual-function) regulator of several signal transduction pathways (Chapter 2). First, Mds3 is a 
large, modular protein containing only protein-protein interaction domains: a well defined six-
bladed Kelch β-propeller at the N-terminus, and a putative BTB/POZ domain at the C-terminus 
(Chapter 2). Mds3 is separated into a minimum of two modules by the flexible serine-rich bridge 
located at the middle of the protein. This arrangement suggests that Mds3 is able to alter its 
conformation in response to posttranslational modifications or upon binding to different targets. 
By altering its conformation, Mds3 would modify its ability to bind specific substrates (Dyson 
and Wright, 2005). Further, stringent evolutionary bioinformatics studies predict that Mds3 has a 
PKA phosphorylation site after the N-terminal Kelch domains (Budovskaya et al., 2005). It is 
interesting to speculate that PKA phosphorylation might lead to alterations in Mds3’s 
conformation and/or in its binding ability, orchestrating a feedback regulatory loop involving 
Mds3, Ras/PKA, and the TOR pathway.  
Recent studies support the potential Mds3-mediated crosstalk between TOR and Ras. 
Mds3 and the TORC1 complex member Tco89 were independently pulled down in a high-
throughput screen for proteins that interact with the enzyme FBP1 in S. cerevisiae, supporting a 
possible role of Mds3 as an upstream regulator of TOR and as a member of the TORC complex 
(Figure 6.1; Brown et al., 2010; Reinke et al., 2004). Further, Bcy1, the regulatory subunit of 
PKA, is a target of TOR in S. cerevisiae (Soulard et al., 2010). Thus, PKA may indirectly affect 
TOR function by phosphorylating and potentially altering the function of Mds3 (potentially a 
TORC complex member); while TOR can directly alter PKA function through Bcy1 
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phosphorylation. In this way, Mds3 would contribute to close the feedback regulatory loop 
between both pathways. Further, Mds3 interacts with the Sit4 phosphatase, a TOR downstream 
effector, suggesting that Mds3 is a Sit4 substrate, and providing a second instance for regulatory 
crosstalk between the TOR and Ras pathways (Zacchi et al. 2010a). Alternatively, Mds3 
conformational changes could also affect the ability of Sit4 to bind to different substrates or 
regulatory proteins, which also provides an instance for regulatory crosstalk between the TOR 
and the Ras/PKA pathways. Finally, the localization of Mds3 on cytoplasmic spots that resemble 
endocytic vesicles or membrane microdomains supports a role for Mds3 in the regulation of 
signaling pathways that converge at these locations, which include both the TOR and Ras 
pathways (Mitchell, 2008; Hancock, 2003; Zurita-Martinez et al., 2007; Sturgill et al., 2008; 
Aronova et al., 2007; Slessareva et al., 2006; Puria et al., 2008; Xu et al., 2004; Hancock and 
Parton, 2005; Tian et al., 2007). Therefore, the modular characteristics and cytoplasmic 
localization of Mds3 support the model in which this protein functions as a scaffold coordinating 
several signal transduction pathways and is involved in a crosstalk regulation between them. 
It would be interesting to explore this connection further, not only to better understand 
the complexity of regulatory pathways in eukaryotic organisms, but also because of the critical 
role these two pathways play in C. albicans growth and pathogenesis. 
What is the relevance of Mds3 in other systems? All searches for homology to Mds3 
returned only proteins from fungal species, indicating that Mds3 appears to be a fungal specific 
protein. However, the putative Kelch/BTB domain combination in Mds3 is common in 
mammalian proteins (Prags and Adams, 2003). Thus, although there is no human homolog of 
Mds3 identified through amino acid sequence identity, the role of this potential Kelch/BTB 
scaffold might be fulfilled by other yet undiscovered human proteins with similar structures. 
Indeed, the TOR pathway is highly conserved throughout evolution, and elements from the 
Ras/cAMP pathways are also conserved in distantly related organisms. Regardless of whether or 
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not there is a human functional homolog of Mds3, this protein is an interesting target of study as 
it represents, to the best of my knowledge, the first fungal protein to be associated to the crosstalk 
regulation of two of the major highly conserved signal transduction pathways in eukaryotes.  
 
For a long time CMPS was known to occur in C. albicans both in vivo in the human host 
and in vitro. Several mechanisms and environmental signals have been suggested to effect CMPS 
in this fungus, but it was unclear how they led to the switch. As it often happens in science, our 
discovery that Mds3 was involved in CMPS was completely serendipitous; but it sparkled our 
interest in understanding the mechanisms that control this phenomenon. I have now found that 
CMPS in C. albicans is regulated by two major signal transduction cascades: the TOR and the 
Ras pathways. These pathways are also associated with phenotypic variation in many other highly 
diverse organsims. Mds3 appears to function at the crossroads between these two major growth 
controlling signal transduction cascades and may be critical in orchestrating a feedback regulatory 
crosstalk between and/or within these networks. The data collected here allows me to propose a 
model of CMPS in C. albicans that is based on the bacterial stress-induced mutagenesis model. In 
this model, random phenotypic variation in CMPS is achieved through the stepwise accumulation 
of genetic (and perhaps epigenetic) alterations during growth under stress and nutrient-limited 
conditions – which should be easily found by C. albicans while thriving in the host- due to 
defective signaling through the TOR and/or Ras pathways. Therefore, the studies described in this 
dissertation have begun to uncover the mechanisms of regulation of colony morphology 
phenotypic switching, a complex phenomenon directly associated with the pathogenesis of one of 
the most important human pathogens, the fungus Candida albicans.  
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SUMMARY 
Epigenetic mechanisms regulate the expression of virulence traits in diverse pathogens, 
including protozoan and fungi. In the human fungal pathogen Candida albicans virulence traits 
such as antifungal resistance, white-opaque switching, and adhesion to lung cells are regulated by 
histone deacetylases (HDACs). However, the role of HDACs in the regulation of the yeast-hyphal 
morphogenetic transitions, a critical virulence attribute of C. albicans, remains poorly explored. 
In this study, we wished to determine the relevance of other HDACs on C. albicans 
morphogenesis. We generated mutants in the HDACs HOS1, HOS2, RPD31, and HDA1, and 
determined their ability to filament in response to different environmental stimuli. We found that 
while HOS1 and RPD31 have no or a more limited role in morphogenesis, the HDACs HOS2 and 
HDA1 have opposite roles in the regulation of hyphal formation. Our results demonstrate an 
important role for HDACs on the regulation of yeast-hyphal transitions in the human pathogen C. 
albicans. 
 265 
INTRODUCTION  
Candida albicans is the most common fungal pathogen of humans and is the fourth most 
common cause of nosocomial bloodstream infections (Pfaller et al., 2001). C. albicans 
pathogenesis depends on its ability to transition between the yeast, pseudophyphal, and hyphal 
cellular morphologies (Sudbery et al., 2004), and these transitions are triggered by diverse 
environmental cues, including temperature, serum, pH, and starvation (Biswas et al., 2007). Both 
the yeast and hyphal morphologies are required for pathogenesis in animal models of infection 
(Lo et al., 1997; Saville et al., 2003, 2008), and are required for the formation of normal biofilms 
(Baillie and Douglas, 1999; Richard et al., 2005), a structure that increases antifungal drug 
resistance and constitutes a source of inoculum for disseminated and recurrent infections (Hawser 
and Douglas, 1995). The different cellular morphologies can also trigger immune tolerance or 
activation against C. albicans (Acosta-Rodriguez et al., 2007; Romani et al., 2003, 2004). 
Therefore, the ability to switch between morphologies has pleiotropic effects on C. albicans 
interaction with the host and on its ability to cause infection.  
As epigenetic regulators of gene expression, chromatin modifying enzymes regulate 
diverse aspects of C. albicans biology. For example, histone modifying enzymes are required for 
the regulation of virulence traits and for pathogenesis in C. albicans (Klar et al., 2001; Smith and 
Edlind, 2001; Hnisz et al., 2009; Lu et al., 2008; Mai et al., 2007; Simonetti et al., 2007; 
Srikantha et al., 2001; Pfaller et al., 2009; Raman et al., 2006; Tebarth et al., 2003; Sellam et al., 
2009). Since the yeast-hyphal switch is critical for pathogenesis, we investigated the role of 
histone deacetylases (HDACs) in the regulation of this virulence trait. Here, we screened mutants 
in HOS1, HOS2, RPD31, and HDA1 for a role in C. albicans morphogenesis. We found that 
HOS1 and RPD31 have little to no role in morphogenesis, and that HOS2 and HDA1 encode 
proteins with opposing roles in morphogenesis: Hos2 functions as a repressor, while Hda1 
functions as an inducer of filamentation. 
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MATERIALS AND METHODS 
Strains and plasmids 
All C. albicans strains used in this study derive from C. albicans strain BWP17 (Table 
A.3). The hos1/hos1, hos2/hos2, and rpd31/rpd31 strains were generated using the Tn7::UAU1 
insertional mutagenesis system (Davis et al., 2002) using clones obtained from TIGR. 
Mutagenesis and selection of Tn7::UAU1 transformants was performed using primers in Table 
A.4 as previously described (Davis et al., 2002). The hda1∆/∆ mutant DAY694 was constructed 
by sequentially deleting both HDA1 alleles from the start to the stop codon from BWP17 strain, 
using hda1::ARG4 and hda1::URA3-dpl200 disruption cassettes PCR amplified with primers 
HDA1 5DR and HDA1 3DR (Table A.4). The complemented and prototrophic strains (Table 
A.3) were constructed by transformation with NruI digested plasmids pDDB503 for HOS2 
complementation, pDDB504 for HDA1 complementation, and empty vector pDDB78. 
The HOS2 and HDA1 complementation vectors pDDB503 and pDDB504 were 
constructed as follows. Wild-type HOS2 and HDA1 open reading frames (ORF), together with 
~1kb upstream and 0.5kb downstream of the HOS2 and HDA1 ORF, were amplified in high 
fidelity PCRs (Pfu Turbo DNA polymerase, Stratagene) from BWP17 DNA using primers HOS2 
DDB78 comp 5’ and HOS2 DDB78 comp 3’, and HDA1 5’ comp, HDA1 5-1 comp, HDA1 3-1 
comp and HDA1 3’ comp (Table A.4). The resulting PCR products were in vivo recombined in S. 
cerevisiae strain L40 into a NotI/EcoRI-digested pDDB78 to generate plasmids pDDB503 and 
pDDB504.  
 
Media and growth conditions 
C. albicans was routinely grown at 30ºC in YPD (2% Bacto-peptone, 2% dextrose, 1% 
yeast extract). For selection of Ura
+
, Arg
+
, His
+
 or Trp
+
 transformants, synthetic medium without 
uridine, arginine, histidine or tryptophan was used (0.17% yeast nitrogen base without 
ammonium sulfate (Q-BioGene), 0.5% ammonium sulfate, 2% dextrose, and supplemented with a 
dropout mix containing amino and nucleic acids except those necessary for the selection (Adams 
et al., 1997)). M199 medium (Gibco BRL) was buffered at the indicated pH using 150mM 
HEPES. The filamentation assays in solid media were performed in M199 medium buffered at 
pH 8, SLAD (0.17% yeast nitrogen base without ammonium sulfate (Q-BioGene), 50µM 
ammonium sulfate, 2% dextrose), Spider medium (1% mannitol, 1% nutrient broth, 0.2% 
K2HPO4, pH 7.2 before autoclaving) (Liu et al., 1994), embedded agar (2% Bacto-peptone, 2% 
sucrose, 1% yeast extract) (Brown et al., 1999), and synthetic medium supplemented with 4% 
bovine calf serum (BCS). The filamentation assays in liquid media were performed in M199 pH 
8, Spider, YP + 0.5% N-acetyl glucosamine (GlcNAc), and YP + 10% fetal bovine serum (FBS) 
(Gibco). Filamentation assays were conducted at 37ºC except for embedded agar which was 
incubated at 23ºC. The liquid assays for filamentation were performed as follows. Strains were 
grown overnight in liquid YPD at 30ºC, pelleted, resuspended in an equal volume of PBS and 
diluted 1:100 in M199 pH 8, Spider, YP+GlcNAc or YP+FBS. Samples were incubated at 37ºC. 
The samples from Spider medium were gently sonicated to disrupt clumping. The percentage of 
cells forming germ tubes in M199 pH 8 medium at 60 min or in Spider medium at 45 min was 
determined by counting 300 cells/sample, in triplicate.  All media except that for selection of Ura
+
 
transformants were supplemented with 80 µg/ml uridine. For solid media, 2% Bacto-agar was 
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added, except for Spider medium and embedded agar which required 1.35% and 1% Bacto-agar, 
respectively. 
 
Microscopy 
 Pictures of colonies were taken using a Canon Powershot A560 digital camera on a Zeiss 
Opton microscope. Images of liquid cultures were captured using a Zeiss Axio camera, 
Axiovision 4.6.3 software (Zeiss), and a Zeiss AxioImager fluorescence microscope. All images 
were processed with Adobe Photoshop 7.0 software. 
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RESULTS 
Chromatin remodeling proteins effect diverse aspects of C. albicans biology. Several 
histone modifying enzymes in C. albicans, including the histone methyltransferase Set1 and the 
histone acetyl transferase complex NuA4, are required for the expression of virulence factors 
and for pathogenesis in vivo (Lu et al., 2008; Raman et al., 2006). The yeast-to-hyphal transition 
is one biological property of C. albicans required for pathogenesis, and it is governed at least in 
part by epigenetic processes (Lu et al., 2008; Tebarth et al., 2003). To further address the role of 
chromatin remodeling proteins and epigenetic regulation on pathogenesis, we investigated the 
role of HDACs in the yeast-to-hyphal transition. 
We identified Tn7::UAU1 insertion clones located close to the START codon of HOS1 
(orf19.4411), HOS2 (orf19.5377), and RPD31 (orf19.6801) (Table A.1). When available, two 
clones were used to disrupt the same gene to enhance the robustness of the approach. 
(Tn7::UAU1 insertions were identified within additional HDACs, but these plasmids had complex 
or incomplete inserts (data not shown)). We generated hos1/hos1, hos2/hos2, and rpd31/rpd31 
mutants using the Tn7::UAU1 insertional mutagenesis system (Davis et al., 2002). The hda1Δ/Δ 
mutant was generated by sequential gene deletion using auxotrophic markers (Table A.1). All 
mutants were tested for filamentation in solid and liquid media (Figures A.1 and A.2 and Table 
A.2). Since HOS1 and RPD31 had little effect on filamentation (data not shown), we only 
describe the results for the hos2/hos2 and hda1Δ/Δ mutants. 
Several different environmental conditions induce the hyphal morphology in C. albicans. 
Incubation at body temperature (37°C), alkaline pH, starvation, and serum are some of the signals 
that trigger hyphal morphogenesis in this fungus (Biswas et al., 2007). Further, incubation on 
solid surfaces, liquid media, or embedment in a matrix also impact C. albicans morphogenetic 
responses (Brown et al., 1999; Ernst, 2000). Thus, we tested the ability of the HDACs mutants to 
filament in several different environmental conditions, including solid and liquid M199 pH 8, 
serum, and Spider media, solid SLAD medium, embedded agar, and liquid media supplemented 
with GlcNAc. The hos2/hos2 mutants consistently showed enhanced filamentation compared to 
the wild-type strain on most solid media tested (Figure A.1). On M199 pH 8, the hos2/hos2 
mutants filamented robustly, and showed a homogeneous peripheral halo of filamentation after 48 
hrs of incubation, ~24 hrs earlier than the wild-type strain (Figure A.1 and data not shown). 
Similar results were observed on Spider medium, in embedded agar, and on serum (Figure A.1). 
On SLAD, however, the hos2/hos2 mutants showed either no filamentation or irregular 
filamentation around some colonies (Figure A.1 and data not shown). Complementation of the 
hos2/hos2 mutation restored filamentation to wild-type levels in all media except SLAD. Lack of 
complementation on SLAD medium may indicate haploinsufficiency of HOS2, as reported 
previously for other mutants grown on SLAD, such as gap1∆/∆ and gpr1Δ/Δ (Biswas et al., 2003; 
Sciascia et al., 2004). An independent hos2Δ/Δ start-to-stop deletion mutant also showed 
enhanced filamentation, corroborating the results of the insertional mutations (data not shown). 
Thus, Hos2 functions as an inhibitor of filamentation, except in conditions of nitrogen starvation 
(SLAD) in which Hos2 function is required for morphogenesis. 
The hda1Δ/Δ mutant showed poor filamentation compared to the wild-type strain on 
most solid media tested (Figure A.1). On M199 pH 8 and SLAD, the hda1Δ/Δ mutant did not 
filament. On Spider medium, the hda1Δ/Δ mutant showed a slight but reproducible smoother 
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surface than the wild-type strain. In embedded agar, the hda1Δ/Δ mutant showed poor 
filamentation. On serum, the hda1Δ/Δ mutant showed a slight defect in hyphal formation. 
Complementation of the hda1Δ/Δ mutation restored filamentation to wild-type on M199 pH 8, 
Spider, embedded, and serum media, and partially rescued the defects on SLAD. Thus, Hda1 
functions as an inducer of filamentation. 
In liquid media, the hos2/hos2 strain filamented similarly to wild-type in all media tested 
(Figure A.2 and Table A.2). The hda1Δ/Δ mutant also filamented in all media tested, but the 
filaments of the hda1Δ/Δ mutant appeared shorter than wild-type. Accordingly, we detected a 
delay in hda1Δ/Δ mutant germ tube formation in M199 pH 8 and Spider media compared to the 
wild-type, hos2/hos2, and hda1∆/∆+HDA1 strains (Table A.2). We noted that the results obtained 
in liquid media were more variable compared to solid media. Since changes in gene silencing 
occurs over several generations (Xu et al., 2006; Katan-Khaykovich and Struhl, 2005), the rapid 
induction of filamentation in liquid medium may be more susceptible to variations than in solid 
media because of the differences in incubation time (<1 hr vs >24 hrs, respectively). This 
difference between liquid and solid medium filamentation may also be due to the fact that liquid 
filamentation is assessed at the single cell level while solid filamentation is assessed at the 
population (colony) level (Xu et al., 2006). While the requirement for several generations in order 
for silencing to be altered may explain the disparate results for the hda1Δ/Δ mutant in solid vs. 
liquid media, it is also possible that Hda1 might be associated with regulators of filamentation 
that play a more prominent role in solid compared to liquid media. Differences in the function of 
regulators of hyphal formation in C. albicans when cells are incubated in solid, semi-solid, or 
liquid media have been previously described (Brown et al., 1999; Ernst, 2000; Bockmuehl et al., 
2001; Bastidas et al., 2009). Overall, our results demonstrate that the HDACs HOS2 and HDA1 
have opposing roles in the regulation of hyphal formation in C. albicans. 
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DISCUSSION 
Epigenetic mechanisms regulate virulence traits of diverse microbes, including 
Trypanosoma brucei and Candida glabrata (Figueiredo et al., 2008; Domergue et al., 2005). 
Epigenetic mechanisms also regulate aspects of C. albicans pathogenesis. Set1, a histone 
methyltransferase, the chromatin remodeling complex Swi/Snf, the histone acetyltransferase 
NuA4 complex, and the HDAC Sin3 regulate morphogenesis, adherence to epithelial cells, and/or 
are required for pathogenesis in animal models (Lu et al., 2008; Raman et al., 2006; Mao et al., 
2006). Furthermore, histone acetylation, regulated by the SAGA/ADA coactivator complex is 
required for the proper response to oxidative stress and antifungals (Sellam et al., 2009). White-
opaque switching is regulated by transcriptional feedback loops and HDACs (Klar et al., 2001; 
Hnisz et al., 2009; Srikantha et al., 2001; Zordan et al., 2007). HDACs function is also required 
for antifungal resistance and adhesion to human pneumocytes (Smith and Edlind, 2002; Mai et 
al., 2007; Simonetti et al., 2007; Pfaller et al., 2009). Therefore, epigenetic mechanisms play an 
important role in the pathogenesis of C. albicans. 
Here, we show that Hos2 and Hda1 regulate the yeast-to-hyphal transition in opposing 
ways. Previously, Hos2 and Hda1 were reported to have opposing effects on white-opaque 
switching (Hnisz et al., 2009; Srikantha et al., 2001). This suggests that Hos2 and Hda1 may 
inversely govern a common set of genes. Histone deacetylation is usually associated with 
transcriptional repression (Grozinger and Schreiber, 2002; Yang and Seto, 2003). However, 
HDACs are also required for gene expression, and it has been proposed that acetylation and 
deacetylation cycles are responsible for maintaining promoter activity (De Nadal et al., 2004; 
Wang et al., 2002; Clayton et al., 2006). HDACs can deacetylate histones globally (non-targeted 
deacetylation) or at specific promoters to which they are tethered in complex with specific 
transcription factor and other DNA binding proteins (targeted deacetylation) (Kadosh and Struhl, 
1998; Kurdistani et al., 2002). Thus, one possible mechanisms of Hos2 and Hda1 function on 
filamentation in C. albicans is through the association with transcriptional regulators of hyphal 
formation, including the positive regulators Cph1, Cph2, Efg1, Tec1, Bcr1, Czf1, and/or Rim101, 
and the negative regulators Nrg1, Tup1, Rfg1, and/or Sfl1 (Biswas et al., 2007; Brown et al., 
1999; Bauer and Wendland, 2007; Braun et al., 2001; Davis et al., 2000; Khalaf and Zitomer, 
2001). For example, Hos2 and Hda1 have been associated with Tup1 and Efg1 function in S. 
cerevisiae and C. albicans, respectively (Davie et al., 2003; Green and Johnson, 2004; Hnisz et 
al., 2010). HDACs could also impact filamentation by affecting the expression of the regulators 
themselves (Srikantha et al., 2001; Tebarth et al., 2003) or by deacetylating transcription factors 
and other non-histone proteins that have a direct or indirect role in morphogenesis (Wang et al., 
2002; Kurdistani et al., 2002; Glozak et al., 2005; Yang and Gregoire, 2005; Kadosh and Struhl, 
1997; Watson et al., 2000; Robyr et al., 2002). Thus, Hos2 and Hda1 might impact hyphal 
formation through a diverse array of mechanisms. 
Why is HOS2 required for filamentation in SLAD but acts as an inhibitor of hyphal 
formation in all other conditions tested? In C. albicans, hyphal formation on SLAD is modulated 
by transcription factors, some of which function specifically during nitrogen starvation, such as 
Gln3. It is possible that Hos2 is required for the function of these specific transcription factors. 
Alternatively, loss of Hos2 may promote expression of genes that inhibit morphogenesis during 
nitrogen starvation. Thus, the hos2Δ/Δ effect on morphogenesis in C. albicans varies with the 
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environmental conditions, a phenomenon that has also been observed for the histone deacetylase 
Set3 (Hnisz et al., 2010). 
HDAC inhibitors have been proposed as antifungal adjuvants, due to their effect on 
preventing antifungal resistance in vitro (Smith and Edlind, 2002; Mai et al., 2007; Pfaller et al., 
2009). However, no studies have shown the efficacy of HDAC inhibitors as antifungals in vivo. 
These types of experiments become even more critical in lieu of our and others findings that 
HDACs have differential effects on hyphal formation. Previous reports show conflicting in vitro 
results on the effect of different HDAC inhibitors on germ tube formation in liquid serum (Smith 
and Edlind, 2002; Simonetti et al., 2007). However, inhibiting HDAC function could enhance 
filamentation in semi-solid surfaces (Figure A.1) (such as mucosas), possibly leading to enhanced 
tissue invasion and biofilm formation, with the potential to cause more damage and increase 
antifungal resistance (Niimi et al., 2010). On the contrary, the use of specific HDAC inhibitors 
might enhance antifungal effectiveness by limiting hyphal development (e.g. against Hda1 
(Figure A.1)), or by limiting yeast development (e.g. against Hos2 (Figure A.1) and (Hnisz et al., 
2010)). The critical role of HDACs in C. albicans pathogenesis and survival to antifungal 
treatment underscores the necessity to study HDAC function in this organism. A combination of 
in vitro and in vivo studies that assess the role of HDACs in biofilm development, genomic 
instability, colonization, survival, and pathogenesis could determine the potential of HDAC 
inhibitors as antifungal drugs. Overall, our results contribute to demonstrate the importance of 
epigenetic regulators in governing virulence traits in C. albicans, and support the potential of 
HDAC inhibitors to prevent and/or treat candidal infections.  
 
 2
7
2 
Table A.1. List of mutants in histone deacetylases, the mutagenesis strategies, and corresponding TIGR CAG clones 
ORF19 Gene Clone ID Mutagenesis strategy pDDB# Strain 
orf19.4411 HOS1 36246 Tn7 insertion clone CAGLH56 362 DAY1249 
orf19.5377 HOS2 51640 Tn7 insertion clone CAGN203 363 DAY1242 
orf19.5377 HOS2 17390 Tn7 insertion clone CAGFC21 357 DAY1243 
orf19.2772 HOS3 65221 Tn7 insertion clone CAGR472 365 DAY1248 
orf19.6801 RPD31 38517 Tn7 insertion clone CAGJX54 361 DAY1247 
orf19.6801 RPD31 32377 Tn7 insertion clone CAGH755 358 DAY1246 
orf19.2606 HDA1 - Start-to-stop deletion  DAY694 
 
Table A.2. Germ tube formation delay of the hda1Δ/Δ mutant in M199 pH 8 and Spider media 
Strain % germ tube ± SE 
  M199 pH 8 Spider 
DAY185 Wild-type 62.5 ± 2.4 71.2 ± 4.3 
DAY1252 hos2/hos2 69.8 ± 2.8 71.0 ± 4.2 
DAY1250 hos2/hos2 + HOS2 66.1 ± 3.4 77.5 ± 3.2 
DAY1240 hda1Δ/Δ 27.3 ± 2.8** 55.2 ± 3.8* 
DAY1241 hda1Δ/Δ + HDA1 67.2 ± 2.2 72.7 ± 2.5 
Mean (% germ tubes) ± SE (Standard Error) of two independent experiments (n=6). * p<0.03, ** p<0.003. Statistical analysis was performed 
using two tailed, paired T-Test. 
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Table A.3. C. albicans strains 
Strain Parent Genotype Reference 
DAY1 
(BPW17) 
SC5314 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG 
arg4::hisG/arg4::hisG 
(Wilson et al., 
1999)  
DAY185 DAY286 ura3::λimm434/ura3::λimm434  pHIS1::his1::hisG/his1::hisG  
ARG4::URA3::arg4::hisG/arg4::hisG 
(Davis et al., 
2002)  
DAY1242 DAY1 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG 
arg4::hisG/arg4::hisG  hos2::Tn7::ARG4/hos2::Tn7::URA3 
This study 
DAY1243 DAY1 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG 
arg4::hisG/arg4::hisG  hos2::Tn7::ARG4/hos2::Tn7::URA3 
This study 
DAY1246 DAY1 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG 
arg4::hisG/arg4::hisG  rpd31::Tn7::ARG4/ rpd31::Tn7::URA3 
This study 
DAY1247 DAY1 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG 
arg4::hisG/arg4::hisG  rpd31::Tn7::ARG4/ rpd31::Tn7::URA3 
This study 
DAY1249 DAY1 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG 
arg4::hisG/arg4::hisG  hos1::Tn7::ARG4/hos1::Tn7::URA3 
This study 
DAY694 DAY1 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG 
arg4::hisG/arg4::hisG  hda1::ARG4/hda1::URA3-dpl200 
This study 
DAY1250 DAY1242 ura3::λimm434/ura3::λimm434  
pHIS1::HOS2::his1::hisG/his1::hisG arg4::hisG/arg4::hisG  
hos2::Tn7::ARG4/hos2::Tn7::URA3 
This study 
DAY1251 DAY1243 ura3::λimm434/ura3::λimm434  
pHIS1::HOS2::his1::hisG/his1::hisG arg4::hisG/arg4::hisG  
hos2::Tn7::ARG4/hos2::Tn7::URA3 
This study 
DAY1252 DAY1242 ura3::λimm434/ura3::λimm434  pHIS1::his1::hisG/his1::hisG 
arg4::hisG/arg4::hisG  hos2::Tn7::ARG4/hos2::Tn7::URA3 
This study 
DAY1253 DAY1243 ura3::λimm434/ura3::λimm434  pHIS1::his1::hisG/his1::hisG 
arg4::hisG/arg4::hisG  hos2::Tn7::ARG4/hos2::Tn7::URA3 
This study 
DAY1241 DAY694 ura3::λimm434/ura3::λimm434  
pHIS1::HDA1::his1::hisG/his1::hisG arg4::hisG/arg4::hisG  
hda1::ARG4/hda1::URA3-dpl200 
This study 
DAY1240 DAY694 ura3::λimm434/ura3::λimm434  pHIS1::his1::hisG/his1::hisG 
arg4::hisG/arg4::hisG  hda1::ARG4/hda1::URA3-dpl200 
This study 
DAY1305 DAY1249 ura3::λimm434/ura3::λimm434  pHIS1::his1::hisG/his1::hisG 
arg4::hisG/arg4::hisG  hos1::Tn7::ARG4/hos1::Tn7::URA3 
This study 
DAY1306 DAY1246 ura3::λimm434/ura3::λimm434  pHIS1::his1::hisG/his1::hisG 
arg4::hisG/arg4::hisG  rpd31::Tn7::ARG4/ rpd31::Tn7::URA3 
This study 
DAY1307 DAY1247 ura3::λimm434/ura3::λimm434  pHIS1::his1::hisG/his1::hisG 
arg4::hisG/arg4::hisG  rpd31::Tn7::ARG4/ rpd31::Tn7::URA3 
This study 
DAY414 
(L40) 
S. 
cerevisiae 
MATα  his3∆200  trp1-901  leu2-3,-112  ade2 LYS2::(lexAop)4-
HIS3  URA3::(lexAop)8-lacZ  GAL4 
(Vojtek et al., 
1993) 
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Table A.4. Primers used in this study 
Name Sequence (5’to 3’) Reference 
HOS2 DDB78 comp 5' ACGACGGCCAGTGAATTGTAATACGACTCACTATAGGGCGCCAATCACAGAACTCAAGGC This study 
HOS2 DDB78 comp 3' AAGCTCGGAATTAACCCTCACTAAAGGGAACAAAAGCTGGCTATCTTGTTAATTGATGGG This study 
HDA1 5' comp AAGCTCGGAATTAACCCTCACTAAAGGGAACAAAAGCTGGTCATCTGCTCTCCATTGACG This study 
HDA1 3' comp ACGACGGCCAGTGAATTGTAATACGACTCACTATAGGGCGGAATTTAATGAACCCGATGG This study 
HDA1 5-1 comp ATATATCCATATCCGGCTGG This study 
HDA1 3-1 comp TTCTGGTATGCACGACGGTG This study 
ARG4-detect GGAATTGATCAATTATCTTTTGAAC This study 
FC21 5detect TTTTTACAATCGATAACTCC This study 
FC21 3detect ACGTTGGTTGAAATTTCGTG This study 
N203 5detect CCAATATATAACCATAGGAG This study 
N203 3detect GGCAATATCTGACATTCCTG This study 
H755 5detect GCTGATATTGGGAATTATGC This study 
H755 3detect GCTTCTTCAACACCATCACC This study 
JX54 5detect GCCGCCAGATTGAATCGTGG This study 
JX54 3detect CCACCAACTACCATCATTGG This study 
R472 5detect GCATTTGAAACAACATTGAC This study 
R472 3detect GCCAATAATCGTTGTGGACG This study 
LH56 5detect CCCGTCCAATAAGGGAAGAC This study 
LH56 3detect CAACCCCATCCCCATGATGC This study 
HDA1 3DR CAATCTTCGGAAGAGGAGTAGTCTTCAATTGAATCTAATATGAAATCTACTCCTTCATCGTGGAATTGTGAGCGGATA This study 
HDA1 5DR ATGTCGACTGGTCAAGAAGAACATCTAGATTCTAAGCTAGAAAATCAAATCTCAGAGGATTTCCCAGTCACGACGTT This study 
HDA1 5-detect ATAGAAGCTACCATTTTCAC This study 
HDA1 3-detect AGAGATTTCCTAGTTATGTG This study 
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FIGURES 
 
Figure A.1: HDACs regulate filamentation on solid media. Overnight cultures of C. albicans 
wild-type (DAY185), hos2/hos2 (DAY1252), hos2/hos2 +HOS2 (DAY1250), hda1Δ/Δ 
(DAY1240), and hda1Δ/Δ +HDA1 (DAY1241) strains grown in YPD at 30°C were: spotted onto 
M199 buffered to pH 8; serially diluted in PBS up to ~100 CFU and plated on Spider and SLAD 
media; diluted 1:1000 in 2 ml fresh YPD, incubated 4 hrs at 30°C and 8µl were plated in 
embedded agar; streaked in synthetic complete medium supplemented with 4% bovine calf serum 
(BCS). All plates were incubated at 37°C, except for embedded agar which was incubated at 
23°C. A minimum of three independent repetitions for each filamentation assay was performed.  
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Figure A.2: HDACs regulate filamentation in liquid media. Overnight YPD cultures of C. 
albicans wild-type (DAY185), hos2/hos2 (DAY1252), hos2/hos2 +HOS2 (DAY1250), hda1Δ/Δ 
(DAY1240), and hda1Δ/Δ +HDA1 (DAY1241) strains were washed in PBS, diluted 1:100 in 
M199 pH 8, Spider, YP+10% BCS, and YP+0.5% GlcNAc media and incubated 3 hrs at 37°C.  
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LOW DOSAGE OF HISTONE H4 LEADS TO GROWTH DEFECTS AND 
MORPHOLOGICAL CHANGES IN CANDIDA ALBICANS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Zacchi, L.F., Selmecki, A.M., Berman, J., Davis, D.A. (2010). Low dosage of histone H4 leads 
to growth defects and morphological changes in Candida albicans. PLoS ONE.  5(5):e10629 
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SUMMARY 
Chromatin function depends on adequate histone stoichiometry. Alterations in histone 
dosage affect transcription and chromosome segregation, leading to growth defects and 
aneuploidies. In the fungal pathogen Candida albicans, aneuploidy formation is associated with 
antifungal resistance and pathogenesis. Histone modifying enzymes and chromatin remodeling 
proteins are also required for pathogenesis. However, little is known about the mechanisms that 
generate aneuploidies or about the epigenetic mechanisms that shape the response of C. albicans 
to the host environment. Here, we determined the impact of histone H4 deficit in the growth and 
colony morphology of C. albicans. We found that C. albicans requires at least two of the four 
alleles that code for histone H4 (HHF1 and HHF22) to grow normally. Strains with only one 
histone H4 allele show a severe growth defect and unstable colony morphology, and produce 
faster-growing, morphologically stable suppressors. Segmental or whole chromosomal trisomies 
that increased wild-type histone H4 copy number were the preferred mechanism of suppression. 
This is the first study of a core nucleosomal histone in C. albicans, and constitutes the prelude to 
future, more detailed research on the function of histone H4 in this important fungal pathogen. 
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INTRODUCTION 
 Candida albicans is a major human fungal pathogen and is the fourth most common 
cause of nosocomial bloodstream infections (Pfaller et al., 2001). C. albicans is a common 
commensal of the skin and mucosa, and often causes superficial, non-life threatening infections at 
these sites (Calderone, 2002). However, in immune-compromised individuals C. albicans can 
cause systemic infections, which have a mortality rate of > 30% even in patients undergoing 
antifungal therapy (Pfaller et al., 1998). The steady increase in the population of immune-
compromised individuals due to modern medical practices such as chemotherapy and organ 
transplantation, as well as because of the AIDS epidemic continues to provide niches for the 
development of C. albicans systemic and mucosal infections. 
C. albicans pathogenesis has been increasingly linked to alterations in chromosome 
structure and dynamics. C. albicans strains with altered karyotypes are frequently isolated from 
clinical samples, from passage through mammalian hosts, and by growth in specific carbon 
sources or antifungals in vitro (Forche et al., 2009; Rustchenko, 2007). C. albicans has a high 
tolerance to aneuploidies, perhaps because they provide a source for phenotypic variation, critical 
for survival and pathogenesis (Rustchenko-Bulgac et al., 1990). Aneuploidies are associated with 
antifungal resistance, metabolic changes, and mating (Perepnikhatka et al., 1999; Janbon et al., 
1998; Rustchenko et al., 1994; Selmecki et al., 2006; Wu et al., 2005; Magee and Magee, 2000; 
Coste et al., 2007). Altered karyotypes have also been associated with variations in colony 
morphology (Forche et al., 2005, 2009; Rustchenko-Bulgac et al., 1990; Suzuki et al., 1989). 
However, the mechanisms that promote ploidy changes and genomic rearrangements are not well 
understood. 
Histone modifying enzymes and chromatin remodeling proteins also contribute to the 
regulation of pathogenesis traits. For example, mutants in histone deacetylases, methylases,  
acetyltransferases, and members of chromatin remodeling complexes show defects in yeast-
hyphal transitions, white-opaque switching, adhesion to epithelial cells, and/or antifungal and 
stress resistance (Hnisz et al., 2009; Klar et al., 2001; Lu et al., 2008; Mao et al., 2006; Raman et 
al., 2006; Srikantha et al., 2001; Smith and Edling, 2002; Sellam et al., 2009). Therefore, changes 
in the structure and function of the chromatin leads to epigenetic defects and potentially to 
karyotypic variations that have a direct impact on C. albicans virulence. 
Chromatin is a dynamic structure composed of DNA and DNA binding proteins that 
allows for an efficient storage and usage of the genetic information. The basic unit of chromatin 
architecture is the nucleosome, which is composed of the evolutionary conserved histones H2A, 
H2B, H3 and H4 assembled in a hetero-octamer of two H2A/H2B dimers and one H3/H4 
tetramer. The DNA is wrapped around the nucleosome, constituting the first level of chromatin 
compaction. Due to this intimate relationship with the DNA, histones are involved in all 
processes associated with chromatin structure and function, including transcription, replication, 
DNA repair, recombination, and chromosome segregation. Histones participate in the regulation 
of these processes by providing a platform to transmit information to other proteins (e.g. DNA 
and RNA polymerases) through posttranslational modifications in their residues (Jenuwein and 
Allis, 2001; Taverna et al., 2007) and through nucleosomal occupancy of regulatory regions in 
the DNA (Workman, 2006; Li et al., 2007). Thus, histones constitute the primary regulators of 
chromatin activity. 
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Alterations in histone availability have profound effects on the cell. Unbalanced histone 
dimer stoichiometry causes defects in the segregation of mitotic chromosomes, increases 
recombination and genetic instability, and leads to sporulation defects in S. cerevisiae (Kim et al., 
1988; Meeks-Wagner and Hartwell, 1986; Smith et al., 1996; Au et al., 2008; Tsui et al., 1997; 
Hanlon et al., 2003; Norris and Osley, 1987; Saunders et al., 1990; Venditti et al., 1999; Prado 
and Aguilera, 2005). Furthermore, incomplete nucleosomal occupancy due to histone dosage 
defects directly impacts transcriptional regulation (Han and Grunstein, 1988; Han et al., 1988; 
Wyrick et al., 1999; Clark-Adams et al., 1988; Durrin et al., 1992; Lee et al., 2004; Svaren and 
Horz, 1993). Therefore, alterations in histone stoichiometry have pleiotropic effects in cells. 
In this study we performed serial deletions of C. albicans histone H4 genes and 
determined the effect of a deficit in histone H4 on growth. We found that reduced histone H4 
dosage caused a severe growth defect and the formation of colony morphology variants. C. 
albicans primarily counterbalanced the low dosage of histone H4 by increasing histone H4 gene 
copy number through the formation of aneuploidies. Suppression of the growth defect associated 
with low histone H4 dosage also restored colony morphology to the wild-type morphology. This 
is the first study on core histones in C. albicans, which provides background genetic information 
for future experiments that address the role of chromatin structure and function in C. albicans 
biology and pathogenesis. 
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MATERIALS AND METHODS 
Strains and plasmids 
All strains used in this study are listed in Table B.1. Strain DAY1069 was generated as 
follows. BWP17 was transformed with a hht2-hhf22::URA3-dpl200 disruption cassette amplified 
in a PCR using primers HHT2-HHF22 5DR and 3DR new (Table B.2) to give strain DAY1067. 
DAY1067 was then transformed with a hht2-hhf22::ARG4 disruption cassette amplified as above. 
The hht2-hhf22 disruption cassettes delete the region from nucleotide +329 of HHT2 to the stop 
codon of HHF22 (Figure B.1). The URA3-dpl200 marker from strain DAY1069 was recycled by 
plating the cells in synthetic medium supplemented with 5-fluoroorotic acid (5-FOA) to obtain 
strain DAY1071. Strain DAY1072 was generated by replacing nucleotide +114 to the stop codon 
of one HHF1 alleles in DAY1071 using the hhf1::URA3 disruption cassette, which was amplified 
in a PCR using primers HHF1 5DR 100 in and HHF1 3DR new (Figure B.1 and Table B.2). 
DAY1068 was generated by transforming strain BWP17 with the hhf1::URA3-dpl200  
disruption cassette (Figure B.1) to generate strain DAY1066, followed by transformation with the 
hht2-hhf22::ARG4 disruption cassette (Table B.2). Strain DAY1070 was obtained by plating 
DAY1068 in synthetic medium supplemented with 5-FOA to recycle the URA3-dpl200 marker. 
Strains DAY1074, DAY1076 and DAY1078 were generated by partially deleting the last HHF1 
copy from DAY1070 using an hhf1::URA3 disruption cassette amplified from plasmid DDB383 
with primers HHF1 5’ fragm DDB78 and HHF1 3’ fragm DDB78. Plasmid DDB383 contains the 
disruption cassette bordered by additional HHF1 flanking regions in order to increase the 
efficiency of integration into the HHF1 locus. Strains DAY1075 and DAY1079 are large colony 
revertants of strains DAY1074 and 1078, respectively. The genotypes of the strains and the 
correct integration of the disruption cassettes were verified by the PCR using primers HHF1 5 
detect, HHF1 3 detect, HHT2-HHF22 5 detect and HHT2-HHF22 3’detect-new that flank the 
integration site (Table B.2), and by Southern blot. 
Plasmid DDB383 was generated by in vivo recombination as follows. An hhf1::URA3 
disruption cassette was amplified in a PCR from DDB245 (Wilson et al., 1999) using primers 
HHF1 5’ 100 in for DDB78 and HHF1 3’ for DDB78 (Table B.2). The two flanking HHF1 
regions of 570 bp and 523 bp with homology upstream (including the first 113 nucleotides of 
HHF1) and downstream of HHF1, respectively, were amplified in two high fidelity PCRs (Pfu 
Turbo DNA polymerase, Stratagene) from BWP17 genomic DNA using the primer pairs HHF1 
5’ fragm DDB78 and HHF1 5’ fragm 3’, and HHF1 3’ fragm DDB78 and HHF1 3’ fragm 5’, 
respectively. The three PCR products were co-transformed with a NotI/EcoRI double digestion of 
DDB78 into trp
-
 Saccharomyces cerevisiae L40 strain to generate DDB383.  
 
Media and growth conditions 
C. albicans was routinely grown at 30ºC in YPD supplemented with uridine (2% bacto-
peptone, 1% yeast extract, 2% dextrose, and 80 µg ml
-1
 of uridine). Mutants were selected on 
synthetic medium (0.17% yeast nitrogen base without ammonium sulfate (Q-BioGene), 0.5% 
ammonium sulfate, 2% dextrose, and supplemented with a dropout mix containing amino and 
nucleic acids except those necessary for the selection (Adams et al., 1997). Solid media were 
prepared by addition of 2% Bacto-agar. 
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Southern blot and comparative genomic hybridizations 
 For the HHF1 and HHF22 dosage experiments, genomic DNA was digested with HindIII 
or NcoI, respectively (Figure B.1), separated in a 1.2% agarose gel by electrophoresis, and 
transferred by capillary action to a nylon membrane. Probes D (for HHF1) and G (for HHF22) 
were PCR amplified from C. albicans BWP17 genomic DNA using primer pairs HHF1 5’ fragm 
5’ and HHF1 5’ fragm 3’, and HHF22 5’ SB and HHF22 3’ detect, respectively (Figure B.1 and 
Table B.2). The probes were radiolabelled with [α-32P]-dCTP using the Prime-a-Gene labeling 
system (Promega). Blots were developed with a phosphoimager (STORM system). Densitometry 
analysis of the images was performed using ImageJ 1.30v (Wayne Rasband, NIH, USA). For 
comparative genomic hybridizations (CGH), genomic DNA was prepared from C. albicans 
strains grown overnight to saturation in 5 ml YPAD medium using phenol/chloroform as 
described (Hoffman and Winston, 1987). 3 µg of DNA was digested with HaeIII (Invitrogen), 
labeled with Cy3 (experimental strains) or Cy5 (reference strain, SC5314), and hybridized to 
microarrays as described previously (Selmecki et al., 2005). The microarrays were printed in-
house and contain 14,688 total spots, representing 6175 ORFs, designed using Assembly six C. 
albicans ORFs (Bensen et al., 2004) and updated with Assembly 19 ORFs. Arrays were scanned 
(ScanArray 5000) using QuantArray v.2.01 software (GSI Lumonics, Watertown, MA). Data 
were analyzed using GenePixPro 5.1 and GeneTraffic 3.1. The average mean log2 ratio average 
of two duplicate spots per microarray slide was calculated and plotted as a function of 
chromosome position using Chromosome_Map (Selmecki et al., 2005). 
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RESULTS AND DISCUSSION 
Histone H3 and H4 genes in Candida albicans 
 Several characteristics of histones H3 and H4 prompted us to focus on them for the 
purpose of this study. First, histones H3 and H4 show greater conservation than histones H2A and 
H2B (Thatcher and Gorovsky, 1994). Second, the H3/H4 tetramer has a more critical role in 
nucleosome assembly and chromatin condensation, as the H3/H4 tetramer interacts more strongly 
with the central portion of the nucleosomal DNA than the H2A/H2B dimers (Pruss et al., 1995; 
Dorigo et al., 2003), and it has the ability to block transcriptional elongation in vitro (Chang and 
Luse, 1997). Third, the effect of histones H3 and H4 posttranslational modifications is better 
understood and includes modifications in both the amino terminal tail and globular core domains 
(Zhang et al., 2003; Hyland et al., 2005). Based on the higher conservation, the prominent role in 
chromatin structure, and the extensive knowledge on histone H3 and H4 posttranslational 
modifications, we focused on the histone H3-H4 cluster and, in particular, on histone H4, for 
reasons discussed below.  
Most eukaryotes, including C. albicans, contain multiple copies of histone H3 and H4 
genes, which are generally organized in clusters (Osley, 1991). The S. cerevisiae genome 
contains two genes, HHT1 and HHT2, which encode identical proteins for the canonical histone 
H3 isoform. The C. albicans genome contains three genes that encode histone H3: HHT1 
(orf19.6791), HHT2 (orf19.1853), and HHT21 (orf19.1061). HHT2 and HHT21 encode identical 
histone H3 isoforms, whereas HHT1 encodes a histone H3 with three differences when compared 
to HHT2/21: a non-conserved S32V change, and two conserved S33T and S81T changes (Figure 
B.2A). When compared to S. cerevisiae HHT1/2, there are five amino acid differences, which are 
found in all three C. albicans histone H3 genes and are located in the C terminal half of the 
protein (Figure B.2A).  
Similar to S. cerevisiae and Schizosaccharomyces pombe (Matsumoto and Yanagida, 
1985; Smith and Andresson, 1983), C. albicans HHT2 and HHT21 are divergently transcribed 
from the histone H4 genes HHF22 (orf19.1059) and HHF1 (orf19.1854), respectively. HHT2-
HHF22 is on chromosome R; HHT21-HHF1 is on chromosome 1 (Figure B.1). HHT1, on 
chromosome 3, is unique in that it is not paired with a histone H4 gene. Unpaired histone genes 
are also observed in other fungi, including S. pombe, which has an unpaired histone H2A 
(Matsumoto and Yanagida, 1985; Smith and Andresson, 1983; Choe et al., 1985). HHT2 and 
HHT21 are located 900-1000 bp from their cognate histone H4 gene and likely share the same 
promoter. However, we noted a potential open reading frame (ORF), orf19.1060, within the 
HHT21-HHF1 intergenic region (Figure 1).  This ORF can encode a protein of 169 residues. 
However, this predicted protein has no significant homology to other proteins or identifiable 
motifs, suggesting that orf19.1060 is a spurious ORF. Therefore, the genomic arrangement of the 
H3/H4 cluster in C. albicans is similar to S. cerevisiae, except for the presence in C. albicans of a 
single unpaired, divergent third histone H3 gene. 
Since Hht1 has a divergent amino acid sequence compared to Hht2/21 and is expressed 
independent of a histone H4, we propose that Hht1 is a histone H3 variant. Histone variants are 
usually replication-independent, diverge from the canonical histone sequences, and have a 
different function (Ausio et al., 2001; Stein et al., 1992). For example, Drosophila melanogaster 
and vertebrates express histone H3.3, a canonical histone H3 variant that differs in four amino 
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acids, three of which are clustered in the histone fold domain (Fretzin et al., 1991; Wells et al., 
1989; Ahmad and Henikoff, 2002a, b). Although all three C. albicans histone H3s are of the H3.3 
class and the amino acid differences in Hht1 are not within the histone fold domain, Hht1 might 
still constitute a histone H3 variant. In particular, the S32V change in Hht1 could affect 
epigenetic regulatory events as it eliminates a potential phosphorylation site in the N-terminus tail 
of Hht1 (Hake et al., 2005; Wong et al., 2009). Thus, HHT1 may encode a histone H3 
homomorphic variant. 
 The C. albicans genome contains two genes, HHF1 and HHF22, that encode identical 
histone H4 proteins. The S. cerevisiae genome also encodes two identical histone H4 proteins. 
Comparison of C. albicans Hhf1/22 to S. cerevisiae Hhf1/2, revealed seven amino acids 
differences (Figure B.2B). Therefore, the genomic arrangement of histone H4 genes in C. 
albicans is similar to S. cerevisiae. Since C. albicans contains three non-allelic histone H3 genes 
as well as a heteromorphic histone H3 variant Cse4, which replaces histone H3 in centromeric 
chromatin (Ketel et al., 2009; Sanyal and Carbon, 2002), we focused our studies on histone H4, 
which is encoded by two genes and is present in all nucleosomes. 
 
Reduced histone H4 dosage impairs C. albicans growth. 
 Previous work in S. cerevisiae, S. pombe, and D. melanogaster showed that alterations in 
the dosage of the core nucleosomal histones can lead to pleiotropic phenotypes, including growth 
and cell cycle defects, chromosomal and telomere instability and gene expression deregulation 
(Kim et al., 1988; Meeks-Wagner and Hartwell, 1986; Norris and Osley, 1987; Venditti et al., 
1999; Han and Grunstein, 1988; Han et al., 1988; Clark-Adams et al., 1988; Smith and Stirling, 
1988; Castillo et al., 2007; Moore et al., 1983). In order to understand the effects of altering 
histone H4 dosage in C. albicans, sequential deletions of three of the four histone H4 alleles were 
performed. 
First, we generated a deletion of the HHF22-HHT2 region, which lacks additional ORFs 
(Figure B.1). HHF22 and HHT2 were simultaneously deleted in order to reduce any potentially 
harmful effects of changing the histone H3/histone H4 ratio (Venditti et al., 1999; Clark-Adams 
et al., 1988; Castillo et al., 2007; Moran et al., 1990). The entire HHF22 ORF, 80% of the HHT2 
ORF, and the intergenic region were replaced by an auxotrophic marker cassette (Figure B.1). We 
were able to generate both HHF22-HHT2/hhf22-hht2∆ heterozygous and hhf22-hht2∆/∆ 
homozygous strains, and these strains had no overt growth or morphological phenotypes (Figure 
B.3A). This suggests that Hhf22 and Hht2 are not essential for growth. 
S. cerevisiae diploids containing a single H3-H4 locus have a longer generation time and 
a more prolonged G1 phase than wild-type cells (Smith and Stirling, 1988). Further, deletion of 
HHT2-HHF2 in S. cerevisiae, but not HHT1-HHF1, causes greater minichromosome loss 
compared to wild-type (Smith and Stirling, 1988), indicating that, although both H3-H4 loci are 
generally functionally redundant, there are differences between both loci. To determine if C. 
albicans has a different requirement for HHF1 or HHF22 for growth, we constructed a strain in 
which both copies of HHF1 were deleted. We were readily able to generate HHF1/hhf1∆ and 
hhf1∆/∆ strains, and these strains did not show growth or morphological defects (Figure B.3B and 
data not shown), indicating that Hhf1 is also not essential for growth in C. albicans. Therefore, 
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unlike in S. cerevisiae, in C. albicans the presence of either one of the histone H4 gene is 
sufficient to ensure normal growth and colony morphology. 
 When we attempted to mutate one copy of HHF1 in the hhf22-hht2∆/∆ background, we 
only recovered a single homologous recombinant (1 homologous recombinant/395 transformants 
screened). Similarly, when we attempted to mutate the remaining copy of HHF22-HHT2 copy 
from a HHF22-HHT2/hhf22-hht2∆ HHF1/hhf1∆ double heterozygote, we only recovered 
homologous recombinants 7% of the time (32 homologous recombinants/437 transformants 
screened). However, all of these recombinants retained a wild-type HHF22-HHT2 copy and arose 
by a marker exchange (29/32) or a by a increased HHF22-HHT2 copy number (3/32). To increase 
the rate of homologous recombination, we generated an hhf1::URA3 disruption cassette 
containing regions of homology ~9x larger than the original cassettes (Table B.2). Using this 
extended disruption cassette we increased homologous recombination in the hhf22-hht2∆/∆ strain 
to 50% (11/22). All hhf22-hht2∆/∆ HHF1/hhf1∆ transformants had a pronounced growth defect 
(Figure 3A) and gave rise to both smooth and wrinkly colonies of heterogeneous size (Figure 
B.4A and B). The difficulty in eliminating a third histone H4 gene and the severe growth defects 
observed in the mutant with only one HHF1 copy suggested that C. albicans might require at 
least two copies of histone H4 for normal growth. Alternatively, HHF22 might be the primary 
histone H4 gene in C. albicans. 
If HHF22 is indeed the primary histone H4 gene in C. albicans, we predicted that we 
could construct an HHF22/hhf22∆ hhf1∆/∆ mutant without impacting growth. To construct this 
mutant, we eliminated the last HHF1 copy from a HHF22-HHT2/hhf22-hht2∆ HHF1/hhf1∆ 
double heterozygous strain. As before, the use of longer regions of homology increased the rate 
of homologous recombinants (44/45). However, in most cases (40/44) the wild-type HHF1 copy 
was retained. While the HHF22-HHT2/hhf22-hht2∆ HHF1/hhf1∆ strain had no overt growth 
defects compared to wild-type colonies, the four HHF22-HHT2/hhf22-hht2∆ hhf1∆/∆ mutants 
obtained had severe growth defects (Figure B.3B). HHF22-HHT2/hhf22-hht2∆ hhf1∆/∆ strains 
also gave rise to heterogeneous colony sizes with both smooth and wrinkly morphologies (Figure 
B.4 and B.5). The similar growth defects in the HHF22-HHT2/hhf22-hht2∆ hhf1∆/∆ and hhf22-
hht2∆/∆ HHF1/hhf1∆ strains suggest that HHF22 is not the primary histone H4 gene. Rather, C. 
albicans growth is dependent on the presence of at least two copies of histone H4. 
 We noticed that both hhf22-hht2∆/∆ HHF1/hhf1∆ and HHF22-HHT2/hhf22-hht2∆ 
hhf1∆/∆ strains gave rise to larger colonies at a low frequency (Figure B.3 and B.4). We 
considered the possibility that the larger colonies contained stable suppressor mutations. To 
address this, we re-isolated small and large colonies on fresh medium. When re-isolated, hhf22-
hht2∆/∆ HHF1/hhf1∆ small colonies gave rise to primarily small colonies with distinct 
morphologies (Figure B.5), and a few large and always smooth colonies (Figure B.4C). However, 
hhf22-hht2∆/∆ HHF1/hhf1∆ large colonies gave rise to uniformly large and smooth colonies 
(Figure B.4C). Re-isolation of small colonies from the HHF22-HHT2/hf22-hht2∆ hhf1/hhf1∆ 
strain also gave rise to small colonies with distinct morphologies, and to large colonies (Figure 
B.4D and B.5). In contrast to the hhf22-hht2∆/∆ HHF1/hhf1∆ strain (Figure B.4E), re-isolation of 
large colonies from the HHF22-HHT2/hhf22-hht2∆ hhf1∆/∆ strain gave rise to primarily large 
colonies, but also occasionally to small colonies (Figure B.4F). When re-isolated, these small 
colonies behaved like the parental HHF22-HHT2/hhf22-hht2∆ hhf1∆/∆ small colonies (data not 
286 
 
shown), indicating that the suppressor phenotype may be reversible. These results suggest that the 
severe growth defect caused by the low dosage of both HHF1 and HHF22 confers a strong 
selective pressure for the generation of secondary suppressor, reversible mutations, which restore 
growth. Further, the differences observed in the emergence of small colonies during re-isolation 
of large colonies in both type of mutants is likely a consequence of how the stability of the 
suppressors that arose in the mutants. 
 
Aneuploidy as a mechanism for H4 dosage compensation in C. albicans 
 Two copies of histone H4 are necessary and sufficient for wild-type growth. Thus, we 
reasoned that the increased colony size and phenotypic stability observed in the large suppressor 
colonies reflected an increase in histone H4 copy number. Since aneuploidies are common in C. 
albicans strains (Rustchenko, 2007; Perepnikhatka et al., 1999; Janbon et al., 1998; Selmecki et 
al., 2005, 2006; Wu et al., 2005; Coste et al., 2007; Chen et al., 2004; Magee et al., 1992; Arbour 
et al., 2009; Diogo et al., 2009; Legrand et al., 2004), we hypothesized that the large suppressor 
colonies had duplicated the remaining histone H4 gene, thereby restoring the number of histone 
H4 alleles to two, which supports normal and phenotypically stable growth (Figure B.3). The 
duplication of large DNA fragments, including whole chromosomes, as a mechanism to suppress 
a slow growth defect has also been described in S. cerevisiae (Hughes et al., 2000). 
 In order to determine if the large colonies of the hhf22-hht2∆/∆ HHF1/hhf1∆ and 
HHF22-HHT2/hhf22-hht2∆ hhf1∆/∆ mutants had increased the number of wild-type H4 allele 
copies, we performed quantitative Southern blot analysis. Two probes, Probe D and Probe G, 
were designed to anneal equally to both the wild-type and the mutated versions of HHF1 or 
HHF22, respectively (Figure B.1). Densitometry analysis was performed on Southern blots of 
small and large colonies isolated from the mutants to determine the ratio of mutated to wild-type 
histone H4 allele (Figure B.6). We included the HHF22-HHT2/hhf22-hht2∆ HHF1/hhf1∆ 
heterozygous strain DAY1070 as a control, which had a 1:1.1 hhf22∆/HHF22 ratio by 
quantitative Southern blot (Figure B.6B). Indeed, the small colonies of the histone mutants 
retained a 1:0.9-1.1 ratio of mutated to wild-type H4 alleles while the large colonies presented a 
1:1.5-2.6 ratio of mutated to wild-type H4 alleles (Figure B.6A and B.6B). Thus, the large 
colonies of the hhf22-hht2∆/∆ HHF1/hhf1∆ and HHF22-HHT2/hhf22-hht2∆ hhf1∆/∆ mutants 
analyzed showed an increase in DNA associated with the wild-type histone H4 compared to the 
small colonies. Thus, the suppressor colonies arise by increasing the genomic dosage of histone 
H4. 
We reasoned that an increase in histone H4 copy number could involve either a 
segmental aneuploidy or a trisomy. Using comparative genome hybridization (CGH) arrays, we 
found that, as expected, a small colony of hhf22-hht2∆/∆ HHF1/hhf1∆ had a diploid content of 
chromosome 1 (Figure B.7). However, CGH analysis of a large suppressor colony derived from 
the hhf22-hht2∆/∆ HHF1/hhf1∆ small colony revealed a trisomy of chromosome 1. Thus, a 
reduction in histone H4 dosage causes a severe growth defect that can be overcome through 
whole chromosome aneuploidy to increase histone H4 copy number. While we cannot rule out 
segmental aneuploidy as a mechanism to restore histone H4 dosage, whole chromosome 
aneuploidy is clearly one mechanism that can restore histone H4 dosage. 
287 
 
We noted two additional aneuploidies in our CGH analysis. First, a segmental monosomy 
of one end of chromosome 5 in both the small and large colony (Figure B.7). This is an attribute 
of the RM1000 background from which these strains are descended which is known to have a 
stable deletion in one arm of chromosome 5 (Magee and Magee, 2000; Selmecki et al., 2005). 
Second, a whole chromosome monosomy in chromosome 3 was observed in the hhf22-hht2∆/∆ 
HHF1/hhf1∆ small colony, but not the large suppressor colony derivative. Defects on histone 
dosage have been implicated in the generation of aneuploidies and chromosome instability, and 
this may reflect evidence of that phenomenon in C. albicans. However, it is also possible that 
reduced chromosome 3 dosage provides some advantage to cells containing one histone H4 locus. 
 It is noteworthy that not all large colonies gave the expected 1:~2 ratio of mutant to wild-
type histone H4 by quantitative Southern blot (Figure B.6C). We found a 0:1 ratio (arbitrarily set 
to 1 as there was no mutant allele to normalize to), which lost the mutant histone H4 allele, a 1:1 
ratio, which maintained the ratio of the starting strain, and a ~2:1 ratio, which duplicated the 
mutant histone H4 allele. The 0:1 ratio found in large colonies indicates that the mutated version 
of the histone H4 was replaced with the wild-type histone H4 by mitotic recombination or by loss 
of the chromosome carrying the mutant allele followed by duplication of the remaining 
chromosome containing the wild type allele. The 1:1 ratio found in large colonies indicates that 
either the strain became tetrasomic for both loci or that there exist alternative suppressor 
mechanisms. The ~2:1 ratio found in large colonies indicates that the mutated version of the 
histone H4 was duplicated, perhaps causing a trisomy of part or all of chromosome R. This type 
of aneuploidy may restore growth, however we cannot rule out the possibility that chromosome R 
is found in a 4:2 mutant to wild-type ratio in these cells. In fact this latter possibility seems to be 
supported by the increased hhf22∆ and HHF22 signals observed in this sample (Figure B.6C). We 
noted that the large colonies carrying a 0:1, 1:1, and 1:2 ratio of mutant to wild-type histone H4 
had the typical smooth morphology, but the colonies carrying a 2:1 ratio showed a wrinkly top 
and were more heterogeneous in size (Figure B.6D). These differences in colony morphology are 
in agreement with the formation of alternative karyotypes (see below). The 0:1, 1:1, and 2:1 ratio 
for large colonies arose from the HHF22-HHT2/hhf22-hht2∆ hhf1∆/∆ mutant but not from the 
hhf22-hht2∆/∆ HHF1/hhf1∆ mutant, which suggests that Chromosome R is less stable than 
Chromosome 1. 
Since maintenance of genomic integrity is critical for survival, cells have different 
mechanisms to compensate for histone dosage defects, including genomic rearrangements and, 
more commonly, transcriptional alterations. Genomic rearrangements have been observed in S. 
cerevisiae, which can increase histone H2A-H2B copy number by forming a small circular 
chromosome (Libuda and Winston, 2006). Dosage compensation through transcriptional up-
regulation of histone gene expression has been observed both in S. cerevisiae, where the 
expression of one of the H2A-H2B loci (HTA1-HTB1) is regulated by the availability of histones 
H2A-H2B in the cell (Moran et al., 1990), as well as in S. pombe (Takayama and Takahashi, 
2007). Thus, while we observed an increase in gene copy number in the large colonies screened, 
we cannot rule out the possibility that C. albicans can increase histone H4 availability by 
transcriptional mechanisms.  
 We observed that while the large colonies of the hhf22-hht2∆/∆ HHF1/hhf1∆ strain were 
phenotypically stable, the large colonies isolated from the HHF22-HHT2/hhf22-hht2∆ hhf1∆/∆ 
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strain often gave rise to small colonies. This observation suggests that a Chromosome R trisomy 
(HHF22) is less stable than a Chromosome 1 trisomy (HHF1). Chromosome R has a variable 
electrophoretic mobility. These variations are found in natural isolates, in spontaneous 
morphological mutants, and in randomly selected colonies from a clonal population of a reference 
strain (Wickes et al., 1991; Asakura et al., 1991; Rustchenko et al., 1993). However, chromosome 
R variations are attributed to changes in the number of rDNA repeats, and not to ploidy changes 
(Rustchenko et al., 1993; Iwaguchi et al., 1992). A random gain and subsequent loss of an extra 
copy of Chromosome R might explain the slightly unstable phenotype of the large colonies with 
only HHF22. Acquiring a third Chromosome R copy would provide a selective growth advantage 
because it increases histone H4 copy number. However, excess of rDNA synthesis, or other 
chromosome R associated locus, could be deleterious for cells growing at suboptimal conditions 
(Rustchenko et al., 1993; Ganley et al., 2009; Warner, 1999). Thus, some suppressor cells might 
randomly lose the extra Chromosome R copy and revert to a slow growth small colony 
phenotype. Trisomy in Chromosome 1 might not have as negative an effect on growth, explaining 
the more stable colony morphology of the suppressors from strains with only a single allele of 
HHF1. In fact, some stocks of the routinely used laboratory strain CAI-4 are stably trisomic for 
Chromosome 1 under non-stress conditions with no obvious effects on growth or colony 
morphology (Chen et al., 2004). Therefore, the alterations in colony size observed in both histone 
H4 mutants could be attributed to the gain and loss of a segment or an entire copy of 
Chromosome R or Chromosome 1. 
 
Histone H4 deficit causes colony morphology changes 
When growing on agar plates at 30ºC, C. albicans normally forms smooth, round, cream-
colored colonies composed of yeast cells. Wrinkly colonies are generally composed of a higher 
percentage of cells that are filamenting, a fact that explains why it is possible to exacerbate some 
colony morphology phenotypic differences at 37ºC. Altered C. albicans colony morphologies 
have been detected in strains isolated from infected patients, from studies in mouse models, and 
can also be induced in the laboratory through UV irradiation and genetic manipulation (Forche et 
al., 2005, 2009; Soll et al., 1987, 1988, 1989; Garcia-Sanchez et al., 2005; Slutsky et al., 1985; 
Barton and Scherer, 1994). The changes in colony morphology are a manifestation of underlying 
genomic changes that can involve a group of genes (like in the white-opaque switching) or major 
karyotypic rearrangements (Rustchenko et al., 1994). Thus, alterations in diverse factors can lead 
to changes in colony morphology.  
When small, smooth colonies that carry only one H4 allele are sub-cultured onto a rich 
medium plate they give rise to colonies that have different morphologies (Figure B.5A). The 
change in colony morphologies of small colonies was generally penetrant, although they also 
gave rise to colonies with other types of morphologies (Figure B.5B). On the contrary, the large 
and smooth suppressor colonies did not produce colonies with altered morphology when they 
were sub-cultured, indicating that their colony morphology phenotype is stable (Figure B.5C). 
One exception to this statement is the already mentioned formation of small colonies from re-
streaking of the large colonies, which most likely arise by the loss of the duplicated chromosome 
R. 
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One explanation for the formation of semi-penetrant morphological variants in the 
histone mutants is karyotypic rearrangements. As previously mentioned, altered colony 
morphologies have been associated with altered karyotypes or with loss of heterozygozity 
(Rustchenko et al., 1994; Forche et al., 2009; Uhl et al., 2003). Imbalances in histone dosage can 
lead to chromosome missegregation (Kim et al., 1988; Meeks-Wagner and Hartwell, 1986; Smith 
et al., 1996; Au et al., 2008). Further, the histone mutants grow slowly, a condition that might be 
more permissive to the accumulation and tolerance of aneuploidies (Forche et al., 2009). This 
latter idea is supported by the presence of a monosomic chromosome 3 in a hhf22-hht2∆/∆ 
HHF1/hhf1∆ small colony (Figure B.7). Thus, karyotypic rearrangements favored by the 
combination of the slow growth and the nucleosomal deficit of the histone H4 mutants might be 
one mechanism behind the formation of colony variants. 
Candida albicans is the most important human fungal pathogen, causing serious 
infections in immunosuppressed individuals. C. albicans has a diploid genome with an 
unexpectedly high level of heterozygozity, given the primarily clonal reproductive style of this 
organism (Jones et al., 2004). The genome of C. albicans has a remarkably high tolerance for 
genomic rearrangements. The ability to thrive with an altered karyotype may provide a profound 
advantage to this organism, because it represents a potential source of genetic variation 
(Rustchenko, 2007). Karyotypic rearrangements and aneuploidies in C. albicans are associated 
with pathogenesis: they affect cellular and colonial morphology, increase metabolic diversity, are 
required for mating, and, importantly, constitute a mechanism of antifungal resistance. Histone 
modifying enzymes and chromatin remodeling proteins are also required for pathogenesis in C. 
albicans (Hnisz et al., 2009; Klar et al., 2001; Lu et al., 2008; Mao et al., 2006; Raman et al., 
2006; Srikantha et al., 2001; Smith and Edling, 2002; Sellam et al., 2005). The study of chromatin 
dynamics and structure in this fungus therefore is critical for understanding the nature of C. 
albicans pathogenicity and, furthermore, it may uncover potential targets for antifungal therapies. 
In this study, we have generated and characterized strains that can be used for future analysis of 
specific histone H4 mutant alleles, in order to begin to dissect the function and impact of 
epigenetic regulation in C. albicans lifestyle and pathogenesis. 
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Table B.1. Strains used in this study 
Strain Parent Genotype Reference 
DAY1 BWP17 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  arg4::hisG/arg4::hisG Wilson et al., 1999 
DAY286 DAY1 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  ARG4::URA3::arg4::hisG/arg4::hisG Davis et al., 2002 
DAY963 SC5314 Prototrophic clinical isolate Davis et al., 2002 
DAY1066 DAY1 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  arg4::hisG/arg4::hisG 
HHF1/hhf1::URA3-dpl200 
This study 
DAY1067 DAY1 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  arg4::hisG/arg4::hisG  
HHT2-HHF22/hht2-hhf22::URA3-dpl200 
This study 
DAY1068 DAY1066 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  arg4::hisG/arg4::hisG  
HHF1/hhf1::URA3-dpl200  HHT2-HHF22/hht2-hhf22::ARG4 
This study 
DAY1069 DAY1067 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  arg4::hisG/arg4::hisG  
hht2-hhf22::ARG4/hht2-hhf22::URA3-dpl200 
This study 
DAY1070 DAY1068 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  arg4::hisG/arg4::hisG  
HHF1/hhf1::dpl200  HHT2-HHF22/hht2-hhf22::ARG4 
This study 
DAY1071 DAY1069 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  arg4::hisG/arg4::hisG   
hht2-hhf22::ARG4/hht2-hhf22::dpl200 
This study 
DAY1072 DAY1071 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  arg4::hisG/arg4::hisG  
HHF1/hhf1::URA3  hht2-hhf22::ARG4/hht2-hhf22::dpl200 
This study 
DAY1074 DAY1070 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  arg4::hisG/arg4::hisG  
hhf1::URA3/hhf1::dpl200  HHT2-HHF22/hht2-hhf22::ARG4 
This study 
DAY1075 DAY1074 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  arg4::hisG/arg4::hisG  
hhf1::URA3/hhf1::dpl200  HHT2-HHF22/hht2-hhf22::ARG4 
This study 
DAY1076 DAY1070 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  arg4::hisG/arg4::hisG  
hhf1::URA3/hhf1::dpl200  HHT2-HHF22/hht2-hhf22::ARG4 
This study 
DAY1078 DAY1070 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  arg4::hisG/arg4::hisG  
hhf1::URA3/hhf1::dpl200  HHT2-HHF22/hht2-hhf22::ARG4 
This study 
DAY1079 DAY1078 ura3::λimm434/ura3::λimm434  his1::hisG/his1::hisG  arg4::hisG/arg4::hisG  
hhf1::URA3/hhf1::dpl200  HHT2-HHF22/hht2-hhf22::ARG4 
This study 
DAY414 
(L40) 
S. 
cerevisiae 
MAT  his3∆200  trp1-901  leu2-3, 112  ade2 LYS2::(lexAop)4-HIS3  URA3::(lexAop)8-lacZ  
GAL4 
Vojtek et al., 1993 
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Table B.2. Primers used in this study 
Name Sequence (5’to 3’) Reference 
HHF1 5 DR 100 in TAAACGTCACAGAAAGATTTTAAGAGATAACATTCAAGGTATTACAAAACCAGCTATCAGTTTCCC
AGTCACGACGTT 
This study 
HHF1 3 DR new TTAATACTATACAATAAAGAAAACGAACTAAAAAGACAATTAGAAATACAACCCAGTTTAGTGGA
ATTGTGAGCGGATA 
This study 
HHT2-HHF22 5 DR CTTCTAGCTAATTGCATATCTTTCTTTTGAATGGTAACTCTCTTAGCATGGATAGCACACTTTCCCA
GTCACGACGTT 
This study 
HHT2-HHF22 3 DR new TAATCTAAAAATACAGTTATCATGAATCGAAAAACATAAAGAAAAGAAGATATTTCTTTAGTGGA
ATTGTGAGCGGATA 
This study 
HHF1 5 detect TCTTAGTGTAAGGAACCTCC This study 
HHF1 3 detect ACGATTATAAAGGAGAAGGTG This study 
HHT2-HHF22 5 detect AAATGTCCAATACCAGCACC This study 
HHT2-HHF22 3'detect-new CCGAAAATAATTTGCTTGCCTTGCC This study 
HHF1 5' fragm DDB78 ACGACGGCCAGTGAATTGTAATACGACTCACTATAGGGCGGCTCACTCTTAGTGTAAGGAACCTCC This study 
HHF1 5'fragm 3' CTGATAGCTGGTTTTGTAATACC This study 
HHF1 3'fragm 5' ACTGGGTTGTATTTCTAATTGTC This study 
HHF1 3' fragm DDB78 AAGCTCGGAATTAACCCTCACTAAAGGGAACAAAAGCTGGTCTCAGTGAGCTGTTACGAGGC This study 
HHF1 5'fragm 5 CTCACTCTTAGTGTAAGGAACCTCC This study 
HHF1 5'fragm 3' CTCAGTGAGCTGTTACGAGGC This study 
HHF1 5’ 100 in for DDB78 TAAACGTCACAGAAAGATTTTAAGAGATAACATTCAAGGTATTACAAAACCAGCTATCAGGGGCG
AATTGGGGAGCTCCC 
This study 
HHF1 3’ for DDB78 TTAATACTATACAATAAAGAAAACGAACTAAAAAGACAATTAGAAATACAACCCAGTTTACGATA
AGCTTCATCTAGAAGG 
This study 
HHF22 5 SB ACCTTGTATGGTTTCGGTGG This study 
HHF22 3 detect GTTATTCGGTTAGAAAGCGG This study 
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FIGURES 
 
Figure B.1: Genomic organization of the histone H3 and H4 loci in Candida albicans. The black 
boxes indicate the extent of the deleted regions in the mutants, which are replaced by the 
auxotrophic markers ARG4, URA3, URA3-dpl200 or the dpl200 loop-out. HHF1 is deleted from 
nucleotide +114 to the STOP codon (65% of the gene) and the HHF22-HHT2 cluster is deleted 
from the STOP codon of HHF22 to nucleotide +329 of HHT2 (80% of the HHT2 gene). 
Orf19.1060 is a possible spurious ORF. In red, the regions recognized by the probes D and G 
used for determining HHF1 or HHF22 copy dosage by Southern Blot are shown. H: HindIII; N: 
NcoI. 
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Figure B.2: Amino acid sequence alignment of histone H3 and H4 genes. Comparison of the 
amino acid sequences of histone H3 (A) and histone H4 (B) alleles from C. albicans and S. 
cerevisiae using ClustalW. 
 
 294 
Figure B.3: Growth of (A) wild-type (DAY286), HHF22-HHT2/hhf22-hht2∆ (DAY1067), 
hhf22-hht2∆/hhf22-hht2∆ (DAY1069), and hhf22-hht2∆/hhf22-hht2∆ HHF1/hhf1∆ (DAY1072) 
or (B) wild-type (DAY286), HHF1/hhf1∆ (DAY1066), HHF1/hhf1∆ HHF22-HHT2/hhf22-hht2∆ 
(DAY1068), and hhf1∆/hhf1∆ HHF22-HHT2/hhf22-hht2∆ (DAY1074) histone H4 mutants in 
rich medium. All strains were grown overnight at 30ºC in liquid YPD, streaked on YPD, and 
incubated at 30ºC for 48 hrs. 
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Figure B.4: Growth defect and phenotypic instability of mutants containing a single allele of 
histone H4. A small colony of a histone H4 mutant (DAY1072) was re-streaked on YPD medium 
and incubated 4 days at 30ºC (A), close-up picture (B). Re-isolated small (C) and large (C, E) 
colonies of hhf22-hht2∆/∆ HHF1/hhf1∆ (DAY1072), and small (D) and large (D, F) colonies of 
HHF22-HHT2/hhf22-hht2∆ hhf1∆/∆ (DAY1074 and DAY1079) incubated on YPD for 48 hrs at 
30ºC. 
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Figure B.5: Histone deficit causes alterations in colony morphology. Examples of 
morphologically altered colonies that arise in mutants with only one HHF1 (DAY1072) or one 
HHF22 (DAY1079) allele after overnight incubation at 30ºC on YPD (A). Partial penetrance of 
the morphological change in the small colonies (B). Stable morphology of the large smooth 
suppressor colonies after subculturing (C). 
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Figure B.6: Quantitative Southern blot of histone H4 alleles.  DNA samples were obtained from 
30ºC overnight cultures of small and large colonies isolated from (A) hhf22-hht2∆/∆ 
HHF1/hhf1∆ (DAY1072) and (B and C) HHF22-HHT2/hhf22-hht2∆ hhf1∆/∆ (DAY1074, 
DAY1075, DAY1076, DAY1078 and DAY1079). Due to the formation of suppressors, the 
proportion of small to large colonies was verified for each overnight culture by colony count on 
YPD to ensure that the DNA extraction was representative of a small or a large colony 
population. Overnight cultures from small colonies with a minimum of 80% of small colonies 
were used to prepare DNA for the Southern blot. Representative colonies from these plates 
corresponding to different ratios of mutated to wild-type histone H4 ratio are shown (D). Probes 
D and G were used to detect the alleles: hhf1::URA3 and HHF1, and hhf22::ARG4 and HHF22, 
respectively. HHF22-HHT2/hhf22-hht2∆ HHF1/∆ (DAY1070) was used in (B) as a control for a 
1:1 mutated to wild-type HHF22 ratio. 
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Figure B.7: CGH analysis of a hhf22-hht2∆/∆ HHF1/hhf1∆ (DAY1072) small colony (A) and a 
spontaneous large colony suppressor (B). Genomic DNA was purified from both a DAY1072 
small colony and large colony and compared to genomic DNA from SC5314. The DAY1072 
small colony is monosomic for Chromosome 3 while the DAY1072 large colony is trisomic for 
Chromosome 1. Both isolates have a short segmental aneuploidy on Chromosome 5R, which is 
present in the strain background (Magee and Magee, 2000; Selmecki et al., 2005). 
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OPEN QUESTIONS AND SHORT PROJECTS 
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OPEN QUESTIONS 
 
The work presented in this dissertation originates many open questions. Below I provide 
some of them: 
 
1) Does the deregulation of the TOR and Ras/cAMP pathways lead to increased DNA 
damage, genomic instability, LOH, and epigenetic or cell cycle checkpoints defects? 
a. If yes, what is the mechanism through which they do that? Is there a defect 
in Rad53 function in switched isolates? Do the original mutants or the switched 
strains have cell cycle defects? 
b. What is the level of LOH and genomic rearrangements in the switched 
strains? Deep sequencing, together with CGHs, CHEFs, SNP RFLP analysis, and 
microarray analyses of several switched strains would show if there are specific 
genomic or genetic alterations responsible for the switch or for particular 
phenotypes. 
c. Do the switched strains in mutants in the Ras/cAMP and in the TOR 
pathways show similar defects in rapamycin and genotoxic agents resistance than 
the mds3Δ/Δ switched strains? 
2) Is there crosstalk between the TOR and Ras/cAMP pathways in C. albicans? 
3) Is the function of the TOR and Ras/cAMP pathways altered in the switch strains? If 
yes, How? 
a. How do the downstream effectors of TOR and Ras/cAMP pathways behave 
in the switched strains compared to their parental counterparts? This analysis 
should include transcription factors commonly regulated by both pathways, like 
Msn2/4 and Maf1; and other (apparently) TOR-dependent effectors only such as 
Tap42, Rtg1/3, Gln3, Npr1, and Sch9.  
4) Do switched papilli arise due to mutations that suppress defects in the TOR and 
Ras/cAMP pathways? 
5) Is there any correlation between Chromosome 2 aneuploidies and the mechanism of 
suppression? If yes, is Rad53 function associated with Chromosome 2 aneuploidy 
formation? 
6) Is there a fragile site in Chromosome 2, and can we exploit this to further understand 
genomic instability in eukaryotes? 
7) How do glucose starvation, alkaline pH, zinc, and the amino acid composition in the 
media affect CMPS and the function of the TOR and Ras pathways? 
a. Is there any other nutrient becoming limiting during glucose starvation? 
8) Can we monitor alterations in TOR or Ras/cAMP signaling in vivo? And can we 
correlate these alterations with changes in CMPS frequency? 
9) Does CMPS happen in vivo and does it affect the outcome of infection? (Dutton and 
Penn, 1989) (This question is vital to answer if we want to confirm a role for CMPS in 
pathogenesis in C. albicans). 
10) Do the clinical C. albicans isolates that are in high frequency switching mode also have 
defects in TOR or Ras/cAMP signaling? 
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11) Is Mds3 localized in vesicles? Does it interact with Cdc25? What other proteins does 
Mds3 interact with? (since we are able to pull down Mds3, it would be interesting to 
pursue high-throughput immunoprecipitation studies coupled to mass spectrometry to 
detect potential interacting partners). 
12) Is Mds3 a phosphoprotein? If yes: 
a. Is Mds3 phosphorylation TOR- or PKA-dependent?  
b. Is Mds3 a substrate of PKA or TOR?  
c. How does the phosphorylation of Mds3 affect the ability of Mds3 to interact 
with its binding partners? And its localization?  
d. Does an alteration in Mds3 phosphorylation change its ability to regulate 
CMPS? Is this caused by a defect on TOR or Ras/cAMP signaling? 
13) Are the switching systems in other fungi also regulated by these signal transduction 
cascades and/or mechanisms? 
 
SHORT PROJECTS FOR UNDERGRADUATES 
 
1) Is the phenotypic switch associated with changes in centromeric silencing? 
Plate mds3Δ/Δ CEN5/cen5::URA3 and mds3Δ/Δ+MDS3 CEN5/cen5::URA3 strains in YPD. 
Isolate cells from papilli and from the colony where the papilli originated. Compare URA3 
silencing frequency of the mds3Δ/Δ CEN5/cen5::URA3 switched with the non-switched 
counterparts, and with the original mds3Δ/Δ CEN5/cen5::URA3 and the wild-type 
CEN5/cen5::URA3 strains. Get silencing protocol and the wild-type CEN5/cen5::URA3  strain 
from Berman lab. 
 
2) Does Mds3 affect Rad53 function? 
Tag Rad53 in the mds3Δ/Δ mutant with the construct obtained from Richard Bennett’s lab (Alby 
and Bennett, 2009), and compare Rad53 phosphorylation with the wild-type control (also 
obtained from Alby and Benett, 2009), in the presence of different concentrations of MMS and 
rapamycin. Also look at Rad53 in the ras1Δ/Δ mutant, the sit4Δ/Δ mutant, and the TOR1-1 
variant strains.  
Isolate papilli from the mds3Δ/Δ RAD53/RAD53::TAG strain and test Rad53 phosphorylation in 
the same conditions as above. Compare with non-switched parental strains. 
 
3) How common is Chromosome 2 aneuploidy in switched mds3Δ/Δ strains? 
Obtain genomic DNA from different SSY strains and determine by SNP-RFLP whether there are 
Chromosome 2 aneuploidies or LOH events. 
 
4) Is PKA deregulation associated with the switching in the mds3Δ/Δ mutant?  
Get the BCY1 complementation vector from Berman lab and transform SSY strains, test if there is 
a change in colony morphology or in switching frequency. Make sure to include in the 
transformation those strains that have a Chromosome 2 aneuploidy by CGH. Also, put BCY1 
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under the control of a promoter that activates in early or in late stationary phase. Transform the 
mds3Δ/Δ mutant. Verify proper expression of construct by Northern blot or RT-PCR and then 
determine the ability of these strains to form papilli.  
 
5) Is the MTL loci associated with CMPS? And is Mds3 involved in white-opaque 
switching? 
Determine white-opaque and CMPS switching frequencies of the wild-type MTLa/alpha, wild-
type MTLa/a, mds3Δ/Δ MTLa/alpha, and mds3Δ/Δ MTLa/a. Construct an mds3Δ/Δ strain in the 
WO-1 background and determine white-opaque and CMPS switching frequency. 
 
6) Is Mds3 associated with CMPS in other yeasts?  
Look for Mds3 orthologs in C. glabrata and C. neoformans (among other fungi). Make deletion 
or insertion mutants and determine frequencies of phenotypic variation compared to the wild-type 
strains. 
7) Is MDS3 involved in entry in/progression through stationary phase? Does the switch 
affect the ability of cells to enter, survive, and/or exit stationary phase? 
8) Does the nitrogen source in the medium affect CMPS? My preliminary data suggests that 
presence of glutamine (a TOR activator) enhaces CMPS, while presence of proline 
(mimics TOR inactivation) represses it.  
Plate the mds3Δ/Δ mutant in YNB media supplemented with specific nitrogen sources: 
ammonium, proline, glutamine, and glucose or glycerol as carbon sources. Measure papilli 
formation during time. Since the nitrogen source signal should feed through Gln3, determine 
what happens with Gln3 (and Npr1) phosphorylation in the switched strains in the different 
media. 
 
9) Does zinc affect colony morphology? 
Plate the mds3Δ/Δ mutant in YPD with different concentrations of zinc (this is to re-verify my 
preliminary data that high zinc concentration inhibit CMPS in the mds3Δ/Δ mutant). Make a 
strain that overexpresses ZRT2 (or just add one more copy) and delete ZRT2 in a wild-type and 
mds3Δ/Δ background, and determine papilli formation.  
 
10) Does Mds3 physically interact with Cdc25? 
Tag Cdc25 with V5 or Flag. Verify expression by Western Blot. Co-IP Mds3 with Cdc25. Use a 
positive control like a tagged Ras1, for example, to ensure that Cdc25 pull downs are working 
properly. If pull down is successful, determine whether rapamycin treatment, sit4Δ, or growth 
condition (log vs. stationary phase) affect this interaction. 
 
11) Analyze if there is an increase in mutation rate in mds3Δ/Δ colonies as they progress 
through stationary phase, in low glucose, and at different pH. 
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Introduce different markers: lacZ, NAT1, ADE2, GFP, etc into an mds3Δ/Δ and wild-type strain. 
Plate strains and let colonies age on the plate. At different time points, take colonies and assay the 
cells in them for loss of function of the different markers, including gain of function in resistance 
to fluconazole. It would also be useful to analyze different LOH by RFLP. The fluorescent 
marker can aid in visualization by doing flow cytometry. The Berman lab has a high-throughput 
screening system set up (384 strains simultaneously) that could be very useful for an experiment 
like this. 
 
12) Can we observe phenotypic switching in liquid media? 
If YES, then we can use a 96 well system to try many different conditions simultaneously, 
including different mutants, environmental conditions, and supplementation of chemicals that 
inhibit or induce different signaling pathways. 
 
13) Do the mds3Δ/Δ, ras1Δ/Δ, and sch9Δ/Δ mutants have a longer life span than the wild-
type? Are these mutants able to survive longer condition of nutrient limitation? Do they 
produce adaptive regrowth mutants at higher frequency than the wild-type strain during 
liquid growth? How do the switched vs non-switch strains compare in these assays? 
14) Do alkaline pH and glucose starvation affect life span in the wild-type and the mds3Δ/Δ, 
ras1Δ/Δ, sit4Δ/Δ, and sch9-/- strains? 
 
 
